User Image Cart Icon 0 Search Image

Ceramides

  1. Many ceramides
  2. Ceramides and skin function
  3. Chain length-specific properties of Ceramides
  4. Ceramides–lipotoxic inducers of metabolic disorders
  5. Ceramides and depression: A systematic review
  6. Ceramides in the skin barrier
  7. Roles of diacylglycerols and Ceramides in hepatic insulin resistance
  8. Role of Ceramides in nonalcoholic fatty liver disease
  9. The composition of the Ceramides from human stratum corneum and from comedones
  10. Ceramides of pig epidermis: structure determination
  11. Ceramides in insulin resistance and lipotoxicity
  12. Ceramides modulate programmed cell death in plants
  13. Mammalian Lass6 and its related family members regulate synthesis of specific Ceramides
  14. Ceramides as modulators of cellular and whole-body metabolism
  15. Serum sphingomyelins and Ceramides are early predictors of memory impairment
  16. Role of Ceramides in barrier function of healthy and diseased skin
  17. Circulating Ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort
  18. Ceramides and glucosylCeramides are independent antagonists of insulin signaling
  19. Ceramides in the skin lipid membranes: length matters
  20. Relationship between covalently bound Ceramides and transepidermal water loss (TEWL)
  21. Synthesis and degradation pathways, functions, and pathology of Ceramides and epidermal acylCeramides
  22. Quantitative analysis of Ceramides using a novel lipidomics approach with three dimensional response modelling
  23. Ceramides and sphingomyelinases in senile plaques
  24. Plasma Ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance
  25. Long chain Ceramides and very long chain Ceramides have opposite effects on human breast and colon cancer cell growth
  26. Elevated plasma Ceramides in depression
  27. Quantification of stratum corneum Ceramides and lipid envelope Ceramides in the hereditary ichthyoses
  28. Potential applications of phyto-derived Ceramides in improving epidermal barrier function
  29. Hydroxylation of Saccharomyces cerevisiae Ceramides requires Sur2p and Scs7p
  30. Quantitative determination of the neutral glycosyl Ceramides in human blood
  31. Epidermal sphingomyelins are precursors for selected stratum corneum Ceramides
  32. Modulation of cell signalling by Ceramides
  33. CERT mediates intermembrane transfer of various molecular species of Ceramides
  34. Serum Ceramides increase the risk of Alzheimer disease: the Women’s Health and Aging Study II
  35. Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases
  36. Human epidermal glucosylCeramides are major precursors of stratum corneum Ceramides
  37. Decreased level of Ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?
  38. Key role for Ceramides in mediating insulin resistance in human muscle cells
  39. Rapid Transbilayer Movement of Ceramides in Phospholipid Vesicles and inHumanErythrocytes
  40. Link between plasma Ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease
  41. Association of Ceramides in human plasma with risk factors of atherosclerosis
  42. Properties of Ceramides and Their Impact on the Stratum Corneum Structure: A Review: Part 1: Ceramides
  43. FTIR spectroscopy studies of the conformational order and phase behavior of Ceramides
  44. Intercellular and intracellular functions of Ceramides and their metabolites in skin
  45. Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope
  46. The structure, function, and importance of Ceramides in skin and their use as therapeutic agents in skin-care products
  47. Skeletal muscle triglycerides, diacylglycerols, and Ceramides in insulin resistance: another paradox in endurance-trained athletes?
  48. Apoptosis in skeletal muscle myotubes is induced by Ceramides and is positively related to insulin resistance
  49. Ceramides as Natural Moisturizing Factors
  50. Ceramides and mitochondrial fatty acid oxidation in obesity
  51. Plasma Ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
  52. Biophysics (and sociology) of Ceramides.
  53. The chemistry, function and (patho) physiology of stratum corneum barrier Ceramides
  54. Ceramides in the pathophysiology of the anterior segment of the eye
  55. Molecular arrangements of sphingolipids. The monolayer behaviour of Ceramides
  56. Hepatic Ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
  57. Phase behavior of lipid mixtures based on human Ceramides: coexistence of crystalline and liquid phases
  58. Scalable synthesis of human ultralong chain Ceramides
  59. Different effects of enzyme-generated Ceramides and diacylglycerols in phospholipid membrane fusion and leakage
  60. Synthesis and structure-activity relationships of skin Ceramides
  61. Characterization and quantification of Ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls
  62. On Ceramides, other sphingolipids and impaired glucose homeostasis
  63. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance
  64. Plasma Ceramides are elevated in female children and adolescents with type 2 diabetes
  65. Ceramides in Alzheimer’s Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation
  66. Plasma Ceramides, Mediterranean diet, and incident cardiovascular disease in the PREDIMED trial (Prevención con Dieta Mediterránea)
  67. Short-chain Ceramides decrease skin barrier properties
  68. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise
  69. Ceramides in a patient with lipogranulomatosis (Farber’s disease) with chronic course
  70. Characterization of Plasma Membrane Ceramides by Super‐Resolution Microscopy
  71. Development and validation of a high-throughput LC–MS/MS assay for routine measurement of molecular Ceramides
  72. Plasma Ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss
  73. Glycosphingolipids and Ceramides in human and pig epidermis
  74. Increase in short-chain Ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients [S]
  75. Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of Ceramides, PKC-α, and JNK
  76. Recent advances in the glycosylation of sphingosines and Ceramides
  77. Cerebrospinal fluid Ceramides from patients with multiple sclerosis impair neuronal bioenergetics
  78. Profiling of human stratum corneum Ceramides by means of normal phase LC/APCI–MS
  79. Evidence that accumulation of Ceramides and cholesterol esters mediates oxidative stress–induced death of motor neurons in amyotrophic lateral sclerosis
  80. Profiling and characterizing skin Ceramides using reversed-phase liquid chromatography–quadrupole time-of-flight mass spectrometry
  81. A rabidopsis mutants of sphingolipid fatty acid α‐hydroxylases accumulate Ceramides and salicylates
  82. Ethnicity and stratum corneum Ceramides
  83. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics …
  84. Determination of Ceramides and diglycerides by the diglyceride kinase assay
  85. Ceramides and barrier function in healthy skin
  86. Nicotinamide increases biosynthesis of Ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier
  87. Current methods for the identification and quantitation of Ceramides: an overview
  88. Long chain Ceramides activate protein phosphatase-1 and protein phosphatase-2A: activation is stereospecific and regulated by phosphatidic acid
  89. Production of Ceramides causes apoptosis during early neural differentiation in vitro
  90. Importance of the sphingoid base length for the membrane properties of Ceramides
  91. Biophysics of sphingolipids I. Membrane properties of sphingosine, Ceramides and other simple sphingolipids
  92. Adipocyte Ceramides regulate subcutaneous adipose browning, inflammation, and metabolism
  93. Efficacy of nutritional interventions to lower circulating Ceramides in young adults: FRUVEDomic pilot study
  94. Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and Ceramides
  95. A novel enzyme that catalyzes the esterification of N-acetylsphingosine: metabolism of C2-Ceramides
  96. The ART of lowering Ceramides
  97. Molecular associations and surface-active properties of short-and long-N-acyl chain Ceramides
  98. Isolation of new Ceramides from the gorgonian Acabaria undulata
  99. Ceramides: A new player in the inflammation–insulin resistance paradigm?
  100. The phase behaviour of skin lipid mixtures based on synthetic Ceramides
  101. Conformational characterization of Ceramides by nuclear magnetic resonance spectroscopy
  102. Quantitative study of stratum corneum Ceramides contents in patients with sensitive skin
  103. A novel endoglycoceramidase hydrolyzes oligogalactosylCeramides to produce galactooligosaccharides and Ceramides
  104. Physical properties of Ceramides: effect of fatty acid hydroxylation.
  105. Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of Ceramides
  106. Progress in the analysis of stratum corneum Ceramides
  107. Effect of pioglitazone on plasma Ceramides in adults with metabolic syndrome
  108. The role of Ceramides 1 and 2 in the stratum corneum lipid organisation
  109. Asymmetric addition of Ceramides but not dihydroCeramides promotes transbilayer (flip-flop) lipid motion in membranes
  110. Apoptotic sphingolipid signaling by Ceramides in lung endothelial cells
  111. Phase behavior of stratum corneum lipid mixtures based on human Ceramides: the role of natural and synthetic Ceramide 1
  112. Association between plasma Ceramides and phosphatidylcholines and hippocampal brain volume in late onset Alzheimer’s disease
  113. The equilibrium between long and very long chain Ceramides is important for the fate of the cell and can be influenced by co-expression of CerS
  114. Quantitation and molecular species determination of diacylglycerols, phosphatidylcholines, Ceramides, and sphingomyelins with gas chromatography
  115. Novel lipid mixtures based on synthetic Ceramides reproduce the unique stratum corneum lipid organization
  116. Increased apoptosis in cancer cells in vitro and in vivo by Ceramides in transferrin-modified liposomes
  117. The path to insulin resistance: paved with Ceramides?
  118. Biophysical properties of sphingosine, Ceramides and other simple sphingolipids
  119. Enzymatic formation of hydroxy Ceramides and comparison with enzymes forming nonhydroxy Ceramides
  120. Isolation and characterization of poly (glycosyl) Ceramides (megaloglycolipids) with A, H and I blood‐group activities
  121. Interferon-γ decreases Ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis
  122. Optical control of lipid rafts with photoswitchable Ceramides
  123. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and Ceramides
  124. A role for Ceramides, but not sphingomyelins, as antagonists of insulin signaling and mitochondrial metabolism in C2C12 myotubes
  125. Ceramides and cardiac function in children with chronic kidney disease
  126. Incorporation studies of clickable Ceramides in Jurkat cell plasma membranes
  127. Evaluation of skin-moisturizing effects of oral or percutaneous use of plant Ceramides
  128. Effects of cell-permeable Ceramides and tumor necrosis factor-α on insulin signaling and glucose uptake in 3T3-L1 adipocytes
  129. The human skin barrier is organized as stacked bilayers of fully extended Ceramides with cholesterol molecules associated with the Ceramide sphingoid …
  130. Ceramides–Friend or Foe in Hypoxia?
  131. Lipid mixtures prepared with well-defined synthetic Ceramides closely mimic the unique stratum corneum lipid phase behavior
  132. Induction of membrane Ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression
  133. Unsaturation of Very-Long-Chain Ceramides Protects Plant from Hypoxia-Induced Damages by Modulating Ethylene Signaling in Arabidopsis
  134. CWH43 is required for the introduction of Ceramides into GPI anchors in Saccharomyces cerevisiae
  135. Keratinocyte differentiation is induced by cell-permeant Ceramides and its proliferation is promoted by sphingosine
  136. Very long chain Ceramides interfere with C16-Ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis
  137. Basic nanostructure of stratum corneum lipid matrices based on Ceramides [EOS] and [AP]: a neutron diffraction study
  138. PAQRs: a counteracting force to Ceramides?
  139. The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of Ceramides in Candida albicans
  140. Infrared spectroscopic study of stratum corneum model membranes prepared from human Ceramides, cholesterol, and fatty acids
  141. , Accumulation of specific Ceramides in ischemic/reperfused rat heart; effect of ischemic preconditioning
  142. Ceramides induce programmed cell death in Arabidopsis cells in a calcium-dependent manner
  143. Enzymatic synthesis of Gb3 and iGb3 Ceramides
  144. AT2 receptor stimulation induces generation of Ceramides in PC12W cells
  145. Membrane microdomains: role of Ceramides in the maintenance of their structure and functions
  146. Depletion of Ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice
  147. A convenient procedure for the synthesis of Ceramides
  148. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in Ceramides and sphingomyelin
  149. Triangulated mal-signaling in Alzheimer’s disease: roles of neurotoxic Ceramides, ER stress, and insulin resistance reviewed
  150. Gangliosides and Ceramides change in a mouse model of blast induced traumatic brain injury
  151. A look at epidermal barrier function in atopic dermatitis: physiologic lipid replacement and the role of Ceramides.
  152. On-tissue localization of Ceramides and other sphingolipids by MALDI mass spectrometry imaging
  153. Characterization of Ceramides by low energy collisional-activated dissociation tandem mass spectrometry with negative-ion electrospray ionization
  154. Intramyocellular Ceramides: subcellular concentrations and fractional de novo synthesis in postabsorptive humans
  155. A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular Ceramides in …
  156. Total synthesis of globotriaosyl-E and Z-Ceramides and isoglobotriaosyl-E-Ceramide
  157. A facile synthesis of Ceramides
  158. The association between plasma Ceramides and sphingomyelins and risk of Alzheimer’s disease differs by sex and APOE in the Baltimore Longitudinal Study of Aging
  159. Characterization of glycosyl inositol phosphoryl Ceramides from plants and fungi by mass spectrometry
  160. Comparative investigation of human stratum corneum Ceramides
  161. Ethanol‐induced changes in the content of triglycerides, Ceramides, and glucosylCeramides in cultured neurons
  162. GIPC: Glycosyl Inositol Phospho Ceramides, the major sphingolipids on earth
  163. Lipid bilayers containing sphingomyelins and Ceramides of varying N-acyl lengths: a glimpse into sphingolipid complexity
  164. Molecular interactions of penetration enhancers within Ceramides organization: a FTIR approach
  165. Complete structural characterization of Ceramides as [M− H]− ions by multiple-stage linear ion trap mass spectrometry
  166. Sodium lauryl sulfate (SLS) induced irritant contact dermatitis: a correlation study between Ceramides and in vivo parameters of irritation
  167. Choline kinase inhibition induces the increase in Ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of …
  168. Saccharomyces cerevisiae CWH43 Is Involved in the Remodeling of the Lipid Moiety of GPI Anchors to Ceramides
  169. Plasma Ceramides are elevated in overweight Holstein dairy cows experiencing greater lipolysis and insulin resistance during the transition from late …
  170. Cell-permeable Ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts.
  171. Associations between plasma Ceramides and cognitive and neuropsychiatric manifestations in Parkinson’s disease dementia
  172. Scanning electron microscopy study on nanoemulsions and solid lipid nanoparticles containing high amounts of Ceramides
  173. Phytosphingosine, sphingosine and dihydrosphingosine Ceramides in model skin lipid membranes: permeability and biophysics
  174. Properties of Ceramides and their impact on the stratum corneum structure: part 2: stratum corneum lipid model systems
  175. Liquid chromatography–tandem mass spectrometric determination of Ceramides and related lipid species in cellular extracts
  176. Different effects of long-and short-chain Ceramides on the gel-fluid and lamellar-hexagonal transitions of phospholipids: a calorimetric, NMR, and x-ray …
  177. Different phase behavior and packing of Ceramides with long (C16) and very long (C24) acyls in model membranes: infrared spectroscopy using deuterated lipids
  178. Ceramides: a potential therapeutic target in pulmonary emphysema
  179. Structural studies on Ceramides as lithiated adducts by low energy collisional-activated dissociation tandem mass spectrometry with electrospray ionization
  180. Interaction of Ceramides with phosphatidylcholine, sphingomyelin and sphingomyelin/cholesterol bilayers
  181. Endurance and resistance training affect high fat diet-induced increase of Ceramides, inflammasome expression, and systemic inflammation in mice
  182. Thin-layer chromatography of Ceramides
  183. Thermal dependence of Raman descriptors of Ceramides. Part I: effect of double bonds in hydrocarbon chains
  184. Liposome-encapsulated ursolic acid increases Ceramides and collagen in human skin cells
  185. Interaction of Ceramides, Sphingosine, and Sphingosine 1-Phosphate in Regulating DNA Synthesis and Phospholipase D Activity (∗)
  186. Structure determination of Ceramides and neutral glycosphingolipids by collisional activation of [M + Li]+ ions
  187. Regional analysis of Ceramides within the stratum corneum in relation to seasonal changes
  188. Bacterial Ceramides and sphingophospholipids induce apoptosis of human leukaemic cells
  189. Novel Ceramides recovered from Porphyromonas gingivalis: relationship to adult periodontitis
  190. Ceramides stimulate caspase‐14 expression in human keratinocytes
  191. Structure-specific collision-induced fragmentations of Ceramides cationized with alkali-metal ions
  192. Lipid remodeling leads to the introduction and exchange of defined Ceramides on GPI proteins in the ER and Golgi of Saccharomyces cerevisiae
  193. A phase II study of topical Ceramides for cutaneous breast cancer
  194. Permeability and microstructure of model stratum corneum lipid membranes containing Ceramides with long (C16) and very long (C24) acyl chains
  195. The impact of Ceramides NP and AP on the nanostructure of stratum corneum lipid bilayer. Part I: neutron diffraction and 2H NMR studies on multilamellar models …
  196. Ceramides and cytotoxic constituents from Ficus glumosa Del.(Moraceae)
  197. Separation and mass spectrometric characterization of covalently bound skin Ceramides using LC/APCI-MS and Nano-ESI-MS/MS
  198. Inflammatory cells, Ceramides, and expression of proteases in perivascular adipose tissue adjacent to human abdominal aortic aneurysms
  199. Ceramides from the fungus Phellinus pini
  200. Characterization of the Ceramide moieties of sphingoglycolipids from mouse brain by ESI-MS/MS: identification of Ceramides containing sphingadienine
  201. Synthesis of Ceramides using N-hydroxysuccinimide esters
  202. Occurrence of Free Ceramides in Bacteroides fragilis NCTC 9343
  203. Infrared determination of conformational order and phase behavior in Ceramides and stratum corneum models
  204. Biological activity of Ceramides and other sphingolipids
  205. Use of Ceramides and related products for childhood-onset eczema
  206. Fenretinide differentially modulates the levels of long-and very long-chain Ceramides by downregulating Cers5 enzyme: evidence from bench to bedside
  207. New Ceramides and isoflavone from the Egyptian Iris germanica L. rhizomes
  208. Role of Ceramides 2 and 5 in the structure of the stratum corneum lipid barrier
  209. Mitochondrially targeted Ceramides preferentially promote autophagy, retard cell growth, and induce apoptosis
  210. Synthetic phytoCeramides induce apoptosis with higher potency than Ceramides
  211. Lipid organization in human and porcine stratum corneum differs widely, while lipid mixtures with porcine Ceramides model human stratum corneum lipid …
  212. Influence of hydroxylation, chain length, and chain unsaturation on bilayer properties of Ceramides
  213. AFM study of lipid monolayers: III. Phase behavior of Ceramides, cholesterol and fatty acids
  214. Sphingolipids and Ceramides in human aqueous humor
  215. Separation and identification of Ceramides derived from human plasma sphingomyelins
  216. Ceramides mediate cigarette smoke-induced metabolic disruption in mice
  217. Plasma Ceramides and neuropsychiatric symptoms of Alzheimer’s disease
  218. Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and Ceramides: variations in metabolic …
  219. Liquid chromatography–electrospray mass spectrometry and tandem mass spectrometry of Ceramides
  220. Disruption and destabilization of meibomian lipid films caused by increasing amounts of Ceramides and cholesterol
  221. Synthesis of C18-and C20-dihydrosphingosines, ketodihydrosphingosines, and Ceramides by microsomal preparations from mouse brain
  222. Isolation and Structure of Three New Ceramides from the Starfish Acanthaster planci
  223. The long-chain sphingoid base of Ceramides determines their propensity for lateral segregation
  224. Infrared spectroscopy studies of mixtures prepared with synthetic Ceramides varying in head group architecture: coexistence of liquid and crystalline phases
  225. Gas-liquid chromatography-mass spectrometry of synthetic Ceramides
  226. Very long-chain polyunsaturated fatty acids are the major acyl groups of sphingomyelins and Ceramides in the head of mammalian spermatozoa
  227. Lipid droplet remodelling and reduced muscle Ceramides following sprint interval and moderate-intensity continuous exercise training in obese males
  228. Two Novel Ceramides with a Phytosphingolipid and a Tertiary Amide Structure from Zephyranthes candida
  229. Gender-dependent accumulation of Ceramides in the cerebral cortex of the APPSL/PS1Ki mouse model of Alzheimer’s disease
  230. On-line solid-phase extraction of Ceramides from yeast with Ceramide III imprinted monolith
  231. High performance liquid chromatography of Ceramides: application to analysis in human tissues and demonstration of Ceramide excess in Farber’s disease
  232. CFTR regulation of intracellular pH and Ceramides is required for lung endothelial cell apoptosis
  233. Tumor necrosis factor‐α and Ceramides in insulin resistance
  234. Ceramides and sphingomyelins with high proportions of very long-chain polyunsaturated fatty acids in mammalian germ cells
  235. Novel synthesis of α-galactosyl-Ceramides and confirmation of their powerful NKT cell agonist activity
  236. Novel Ceramides from the Fungus Lactarium volemus
  237. Optimization of submerged keratinocyte cultures for the synthesis of barrier Ceramides
  238. Nerve growth factor and Ceramides modulate cell death in the early developing inner ear
  239. Some Peroxysterols and Ceramides from
  240. Occurrence of Ceramides and neutral glycolipids with unusual long-chain base composition in purified rat liver mitochondria
  241. Ceramides and Cerebrosides from Ligusticum chuanxiong Hort.
  242. Ceramides perturb the structure of phosphatidylcholine bilayers and modulate the activity of phospholipase A2
  243. Labeling Golgi with fluorescent Ceramides
  244. Uneven distribution of Ceramides, sphingomyelins and glycerophospholipids between heads and tails of rat spermatozoa
  245. Molecular species of Ceramides from the ascomycete truffle Tuber indicum
  246. … and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain Ceramides
  247. Ceramides of human normal and cataractous lens
  248. Ceramides with a pentadecasphingosine chain and short acyls have strong permeabilization effects on skin and model lipid membranes
  249. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding Ceramides
  250. Staphylococcus aureus α-toxin induces inflammatory cytokines via lysosomal acid sphingomyelinase and Ceramides
  251. Eczema and Ceramides: an update
  252. Protective effects of fish oil on pre-diabetes: A lipidomic analysis of liver Ceramides in rats
  253. Biochemistry of the sphingolipids: XII. conversion of cerebrosides to Ceramides and sphingosine; structure of Gaucher cerebroside
  254. Isolation and identification of human hair Ceramides
  255. Validation of an in vivo extraction method for human stratum corneum Ceramides
  256. Apoptosis induced by Rac GTPase correlates with induction of FasL and Ceramides production
  257. Activity and structure elucidation of Ceramides
  258. Extraction and analysis of Ceramides from internal wool lipids
  259. Cell-permeable Ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and RhoA
  260. Singlet oxygen-induced attenuation of growth factor signaling: possible role of Ceramides
  261. Thermal dependence of Raman descriptors of Ceramides. Part II: effect of chains lengths and head group structures
  262. Novel Ceramides and a new glucoCeramide from the roots of Incarvillea arguta
  263. Ceramides and the Skin
  264. Tailoring structure–function and targeting properties of Ceramides by site-specific cationization
  265. Structural studies on Ceramides by electrospray tandem mass spectrometry
  266. Liposomal ursolic acid (merotaine) increases Ceramides and collagen in human skin
  267. Sex Pheromones of the Hair Crab Erimacrus isenbeckii. II. Synthesis of Ceramides
  268. Hydration effects on the barrier function of stratum corneum lipids: Raman analysis of Ceramides 2, III and 5
  269. Controlled penetration of Ceramides into and across the stratum corneum using various types of microemulsions and formulation associated toxicity studies
  270. Structure of stratum corneum lipids characterized by FT-Raman spectroscopy and DSC. II. Mixtures of Ceramides and saturated fatty acids
  271. New Ceramides from Rantherium suaveolens
  272. Involvement of VDAC, Bax and Ceramides in the efflux of AIF from mitochondria during curcumin-induced apoptosis
  273. Useful syntheses of erythro-and threo-N-oleoyl-D-sphingosines (Ceramides) and galactosylCeramides (cerebrosides) from L-serine
  274. B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of Ceramides
  275. Solid character of membrane Ceramides: a surface rheology study of their mixtures with sphingomyelin
  276. A novel mechanism for improvement of dry skin by dietary milk phospholipids: Effect on epidermal covalently bound Ceramides and skin inflammation in hairless mice
  277. Ceramides modulate cell-surface acetylcholine receptor levels
  278. Pituitary adenylate cyclase-activating polypeptide prevents the effects of Ceramides on migration, neurite outgrowth, and cytoskeleton remodeling
  279. Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of Ceramides
  280. Bioactives of Artemisia dracunculus L. Mitigate the Role of Ceramides in Attenuating Insulin Signaling in Rat Skeletal Muscle Cells
  281. A lipidomic platform establishment for structural identification of skin Ceramides with non-hydroxyacyl chains
  282. Identification of Ceramides in human cells using liquid chromatography with detection by atmospheric pressure chemical ionization‐mass spectrometry
  283. Analysis of derivatized Ceramides and neutral glycosphingolipids by high-performance tandem mass spectrometry
  284. Separation, identification and quantitation of Ceramides in human cancer cells by liquid chromatography–electrospray ionization tandem mass spectrometry
  285. Comparative investigation of sphingoid bases and fatty acids in Ceramides and sphingomyelins from human ovarian malignant tumors and normal ovary.
  286. Influence of different Ceramides on the structure of in vitro model lipid systems of the stratum corneum lipid matrix
  287. A Novel Enzyme That Cleaves the N-Acyl Linkage of Ceramides in Various Glycosphingolipids as Well as Sphingomyelin to Produce Their Lyso Forms (∗)
  288. Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA
  289. Stratum Corneum Ceramides and Their Role
  290. Ceramides are involved in the regulation of food intake in rainbow trout (Oncorhynchus mykiss)
  291. Circulating Ceramides are inversely associated with cardiorespiratory fitness in participants aged 54–96 years from the Baltimore Longitudinal Study of Aging
  292. Immunosuppressive diacetylenes, Ceramides and cerebrosides from Hydrocotyle leucocephala
  293. Disruption of lipid order by short-chain Ceramides correlates with inhibition of phospholipase D and downstream signaling by FcϵRI
  294. Atypical surface behavior of Ceramides with nonhydroxy and 2-hydroxy very long-chain (C28–C32) PUFAs
  295. Changes in Ceramides and glucosylCeramides in mouse skin and human epidermal equivalents by rice-derived glucosylCeramide
  296. Fruiting of Schizophyllum commune Induced by Certain Ceramides and Cerebrosides from Penicillium funiculosum
  297. Efficacy of a cream containing Ceramides and magnesium in the treatment of mild to moderate atopic dermatitis: a randomized, double-blind, emollient-and …
  298. Novel roles for Ceramides, calpains and caspases in kidney proximal tubule cell apoptosis: lessons from in vitro cadmium toxicity studies
  299. Potential application of oat-derived Ceramides in improving skin barrier function: Part 1. Isolation and structural characterization
  300. Structure of stratum corneum lipids characterized by FT-Raman spectroscopy and DSC. I. Ceramides
  301. New Ceramides from Acnistus arborescens
  302. Investigation of the molecular structure of the human stratum corneum Ceramides [NP] and [EOS] by mass spectrometry
  303. Ceramides as key players in cellular stress response
  304. Cytotoxic Ceramides and glycerides from the roots of Livistona chinensis
  305. Ceramides increase the activity of the secretory phospholipase A2 and alter its fatty acid specificity
  306. Increasing Ceramides sensitizes genistein-induced melanoma cell apoptosis and growth inhibition
  307. Total synthesis of the mollu-series glycosyl Ceramides α-d-Manp-(1→ 3)-β-d-Manp-(1→ 4)-β-d-Glcp-(1→ 1)-Cer and α-d-Manp-(1→ 3)-[β-d-Xylp-(1→ 2)]-β-d-Manp-(1 …
  308. A novel synthetic route to α-galactosyl Ceramides and iGb3 using DTBS-directed α-selective galactosylation
  309. Ceramides and cerebrosides
  310. Structure of stratum corneum lipids characterized by FT-Raman spectroscopy and DSC. III. Mixtures of Ceramides and cholesterol
  311. Intramyocellular Ceramides and skeletal muscle mitochondrial respiration are partially regulated by Toll-like receptor 4 during hindlimb unloading
  312. Age‐related remodeling of small arteries is accompanied by increased sphingomyelinase activity and accumulation of long‐chain Ceramides
  313. Synthetic Ceramides induce growth arrest or apoptosis by altering cellular redox status
  314. Phase properties of mixtures of Ceramides
  315. Detailed structure of sphingomyelins and Ceramides from different regions of bovine kidney with special reference to long-chain bases
  316. Ceramides modulate protein kinase C activity and perturb the structure of phosphatidylcholine/phosphatidylserine bilayers
  317. Ceramides are transported through the Golgi apparatus in human keratinocytes in vitro
  318. Plasma Ceramides target skeletal muscle in type 2 diabetes
  319. Stratum corneum Ceramides: function, origins, and therapeutic applications
  320. Structures of the Ceramides from porcine palatal stratum corneum
  321. Nanogram scale absolute configurational assignment of Ceramides by circular dichroism
  322. Comparison of the metabolism of L-erythro-and L-threo-sphinganines and Ceramides in cultured cells and in subcellular fractions
  323. Asymmetry determines the effects of natural Ceramides on model membranes
  324. Analysis of Ceramides in cosmetics by reversed‐phase liquid chromatography/electrospray ionization mass spectrometry with collision‐induced dissociation
  325. Synthesis of Ceramides NS and NP with perdeuterated and specifically ω deuterated N‐acyl residues
  326. Production of rare phyto-Ceramides from abundant food plant residues
  327. Reduced cardiovascular risk after bariatric surgery is linked to plasma Ceramides, apolipoprotein-B100, and ApoB100/A1 ratio
  328. Above-normal urinary excretion of urinary Ceramides in Farber’s disease, and characterization of their components by high-performance liquid chromatography
  329. New Ceramides from the flower of Albizia julibrissin
  330. … the formation of the protein and lipid domains of the stratum corneum: Role of fatty acids, oxysterols, cholesterol sulfate, and Ceramides as signaling molecules
  331. Antiepileptic Ceramides from the Red Sea Sponge Negombata corticata
  332. Investigations on the effects of a topical Ceramides-containing emulsion (allerderm spot on) on clinical signs and skin barrier function in dogs with topic dermatitis: a …
  333. Ceramides are associated with inflammatory processes in human mediastinal adipose tissue
  334. Solid lipid nanoparticles and nanoemulsions containing Ceramides: Preparation and physicochemical characterization
  335. Accessibility of galactosyl Ceramides to probe reagents in central nervous system myelin
  336. Identification and quantitation of free Ceramides in human platelets
  337. Triumfettamide and Triumfettoside Ic, Two Ceramides and Other Secondary Metabolites from the Stems of Wild Triumfetta cordifolia A. Rich. (Tiliaceae)
  338. Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH Ceramides during keratinocyte differentiation
  339. Concentrations of glycosyl Ceramides in plasma and red cells in Fabry’s disease, a glycolipid lipidosis
  340. Analysis of free and protein-bound Ceramides by tape stripping of stratum corneum from dogs
  341. Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study
  342. Synthesis of cerebroside B1b with antiulcerogenic activity I. Synthesis of Ceramides with optically active α-hydroxypalmitic acids.
  343. Surfactant-induced depletion of Ceramides and other intercellular lipids: implication for the mechanism leading to dehydration of the stratum corneum
  344. Molecular analysis of a novel family of complex glycoinositolphosphoryl Ceramides from Cryptococcus neoformans: structural differences between encapsulated and …
  345. New advances on the functions of epidermal growth factor receptor and Ceramides in skin cell differentiation, disorders and cancers
  346. Transduction to self-assembly of molecular geometry and local interactions in mixtures of Ceramides and ganglioside GM1
  347. Ceramides from the spongeDysidea etheria
  348. Association between plasmatic Ceramides profile and AST/ALT ratio: C14: 0 Ceramide as predictor of hepatic steatosis in adolescents independently of obesity
  349. … of topical synthetic pseudoCeramides: comparison of possible keratinocyte toxicities provoked by the pseudoCeramides, PC104 and BIO391, and natural Ceramides
  350. Schistosoma mansoni: human skin Ceramides are a chemical cue for host recognition of cercariae
  351. Structures of New Ceramides from the Fruit Bodies of Grifola frondasa
  352. Transient relaxation of rat mesenteric microvessels by Ceramides
  353. Glycosylphosphatidylinositol membrane anchors in Saccharomyces cerevisiae: absence of Ceramides from complete precursor glycolipids.
  354. Synthesis of fluorescent C24-Ceramide: evidence for acyl chain length dependent differences in penetration of exogenous NBD-Ceramides into human skin
  355. Ceramides as possible nutraceutical compounds: characterization of the Ceramides of the Moro blood orange (Citrus sinensis)
  356. Effect of hypothyreosis on the content of Ceramides in rat tissues
  357. Molecular interactions of penetration enhancers within Ceramides organization: a Raman spectroscopy approach
  358. Effects of α-and β-Galactosylated C2-Ceramides on the Immune System
  359. Role of intracellular lipid logistics in the preferential usage of very long chain-Ceramides in glucosylCeramide
  360. Topical emulsions containing Ceramides: Effects on the skin barrier function and anti‐inflammatory properties
  361. Lipid metabolic changes caused by short-chain Ceramides and the connection with apoptosis
  362. Glycolipids from sponges. IV. Immunomodulating glycosyl Ceramides from the marine sponge agelas dispar.
  363. GlucosylCeramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous Ceramides: consequences to morphology …
  364. Concentration and composition of free Ceramides in human plasma
  365. Spontaneous membrane fusion induced by chemical formation of Ceramides in a lipid bilayer
  366. … in marine microalgae: Development and application of a mass spectrometric method for global structural characterization of Ceramides and glycosphingolipids in …
  367. Structure of stratum corneum lipids characterized by FT-Raman spectroscopy and DSC. IV. Mixtures of Ceramides and oleic acid
  368. Ceramides inhibit phospholipase D-dependent insulin signaling in liver cells of old rats
  369. Ceramides from Urtica dioica roots
  370. Fatty acid composition of free Ceramides of kidney and cerebellum from a patient with Farber’s disease
  371. Association of plasma Ceramides and sphingomyelin with VLDL apoB-100 fractional catabolic rate before and after rosuvastatin treatment
  372. Growth-dependent regulation of cellular Ceramides in human T-cells
  373. Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and Ceramides in mice
  374. Identification and quantitative determination of Ceramides in human plasma
  375. Ceramides, cerebrosides, and related long chains containing derivatives from the medicinal plants of Africa
  376. Syntheses and interfacial behaviour of neoglycolipid analogues of glycosyl Ceramides
  377. Synthesis of D-ribo-and L-lyxo-phytosphingosine: Transformation into the corresponding lactosyl-Ceramides
  378. Shear and compression rheology of Langmuir monolayers of natural Ceramides: solid character and plasticity
  379. The separation and direct detection of Ceramides and sphingoid bases by normal-phase high-performance liquid chromatography and evaporative light-scattering …
  380. Separation and analysis of free Ceramides containing 2-hydroxy fatty acids in Sphingobacterium species
  381. Gas-liquid chromatography-mass spectrometry of synthetic Ceramides containing phytosphingosine
  382. Isolation and structure of four new Ceramides from the starfish Luidia maculata
  383. Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages
  384. NeritinaCeramides A–E, New Ceramides from the Marine Bryozoan Bugula neritina Inhabiting South China Sea and Their Cytotoxicity
  385. The hydrophobic mismatch determines the miscibility of Ceramides in lipid monolayers
  386. Two Ceramides from Tanacetum artemesioides
  387. PalyosulfonoCeramides A and B: Unique Sulfonylated Ceramides from the Brazilian Zoanthids Palythoa caribaeorum and Protopalyhtoa variabilis
  388. 6-Hydroxy-4-sphingenine in human epidermal Ceramides.
  389. Profile and quantification of human stratum corneum Ceramides by normal-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass …
  390. Biased distribution of the branched‐chain fatty acids in Ceramides of vernix caseosa
  391. Short-chain Ceramides depress integrin cell surface expression and function in colorectal cancer cells
  392. Local rhamnosoft, Ceramides and L‐isoleucine in atopic eczema: a randomized, placebo controlled trial
  393. Supercritical fluid extraction to obtain Ceramides from wool fibers
  394. Distinct pathways for tumor necrosis factor alpha and Ceramides in human cytomegalovirus infection
  395. The role of Ceramides in selected brain pathologies: ischemia/hypoxia, Alzheimer disease
  396. Strepsiamide AC, New Ceramides from the Marine Sponge Strepsichordaia Lendenfeldi
  397. CalyCeramides A–C: neuraminidase inhibitory sulfated Ceramides from the marine sponge Discodermia calyx
  398. Mass Spectrometric Characterization of Ceramides: Derived from Brain Cerebrosides
  399. Formation of an ordered phase by Ceramides and diacylglycerols in a fluid phosphatidylcholine bilayer—correlation with structure and hydrogen bonding …
  400. Imaging mass spectrometry visualizes Ceramides and the pathogenesis of dorfman-chanarin syndrome due to Ceramide metabolic abnormality in the skin
  401. Contribution to liquid chromatographic analysis of cutaneous Ceramides
  402. Cytotoxic Ceramides from the Red Sea sponge Spheciospongia vagabunda
  403. Gas phase analytical separation and structural study of Ceramides
  404. Ceramides And Stress Signalling Intersect With Autophagic Defects In Neurodegenerative Drosophila blue cheese (bchs) Mutants
  405. Synthesis of Ceramides and cerebrosides containing both alpha-hydroxy and nonhydroxy fatty acids from lignoceroyl-CoA by rat brain microsomes.
  406. Two new Ceramides from the stems of Piper betle L.
  407. In vivo metabolism of Ceramides in rat brain. Fatty acid replacement and esterification of Ceramide.
  408. Biosynthesis of sphingomyelin from Eryrtro-Ceramides and phosphatidylcholine by a microsomal cholinephosphotransferase
  409. Biophysical properties of novel 1-deoxy-(dihydro) Ceramides occurring in mammalian cells
  410. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of Ceramide synthases and viral lytic gene expression
  411. Qualitative on-line profiling of Ceramides and cerebrosides by high performance liquid chromatography coupled with electrospray ionization ion trap tandem mass …
  412. Dermatophagoides farinae house dust mite allergen challenges reduce stratum corneum Ceramides in an experimental dog model of acute atopic dermatitis
  413. Structural analysis of commercial Ceramides by gas chromatography–mass spectrometry
  414. Concise syntheses of immunostimulating glycolipids, α-galactosyl Ceramides
  415. Anti-choline esterase activity of Ceramides from the Red Sea marine sponge Mycale euplectellioides
  416. Gas–liquid chromatography–mass spectrometry of synthetic Ceramides containing 2-hydroxy acids
  417. Profiling of human stratum corneum Ceramides by liquid chromatography–electrospray mass spectrometry
  418. Structure and blood-group I activity of poly (glycosyl)-Ceramides
  419. N-Oleoylethanolamine inhibits glucosylation of natural Ceramides in CHP-100 neuroepithelioma cells: possible implications for apoptosis
  420. Influence of phytosphingosine-type Ceramides on the structure of DMPC membrane
  421. Soft coral Cespitularia stolonifera: New cytotoxic Ceramides and gastroprotective activity
  422. Isolation and Characterization of New Ceramides from Aerial Parts of Lepidaploa cotoneaster
  423. Ceramides and cerebrosides from the marine bryozoan Bugula neritina inhabiting South China Sea
  424. Incorporation of 13-hydroxyoctadecadienoic acid (13-HODE) into epidermal Ceramides and phospholipids: phospholipase C-catalyzed release of novel 13-HODE …
  425. Short-chain Ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable Ceramides.
  426. Limonoid compounds inhibit sphingomyelin biosynthesis by preventing CERT protein-dependent extraction of Ceramides from the endoplasmic reticulum
  427. Short chain Ceramides as substrates for glucocerebroside synthetase. Differences between liver and brain enzymes
  428. Two new Ceramides from the fruit pulp of Acanthopanax senticosus (Rupr. et Maxim) Harms
  429. Two new Ceramides from Zephyranthes candida
  430. Ceramides extracted from wool: pilot plant solvent extraction
  431. Sphingolipids and Ceramides of mouse aqueous humor: Comparative profiles from normotensive and hypertensive DBA/2J mice
  432. Two new Ceramides from the radix of Angelica sinensis
  433. Cholesteryl phosphocholine–a study on its interactions with Ceramides and other membrane lipids
  434. Inhibition of human neutrophil elastase by wheat Ceramides
  435. Cell-permeable Ceramides act as novel regulators of U937 cell–cell adhesion mediated by CD29, CD98, and CD147
  436. Retention behaviour of Ceramides in sub-critical fluid chromatography in comparison with non-aqueous reversed-phase liquid chromatography
  437. Fatty acid composition of cerebrosides, sulphatides and Ceramides in murine sudanophilic leucodystrophy: the Jimpy mutant
  438. Quantitation of yeast Ceramides using high-performance liquid chromatography–evaporative light-scattering detection
  439. Fatty acid composition of cerebrosides, sulphatides and Ceramides in murine leucodystrophy: the quaking mutant
  440. Isolation, structural determination and cytotoxic activity of two new Ceramides from the root of Isatis indigotica
  441. Ceramides with 2-hydroxylated, very long-chain polyenoic fatty acids in rodents: From testis to fertilization-competent spermatozoa
  442. Nano-LC–MS/MS for the quantitation of Ceramides in mice cerebrospinal fluid using minimal sample volume
  443. Stannyl Ceramides as efficient acceptors for synthesising β-galactosyl Ceramides
  444. The impact of ultraviolet therapy on stratum corneum Ceramides and barrier function
  445. Chemical and apoptotic properties of hydroxy-Ceramides containing long-chain bases with unusual alkyl chain lengths
  446. Change in liver and plasma Ceramides during d-galactosamine-induced acute hepatic injury by LC–MS/MS
  447. Effects of topical corticosteroid and tacrolimus on Ceramides and irritancy to sodium lauryl sulphate in healthy skin
  448. Ceramides Isolated from Helianthus annuus L.
  449. Surface behavior of sphingomyelins with very long chain polyunsaturated fatty acids and effects of their conversion to Ceramides
  450. Enzymatic synthesis of Ceramides and hybrid Ceramides
  451. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain Ceramides
  452. Ceramides from the Taiwan Red Alga Ceratodictyon Spongiosum and Symbiotic Sponge Sigmadocia Symbiotica
  453. Mesophase formation by Ceramides and cholesterol: a model for stratum corneum lipid packing?
  454. Gas-Chromatographie Analysis of Permethylated Ceramides
  455. Another two novel Ceramides from Zephyranthes candida
  456. Spontaneous interbilayer transfer of hexosyl Ceramides between phospholipid bilayers
  457. Studies on the Structure and I‐Blood‐Group Activity of Poly (glycosyl) Ceramides
  458. Signal transduction leading to appressorium formation in germinating conidia of Magnaporthe grisea: effects of second messengers diacylglycerols, Ceramides and …
  459. Microanalytical systems for separations of stratum corneum Ceramides
  460. Commitment to apoptosis by Ceramides depends on mitochondrial respiratory function, cytochrome c release and caspase-3 activation in Hep-G2 cells
  461. Novel Ceramides from aerial parts of Saussurea involucrata Kar. et. Kir.
  462. Lipidomic platform for structural identification of skin Ceramides with α-hydroxyacyl chains
  463. Lipase-catalyzed enantiomeric resolution of Ceramides
  464. New Ceramides from the hypotensive extract of a sea anemone, Paracondylactis indicus
  465. Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis.
  466. N-Diphenylmethylene-protected glycosyl acceptors. Selective β-O-glycosylation to form lactosyl-threo-Ceramides
  467. Increasing effect of Ceramides in skin by topical application of sphingosine
  468. Longifoamide-A and B: Two new Ceramides from Mentha longifolia (Lamiaceae)
  469. Ceramide synthase 4 and de novo production of Ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 β-cells
  470. New Nortriterpenoid and Ceramides From Stems and Leaves of Cultivated Triumfetta cordifolia A Rich (Tiliaceae)
  471. Molecular Species of Free Ceramides in Aspergillus oryzae
  472. Analysis of sphingosine 1-phosphate, Ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry
  473. A new twist to the emerging functions of Ceramides in cancer: novel role for platelet acid sphingomyelinase in cancer metastasis
  474. Continuous lipase-catalyzed production of pseudo-Ceramides in a packed-bed bioreactor
  475. Structure–retention diagrams of Ceramides established for their identification
  476. Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain Ceramides, and its down-regulation inhibits both cell proliferation and apoptosis
  477. Distribution and metabolism of fluorescent sphingosines and corresponding Ceramides bearing the diphenylhexatrienyl (DPH) fluorophore in cultured human …
  478. New Ceramides from Platytaenia multicaule
  479. Isolation, structure elucidation, total synthesis, and evaluation of new natural and synthetic Ceramides on human SK-MEL-1 melanoma cells
  480. Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on cutaneous Ceramides, in a human skin organ culture model
  481. Two New Ceramides from the Marine Sponge Ircinia fasciculata
  482. Metabolic conversion of Ceramides in HeLa cells-a cholesteryl phosphocholine delivery approach
  483. cis- versus trans-Ceramides: Effects of the Double Bond on Conformation and H-Bonding Interactions
  484. Iotrochotamides I and II: New Ceramides from the Indonesian sponge Iotrochota purpurea
  485. Activation of de Novo Synthetic Pathway of Ceramides is Responsible for the Initiation of Hydrogen Peroxide–induced Apoptosis in HI-60 Cells
  486. Synthesis and biological activity of α-l-fucosyl Ceramides, analogues of the potent agonist, α-d-galactosyl Ceramide KRN7000
  487. Increase in secretory sphingomyelinase activity and specific Ceramides in the aorta of apolipoprotein E knockout mice during aging
  488. Differential effects of Ceramides upon adenylyl cyclase subtypes
  489. Effect of different concentrations of collagen, Ceramides, N-acetyl glucosamine, or their mixture on enhancing the proliferation of keratinocytes, fibroblasts and the …
  490. New Ceramides from the sponge Cinachyra cavernosa
  491. New tetracyclic diterpenoid and new Ceramides from the soft coral Sinularia conferta
  492. Interactions of PACAP and Ceramides in the control of granule cell apoptosis during cerebellar development
  493. Galactosyl Ceramides of the myelin sheath: thermal studies
  494. Characterization of a complex mixture of Ceramides by fast atom bombardment and precursor and fragment analysis tandem mass spectrometry
  495. Ceramides from wool wax
  496. Ceramides and cerebrosides from Bugula neritina
  497. Synthesis of unique Ceramides and cerebrosides occurring in human epidermis
  498. Simultaneous quantitation of Ceramides and 1, 2‐diacylglycerol in tissues by latroscan thin‐layer chromatography‐flame‐ionization detection
  499. Increase of Ceramides and its inhibition by catalase during chemically induced apoptosis of HL-60 cells determined by electrospray ionization tandem mass …
  500. Normal-phase liquid chromatographic separation of stratum corneum Ceramides with detection by evaporative light scattering and atmospheric pressure chemical …
  501. Identification and initial characterizations of free, glycosylated, and phosphorylated Ceramides of Paramecium
  502. Separation of molecular species of Ceramides as benzoyl andp‐nitrobenzoyl derivatives by high performance liquid chromatography
  503. Novel myelin penta-and hexa-acetyl-galactosyl-Ceramides: structural characterization and immunoreactivity in cerebrospinal fluid [S]
  504. The influence of carbon source on the level and composition of Ceramides of the Candida lipolytica yeast
  505. Analysis of commercial Ceramides by non-aqueous reversed-phase liquid chromatography with evaporative light-scattering detection
  506. Divergent fate of unsaturated and saturated Ceramides and sphingomyelins in rat liver and cells in culture
  507. Interferon-beta increases plasma Ceramides of specific chain length in multiple sclerosis patients, unlike fingolimod or natalizumab
  508. Glycolipids from sponges, III. Glycosyl Ceramides from the marine sponge Agelas conifera
  509. A glucosylCeramide with a novel Ceramide and three novel Ceramides from the basidiomycete Cortinarius umidicola
  510. Separation and identification of Ceramides in the human stratum corneum by high-performance liquid chromatography coupled with electrospray ionization mass …
  511. … cells lacking all known Ceramide synthases continue to make complex sphingolipids and to incorporate Ceramides into glycosylphosphatidylinositol (GPI) …
  512. Randomized, double‐blinded, placebo‐controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, Ceramides and 18‐beta …
  513. Synthesis of a Versatile Building Block for the Preparation of 6-N-Derivatized α-Galactosyl Ceramides: Rapid Access to Biologically Active Glycolipids
  514. Pore formation in and enlargement of phospholipid liposomes by synthetic models of Ceramides and sphingomyelin
  515. A simple method for the synthesis of Ceramides and radiolabeled analogues
  516. Exogenous and endogenous Ceramides elicit volume-sensitive chloride current in ventricular myocytes
  517. N-Acyl migration in Ceramides
  518. Thermotropic behavior of Ceramides and their isolation from wool
  519. Cell-permeable Ceramides increase basal glucose incorporation into triacylglycerols but decrease the stimulation by insulin in 3T3-L1 adipocytes
  520. Photouncaging of Ceramides promotes reorganization of liquid-ordered domains in supported lipid bilayers
  521. Effect of Ceramides on phospholipid biosynthesis and its implication for apoptosis
  522. Interaction of the verotoxin 1B subunit with soluble aminodeoxy analogues of globotriaosyl Ceramides
  523. New Ceramides from sea sponge Oceanapia sp.
  524. Novel free Ceramides as components of the soldier defense gland of the Formosan subterranean termite (Coptotermes formosanus)
  525. Effects of oral intake of gromwell water fraction on Ceramides content and the development of atopic dermatitis in NC/Nga mice
  526. In situ synthesis of fluorescent membrane lipids (Ceramides) using click chemistry
  527. Galactofuranosylated galactocerebrosides, a new drug delivery system for Ceramides to colon
  528. Ceramides and adhesive molecules in stable ischaemic heart disease
  529. Effects of dietary cholesterol on tissue Ceramides and oxidation products of apolipoprotein B-100 in ApoE-deficient mice
  530. Modulation of T-lymphocyte proliferation by exogenous natural Ceramides and sphingosylphosphorylcholine
  531. Ceramides from the roots of {\sl Serratula chinensis}
  532. Hand eczema and stratum corneum Ceramides
  533. Subcellular distribution and metabolic fate of exogenous Ceramides taken up by HL-60 cells
  534. New Ceramides from the sponges of gulf of Mannar
  535. Reverse Phase High‐Performance Liquid Chromatography of Cerebrosides, Sulfatides and Ceramides: Microanalysis of Homolog Composition Without Hydrolysis …
  536. Combined gas chromatography-chemical ionization mass spectrometry of sphingolipids. I. Glucosyl sphingosine, Ceramides and cerebrosides of the spleen in …
  537. … effect of thrombin on the organization of human platelet membrane glycosphingolipids. The sphingosine composition of platelet glycolipids and Ceramides.
  538. Applications of boronate derivatives in the study of Ceramides by gas-liquid chromatography-mass spectrometry
  539. Moving lipids: Ceramides, glycosphingolipids and the glycolipid transfer protein
  540. Alteration of the 4-sphingenine scaffolds of Ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function
  541. Use of principal component analysis for investigation of factors affecting retention behaviour of Ceramides on porous graphitized carbon column
  542. Influence of the level of Ceramides on the permeability of stratum corneum lipid liposomes caused by a C12-betaine/sodium dodecyl sulfate mixture
  543. Brain Glucosyl Ceramides Containing 2‐Hydroxy Acids: Identification of Molecular Species by Gas‐Liquid Chromatography—Mass Spectrometry
  544. A new route to racemic erythro-sphingosine and Ceramides. The 1, 2-versus 1, 4-addition reaction of hexadec-2-enal with 2-nitroethanol
  545. Quantities and types of Ceramides and their relationships to physical properties of the horn covering the claws of clinically normal cows and cows with …
  546. Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum Ceramides
  547. Dynamics of the heat stress response of Ceramides with different fatty-acyl chain lengths in baker’s yeast
  548. Ceramides predict CV death in stable CAD and ACS
  549. Structural characteristics of the Ceramides of neutral glycosphingolipids in the human female genital tract—their menstrual cycle-associated change in the cervical …
  550. Three new Ceramides from the sponge Spongia suriganensis
  551. Free Ceramides of Echinococcus multilocularis metacestodes
  552. Thermal degradation of Ceramides as studied by mass spectrometry and vibrational spectroscopy
  553. Separation and characterization of hematosides with different sialic acids and Ceramides from rat small intestine. Different composition of epithelial cells versus non …
  554. Analysis of skeletal muscle torque capacity and circulating Ceramides in patients with advanced heart failure
  555. Multicenter clinical study to evaluate safety and clinical efficacy of a body moisturizer based on Ceramides, omegas, glycerin, Imperata cylindrica, erythritol, and …
  556. Development and validation of LC-MS/MS method for determination of very long acyl chain (C22: 0 and C24: 0) Ceramides in human plasma
  557. Ceramides, sphinganine, sphingosine and acid sphingomyelinases in the human umbilical cord blood
  558. Evidence for a high activity of sphingomyelin biosynthesis by phosphocholine transfer from phosphatidylcholine to Ceramides in lung lamellar bodies
  559. Incorporation of Ceramides into Saccharomyces cerevisiae Glycosylphosphatidylinositol-Anchored Proteins Can Be Monitored In Vitro
  560. Structural identification of skin Ceramides containing ω-hydroxy acyl chains using mass spectrometry
  561. … with up to ten sugars by gas chromatography and gas chromatography-mass spectrometry as permethylated oligosaccharides and Ceramides released by Ceramide …
  562. New Ceramides from the marine sponge Clathria fasciculate
  563. Sex pheromones of the hair crab Erimacrus isenbeckii. Part 1: Isolation and structures of novel Ceramides
  564. Flow injection tandem mass spectrometric measurement of Ceramides of multiple chain lengths in biological samples
  565. Cationic Ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors
  566. Ceramides extracted from wool: supercritical extraction processes
  567. Induction of a hardening phenomenon and quantitative changes of Ceramides in stratum corneum
  568. Diminished protein‐bound ω‐hydroxylated Ceramides in the skin of patients with ichthyosis with 12R‐lipoxygenase (LOX) or eLOX‐3 deficiency
  569. Ceramides and glycosphingolipids in maturation process: leukemic cells as an experimental model
  570. Oceanapins A–F, Unique Branched Ceramides Isolated from the Haplosclerid Sponge Oceanapia cf. tenuis of the Coral Sea
  571. Cystic fibrosis: the conductance regulator, Ceramides, and possible treatments
  572. Isolation and structure determination of three new Ceramides from the starfish Distolasterias nipon
  573. A secondary assay for Ceramide kinase inhibitors based on cell growth inhibition by short-chain Ceramides
  574. PACAP and Ceramides exert opposite effects on migration, neurite outgrowth, and cytoskeleton remodeling
  575. Highly Sensitive Determination of Diverse Ceramides in Human Hair Using Reversed-Phase High-Performance Liquid Chromatography–Electrospray Ionization Mass …
  576. Properties of skin in Chinese infants: developmental changes in Ceramides and in protein secondary structure of the stratum corneum
  577. Evidence of accumulation of Ceramides containing [14C] nervonic acid in the rat lung following injection of [14C] erucic acid
  578. Complete 1H and 13C NMR assignment of mono-sulfated galactosylCeramides with four types of Ceramides from human kidney
  579. Syntheses of sphingomyelins and Ceramides bearing a docosahexaenoyl or arachidonoyl group
  580. New CD1d agonists: synthesis and biological activity of 6 ″-triazole-substituted α-galactosyl Ceramides
  581. First asymmetric synthesis of 6-hydroxy-4-sphingenine-containing Ceramides. Use of chiral propargylic alcohols to prepare a lipid found in human skin
  582. Regulation of Cytochrome P450 2C11 (CYP2C11) Gene Expression by Interleukin-1, Sphingomyelin Hydrolysis, and Ceramides in Rat Hepatocytes (∗)
  583. SAFETY EVALUATION OF PHYTOSPHINGOSINE ANO Ceramides OF PHARMACEUTICAL GRADE
  584. Skin Efficacy of liposomes composed of internal wool lipids rich in Ceramides
  585. Influence of the level of Ceramides in the permeability of stratum corneum lipid liposomes caused by sodium dodecyl sulfate
  586. … comparison to progenitor platelets, microparticles are deficient in GpIb, GpIb-derived carbohydrates, glycerophospholipids, glycosphingolipids, and Ceramides
  587. Synthesis of New Trans Double-Bond Sphingolipid Analogues:  Δ4,6 and Δ6 Ceramides
  588. Anti‐tumor activity of Ceramides and glycosphingolipids in a murine tumor system
  589. Ceramides that mediate apoptosis reduce glucose uptake and transporter affinity for glucose in human leukaemic cell lines but not in neutrophils
  590. Flexible, polymer-supported synthesis of sphingosine derivatives provides Ceramides with enhanced biological activity
  591. Stratum corneum and nail lipids in patients with atopic dermatitis. Decrease in Ceramides–a pathogenetic factor in atopic xerosis?
  592. Stereoselective synthesis of fluorinated and nonfluorinated triazolo analogues of Ceramides
  593. Cell-permeable Ceramides preferentially inhibit coated vesicle formation and exocytosis in Chinese hamster ovary compared with Madin–Darby canine kidney cells by …
  594. Molecular association of phytosphingosine Ceramides of type III as investigated by synchrotron X-ray: Part 1
  595. The effect of gromwell (Lithospermum erythrorhizon) extract on the stratum corneum hydration and Ceramides content in atopic dermatitis patients
  596. Studies on the biosynthesis of Ceramide. Does the reversed ceramidase reaction yield Ceramides?
  597. Melicimides A and B: Two new Ceramides from stem bark of Melicia excelsa
  598. A solvent-free approach to glycosyl amides: toward the synthesis of α-N-galactosyl Ceramides
  599. Selective reduction in α‐hydroxypalmitic acid‐containing sphingomyelin and concurrent increase in hydroxylated Ceramides in murine skin tumors induced by an …
  600. Enzymatic glucosylation of dolichol monophosphate and transfer of glucose from isolated dolichyl‐D‐glucosyl phosphate to Ceramides by BHK‐21 cell microsemes
  601. ROLE OF EPIDERMAL Ceramides IN BARRIER FUNCTION
  602. Ceramides/cholesterol mixtures as characterized by FT Raman spectroscopy
  603. Quantitative determination of the neutral glycosyl Ceramides in bovine thyroid gland
  604. Liposome formation with wool lipid extracts rich in Ceramides
  605. CETP inhibitory activity of Ceramides, isolated from the gorgonian Acabaria undulata
  606. In vitro anti‐inflammatory and skin protective properties of extract comprising Ceramides from de‐oiled rice bran
  607. Successful incorporation of pseudo-Ceramides into emulsions at effective concentrations
  608. Long-term biopermanence of Ceramides, cholesteryl esters, and ether-linked triglycerides with very-long-chain PUFA in the cadmium-damaged testis
  609. Effects of expression of lcb1/lcb2 and lac1/lag1 genes on the biosynthesis of Ceramides
  610. Inhibition of phosphatidylcholine and phosphatidylethanolamine biosynthesis in rat‐2 fibroblasts by cell‐permeable Ceramides
  611. Enzymatic deoxyglucosylation of Ceramides by microsomes of BHK-21 cells: The effect of deoxyglucose treatment and herpesvirus infection
  612. Conversion of short-chain Ceramides to short-chain Ceramide GM3 in B16 melanoma cells
  613. Three Ceramides from gorgonian Echinogorgia sp
  614. Antiproliferative activity of Ceramides isolated from normal human ovary and ovarian tumor.
  615. Synthesis of Ceramides and cerebrosides in rat brain: comparison with synthesis of lignoceroyl-coenzyme A
  616. Analysis of molecular species of cellular sphingomyelins and Ceramides
  617. Quantitation of Ceramides in nude mouse skin by normal-phase liquid chromatography and atmospheric pressure chemical ionization mass spectrometry
  618. Improvement of evaporative light scattering detection of Ceramides using triethylamine and formic acid in non-aqueous reversed phase liquid chromatography
  619. A comparison of trabecular meshwork sphingolipids and Ceramides of ocular normotensive and hypertensive states of DBA/2J mice
  620. Sphingomyelins and Ceramides with VLCPUFAs are excluded from low-density raft-like domains in differentiating spermatogenic cells
  621. Synthesis and biological activity of α-glucosyl C24: 0 and C20: 2 Ceramides
  622. Synthesis and Absolute Configuration of 6‐Hydroxylated New Ceramides in Human Skin, Ceramides B, 4, 7 and 8
  623. In vivo studies on the introduction of the 4-t-double bond of the sphingenine moiety of rat brain Ceramides
  624. Ceramides: Branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency
  625. Identification of the individual molecular species of Ceramides derived from human erythrocytes using HPLC/MS and HPLC/MS/MS
  626. A study of Ceramides and related compounds.
  627. Immunochemical study of the blood group-active poly (glycosyl) Ceramides isolated from human erythrocytes
  628. … new procedure for synthesis of 3-keto derivatives of sphingolipids and its application for study of fatty acid composition of brain Ceramides and cerebrosides containing …
  629. Conversion by rat brain preparation of lignoceric acid to Ceramides and cerebrosides containing both alpha-hydroxy and nonhydroxy fatty acids. Effects of compounds …
  630. Studies on Selectin Blockers. 4. Structure− Function Relationships of Sulfated Sialyl Lewis X Hexasaccharide Ceramides toward E-, P-, and L-Selectin Binding
  631. 6-Acyl galactosyl Ceramides of pig brain: structure and fatty acid composition
  632. Synthesis and photochemical properties of PEGylated coumarin-caged Ceramides for cell studies
  633. Differential roles of 2, 6, and 8 carbon Ceramides on the modulation of gap junctional communication and apoptosis during carcinogenesis
  634. Plasma Ceramides are elevated in depression
  635. Covalently bound fatty acids and Ceramides in wool
  636. Sphingolipid metabolic changes during chiral C2-Ceramides induced apoptosis in human leukemia cells
  637. Synergy between vitamin D precursor 25-hydroxyvitamin D and short chain Ceramides on keratinocyte proliferation and differentiation.
  638. Bcl-2 transfected HaCaT keratinocytes resist apoptotic signals of Ceramides, tumor necrosis factor α and 1α,25-dihydroxyvitamin D3
  639. Ceramides and gangliosides in benign and malignant human ovarian tumors
  640. Ceramides and mitochondrial fatty acid oxidation in obesity
  641. Dietary sericin enhances epidermal levels of glucosylCeramides and Ceramides with up-regulating protein expressions of glucosylCeramide synthase, β …
  642. The identification of Ceramides and glyceryl ethers in unsaponifiable lipid of human aorta
  643. Isokinetic torque timing parameters and Ceramides as markers of muscle dysfunction in systolic heart failure
  644. Human ovarian Ceramides and gangliosides in aging
  645. Effect of growth phase on the content and composition of Ceramides of the hydrocarbon-assimilating yeast Candida lipolytica
  646. Synthesis and Growth Inhibitory Activity of Chiral 5-Hydroxy-2-N-Acyl-(3E)-Sphingenines:  Ceramides with an Unusual Sphingoid Backbone
  647. Cytotoxic Ceramides from Antipathes dichotoma
  648. Constituents of Crinoidea, 4. Isolation and structure of Ceramides and glucocerebrosides from the feather star Comanthus japonica
  649. Role of Ceramides in skin stress: ultraviolet light, tape stripping and crowding
  650. Influence of Ceramides in the solubilization of stratum corneum lipid liposomes by C12-betaine/sodium dodecyl sulfate mixtures
  651. Ceramides increase mitochondrial ROS generation via altered mitochondrial dynamics in skeletal muscle
  652. Ceramides induce apoptosis in HeLa cells and enhance cytochrome c-induced apoptosis in Xenopus egg extracts
  653. Plasma Ceramides independently predict coronary artery disease and major adverse cardiovascular events
  654. EFFECTS OF DIETARY ROYAL JELLY ON EPIDERMAL GENERATION OF Ceramides FROM ACIDIC SPHINGOMYELIN AND GLUCOSYLCeramides IN UV …
  655. Characterization of a complexe mixture of phytosphingosine-type Ceramides from the Tunisian Reaumuria vermiculata
  656. [16] Synthesis of ganglioside GM3 and analogs containing modified sialic acids and Ceramides
  657. Synthesis of Enantiopure Fluorinated Ceramides; Analogues of Natural Sphingolipids
  658. Topical Ceramides neither enhance UVB‐induced apoptosis in normal human keratinocytes nor affect viability in UVB‐irradiated reconstructed human epidermis
  659. Ceramides for liposomes
  660. … on the Thioglycosides of N-Acetylneuraminic Acid 7: Synthesis of S-(α-Sialyl)-(2↠ 6)-β-D-Hexopyranosyl and-(2↠ 6)-β-D-Lactosyl Ceramides and their Biological …
  661. On the biosynthesis of cerebrosides from 2-hydroxy acid Ceramides: use of deuterium labeled substrate and multiple ion detector
  662. Influence of short chain Ceramides and lipophilic penetration enhancers on the nano-structure of stratum corneum model membranes studied using neutron diffraction
  663. Ceramides and lipids
  664. Rapid access to 6 ″-functionalized α-galactosyl Ceramides by using 2-naphthylmethyl ether as the permanent protecting group
  665. Analysis of Ceramides in Soy Sauce Oil
  666. Specific distribution of barrier-relevant Ceramides in the emerging epidermis and the periderm/subperiderm during chicken embryogenesis
  667. Improvement of skin moisture capacity through dietary beauty supplement containing Ceramides derived from rice
  668. De novo Ceramides synthesis is not involved in skeletal muscle atrophy induced by short-term mechanical unloading
  669. … METHODS FOR THE SIMULTANEOUS SEPARATION OF FREE DIACYLGLYCEROL SPECIES FROM Ceramides CONTAINING PHYTO-SPHINGOSINE AND …
  670. Identification of the in vivo topically applied” human-identical” Ceramides included in negatively charged liposomes.
  671. Influence of the level of Ceramides on the permeability of stratum corneum lipid liposomes caused by a C14-alkyl betaine/sodium dodecyl sulfate mixture
  672. Total Synthesis of (2S,3S,4R)-N-Tetracosanoyl-2-amino-1,3,4-octadecanetriol, a Ceramide Part of Wheat Flour Glycosyl Ceramides
  673. Synthesis of Ceramides Bearing DL-erythro-and DL-threo-Cn-Dihydrosphingosines, and the Determination of the erythro and threo Isomers by Mass Spectrometry
  674. DPPG liposomes as preferential vehicles for” human-identical” Ceramides
  675. Gromwell (Lithospermum erythrorhizon) Supplementation Enhances Epidermal Levels of Ceramides, GlucosylCeramides, β-Glucocerebrosidase, and Acidic …
  676. LC Separation of Fatty Acid Ceramides Using a Two Column System
  677. Thermotropic Properties of Ceramides in Aqueous or Lipidic Environments
  678. Sphingolipids of Euhadra hickonis. III. Ceramides of the Viscera
  679. Alterations in stratum corneum lipid liposomes due to the action of Triton X-100: influence of the level of Ceramides on this process
  680. Saturated Ceramides from the Sponge Dysidea Robusta
  681. Unraveling the Ceramide-calpain-caspase connection in cadmium-induced apoptosis: a novel role for Ceramides as activators of calpains. Focus on “ …
  682. Synthesis of 1-O-(N-Acetyl-α-and-β-D-Neuraminyl)-Ceramides
  683. C6-Ceramide enhances phagocytic activity of Kupffer cells through the production of endogenous Ceramides
  684. Effects of Ceramides on meibomian lipid layers in vitro
  685. Smart textiles with slow-release Ceramides for sensitive skin
  686. … sphingolipids by gas chromatography-chemical ionization mass spectrometry of their derived aldehydes with particular reference to the Ceramides of children’s plasma
  687. [43] Preparation of radiolabeled Ceramides and phosphosphingolipids
  688. Radiation-induced free-radical fragmentation of Ceramides in a model system
  689. … kinase C and tyrosine kinases in mediating endothelin-1-stimulated phospholipase D activity in rat myometrium: differential inhibition by Ceramides and cyclic AMP
  690. Mn2+ and Mg2+ improved sphingomyelinase production by Lactobacillus rhamnosus FTDC 8313 and binding affinity to sphingomyelin for generation of Ceramides
  691. Membrane properties of structurally modified Ceramides: effects on lipid lateral distribution and sphingomyelin-interactions in artificial bilayer membranes
  692. Stratum corneum Ceramides and free amino acids in the lesion of scaly hand eczema
  693. Developing CHARMM-compatible lipid parameters for Ceramides and united atom chains
  694. Physico-chemical properties and metabolism of lissamine-rhodamine Ceramides: effect of acyl chain length
  695. Changes in the neutral glycosyl Ceramides of duck erythrocytes during infection with the avian malaria parasite, PlasmodiumLophurae
  696. The levels of glycosphingolipids, Ceramides, sialic acid and glycogen are changed in plasma membranes of rat platelets harvested during recovery from immune …
  697. Separation and detection of Ceramides by HPLC followed by evaporative light-scattering detection and thin layer chromatography
  698. Solubilization of stratum corneum lipid liposomes by C14-betaine/sodium dodecyl sulfate mixtures. Influence of the level of Ceramides in the solubilization process
  699. 11 The Lipid Organization in Stratum Corneum and Model Systems Based on Ceramides
  700. THE SYNTHESIS, PHYSICAL PROPERTY, AND THE BIOLOGICAL ACTIVITY OF NOVEL NEO-Ceramides
  701. Ceramides and glucosylCeramides are independent antagonists of insulin action
  702. … Thioglycosides of N-Acetyl-Neuraminic Acid 8: Synthesis of S-(α-Sialyl)-(2→ 6)-β-Hexopyranosyl and -(2→ 6′)-β-Lactosyl Ceramides Containing β-Thioglycosidically …
  703. … sudden cardiac death difficult to prevent and treat: Potential roles of unrecognized ionized hypomagnesemia and release of Ceramides and platelet-activating …
  704. The Relationship Between Very Long Chain Plasma Ceramides and Anxiety in Coronary Artery Disease
  705. Farber bodies found in murine phagocytes after injection of Ceramides and related sphingolipids
  706. The Role of Ceramides in Mediating Endotoxin-Induced Mitochondrial Disruption
  707. Ceramides and gangliosides from bening and malignant tumors of human ovary
  708. Ceramides in Alzheimer’s disease: key mediators of neuronal apoptosis induced by oxidative stress and A accumulation
  709. Role of cell-permeant Ceramides in keratinocyte growth, differentiation and apoptosis.
  710. Activation of UDP-galactose: globotriaosylCeramide. alpha. 1-3-galactosyltransferase during PC12D cell differentiation induced by galactosyl Ceramides
  711. Changes in the physicochemical properties of transferrin upon chemical derivatization with Ceramides
  712. Type 2 diabetes: Ceramides as a therapeutic target?
  713. Novel Ceramides of Porphyromonas Gingivalis Recovered in Human Carotid Endarterectomy Samples
  714. Preparation of Alexa Fluor 350-conjugated nonradioactive or 3H-labeled GM1 ganglioside derivatives with different Ceramides
  715. Reduction of long-chain fatty acid Ceramides in dermatitis caused by repeated exposure to house-dust mite in NC/Nga mice
  716. Ceramides Dissociate Steatosis and Insulin Resistance in the Human Liver in Non-Alcoholic Fatty Liver Disease
  717. Detection and significance of free Ceramides
  718. The structure of sphingolipid long chain bases from Ceramides of the anaerobe genus Bacteroides
  719. Dietary royal jelly improves epidermal hydration with increased levels of Ceramides in the epidermis of mid-aged healthy human subjects
  720. Many Ceramides
  721. Analysis and clinical significance of free Ceramides
  722. Perturbed sphingomyelin metabolism and accumulation of Ceramides and cholesterol esters in Alzheimer’s disease and ALS
  723. Identification of four new Ceramides from Anthopleura pacifica
  724. Methods of analysis of Ceramides and their relation to milk products
  725. Identification of individual molecular species of Ceramides derived from human erythrocytes by high? performance liquid chromatography/mass spectrometry and …
  726. Tumor Necrosis Factor-α, Sphingomyelinase and Ceramides Activate Tyrosine Kinase, P21ras and Phosphatidylinositol 3-Kinase: Implications for Glucose Transport …
  727. … be due to reversible constriction of cerebral blood vessels: potential roles of unrecognized ionized hypomagnesemia, and release of Ceramides and platelet-activating …
  728. Comment: Serum Ceramides—A new biomarker for preclinical AD?
  729. Studies in the Sphingolipids Series. XIII. On the Ceramides and Ceramide Esters of C20-Phytosphingosine and Cio-Phytosphingosine Anhydro Base of Yeast
  730. Identification and quantitation of Ceramides in yeast {\sl Yarrowia lipolitica}
  731. Comparative contents of plant Ceramides in agricultural products analyzed by HPLC
  732. Evaluating the Relationship between Ceramides and Depressive Symptoms in Coronary Artery Disease Patients
  733. Fenretinide increased Ceramides through progressive de novo synthesis and inhibition of sphingomyelin synthesis in a neuroblastoma cell line
  734. Synthesis of diene Ceramides with organozirconium reagents
  735. Ceramides of the psoriatic scale: fatty acids composition
  736. Use of Plasma Ceramides to Predict Major Adverse Cardiovascular Events-A Community-Based Analysis
  737. Attachment of Helicobacter pylori to MonohexosylCeramide with Various Ceramides
  738. Safety Assessment of Ceramides as Used in Cosmetics
  739. The Propensity of Ceramides to Segregate into Ceramides-Rich Phase in Fluid Phosphatidylcholine Bilayer is Markedly Influenced by their Long-Chain …
  740. Growth Inhibitory Effects and Mechanisms of Ceramides in Renal Cell Carcinoma Cells
  741. Ceramides and sphingosine-1-phosphate in molecular mechanisms of neuronal cell death
  742. Cream-gel with Ceramides (part II): An evaluation of the effects on skin hydration and transepidermal water loss
  743. The role of Ceramides in the mitochondrial apoptotic pathway induced by acetic acid
  744. Analysis of Ceramides in Body Fluids by Electrospray LC-MS/MS
  745. The role of Ceramides in cigarette smoke-induced alveolar cell death
  746. Roles of omega-hydroxyacid-containing Ceramides in stratum corneum
  747. Asymmetry Determines the Effect of Ceramides on Model Membranes. In Natural Membranes Too?
  748. Effects of enzyme-generated diacylglycerols and Ceramides in membrane fusion and leakage.
  749. Ceramides in Alzheimer’s Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and A𝛽 Accumulation
  750. Coumarinyl-Caged Ceramides, a New Tool for Assessing the Biological Effects of Ceramide in Cells
  751. Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial
  752. Plasma Ceramides identify residual cardiovascular risk in statin treated coronary artery disease patients
  753. Liver and skeletal muscle Ceramides in alloxan-induced diabetes
  754. Regional analysis of Ceramides within the stratum corneum in relation to seasonal changes
  755. The Essential Role of Esterified omega-Hydroxy Ceramides as Skin Lipids
  756. Semiquantitative discovery of Ceramides by isoenergetic precursor ion scan in the triple quadrupole mass spectrometer: fundamental issues and proof-of-principle …
  757. Muscle-specific Plin2 down-regulation affects accumulation of ectopic lipid metabolites including Ceramides
  758. Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s
  759. New Immunomodulating Glycosyl Ceramides from Marine Sponges
  760. Role of Central Nervous System Ceramides and Free Radicals in a Mouse Model of Orofacial Pain
  761. Long-vs short-chain Ceramides: evidence for different penetration into skin and barrier properties
  762. Bilayer Properties of Ceramides: Role of Interfacial Hydroxylation, Acyl Chain Length, and Chain Unsaturation
  763. Sphingolipids in foods and differential sensitivity of human colon cancer cells to sphingoid bases and Ceramides
  764. Development of lipid A binding agents based on cholic acid scaffolding and the synthesis of monoglycosyl Ceramides for immunological activity studies
  765. Shifting our focus to blood-based biomarkers of Alzheimer’s disease: the promise of Ceramides and sphingomyelins
  766. HMGB1 and Ceramides: Potential Mediators of Cigarette Smoke-induced Metabolic Dysfunction
  767. Sphingomyelins and Ceramides with very-long-chain PUFA are excluded from lowdensity, raft-like domains in differentiating spermatogenic cells
  768. Metformin decreases cellular Ceramides in MCF-7 and MDA-MB 231 breast cancer cell lines by inhibition of Ceramide synthetic enzymes
  769. Impact of Ceramides and penetration enhancers on the nanostructure of Stratum corneum lipid model membranes
  770. In Situ Synthesis of Fluorescent Membrane Lipids (Ceramides) using Click Chemistry
  771. Evaluation of medicines containing mometasone furoate or methylprednisolone aceponate with Ceramides influence on the development of non-specific contact …
  772. Overexpression of hELOVL4 prevents diabetes-induced blood-retinal barrier breakdown through an increase in very long chain Ceramides
  773. Gangliosides and Ceramides in blood serum of patients with ovary tumors
  774. Development and validation of a LC-MS/MS method for the simultaneous analysis of diabetogenic lipids, diacylglycerols and Ceramides, in subcellular fractions of …
  775. Cholesteryl Phosphocholine forms Fluid Bilayer Membranes with Saturated or Monounsaturated Ceramides
  776. Short-Chain Ceramides for Enhancing Cytotoxicity of Liposome-Encapsulated Doxorubicin Toward Human Breast Cancer (MDA-MB-231) and Prostate Cancer (PC-3) …
  777. Ceramides: Quantification, and regulation in the yeast Saccharomyces cerevisiae in response to hypoxia
  778. Novel Tyrosine Kinase Inhibitors Trigger Drug Sensitivity of Primary CLL Cells by Controlling Glucosylation of Ceramides
  779. Semi-pilot scale-up of a continuous packed-bed bioreactor system developed for the lipase-catalyzed production of pseudo-Ceramides
  780. Effects of cell-permeable Ceramides and tumor necrosis (factor-alpha) on insulin signaling and glucose uptake in 3T3-L1 adipocytes
  781. Simultaneous quantitative analysis of cerebrosides and Ceramides from sea cucumbers by high performance liquid chromatography coupled with evaporative light …
  782. On route to stratum corneum-the role of Ceramides towards model skin
  783. Comparative Effect of Gromwell (Lithospermum erythrorhizon) Extract and Borage Oil on the Level of Serum IgE, Pruritus and Epidermal Ceramides in NC/Nga Mice.
  784. Membrane structure in Fc (epsilon) RI signaling: Measurement of lipid order and disruption of order and signaling by short chain Ceramides
  785. Very long chain polyunsaturated fatty acids are the major acyl groups of sphingomyelins and Ceramides located in the head of bull and rat spermatozoa
  786. … and Cardiac Failure in Cancer Patients: Is This a Consequence of Unrecognized Hypomagnesemia and Release of Ceramides and Platelet-Activating Factor?
  787. Contents and composition of Ceramides in the bovine hoof horn from normal cows and cows with subclinical laminitis.
  788. TUMOR NECROSIS FACTOR-o, SPHINGOMYELINASE AND Ceramides ACTIVATE TYROSINE KINASE, p21RAS AND
  789. Thermotropic Behaviour of Ceramides/Oleic Acid Mixtures Studied by FT-Raman Spectroscopy and DSC
  790. Involvement Of Ceramides And DihydroCeramides In Lung Apoptosis And Autophagy
  791. … of Postoperative Atrial Fibrillation after Cardiac and Lung Surgeries Related to Hypomagnesemia and Releases of Ceramides and Platelet-Activating Factor?
  792. Circulating Ceramides Predict Fatal and All Incident Major Adverse Cardiovascular Events: A Prospective Analysis of the FINRISK 2002 Cohort
  793. Differential Comparison of Trabecular Meshwork Ceramides from Control and Glaucomatous Donors
  794. Role of Ceramides and Ceramides-formed pores in the process of mitochondria permeabilization and yeast programmed cell death
  795. The influence of “mometasone with Ceramides” cream in the course of allergic contact dermatitis
  796. ABT-737 increased intracellular Ceramides through sphingomyelin hydrolysis in ALL cell lines
  797. The role of Ceramides in the response to chemotherapy of lung cancer
  798. Interplay between Aβ, Ceramides and Hyperphosphorylated Tau in Alzheimer’s Disease
  799. Synthesis of a versatile building block for the preparation of 6-N-derivatized-galactosyl Ceramides: rapid access to biologically active glycolipids.
  800. In vitro anti ‚Äêinflammatory and skin protective properties of extract comprising Ceramides from de ‚Äêoiled rice bran
  801. Molecular species of free Ceramides in Aspergillus oryzae.
  802. Differential susceptibility of lung endothelial and epithelial cells to Ceramides‐induced apoptosis
  803. Ceramides and steroids of the zoanthides Palythoa caribaeorum and Protopalythoa variabilis
  804. 147: Long-chain Ceramides in women with metabolic abnormalities: a possible mechanistic explanation for off-spring risk for insulin resistance
  805. Atomic force microscopy and spectroscopic studies of the physical effects of Ceramides on model and cell membranes
  806. Synergy between the active vitamin D precursor, 25 hydroxyvitamin D and short chain Ceramides on keratinocyte proliferation and differentiation.
  807. Plasma Ceramides Predict Residual Cardiovascular Death Risk in Optimally Statin Treated Patients With Stable Coronary Artery Disease
  808. Studies on the chemical constituents of the Chinese soft coral (ⅢⅩⅥ)–Structures of two Ceramides
  809. STUDIES ON THE CHEMICAL CONSTITUENTS OF THE CHINESE SOFT CORAL (III X VI)–Structures of two Ceramides
  810. Ceramide Synthase 4 and De Novo Production of Ceramides with Specific N-Acyl Chain Lengths Are Involved in…
  811. Impact of diabetes on Ceramides in skeletal muscle subcellular fractions
  812. Stereoselective preparation of quaternary 2-vinyl sphingosines and Ceramides and their effect on basal sphingolipid metabolism
  813. Profiling and Characterizing Skin Ceramides Using Reversed-Phase Liquid Chromatographyâ Quadrupole Time-of-Flight Mass Spectrometry
  814. Effect of the expression of LCB1 gene on yeast Ceramides synthesis
  815. Synthetic Ceramides inhibit CD36 expression in U937 cells through a reduction in cytosolic peroxide
  816. Constituents of Crinoidea, 4. Isolation and Structure of Ceramides and Glucocerebrosides from the Feather Star Comanthus japonica
  817. 7 Membrane Microdomains Enriched in Ceramides
  818. Stereoselective preparation of quaternary 2-vinyl sphingosines and Ceramides and their effect on basal sphingolipid metabolism
  819. Semi-pilot scale-up of a continuous packed-bed bioreactor system developed for the lipase-catalyzed production of pseudo-Ceramides
  820. Fate of exogenous Ceramides and gangliosides on isolated liver mitochondria
  821. Separation and Detection of Ceramides by HPLC Followed by Evaporative Light-Scattering Detection and Thin Layer Chromatography
  822. Ceramides isolated of Luffa operculatta Cogn. specie; Ceramidas isoladas da especie Luffa operculatta Cogn.
  823. Toward Quantitation and Characterization of Ceramides in Human Meibum and Tear Film
  824. Ceramides, mitochondrial fission, and reactive oxygen species a novel mechanism of obesity‐induced insulin resistance (LB167)
  825. Bcl-2 transfected HaCaT keratinocytes resist apoptotic signals of Ceramides, tumor necrosis factor and 1, 25-dihydroxyvitamin D3
  826. Increased Circulating Levels of Total and Very Long-Chain Ceramides as Markers of Abnormal Lipid Metabolism and Lipotoxicity in Patients With Chronic Stable …
  827. Lipotoxic Induction of Myocardial and Circulating Very Long-chain Ceramides in Patients With Advanced Heart Failure Improves With Mechanical Unloading Through …
  828. Structure determination of glucosyl Ceramides (cerebrosides) from the fungus Cladosporium resinae and antimicrobial action against bacillus species
  829. … Around Christmas, New Year’s, Monday Mornings and in the Morning Hours: Potential Roles of Unrecognized Ionized Hypomagnesemia and Release of Ceramides?
  830. Macrophage‐secreted Ceramides are Necessary for Myocardial Mitochondrial Disruption with LPS Treatments
  831. Macrophage‐secreted Ceramides are Necessary for Skeletal Muscle Mitochondrial Disruption with LPS Treatments
  832. Topically applied γ-linolenic acid restores corneocyte-bound ω-hydroxy Ceramides and ameliorates atopic dermatitis-like symptoms in mice
  833. Stimulatory effect of dietary red ginseng on epidermal levels of hydration and Ceramides in ultraviolet radiated hairless mice
  834. PB18 SYNTHESIS OF Ceramides AND CEREBROSIDES (2) SYNTESIS OF N-LAUROYL-DOCOSASPHINGADIENINE, D-ERYTHRO-SPHINGOSINE, AND (S)-α …
  835. Synthetic Ceramides induce growth arrest or apoptosis by reducing cytosolic peroxide with differing kinetics
  836. Multidrug resistance P‐glycoprotein/ABCB1/MDR1 protects against apoptosis by reducing cellular Ceramides (Cer) induced by cadmium (Cd)
  837. The composition and content of Ceramides and sphingomyelins in gastrointestinal epithelium
  838. Ceramides isolated of Luffa operculatta Cogn. specie
  839. PB35 SYNTHESIS OF Ceramides AND CEREBROSIDES (1): TOTAL SYNTHESIS OF CEREBROSIDE B1a AND B1b
  840. P-28: Effect of gastric bypass surgery on plasma Ceramides, inflammation, and cardiovascular risk factors in severely obese patients
  841. Sphingomyelins and Ceramides of umbilical cord tissues and their alterations in preeclampsia
  842. Expression of glycosyl inositol phosphoryl Ceramides and monohexosyl Ceramides in pathogenic fungi
  843. 6. Oceanapins AF, Unique Branched Ceramides Isolated from the Haplosclerid Sponge Oceanapia cf. tenuis of the Coral Sea
  844. Structure elucidation of glycosylinositol phosphoryl Ceramides from Paracoccidioides brasiliensis
  845. Anti-choline esterase activity of Ceramides from the Red Sea Marine Sponge Mycale euplectellioides
  846. Structural characterization of glycosilinositol-phosphoryl-Ceramides from Mycelium forms of different strain of Sporothrix schenckii
  847. P1. 9.1 Investigation of Water Penetration into Ceramides with Lateral Field Excitation Sensors
  848. … -71] Comparative Effect of Gromwell (Lithospermum erythrorhizon) Extract and Borage Oil on the Level of Serum IgE, Pruritus and Epidermal Ceramides in NC/Nga …
  849. [P10-62] Dietary Supplementation of Gromwell (the dried root of Lithospermum erythrorhizon Sieb. et Zucc.) Increases the Level of Ceramides and Serine, an Amino …
  850. … Matilde Inglese, Peter A. Calabresi, Gang Wu, Aaron E. Miller, Norman J. Haughey, Fred D. Lublin, Patrizia Casaccia. Cerebrospinal fluid Ceramides from patients with …
  851. The role of Ceramides in insulin resistance
  852. Ceramides as novel disease biomarkers
  853. The physical properties of Ceramides in membranes
  854. Ceramides in skin health and disease: an update
  855. Plasma Ceramides pathophysiology, measurements, challenges, and opportunities
  856. Ceramides in metabolism: key lipotoxic players
  857. The role of Ceramides in metabolic disorders: when size and localization matters
  858. Visualizing bioactive Ceramides
  859. Metabolic messengers: Ceramides
  860. Contribution of specific Ceramides to obesity-associated metabolic diseases
  861. Could Ceramides become the new cholesterol?
  862. Ceramides and other sphingolipids as drivers of cardiovascular disease
  863. Ceramides and risk of major adverse cardiovascular events: A meta-analysis of longitudinal studies
  864. Role of Ceramides in the pathogenesis of diabetes mellitus and its complications
  865. The role of Ceramides in diabetes and cardiovascular disease regulation of Ceramides by adipokines
  866. Ceramides in adipose tissue
  867. The long and the short of Ceramides
  868. Contribution of Ceramides metabolism in psychiatric disorders
  869. Ceramides and phosphatidylcholines associate with cardiovascular diseases in the elderly
  870. Roles of Ceramides and other sphingolipids in immune cell function and inflammation
  871. Ceramides and Ceramide scores: clinical applications for cardiometabolic risk stratification
  872. Ceramides and diabetes mellitus: an update on the potential molecular relationships
  873. The lard works in mysterious ways: Ceramides in nutrition-linked chronic disease
  874. Emerging roles of Ceramides in breast cancer biology and therapy
  875. Circulating Ceramides-are origins important for sphingolipid biomarkers and treatments?
  876. Roles of Ceramides in non-alcoholic fatty liver disease
  877. Ceramides and sphingosino-1-phosphate in obesity
  878. Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease
  879. Associations between plasma Ceramides and mortality in patients with coronary artery disease
  880. The role of Ceramides in skin homeostasis and inflammatory skin diseases
  881. Ceramides bind VDAC2 to trigger mitochondrial apoptosis
  882. Whole picture of human stratum corneum Ceramides, including the chain-length diversity of long-chain bases
  883. Circulating Ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies
  884. Ceramides: nutrient signals that drive hepatosteatosis
  885. Sphingomyelins and Ceramides: possible biomarkers for dementia?
  886. Recent advances on topical application of Ceramides to restore barrier function of skin
  887. Plasma Ceramides: a novel predictor of major adverse cardiovascular events after coronary angiography
  888. State of the art in Stratum Corneum research: The biophysical properties of Ceramides
  889. Ceramides in autoimmune rheumatic diseases: Existing evidence and therapeutic considerations for diet as an antiCeramide treatment
  890. Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors
  891. Ceramides and their roles in programmed cell death
  892. Role of Ceramides in diabetic foot ulcers
  893. The relevance of Ceramides and their synthesizing enzymes for multiple sclerosis
  894. Increased serum concentration of Ceramides in obese children with nonalcoholic fatty liver disease
  895. Ceramides in Parkinson’s disease: from recent evidence to new hypotheses
  896. Plasma Ceramides and sphingomyelins in relation to heart failure risk: The Cardiovascular Health Study
  897. Nonalcoholic fatty liver disease, insulin resistance, and Ceramides
  898. Ceramides as Dietary Biomarkers
  899. Adipocyte Ceramides—The nexus of inflammation and metabolic disease
  900. Ceramides and acute kidney injury
  901. Ceramides and cardiovascular risk factors, inflammatory parameters and left ventricular function in AMI patients
  902. Interplay between Ceramides and phytonutrients: New insights in metabolic syndrome
  903. Comparative profiling and comprehensive quantification of stratum corneum Ceramides in humans and mice by LC/MS/MS [S]
  904. Ceramides profile identifies patients with more advanced stages of colorectal cancer
  905. Barrier capability of skin lipid models: effect of Ceramides and free fatty acid composition
  906. The ERAD system is restricted by elevated Ceramides
  907. Ceramides and phospholipids are downregulated with liraglutide treatment: Results from the LiraFlame randomized controlled trial
  908. How Ceramides orchestrate cardiometabolic health—an ode to physically active living
  909. Too much of a good thing? An evolutionary theory to explain the role of Ceramides in NAFLD
  910. Lipotoxic very-long-chain Ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes
  911. Plasma levels of Ceramides relate to ischemic stroke risk and clinical severity
  912. Serum Ceramides in early pregnancy as predictors of gestational diabetes
  913. Overeating saturated fat promotes fatty liver and Ceramides compared with polyunsaturated fat: a randomized trial
  914. Plasma Ceramides as prognostic biomarkers and their arterial and myocardial tissue correlates in acute myocardial infarction
  915. Plasma Ceramides are associated with outcomes in acute ischemic stroke patients
  916. Altered levels of sphingosine, sphinganine and their Ceramides in atopic dermatitis are related to skin barrier function, disease severity and local cytokine …
  917. Lowering Ceramides to overcome diabetes
  918. The fatty acids of sphingomyelins and Ceramides in mammalian tissues and cultured cells: Biophysical and physiological implications
  919. Circulating Ceramides and sphingomyelins and risk of mortality: the Cardiovascular Health Study
  920. Seasonal changes in epidermal Ceramides are linked to impaired barrier function in acne patients
  921. Plasma Ceramides in Cardiovascular Disease Risk Stratification
  922. You aren’t IMMUNE to the Ceramides that accumulate in cardiometabolic disease
  923. The Biological Variability of Plasma Ceramides in Healthy Subjects
  924. Effect of Rice (Oryza sativa L.) Ceramides Supplementation on Improving Skin Barrier Functions and Depigmentation: An Open-Label Prospective Study
  925. Fat-secreted Ceramides regulate vascular redox state and influence outcomes in patients with cardiovascular disease
  926. Role of Ceramides in the molecular pathogenesis and potential therapeutic strategies of cardiometabolic diseases: What we know so far
  927. Genetic, dietary, and sex-specific regulation of hepatic Ceramides and the relationship between hepatic Ceramides and IR [S]
  928. High levels of modified Ceramides are a defining feature of murine and human cancer cachexia
  929. Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes
  930. Relation of plasma Ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study
  931. Ceramides and Ceramide Synthases in Cancer: Focus on Apoptosis and Autophagy
  932. Ceramides during Pregnancy and Obstetrical Adverse Outcomes
  933. Role of Ceramides in drug delivery
  934. Strong heart, low Ceramides
  935. Targeted lipidomics reveal derangement of Ceramides in major depression and bipolar disorder
  936. Plasma Ceramides and sphingomyelins in relation to atrial fibrillation risk: the cardiovascular health study
  937. Circulating lysophosphatidylcholines, phosphatidylcholines, Ceramides, and sphingomyelins and ovarian cancer risk: a 23-year prospective study
  938. Role of Omega-Hydroxy Ceramides in Epidermis: Biosynthesis, Barrier Integrity and Analyzing Method
  939. Cell-intrinsic Ceramides determine T cell function during melanoma progression
  940. Long chain Ceramides raise the main phase transition of monounsaturated phospholipids to physiological temperature
  941. The Role of Ceramides in Diabetes and Cardiovascular Disease
  942. Associations between specific plasma Ceramides and severity of coronary-artery stenosis assessed by coronary angiography
  943. Blood Ceramides as novel markers for renal impairment in systemic lupus erythematosus
  944. New evidence from plasma Ceramides links apoE polymorphism to greater risk of coronary artery disease in Finnish adults [S]
  945. Blood-brain barrier permeability analysis of plant Ceramides
  946. Writing and erasing Ceramides to alter liver disease
  947. Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective Ceramides
  948. Ceramides as risk markers for future cardiovascular events and all-cause mortality in long-standing type 1 diabetes
  949. Why and how increased plasma Ceramides predict future cardiovascular events?
  950. Influence of exercise training on skeletal muscle insulin resistance in aging: spotlight on muscle Ceramides
  951. Role of Ceramides and sphingolipids in Parkinson’s disease
  952. Comprehensive profiling of Ceramides in human serum by liquid chromatography coupled to tandem mass spectrometry combining data independent/dependent …
  953. Nanodelivery strategies for skin diseases with barrier impairment: Focusing on Ceramides and glucocorticoids
  954. Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke
  955. Elevated serum Ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism
  956. Association between increased plasma Ceramides and chronic kidney disease in patients with and without ischemic heart disease
  957. Association of circulating Ceramides with cardiac structure and function in the community: the framingham heart study
  958. Comprehensive characterization of bovine milk lipids: Phospholipids, sphingolipids, glycolipids, and Ceramides
  959. Biochemistry of very-long-chain and long-chain Ceramides in cystic fibrosis and other diseases: the importance of side chain
  960. Long-chain Ceramides are cell non-autonomous signals linking lipotoxicity to endoplasmic reticulum stress in skeletal muscle
  961. Ceramides metabolism and impaired epidermal barrier in cutaneous diseases and skin aging: focus on the role of the enzyme PNPLA1 in the synthesis of ω-O …
  962. Skeletal muscle Ceramides and daily fat oxidation in obesity and diabetes
  963. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study
  964. Ceramides: a cause of insulin resistance in nonalcoholic fatty liver disease in both murine models and humans
  965. Lipidomic Analysis to Assess the Correlation between Ceramides, Stress Hyperglycemia, and HbA1c in Acute Myocardial Infarction
  966. Ceramides regulate defense response by binding to RbohD in Arabidopsis
  967. Inimitable Impacts of Ceramides on Lipid Rafts Formed in Artificial and Natural Cell Membranes
  968. Unraveling the molecular principles by which Ceramides commit cells to death
  969. Yeast Svf1 binds Ceramides and contributes to sphingolipid metabolism at the ER cis-Golgi interface
  970. Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular Ceramides by exosomal release
  971. … from human adipose tissue-derived mesenchymal stem cells promote epidermal barrier repair by inducing de novo synthesis of Ceramides in atopic dermatitis
  972. Intrinsic lipid curvatures of mammalian plasma membrane outer leaflet lipids and Ceramides
  973. Skeletal muscle Ceramides and relationship with insulin sensitivity after 2 weeks of simulated sedentary behaviour and recovery in healthy older adults
  974. Plasma Ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
  975. Short photoswitchable Ceramides enable optical control of apoptosis
  976. An exploratory study of plasma Ceramides in comorbidities in Down syndrome
  977. Development and validation of a RPLC-MS/MS method for the quantification of Ceramides in human serum
  978. CHAPTER THREE Ceramides YASEMİN SAVRANLAR
  979. Metabolomic profiling suggests long chain Ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer
  980. Fluorescently Labeled Ceramides and 1-DeoxyCeramides: Synthesis, Characterization, and Cellular Distribution Studies
  981. Exploring mechanisms involved in the biosynthesis of cutaneous Ceramides in health and disease
  982. Review of available “extraction+ purification” methods of natural Ceramides and their feasibility for sewage sludge analysis
  983. Plasma Ceramides and cardiovascular events in hypertensive patients at high cardiovascular risk
  984. Traceless synthesis of Ceramides in living cells reveals saturation-dependent apoptotic effects
  985. Elevated plasma Ceramides are associated with antiretroviral therapy use and progression of carotid artery atherosclerosis in HIV infection
  986. Optical manipulation of sphingolipid biosynthesis using photoswitchable Ceramides
  987. Autologous hematopoietic stem cell transplantation significantly alters circulating Ceramides in peripheral blood of relapsing-remitting multiple sclerosis …
  988. Abnormal plasma Ceramides refine high-risk patients with worsening heart failure
  989. Structural characterization of plant glucosylCeramides and the corresponding Ceramides by UHPLC-LTQ-Orbitrap mass spectrometry
  990. Associations of NAFLD with circulating Ceramides and impaired glycemia
  991. Differences in plasma levels of long chain and very long chain Ceramides between African Americans and whites: An observational study
  992. Associations of adiposity and diet quality with serum Ceramides in middle-aged adults with cardiovascular risk factors
  993. New insight into phase behavior and permeability of skin lipid models based on sphingosine and phytosphingosine Ceramides
  994. Ceramides mediate positional signals in Arabidopsis thaliana protoderm differentiation
  995. Decreased serum levels of sphingomyelins and Ceramides in sickle cell disease patients
  996. Association of plasma Ceramides with myocardial perfusion in patients with coronary artery disease undergoing stress myocardial perfusion scintigraphy
  997. Plasma Ceramides in relation to coronary plaque characterization determined by optical coherence tomography
  998. Formation of keto-type Ceramides in palmoplantar keratoderma based on biallelic KDSR mutations in patients
  999. Role of hypothalamic de novo Ceramides synthesis in obesity and associated metabolic disorders
  1000. Distinct mechanisms involving diacylglycerol, Ceramides, and inflammation underlie insulin resistance in oxidative and glycolytic muscles from high fat-fed rats
  1001. Determining the structure of protein-bound Ceramides, essential lipids for skin barrier function
  1002. Sex differences in cardiovascular diseases: a matter of estrogens, Ceramides, and sphingosine 1-phosphate
  1003. Accumulation of cholesterol, triglycerides and Ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice
  1004. Anandamide revisited: how cholesterol and Ceramides control receptor-dependent and receptor-independent signal transmission pathways of a lipid neurotransmitter
  1005. Involvement of Ceramides in non-alcoholic fatty liver disease (Nafld) atherosclerosis (ats) development: Mechanisms and therapeutic targets
  1006. Association of Diet Quality and Body Mass Index with Serum Ceramides in Middle-aged Adults
  1007. Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia
  1008. Ceramides are early responders in metabolic syndrome development in rhesus monkeys
  1009. Dysregulated Ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis
  1010. Increased levels of short-chain Ceramides modify the lipid organization and reduce the lipid barrier of skin model membranes
  1011. Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy
  1012. Serum Ceramides as prognostic biomarkers of large thrombus burden in patients with STEMI: a micro-computed tomography study
  1013. Analysis of circulating Ceramides and hexosylCeramides in patients with coronary artery disease and type II diabetes mellitus
  1014. Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic Ceramides metabolism
  1015. Alteration of barrier properties, stratum corneum Ceramides and microbiome composition in response to lotion application on cosmetic dry skin
  1016. Interaction of Ceramides and tear lipocalin
  1017. Ceramides affect alcohol consumption and depressive‐like and anxiety‐like behavior in a brain region‐and Ceramide species‐specific way in male mice
  1018. Association of plasma Ceramides with prevalent and incident type 2 diabetes mellitus in middle and older aged adults
  1019. Associations between plasma Ceramides and cerebral microbleeds or lacunes
  1020. Quantitative imprint mass spectrometry imaging of endogenous Ceramides in rat brain tissue with kinetic calibration
  1021. Following Roux-en-Y gastric bypass surgery, serum Ceramides demarcate patients that will fail to achieve normoglycemia and diabetes remission
  1022. ELOVL4-mediated production of very long-chain Ceramides stabilizes tight junctions and prevents diabetes-induced retinal vascular permeability
  1023. Dietary supplementation with exogenous sea-cucumber-derived Ceramides and glucosylCeramides alleviates insulin resistance in high-fructose-diet-fed rats by …
  1024. Relation between plasma Ceramides and cardiovascular death in chronic heart failure: a subset analysis of the GISSI‐HF trial
  1025. 27742 From the inside-out: A more effective way of delivering Ceramides to the stratum corneum–an in silico simulation study
  1026. Dose-dependent reductions in plasma Ceramides after anthocyanin supplementation are associated with improvements in plasma lipids and cholesterol efflux …
  1027. Comparative Study on Epidermal Moisturizing Effects and Hydration Mechanisms of Rice-Derived GlucosylCeramides and Ceramides
  1028. Silybin-induced apoptosis occurs in parallel to the increase of Ceramides synthesis and miRNAs secretion in human hepatocarcinoma cells
  1029. Epicardial Adipose Tissue Ceramides Are Related to Lipoprotein Lipase Activity in Coronary Artery Disease: Unfolding a Missing Link
  1030. Appearance of intact molecules of dietary Ceramides prepared from soy sauce lees and rice glucosylCeramides in mouse plasma
  1031. Distinct mouse models of Stargardt disease display differences in pharmacological targeting of Ceramides and inflammatory responses
  1032. Lysosomal Ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity
  1033. Endocannabinoid system and the expression of endogenous Ceramides in human hepatocellular carcinoma
  1034. Circulating Ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
  1035. Plasma Ceramides relate to mild cognitive impairment in middle‐aged men: The Maastricht Study
  1036. Plasma Ceramides and Risk of Impaired Lower-Extremity Function in Older Adults: A Nested Case–Control Study
  1037. Alterations in plasma triglycerides and Ceramides: links with cardiac function in humans with type 2 diabetes
  1038. Topically Applied Ceramides Interact with the Stratum Corneum Lipid Matrix in Compromised Ex Vivo Skin
  1039. Decrease of Ceramides with long‐chain fatty acids in psoriasis: Possible inhibitory effect of interferon gamma on chain elongation
  1040. Plasma Ceramides as Biomarkers for Microvascular Disease in Diabetes: Evaluating the Relationship Between Ceramide and Multiple Outcomes
  1041. Hydrogel-mediated delivery of celastrol and doxorubicin induces a synergistic effect on tumor regression via upregulation of Ceramides
  1042. Ceramides and sphingolipids are more than simple building blocks
  1043. Elevated plasma Ceramides are associated with higher white matter hyperintensity volume—brief report
  1044. Elevated peritoneal fluid Ceramides in human endometriosis-associated infertility and their effects on mouse oocyte maturation
  1045. Involvement of ω-O-acylCeramides and protein-bound Ceramides in oral permeability barrier formation
  1046. Panduramides AD, new Ceramides from Ficus pandurata fruits
  1047. Association between Ceramides and coronary artery stenosis in patients with coronary artery disease
  1048. Maternal obesity leads to long-term altered levels of plasma Ceramides in the offspring as revealed by a longitudinal lipidomic study in children
  1049. Coffee, atrial fibrillation, and circulating Ceramides in patients with chronic heart failure
  1050. Arrangement of Ceramides in the skin: sphingosine chains localize at a single position in stratum corneum lipid matrix models
  1051. Ceramides and metabolic profiles of patients with acute coronary disease: a cross-sectional study
  1052. Dietary inulin decreases circulating Ceramides by suppressing neutral sphingomyelinase expression and activity in mice
  1053. … -inflammation and pro-atherosclerotic responses to short-term air pollution exposure associated with alterations in sphingolipid Ceramides and neutrophil extracellular …
  1054. Selectivity in cornified envelop binding of Ceramides in human skin and the role of LXR inactivation on Ceramide binding
  1055. ω-O-AcylCeramides but not ω-hydroxy Ceramides are required for healthy lamellar phase architecture of skin barrier lipids
  1056. Bioactive Ceramides in Health and Disease: Intertwined Roles of Enigmatic Lipids
  1057. Assessment of plasma Ceramides as predictor for subclinical atherosclerosis
  1058. Role of Ceramides in skin disease and skin care formulations-A Review
  1059. Improved organotypic skin model with reduced quantity of monounsaturated Ceramides by inhibiting stearoyl-CoA desaturase-1
  1060. An investigation of the skin barrier restoring effects of a cream and lotion containing Ceramides in a multi-vesicular emulsion in people with dry, eczema-prone …
  1061. Bifunctional DEGS2 has higher hydroxylase activity toward substrates with very-long-chain fatty acids in the production of phytosphingosine Ceramides
  1062. … hepatitis B virus PreS variants synergistically promotes hepatocellular carcinoma development in a high-fat diet context by generating abnormal Ceramides
  1063. … components ENHANCED DISEASE SUSCEPTIBILITY 1 and PHYTOALEXIN DEFICIENT 4 are required for cell death caused by overaccumulation of Ceramides in …
  1064. Differences in the distribution of Ceramides and sphingosine among lipoprotein and lipoprotein-depleted fractions in patients with type 2 diabetes mellitus
  1065. Extraction Optimization, UHPLC-Triple-TOF-MS/MS Analysis and Antioxidant Activity of Ceramides from Sea Red Rice Bran
  1066. Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides
  1067. Effects of sex, age, and apolipoprotein E genotype on brain Ceramides and sphingosine-1-phosphate in Alzheimer’s disease and control mice
  1068. Skeletal muscle Ceramides do not contribute to physical-inactivity-induced insulin resistance
  1069. Ceramides Increase Fatty Acid Utilization in Intestinal Progenitors to Enhance Stemness and Increase Tumor Risk
  1070. Skin mast cell-driven Ceramides drive early apoptosis in pre-symptomatic eczema in mice
  1071. Species-specific accumulation of Ceramides in cerebrospinal fluid from encephalomyeloradiculoneurpathy patients associated with peripheral complement activation …
  1072. High-throughput quantitation of serological Ceramides/dihydroCeramides by LC/MS/MS: pregnancy baseline biomarkers and potential metabolic messengers
  1073. Monanchoramides A–D, Ceramides from the marine sponge Monanchora clathrata with cytotoxic activity
  1074. Early postoperative changes of sphingomyelins and Ceramides after laparoscopic sleeve gastrectomy
  1075. Links between Ceramides and cardiac function
  1076. Association between plasma Ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial …
  1077. Effects of (R)- and (S)-α-Hydroxylation of Acyl Chains in Sphingosine, Dihydrosphingosine, and Phytosphingosine Ceramides on Phase Behavior and Permeability …
  1078. Inhibiting tau-induced elevated nSMase2 activity and Ceramides is therapeutic in an Alzheimer’s disease mouse model
  1079. Ceramides from Sea Red Rice Bran Improve Health Indicators and Increase Stress Resistance of Caenorhabditis elegans through Insulin/IGF-1 Signaling (IIS) …
  1080. Cumulative sugar-sweetened beverage consumption is associated with higher concentrations of circulating Ceramides in the Framingham Offspring Cohort
  1081. Plasma Ceramides independently predict all-cause mortality in men aged 85+
  1082. Relationships between Very Low‐Density Lipoproteins–Ceramides,− Diacylglycerols, and–Triacylglycerols in Insulin‐Resistant Men
  1083. Reduction of stratum corneum Ceramides in Neu-Laxova syndrome caused by phosphoglycerate dehydrogenase deficiency
  1084. Aberrant accumulation of Ceramides in mitochondria triggers cell death by inducing autophagy in Arabidopsis
  1085. Cardiovascular prognosis: a new role for Ceramides and other cardiometabolites
  1086. Effect of cis-and trans-Monounsaturated Fatty Acids on Palmitate Toxicity and on Palmitate-induced Accumulation of Ceramides and Diglycerides
  1087. CERS6-derived Ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease
  1088. Effect of circulating Ceramides on adiposity and insulin resistance in patients with type 2 diabetes: An observational cross‐sectional study
  1089. Genetic Variants Associated with Elevated Plasma Ceramides in Individuals with Metabolic Syndrome
  1090. Ceramides biomarkers determination in quantitative dried blood spots by UHPLC-MS/MS
  1091. Consistent alteration of chain length-specific Ceramides in human and mouse fibrotic kidneys
  1092. Quantification of α-hydroxy Ceramides in mice serum by LC-MS/MS: Application to sepsis study
  1093. Altered Levels of Sphingosine, Sphinganine and Their Ceramides in Atopic Dermatitis Are Related to Skin Barrier Function, Disease Severity and Local Cytokine …
  1094. Duodenal-jejunal bypass reduces serum Ceramides via inhibiting intestinal bile acid-farnesoid X receptor pathway
  1095. Long-and very long-chain Ceramides are predictors of acute kidney injury in patients with acute coronary syndrome: the PEACP study
  1096. FTY720 decreases Ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer’s disease expressing APOE4
  1097. Ceramides and their interactive effects with trimethylamine-N-oxide metabolites on risk of gestational diabetes: A nested case-control study
  1098. Inhibiting tau-induced elevated nSMase2 activity and Ceramides is therapeutic in murine Alzheimer’s disease
  1099. Periplocymarin alleviates doxorubicin-induced heart failure and excessive accumulation of Ceramides
  1100. Ramadan intermittent fasting is associated with ameliorated inflammatory markers and improved plasma sphingolipids/Ceramides in subjects with obesity …
  1101. Molecular docking, SAR analysis and biophysical approaches in the study of the antibacterial activity of Ceramides isolated from Cissus incisa
  1102. A method for quantifying hepatic and intestinal Ceramides on mice by UPLC-MS/MS
  1103. Stratum corneum Ceramide profiles in vitro, ex vivo, and in vivo: characterization of the α-hydroxy double esterified Ceramides
  1104. Elevated Ceramides 18: 0 and 24: 1 with aging are associated with hip fracture risk through increased bone resorption
  1105. Targeted liposomal doxorubicin/Ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells
  1106. Effect of combined testing of Ceramides with high-sensitive troponin T on the detection of acute coronary syndrome in patients with chest pain in China: a …
  1107. Ceramides and pro-inflammatory cytokines for the prediction of acute coronary syndrome: a multi-marker approach
  1108. Plasma Ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
  1109. Ceramides and other bioactive compounds from Celtis tessmannii Rendle
  1110. … and seasonal changes in covalently bound Ceramide content in forearm stratum corneum of Japanese subjects: determination of molecular species of Ceramides
  1111. Ceramides are decreased after liraglutide treatment in two randomized clinical trials
  1112. First report of isolation of antibacterial Ceramides from the leaves of Euclinia longiflora Salisb
  1113. Chasing the major sphingolipids on earth: automated annotation of plant Glycosyl inositol Phospho Ceramides by Glycolipidomics
  1114. Mixing brain cerebrosides with brain Ceramides, cholesterol and phospholipids
  1115. Electrospray ionization with higher-energy collision dissociation tandem mass spectrometry toward characterization of Ceramides as [M+ Li]+ ions: Mechanisms of …
  1116. Development and validation of LC/APCI-MS method for the quantification of oat Ceramides in skin permeation studies
  1117. Changes in Choline Metabolites and Ceramides in Response to a DASH-Style Diet in Older Adults
  1118. Low serum levels of (dihydro-) Ceramides reflect liver graft dysfunction in a real-world cohort of patients post liver transplantation
  1119. Ceramides and sphingosine-1-phosphate mediate the distinct effects of M1/M2-macrophage infusion on liver recovery after hepatectomy
  1120. Long acyl chain Ceramides govern cholesterol and cytoskeleton dependence of membrane outer leaflet dynamics
  1121. Ceramides and other sphingolipids as predictors of incident dysglycemia (CASPID): Design, methods, and baseline characteristics
  1122. Relationship between elevated plasma Ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction
  1123. Ceramides Mediate Insulin-Induced Impairments in Cerebral Mitochondrial Bioenergetics in ApoE4 Mice
  1124. In vivo Pilot Study of Moisturizer Evaluation and Correlation between Ceramides Gene Expression Towards Trans Epidermal Water Loss (TEWL) in Skin Barrier
  1125. Study of the effect of using a foam form with Ceramides and a cholesterol-phytosterol complex in patients with atopic dermatitis
  1126. Effects of wine and tyrosol on the lipid metabolic profile of subjects at risk of cardiovascular disease: Potential cardioprotective role of Ceramides
  1127. Ceramides improve cardiovascular risk prediction beyond LDL-cholesterol
  1128. White matter injury is associated with reduced manual dexterity and elevated serum Ceramides in subjects with cerebral small vessel disease
  1129. Long and very-long-chain Ceramides correlate with a more aggressive behavior in skull base chordoma patients
  1130. Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum Ceramides and worsen atherosclerosis in LDLR−/− mice
  1131. New Ceramides and Cerebrosides from the Deep-Sea Far Eastern Starfish Ceramaster patagonicus
  1132. Syntheses of the ω-pyridinium-containing very-long-chain Ceramides PyrCer (24: 1 (15Z)) and PyrCer (24: 0) and their anticancer activity
  1133. Sex-specific associations of Ceramides with cardiopulmonary fitness in the general population
  1134. Anti-skin-aging effects of human Ceramides via collagen and fibrillin expression in dermal fibroblasts
  1135. Gutting out Myc to decrease Ceramides
  1136. Long-chain and very long-chain Ceramides mediate doxorubicin-induced toxicity and fibrosis
  1137. Two C18 hydroxy-cyclohexenone fatty acids from mammalian epidermis: Potential relation to 12R-lipoxygenase and covalent binding of Ceramides
  1138. Platelet Ceramides drive thrombo-inflammation in aortic aneurysm formation
  1139. A mediterranean style diet is favorably associated with concentrations of circulating Ceramides and Ceramide ratios in the framingham offspring cohort (P18 …
  1140. Enrichment of short-chain Ceramides and free fatty acids in the skin epidermis, liver, and kidneys of db/db mice, a type 2 diabetes mellitus model
  1141. Myocardial Fibrosis and Steatosis in Patients with Aortic Stenosis: Roles of Myostatin and Ceramides
  1142. Mechanical properties of bilayers containing sperm sphingomyelins and Ceramides with very long-chain polyunsaturated fatty acids
  1143. Behavior of 1-Deoxy-, 3-Deoxy- and N-Methyl-Ceramides in Skin Barrier Lipid Models
  1144. Sake (rice wine) brewing hydrolyzes highly polar sphingolipids to Ceramides and increases free sphingoid bases
  1145. Plasma multi-omics analysis reveals very long chain Ceramides as validated biomarkers of Friedreich’s ataxia
  1146. Ormdl3 regulation of specific Ceramides is dispensable for mouse β-cell function and glucose homeostasis under obesogenic conditions
  1147. … to omega hydroxy very long chain fatty acids and free Ceramides of canine stratum corneum without effect on protein-bound Ceramides and skin barrier …
  1148. Chain length of covalently bound Ceramides correlates with skin barrier function in healthy subjects
  1149. Chemical characterization of Ceramides isolated from a gliding marine bacterium Aureispira marina
  1150. Short chain Ceramides disrupt immunoreceptor signaling by inhibiting segregation of Lo from Ld Plasma membrane components
  1151. … of a Ceramide synthase gene, GhCS1, inhibits fiber cell initiation and elongation by promoting the synthesis of Ceramides containing dihydroxy LCB and …
  1152. Azido-Ceramides, a Tool to Analyse SARS-CoV-2 Replication and Inhibition—SARS-CoV-2 Is Inhibited by Ceramides
  1153. Oral intake of milk Ceramides improves skin hydration, elasticity, and wrinkles around the eyes: A 12-week, randomized, double-blind, placebo-controlled trial
  1154. Role of Ceramides and Lysosomes in Extracellular Vesicle Biogenesis, Cargo Sorting and Release
  1155. Microphase transitions of Langmuir-Blodgett lipid-assembled monolayers with new types of Ceramides, ultra-long-chain Ceramide and 1-O-acylCeramide
  1156. … acid ethyl ester ameliorates atopic dermatitis–like symptoms in special diet–fed hairless mice, partly by restoring covalently bound Ceramides in the stratum corneum
  1157. The Use of Ceramides to Predict Metabolic Response to Metformin in Women With PCOS
  1158. Plasma Ceramides are associated with coronary atherosclerotic burden in patients with ST-segment elevation myocardial infarction
  1159. High-Fat Diet and Short-Term Unpredictable Stress Increase Long-Chain Ceramides Without Enhancing Behavioral Despair
  1160. Targeting Ceramides and Adiponectin Receptors in the Islet of Langerhans for Treating Diabetes
  1161. Chiral combinatorial preparation and biological evaluation of unique Ceramides for inhibition of sphingomyelin synthase
  1162. Simplified mass spectrometric analysis of Ceramides using a common collision energy
  1163. Alternative splicing of Ceramide synthase 2 alters levels of specific Ceramides and modulates cancer cell proliferation and migration in Luminal B breast …
  1164. Reduced Ceramides Are Associated with Acute Rejection in Liver Transplant Patients and Skin Graft and Hepatocyte Transplant Mice, Reducing Tolerogenic …
  1165. Diets with higher ω-6/ω-3 ratios show differences in Ceramides and fatty acid levels accompanied by increased amyloid-beta in the brains of male APP/PS1 transgenic …
  1166. Isolation of Ceramides from Tagetes patula L. yellow flowersn> and nematicidal activity of the fractions and pure compounds against cyst nematode, Heterodera zeae
  1167. Novel Role for Ceramides in Colorectal Cancer Liver Metastases
  1168. Dysregulated Ceramides metabolism via PTPN11 exposes a metabolic vulnerability to breast cancer metastasis
  1169. Hypothalamic Ceramides and the ovarian sympathetic system: at the crossroads of obesity and puberty
  1170. Identification of circulating plasma Ceramides as a potential sexually dimorphic biomarker of pancreatic cancer‐induced cachexia
  1171. Clinical Update: Ceramides As Novel Biomarkers of Cardiovascular Disease Risk
  1172. Characterization of Ceramides and glucosylCeramides of the Satsuma mandarin (Citrus unshiu) fruit
  1173. Ceramides: Where do we stand?
  1174. Association between specific plasma Ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes
  1175. Taurine accelerates the synthesis of Ceramides and hyaluronic acid in cultured epidermis and dermal fibroblasts
  1176. Anticancer Effects of New Ceramides Isolated from the Red Sea Red Algae Hypnea musciformis in a Model of Ehrlich Ascites Carcinoma: LC-HRMS …
  1177. Evaluation of methotrexate-loaded surfactants, Ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis
  1178. Enhanced Ceramides production by Lactobacillus rhamnosus IDCC 3201 and its proposed mechanism
  1179. ANTIBACTERIAL ACTIVITY OF Ceramides BY MOLECULAR DOCKING METHOD
  1180. The 24‐hr, 28‐day, and 7‐day post‐moisturizing efficacy of Ceramides 1, 3, 6‐II containing moisturizing cream compared with hydrophilic cream on skin dryness and …
  1181. Effects of age, sex, and breed on the composition of free extractable Ceramides in the stratum corneum of healthy dogs
  1182. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 …
  1183. Fatty acid transport protein 4 is required for incorporation of saturated ultralong-chain fatty acids into epidermal Ceramides and monoacylglycerols
  1184. Ceramides and phospholipids are associated with high risk of major cardiovascular events after carotid endarterectomy
  1185. Molecular species profiles of plasma Ceramides in different clinical types of X-linked adrenoleukodystrophy
  1186. Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-Ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients.
  1187. The combination elexacaftor/tezacaftor/ivacaftor (ETI) modulates the de novo synthethic pathway of Ceramides in a genotype-independent manner
  1188. Membrane restructuring events during the enzymatic generation of Ceramides with very long-chain polyunsaturated fatty acids
  1189. Mechanisms of pulmonary microvascular endothelial cells barrier dysfunction induced by LPS: The roles of Ceramides and the Txnip/NLRP3 inflammasome
  1190. Skin Ceramides based systems in transdermal drug delivery and skin care
  1191. Activation of neutral sphingomyelinase 2 through hyperglycemia contributes to endothelial apoptosis via vesicle-bound intercellular transfer of Ceramides
  1192. Rapid, sensitive, and high-throughput quantification of broad serological Ceramides by using isotope dilution liquid chromatography-negative ion electrospray tandem …
  1193. Serum Ceramides could predict durable diabetes remission following gastric bypass surgery
  1194. Ceramides: focus on obesity
  1195. Anxiolytic and anticonvulsant activity followed by molecular docking study of Ceramides from the Red Sea sponge Negombata sp
  1196. Changes in phospholipid profiles in early larval stages of the marine mussel Mytilus galloprovincialis indicate a role of Ceramides in bivalve development
  1197. Probing the interactions among sphingosine and phytosphingosine Ceramides with non-and alpha-hydroxylated acyl chains in skin lipid model membranes
  1198. The Role of Ceramides in Human Skeletal Muscle Insulin Resistance Development
  1199. Cohort using a Ceramides containing cleanser and cream with salicylic acid for dry, flaking, and scaling skin conditions
  1200. Ceramides and phospholipids are associated with high risk of major cardiovascular events after carotid endarterectomy
  1201. Expert consensus on Ceramides containing skincare in newborns and infants and potential mitigation of atopic dermatitis.
  1202. Plasma Ceramides and triglycerides are elevated during pregnancy in association with markers of insulin resistance in hutterite women
  1203. Sex‐specific effects of Ceramides on White Matter Hyperintensities in the Rhineland Study
  1204. Natural Ceramides and lysophospholipids cosegregate in fluid phosphatidylcholine bilayers
  1205. Supplementation with eicosapentaenoic acid and linoleic acid increases the production of epidermal Ceramides in in vitro canine keratinocytes
  1206. The Role of Ceramides and Sphingomyelinases for Dynamic Membrane Processes in T Cells
  1207. Surplus Ceramides: An Added Twist in the Tale of TREM2 and Insulin Resistance
  1208. Maternal diets affected Ceramides and fatty acids in brain regions of neonatal rats with prenatal ethanol exposure
  1209. Targeted analysis of Ceramides and cerebrosides in yellow lupin seeds by reversed-phase liquid chromatography coupled to electrospray ionization and multistage …
  1210. Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia
  1211. * Effects of Icosapent Ethyl on Plasma Ceramides and Coronary Plaque Progression in EVAPORATE trial
  1212. High-resolution mass spectrometry assay for quantifying Ceramides and dihydroCeramides in the cerebrospinal fluid from patients who experienced intracranial …
  1213. Editorial Comment: Ceramides: novel actors in cardiovascular epigenetics?
  1214. Letter to the Editor Regarding ‘An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-Vesicular …
  1215. Total synthesis of Ceramides and β-O-glucosylCeramides via intramolecular fatty acyl group migration
  1216. Fatty Acid Compositions of Ceramides and Sphingomyelins in Mammalian Tissues and Cultured Cells
  1217. Plasma Ceramides and sphingomyelins of pediatric patients increase in primary ciliary dyskinesia but decrease in cystic fibrosis
  1218. 67P High levels of circulating Ceramides are associated with poor prognosis in patients with metastatic castration-resistant prostate cancer (mCRPC)
  1219. Ceramides, autophagy, and apoptosis mechanisms of ventilator-induced lung injury and potential therapeutic targets
  1220. Pharmacological reduction of Ceramides increases levels of long-chain polyunsaturated fatty acids in the mouse retina
  1221. Chemical Composition of the Red Sea Green Algae Ulva lactuca: Isolation and In Silico Studies of New Anti-COVID-19 Ceramides
  1222. Discrimination of cellular developmental states focusing on glycan transformation and membrane dynamics by using BODIPY-tagged lactosyl Ceramides
  1223. Development of an in vitro submerged culture system to synthesize epidermal Ceramides in canine keratinocytes
  1224. Development of genetically-encoded fluorescent KSR1-based probes to track Ceramides during phagocytosis
  1225. Evaluation of the filming and protective properties of a new trehalose and Ceramides based ingredient
  1226. Wound Healing Effect of “Prolidoxid” and ‘Dexpanthenol With Ceramides: A сomparative Study Based on the Model of Chemical Burns With Expressed Alterative Skin …
  1227. A 14-day Controlled Study Assessing Qualitative Improvement with 15% Lactic Acid and Ceramides in Skin Moisturization and Desquamation
  1228. … kinase 1 (SK1) enhances oncogene-induced senescence through Ceramide synthase 2 (CerS2)-mediated generation of very-long-chain Ceramides
  1229. Grade IV Sacral Sore Treated with an Ointment Rich in PUFAs, Ceramides, and Antimicrobial Peptides
  1230. Ormdl3 regulation of specific Ceramides is dispensable for β-cell function and glucose homeostasis under obesogenic conditions
  1231. … stroke in type 2 diabetics over age 60: roles of unrecognized hypomagnesemia and epigenetics coupled with increased levels of Ceramides, cytokines, ROS, 4 …
  1232. Possible targets related to connexins and Ceramides in the treatment of depression using a combination approach
  1233. Op0053 Ceramides and dihydroCeramides levels are associated with the inflammatory response in a murine model of gout
  1234. The role of asprosin and Ceramides in the development of growth hormone deficiency in children
  1235. Response to: Letter to the Editor Regarding “An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi …
  1236. Quantitative LCMS for Ceramides/dihydroCeramides: pregnancy baseline biomarkers and potential metabolic messengers
  1237. Anti-inflammatory Effects of Ceramides from Incarvillea compacta.
  1238. Diverse effects of single molecules of rice-derived functional lipids, glucosylCeramides, Ceramides, and β-sitosterol glucoside, on epidermal and lung functions
  1239. Treatment of allergic asthma with Fenretinide formulation (LAU-7b) downregulates Ormdl3 expression and normalizes Ceramides imbalance
  1240. Changes in the composition of molecular species of covalently bound and free Ceramides, and their correlation with disease severity in atopic dermatitis
  1241. Molecular Mechanism of hERG1 Channel Regulation by Ceramides
  1242. Detection of 2-hydroxy-fatty acids and 2-hydroxy-fatty acid-containing Ceramides in a gliding marine bacterium Aureispira marina
  1243. Characterization of Ceramides with phytosphingosine backbone by hydrogen-deuterium exchange mass spectrometry
  1244. Using Molecular Dynamics Simulations to Elucidate a Role for Bacterial Ceramides
  1245. Plasma levels of Ceramides and their association with Hematocrit and Thrombocytopenia in Severe and Non-severe dengue
  1246. Jnk Activation Is Accompanied By Ceramides And Diacylglycerol Accumulation In Isolated Hepatocytes
  1247. BS1 Adipose tissue derived Ceramides regulate myocardial redox state and predict cardiovascular outcomes
  1248. Study on Stability of Ceramides in Liquid Crystalline Emulsions at High Temperature
  1249. Cerebrospinal fluid Ceramides and cognition as a function of striatal asymmetry in early Parkinson’s disease
  1250. Plasma Ceramides as a sexually dimorphic biomarker of pancreatic cancer-induced cachexia
  1251. Depending on Chain Length Plasma Ceramides Are Associated With Higher or Lower Cardiorespiratory Fitness in the General Population
  1252. Assessment of plasma Ceramides as predictor for preclinical atherosclerosis
  1253. Effects of White Wine and Tyrosol on Circulating Ceramides in Individuals at Cardiovascular Risk
  1254. Associations of NAFLD with circulating Ceramides and impaired glycemia.
  1255. Decrease of Ceramides with Long-Chain Fatty Acids in Psoriasis: Possible Inhibitory Effect of Interferon Gamma on Chain Elongation
  1256. PMON209 Ceramides Predict Metabolic Response to Metformin in Women with PCOS
  1257. Quantitative analysis of Ceramides by ultrahigh-performance liquid chromatography tandem mass spectrometry
  1258. Borage Oil Enhances Lamellar Body Content and Alters Fatty Acid Composition of Epidermal Ceramides in Essential Fatty Acid‐Deficient Guinea Pigs
  1259. Liquid Crystal Emulsions Containing High Content Ceramides for Improved Skin Barrier Functions
  1260. Functional Insights of Ceramides in Epidermis
  1261. Liraglutide improves myocardial redox state in humans by regulating the adipose tissue-derived long-chain Ceramides
  1262. Ceramides Predict the Development of Type 2 Diabetes
  1263. Glycosylation of stannyl Ceramides promoted by modified montmorillonite in supercritical carbon dioxide
  1264. Impact of Targeting Glycosylated Ceramides on Tumorigenic Properties, and Characterization of Sphingolipids in Head and Neck Tumors
  1265. Association Between Plasma Ceramides and One-Year Mortality in Patients with Acute Coronary Syndrome: Insight from the PEACP Study
  1266. Structure, supramolecular organization and thermotropic phase behavior of N-acyl tris homologs (n= 9–18): Structural analogs of apoptosis inducing Ceramides
  1267. Influence of an adjuvant treatment with an emollient containing 10% urea, Ceramides, glycerin und glyceryl glucoside in patients with psoriasis vulgaris
  1268. Ceramides are related to subclinical atherogenesis in the general population
  1269. Diets with higher¿-6/¿-3 ratios show differences in Ceramides and fatty acid levels accompanied by increased amyloid-beta in the brains of male APP/PS1 transgenic …
  1270. … risks for development of hypertension and heart disease: potential roles of unrecognized ionized hypomagnesemia and release of Ceramides and platelet-activating …
  1271. Anticancer Effects of New Ceramides Isolated from the Red Sea Red Algae Hypnea musciformis in a Model of Ehrlich Ascites Carcinoma: LC-HRMS Analysis Profile …
  1272. Biochemical and planimetric investigations of hydrophilic creams containing Ceramides or dexpanthenol on the model of chemical burns
  1273. A Western Diet Alters Skin Ceramides and Compromises the Skin Barrier in Ears
  1274. Conjugation of peptides to short-acyl-chain Ceramides for delivery across mucosal cell barriers
  1275. Plasma Ceramides and sphingomyelins increase in primary ciliary dyskinesia but decrease in cystic fibrosis
  1276. CerS2 ko in vivo reduces pro-inflammatory Ceramides and improves doxorubicin mediated cardiotoxicity
  1277. Formation of skin permeability barrier by diverse Ceramides
  1278. Syntheses of the Ω-Pyridinium-Containing Very-Long-Chain Ceramides PyrCer (24: 1 (15z)) and PyrCer (24: 0) and Their Evaluation
  1279. Isolation of Ceramides from Tagetes patula L. yellow flowersn> and nematicidal activity of the fractions and pure compounds against cyst nematode, Heterodera zeae.
  1280. Roles of Ceramides in development of insulin resistance
  1281. Molecular Mechanisms of Human ERG1 Channel Blockade by Ceramides
  1282. Rifaximin-α reduces circulating Ceramides and increases phosphatidylcholines in patients with ALD: A lipidome analysis of the GALA-RIF Trial
  1283. PPP1CC Affects the Progression of the Liver by Regulating Ceramides
  1284. … Elderly Due in Large Measure to an Unrecognized Hypomagnesemia, Downregulation of Telomerase and Progressive Release of Ceramides and Platelet-Activating …
  1285. Ceramides Mediate Insulin-Induced Impairments in Cerebral Mitochondrial Bioenergetics in ApoE4 Mice (preprint)
  1286. Ceramides in peripheral arterial plaque lead to endothelial cell dysfunction
  1287. Lipotoxicity-induced metabolic inflammation: potential role of Ceramides in glial cells interaction and inflammatory-damage propagation
  1288. Adipose Tissue Derived Ceramides Regulate the Myocardial Redox State and Predict Cardiovascular Outcomes
  1289. Serum Ceramides and type 2 diabetes are mutually independent predictors of cardiovascular events in patients with peripheral artery disease
  1290. Anti-inflammatory Effects of Ceramides from Incarvillea compacta
  1291. LC-MS/MS analysis of elevated Ceramides by inhibition of SphK1 in IMQ-induced psoriasis mouse model
  1292. A High Fat Diet Increases Plasma Ceramides and Leads to Depressive‐Like Behavior in Female Rats
  1293. Development of novel genetically-encoded fluorescent probes to track Ceramides during phagocytosis
  1294. Associations between specific plasma Ceramides and severity of coronary-artery stenosis assessed by coronary angiography
  1295. Relationship between hepatic and mitochondrial Ceramides: a novel in vivo method to track Ceramide synthesis
  1296. Alkaline ceramidase catalyzes the hydrolysis of Ceramides via a catalytic mechanism shared by Zn2+-dependent amidases
  1297. New method for skin Ceramides profiling by SFC-HRMS
  1298. Expansion microscopy of cellular and bacterial membranes by functionalized Ceramides
  1299. Histological evaluation of therapeutic effects of dexpanthenol composition with Ceramides in rats with skin burn injury
  1300. Role of the most abundant plant sphingolipids, Glycosyl Inositol Phosphoryl Ceramides GIPCs, in membrane structure and host/pathogen interactions
  1301. … pulmonary hypertension: Relevance to treatment of pulmonary hypertension in humans and newborns and the roles of hypomagnesemia, Ceramides and PAF
  1302. Ceramides, crucial actors in the development of insulin resistance and type 2 diabetes
  1303. New method to characterize epidermal Ceramides by Supercritical Fluid Chromatography (SFC) coupled to High Resolution Mass (Q-Tof): Application to various …
  1304. Very long chain Ceramides production mediated by ELOVL4 stabilizes tight junctions and prevents diabetes-induced retinal vascular permeability
  1305. Chiral pool approaches to lycopodium alkaloids, orchidaceae alkaloids and photoswitchable Ceramides
  1306. … metabolomics interrogation of adipose tissue secretome from participants of the oxford cohort for heart, vessels & fat highlighted Ceramides as potential adipokines …
  1307. 16818 An investigation of the skin barrier restoring effects of a cream containing Ceramides in a multivesicular emulsion in people with dry, eczema-prone, skin: The …
  1308. Globo-series glycosphingolipid-protein interactions in immortalized proximal tubular epithelial cells and formation of keto-type Ceramides in the skin of KDSR patients
  1309. Simultaneous Quantification of Selected Ceramides by Uplc-Ms/Ms and the Application to Distribution, Pharmacokinetics and Anti-Hypoxia Activities
  1310. The ERAD system is controlled by Ceramides in the endoplasmic reticulum membrane
  1311. Thiolation of gold surfaces for biomimetic hair surface models; Studying the adsorption of Ceramides and rhamnolipids with QCM-D
  1312. … to various samples with skin barrier default. Conclusion & outlooks Skin Ceramides extraction SFC-QTOF analysis Data Processing Ceramides characterization by MS …
  1313. Author Reply to letter to the editor” Plasma Ceramides are associated with outcomes in acute ischemic stroke patients”
  1314. In Silico Studies, Synthesis and Biological Evaluation of 4, 5-Dehydrospisulosine Butyrate Ceramides as Potential Sphingosine Kinase I Inhibitors
  1315. Investigating the Role of Ceramides in and Optimizing Models of Cancer-Induced Cachexia to Enhance Our Understanding of Human Disease
  1316. Age-induced Endoplasmic Reticulum Stress in the Heart: Role of Increased Very Long-chain Ceramides
  1317. … 3 in liver regeneration impedes the progression of colorectal cancer liver metastasis via exosome-bound intercellular transfer of Ceramides
  1318. Reduced Ceramides are associated with acute rejection in liver transplant patients and skin and hepatocyte transplant mice
  1319. P4497 Serum Ceramides and type 2 diabetes are mutually independent predictors of cardiovascular events in patients with peripheral artery disease
  1320. 158-OR: Ceramides Predict the Development of Type 2 Diabetes
  1321. Therapeutic potential of targeting Ceramides for the treatment of retinal diseases
  1322. … Controlled Study to Assess the Qualitative Improvement in Skin Moisturization and Desquamation of 15% Lactic Acid Moisturizer with Ceramides (LAMC) Treatment in …
  1323. Serum Ceramides and type 2 diabetes are mutually independent predictors of cardiovascular events in patients with peripheral artery disease
  1324. Decreased circulating sphingomyelins and Ceramides in sickle cell disease patients
  1325. 1390-P: Maternal Plasma Ceramides Predict Preeclampsia in Women with Type 1 Diabetes
  1326. Abstract P186: Plasma Ceramides Are Associated With HIV Treatment and Increased Risk of Carotid Artery Plaque in Two Prospective HIV Cohorts
  1327. The Prognostic Value of Plasma Ceramides as Cardiovascular Death Markers for Coronary Artery Disease
  1328. Increased Level of Serum Ceramides Correlate with Liver Steatosis, Hba1c and Cholesterol in Obese Patients
  1329. Metabolomic profiling suggests long chain Ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer
  1330. … triacylglycerides (TAG) with shorter chain lengths localized to the hair follicle region (MW 787.7 and 815.7) as well as lactosyl/galabiosyl Ceramides (MW 994.7 and …
  1331. Ceramides metabolism and impaired epidermal barrier in cutaneous diseases and skin aging: focus on the role of the enzyme PNPLA1 in the synthesis of ω-O …
  1332. 457-P: Ceramides and the Ceramide-Based Risk Scores CERT1 and CERT2 Are Elevated in Patients with the Metabolic Syndrome
  1333. Abstract WP413: White Matter Tract Disruption on Diffusor Tensor Imaging is Associated With Serum Ceramides in a Healthy Middle-Aged High Risk Population
  1334. Inverse relationship between very low‐density lipoprotein (VLDL) Ceramides, diacylglycerols, and triacylglycerols in human hepatic lipid accumulation
  1335. Adipose Tissue Ceramides Reduces Endothelium-Dependent Vasorelaxation, Amplifies Vascular Oxidative Stress & Induces Systemic Inflammation Ultimately …
  1336. Phytosphingosine and Its Derived Ceramides; Their Versatile Roles on ‘Bricks & Mortar’Formation in Stratum Corneum
  1337. VERY LONG-CHAIN Ceramides ARE INCREASED IN SERUM EXOSOMES WITH AGING IN BOTH HUMAN SUBJECTS AND NON-HUMAN PRIMATES
  1338. Development and validation of an LC-MS/MS method for the determination of 12 Ceramides in human plasma
  1339. 2-D microphase properties of 1-o-acylCeramide and ultra-long chain Ceramides-assembled lipid membranes
  1340. 2-D microphase properties of novel Ceramides assembled to intercellular lipid membranes
  1341. 1349-P: Bariatric Surgery Causes an Early Improvement in the Lipidomic Profile and a Decrease in Plasma Ceramides and Diacylglycerols in Patients with Type 2 …
  1342. 5893 Adipose tissue secreted Ceramides and related sphingolipids-potential modulators of vascular redox signalling in cardiovascular disease
  1343. 1900-P: Very Low-Density Lipoprotein Ceramides and Hepatic Lipid Accumulation
  1344. Ceramide: an intracellular signal for apoptosis
  1345. Functions of Ceramide in coordinating cellular responses to stress
  1346. Ceramide signaling in apoptosis
  1347. Programmed cell death induced by Ceramide
  1348. Role for Ceramide in Cell Cycle Arrest (∗)
  1349. Role of Ceramide in Cellular Senescence (∗)
  1350. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals
  1351. Ceramide composition of the psoriatic scale
  1352. Ceramide signalling and the immune response
  1353. Role of Ceramide-activated protein phosphatase in Ceramide-mediated signal transduction.
  1354. Globotriosyl Ceramide is specifically recognized by the Escherichia coli verocytotoxin 2
  1355. Suppression of Ceramide-mediated programmed cell death by sphingosine-1-phosphate
  1356. Ionizing radiation acts on cellular membranes to generate Ceramide and initiate apoptosis.
  1357. Compartmentalized production of Ceramide at the cell surface
  1358. Implication of mitochondrial hydrogen peroxide generation in Ceramide-induced apoptosis
  1359. Ceramide stimulates a cytosolic protein phosphatase.
  1360. Ceramide activates heterotrimeric protein phosphatase 2A
  1361. Ceramide Activates the Stress-activated Protein Kinases (∗)
  1362. Stimulation of DNA synthesis by natural Ceramide 1-phosphate
  1363. Ceramide inactivates cellular protein kinase Cα
  1364. Selectivity of Ceramide-mediated biology. Lack of activity of erythro-dihydroCeramide.
  1365. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable Ceramide
  1366. Ceramide: a stress signal and mediator of growth suppression and apoptosis
  1367. Characterization of a Ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha.
  1368. Abnormality of water barrier function in psoriasis: role of Ceramide fractions
  1369. Ceramide-binding and activation defines protein kinase c-Raf as a Ceramide-activated protein kinase.
  1370. A Ceramide-activated protein phosphatase mediates Ceramide-induced G1 arrest of Saccharomyces cerevisiae.
  1371. Kinase suppressor of Ras is Ceramide-activated protein kinase
  1372. Modulation of cell growth and differentiation by Ceramide
  1373. Ceramide UDPgalactosyltransferase from myelinating rat brain: purification, cloning, and expression.
  1374. Ceramide: a signal for apoptosis or mitogenesis?
  1375. Requirement for Ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
  1376. Lipopolysaccharide induces disseminated endothelial apoptosis requiring Ceramide generation
  1377. Role of Ceramide as a lipid mediator of 1 alpha, 25-dihydroxyvitamin D3-induced HL-60 cell differentiation.
  1378. Ceramide: a novel second messenger
  1379. Role for Ceramide as an endogenous mediator of Fas-induced cytotoxicity.
  1380. Ceramide: a novel second messenger.
  1381. Phosphorylation of Raf by Ceramide-activated protein kinase
  1382. Ceramide: an endogenous regulator of apoptosis and growth suppresion
  1383. Enzymatic synthesis of Ceramide-glucose and Ceramide-lactose by glycosyltransferases from embryonic chicken brain
  1384. Daunorubicin‐induced apoptosis: triggering of Ceramide generation through sphingomyelin hydrolysis.
  1385. Ceramide-mediated biology. Determination of structural and stereospecific requirements through the use of N-acyl-phenylaminoalcohol analogs.
  1386. Distinct roles for Ceramide and glucosylCeramide at different stages of neuronal growth
  1387. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion.
  1388. PKC zeta is a molecular switch in signal transduction of TNF‐alpha, bifunctionally regulated by Ceramide and arachidonic acid.
  1389. A sphingolipid having a novel type of Ceramide and lacto-N-fucopentaose III
  1390. Ceramide 1-phosphate, a novel phospholipid in human leukemia (HL-60) cells. Synthesis via Ceramide from sphingomyelin.
  1391. Retinoblastoma gene product as a downstream target for a Ceramide-dependent pathway of growth arrest.
  1392. Role of the Ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli.
  1393. Ceramide 1‐phosphate phosphatase activity in brain
  1394. Molecular arrangements in sphingolipids Conformation and hydrogen bonding of Ceramide and their implication on membrane stability and permeability
  1395. Direct effect of Ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species: role of mitochondrial glutathione
  1396. A mediator role of Ceramide in the regulation of neuroblastoma Neuro2a cell differentiation
  1397. Analogs of Ceramide that inhibit glucocerebroside synthetase in mouse brain
  1398. Loss of Ceramide production confers resistance to radiation-induced apoptosis
  1399. Conversion of dihydroCeramide into Ceramide: involvement of a desaturase
  1400. Bacterial lipopolysaccharide has structural similarity to Ceramide and stimulates Ceramide-activated protein kinase in myeloid cells
  1401. Ceramide-mediated growth inhibition and CAPP are conserved in Saccharomyces cerevisiae
  1402. Mechanisms of Ceramide-mediated apoptosis
  1403. Characterization of Ceramide synthesis: a dihydroCeramide desaturase introduces the 4, 5-trans-double bond of sphingosine at the level of dihydroCeramide
  1404. FAS-induced apoptosis is mediated via a Ceramide-initiated RAS signaling pathway
  1405. Lipid microdomains in dimyristoylphosphatidylcholine–Ceramide liposomes
  1406. Determination of aminosugar linkages in glycolipids by methylation: aminosugar linkages of Ceramide pentasaccharides of rabbit erythrocytes and of Forssman …
  1407. Requirement for GD3 ganglioside in CD95-and Ceramide-induced apoptosis
  1408. TAK1 mediates the Ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase
  1409. Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat
  1410. Ceramide induces apoptosis via CPP32 activation
  1411. Constituents of Ceramide and Ceramide monohexoside in rice bran
  1412. Conversion of dihydroCeramide to Ceramide occurs at the cytosolic face of the endoplasmic reticulum
  1413. The presence of sphingomyelin-and Ceramide-cleaving enzymes in the small intestinal tract
  1414. In vivo conversions of cerebroside and Ceramide in rat brain
  1415. Ceramide induces apoptosis in cultured mesencephalic neurons
  1416. Endothelial cell inflammatory responses to tumor necrosis factor α: Ceramide-dependent and-independent mitogen-activated protein kinase cascades
  1417. Expression cloning of a cDNA for human Ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis.
  1418. Sphingolipid metabolism in cultured fibroblasts: microscopic and biochemical studies employing a fluorescent Ceramide analogue.
  1419. prICE: a downstream target for Ceramide-induced apoptosis and for the inhibitory action of Bcl-2.
  1420. Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases
  1421. Enzymatic synthesis of Ceramide
  1422. Tumor necrosis factor-alpha and its second messenger, Ceramide, stimulate apoptosis in cultured ovarian follicles
  1423. The enzymatic formation of sphingomyelin from Ceramide and lecithin in mouse liver
  1424. Ceramide profiling of complex lipid mixtures by electrospray ionization mass spectrometry
  1425. Ceramide signalling: regulatory role in cell proliferation, differentiation and apoptosis in human epidermis
  1426. Ceramide synthesis enhances transport of GPI‐anchored proteins to the Golgi apparatus in yeast.
  1427. Ceramide inhibits antigen uptake and presentation by dendritic cells
  1428. The fatty acid composition of brain sphingolipids: sphingomyelin, Ceramide, cerebroside, and cerebroside sulfate
  1429. Mitochondrial free radical signal in Ceramide‐dependent apoptosis: a putative mechanism for neuronal death in Parkinson’s disease
  1430. Ceramide induces structural defects into phosphatidylcholine bilayers and activates phospholipase A2
  1431. Identification of Ceramide phosphorylethanolamine and Ceramide phosphorylglycerol in the lipids of an anaerobic bacterium
  1432. Requirement of an ICE-like protease for induction of apoptosis and Ceramide generation by REAPER
  1433. Characterization of a Ceramide kinase activity from human leukemia (HL-60) cells. Separation from diacylglycerol kinase activity.
  1434. The role of diacylglycerol and Ceramide in tumor necrosis factor and interleukin-1 signal transduction
  1435. Ceramide structure predicts tumor ganglioside immunosuppressive activity.
  1436. Phosphatidate phosphohydrolase catalyzes the hydrolysis of Ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate
  1437. Chemistry of lipid of the posthemolytic residue or stroma of erythrocytes: XVI. occurrence of Ceramide pentasaccharide in the membrane of erythocytes and …
  1438. Synaptic vesicle Ceramide kinase: a calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles
  1439. Ceramide induces apoptosis in PC12 cells
  1440. Coordinate regulation of stress-and mitogen-activated protein kinases in the apoptotic actions of Ceramide and sphingosine
  1441. A novel fluorescent Ceramide analogue for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the …
  1442. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for Ceramide deficiency?
  1443. Phospholipase A2 is necessary for tumor necrosis factor α-induced Ceramide generation in L929 cells
  1444. Resistance to radiation-induced apoptosis in Burkitt’s lymphoma cells is associated with defective Ceramide signaling
  1445. Attenuation of Ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells.
  1446. Ceramide-induced Translocation of Protein Kinase C-δ and-ϵ to the Cytosol: IMPLICATIONS IN APOPTOSIS
  1447. Galactosyl Ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.
  1448. Ceramide As a Modulator of Endocytosis∗
  1449. Sphingomyelinase and Ceramide Suppress Insulin-induced Tyrosine Phosphorylation of the Insulin Receptor Substrate-1 (∗)
  1450. Induction of apoptotic DNA fragmentation and cell death by natural Ceramide
  1451. Possible role of Ceramide in defining structure and function of membrane glycolipids.
  1452. Synthesis of galactosyl Ceramide and glucosyl Ceramide by rat brain: assay procedures and changes with age
  1453. Lipid mediators of insulin resistance: Ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes
  1454. Seasonal influences on stratum corneum Ceramide 1 fatty acids and the influence of topical essential fatty acids
  1455. Does endotoxin stimulate cells by mimicking Ceramide?
  1456. Ceramide trihexosidosis (Fabry’s disease) without skin lesions
  1457. Elevated Ceramide levels in GH4C1 cells treated with retinoic acid
  1458. Fas-or Ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153
  1459. Ceramide formation during heat shock: a potential mediator of alpha B-crystallin transcription.
  1460. Ceramide: a novel lipid mediator of apoptosis
  1461. Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. Evidence that Ceramide may mediate sphingosine …
  1462. Ceramide and the eukaryotic stress response
  1463. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation
  1464. Role of Ceramide in mitogenesis induced by exogenous sphingoid bases.
  1465. Defective Ceramide response in C3H/HeJ (Lpsd) macrophages.
  1466. Ceramide induces interleukin 6 gene expression in human fibroblasts.
  1467. Synthesis of cerebroside by brain from uridine diphosphate galactose and Ceramide containing hydroxy fatty acid
  1468. Galactosyl Ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells
  1469. Distribution of Ceramide 2-aminoethylphosphonate and Ceramide aminoethylphosphate (sphingoethanolamine) in some aquatic animals
  1470. Ceramidase and Ceramide synthesis in human kidney and cerebellum: description of a new alkaline ceramidase
  1471. Cell‐free reconstitution of Fas‐, UV radiation‐and Ceramide‐induced apoptosis.
  1472. Ceramide: an intracellular mediator of apopotosis and growth supression
  1473. Detection and characterization of Ceramide-1-phosphate phosphatase activity in rat liver plasma membrane.
  1474. Induction of apoptotic cell death in hen granulosa cells by Ceramide
  1475. Ceramide di-and trihexosides of wheat flour
  1476. Ceramide inhibits phospholipase D in a cell-free system
  1477. Cytokine response modifier A (CrmA) inhibits Ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the …
  1478. Ceramide-induced nuclear translocation of NF-κB is a potential mediator of the apoptotic response to TNF-α in murine clonal osteoblasts
  1479. Effect of lactic acid isomers on keratinocyte Ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function
  1480. Ceramide: a novel cell signaling mechanism for vasodilation
  1481. Induction of apoptosis and potentiation of Ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells
  1482. … that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting Ceramide glycosylation in human …
  1483. Staurosporine induces programmed cell death in embryonic neurons and activation of the Ceramide pathway
  1484. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of Ceramide in vivo
  1485. Low nanogram range quantitation of diglycerides and Ceramide by high-performance liquid chromatography
  1486. Induction of glucosylCeramide synthase by synthase inhibitors and Ceramide
  1487. Fas-induced apoptosis of T cells occurs independently of Ceramide generation
  1488. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β‐peptide toxicity
  1489. The sphingomyelin-Ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation
  1490. Farber’s lipogranulomatosis: Report of a case and demonstration of an excess of free Ceramide and ganglioside
  1491. Tumor necrosis factor-alpha (TNF-alpha) signal transduction through Ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor …
  1492. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and Ceramide synthesis in the epidermis
  1493. Different Ceramide compositions of gangliosides between human motor and sensory nerves
  1494. Sphingomyelinase and Ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells
  1495. Structures of Ceramide tetrasaccharides from various sources: uniqueness of rat kidney Ceramide tetrasaccharide
  1496. Specificity in Ceramide biosynthesis from long chain bases and various fatty acyl coenzyme A’s by brain microsomes
  1497. Ceramide inhibits pancreatic β-cell insulin production and mitogenesis and mimics the actions of interleukin-1β
  1498. Molecular trapping of a fluorescent Ceramide analogue at the Golgi apparatus of fixed cells: interaction with endogenous lipids provides a trans-Golgi marker for both …
  1499. Mycotoxins reveal connections between plants and animals in apoptosis and Ceramide signaling
  1500. On the structure of brain cerebroside sulfuric ester and Ceramide dihexoside of erythrocytes
  1501. Lactosyl ceramidosis: Normal activity for two lactosyl Ceramide β-galactosidases
  1502. Sphingolipid Biosynthesis de Novo by Rat Hepatocytes in Culture.: Ceramide AND SPHINGOMYELIN ARE ASSOCIATED WITH, BUT NOT REQUIRED FOR …
  1503. Selective involvement of Ceramide in cytokine-induced apoptosis: Ceramide inhibits phorbol ester activation of nuclear factor κB
  1504. Altered Ceramide and sphingosine expression during the induction phase of ischemic acute renal failure
  1505. Anomeric structures of globoside and Ceramide trihexoside of human erythrocytes and hamster fibroblasts
  1506. Phosphorylation of Ceramide by diglyceride kinase preparations from Escherichia coli
  1507. Induction of intracellular Ceramide by interleukin‐1β in oligodendrocytes
  1508. Globoid cell leukodystrophy: deficiency of lactosyl Ceramide beta-galactosidase
  1509. Isolation and characterization of Ceramide glycanase from the leech, Macrobdella decora
  1510. Changes in the Ceramide composition of rat forebrain gangliosides with age
  1511. Role of Ceramide in stimulation of the transcription of cytosolic phospholipase A2and cyclooxygenase 2
  1512. Accumulation of Ceramide in ischemic human brain of an acute case of cerebral occlusion.
  1513. Synthesis of branched poly-N-acetyl-lactosamine type pentaantennary pentacosasaccharide: Glycan part of a glycosyl Ceramide from rabbit erythrocyte membrane
  1514. Involvement of Ceramide in inhibitory effect of IL-1 beta on L-type Ca2+ current in adult rat ventricular myocytes
  1515. Ceramide: A new lipid “second messenger”?
  1516. Bcl-2 interrupts the Ceramide-mediated pathway of cell death.
  1517. Synthesis of non-hydroxy-galactosylCeramides and galactosyldiglycerides by hydroxy-Ceramide galactosyltransferase
  1518. A novel glycosphingolipid-degrading enzyme cleaves the linkage between the oligosaccharide and Ceramide of neutral and acidic glycosphingolipids.
  1519. Analysis and quantitation of free Ceramide containing nonhydroxy and 2-hydroxy fatty acids, and phytosphingosine by high-performance liquid chromatography.
  1520. Inhibition of glycoprotein traffic through the secretory pathway by Ceramide.
  1521. CD95/Fas-induced Ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition
  1522. An efficient approach to stereoselective glycosylation of Ceramide derivatives: use of pivaloyl group as a stereocontrolling auxiliary
  1523. Transfer of ganglioside GM3 oligosaccharide from a water soluble polymer to Ceramide by Ceramide glycanase. A novel approach for the chemical-enzymatic …
  1524. Immunohistochemical localization of galactosyl and sulfogalactosyl Ceramide in the brain of the 30-day-old mouse
  1525. Changes in bioactive lipids, alkylacylglycerol and Ceramide, occur in HIV-infected cells
  1526. A fluorescent derivative of Ceramide: physical properties and use in studying the Golgi apparatus of animal cells
  1527. A Ceramide analog inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N, N-dimethylsphingosine synthesis
  1528. The accumulation and metabolism of a fluorescent Ceramide derivative inPlasmodium falciparum-infected erythrocytes
  1529. Plasma membrane ubiquinone controls Ceramide production and prevents cell death induced by serum withdrawal
  1530. Ceramide inhibits IgG-dependent phagocytosis in human polymorphonuclear leukocytes
  1531. Abnormalities of glycosphingolipid, sulfatide, and Ceramide in the polycystic (cpk/cpk) mouse.
  1532. Ceramide regulates oxidant release in adherent human neutrophils
  1533. Sphingomyelin‐Ceramide turnover in CD28 costimulatory signaling
  1534. Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation
  1535. The galactosyl Ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275
  1536. Ceramide and Ganglioside Accumulation in Farber’s Lipogranulomatosis.
  1537. A unique glycosphingolipid-splitting enzyme (Ceramide-glycanase from leech) cleaves the linkage between the oligosaccharide and the Ceramide
  1538. Inhibition of Ceramide-induced apoptosis by Bcl-2.
  1539. Brain Ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis)
  1540. Isolation and characterization of an I-active Ceramide decasaccharide from rabbit erythrocyte membranes
  1541. … carbohydrates of hamster fibroblasts. I. Chemical characterization of surface-labeled glycosphingolipids and aspecific Ceramide tetrasaccharide for transformants.
  1542. [51] Enzymes of Ceramide biosynthesis
  1543. A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: application to Ceramide-induced apoptosis
  1544. The carbohydrate structures of the neutral Ceramide glycolipids in kidneys of different mouse strains with special reference to the Ceramide dihexosides
  1545. Substrate recognition by Ceramide-activated protein kinase. Evidence that kinase activity is proline-directed.
  1546. c-Jun is a downstream target for Ceramide-activated protein phosphatase in A431 cells
  1547. Hexadecylpalmitoyglycerol or Ceramide is linked to similar glycophosphoinositol anchor‐like structures in Trypanosoma cruzi
  1548. Two distinct binding sites for globotriaosyl Ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new …
  1549. CPP32 inhibition prevents Fas‐induced Ceramide generation and apoptosis in human cells
  1550. The isolation and partial characterization of two novel sphingolipids from Neurospora crassa: di (inositolphosphoryl) Ceramide and [(gal) 3glu] Ceramide
  1551. Pathway of C6-NBD-Ceramide on the Host Cell Infected with Toxoplasma gondtii
  1552. Regulatory Role of Ceramide in Interleukin (IL)-1β-induced E-selectin Expression in Human Umbilical Vein Endothelial Cells: Ceramide ENHANCES IL-1β …
  1553. The human gene CGT encoding the UDP-galactose Ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human …
  1554. Ceramide‐activated protein phosphatase‐2A activity in insulin‐secreting cells
  1555. Effect of cyclodextrins on the solubilization of lignoceric acid, Ceramide, and cerebroside, and on the enzymatic reactions involving these compounds.
  1556. Modified low density lipoprotein delivers substrate for Ceramide formation and stimulates the sphingomyelin-Ceramide pathway in human macrophages
  1557. … receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl Ceramide fatty acid homologues
  1558. Protein kinase C inhibition induces apoptosis and Ceramide production through activation of a neutral sphingomyelinase
  1559. Central glial and neuronal populations display differential sensitivity to Ceramide‐dependent cell death
  1560. Ceramide generation in response to photodynamic treatment of L5178Y mouse lymphoma cells
  1561. Programmed cell death in neurotumour cells involves the generation of Ceramide
  1562. … -carbohydrate interaction between galactosylCeramide-containing liposomes and cerebroside sulfate-containing liposomes: dependence on the glycolipid Ceramide …
  1563. Evidence That Ceramide Selectively Inhibits Protein Kinase C-α Translocation and Modulates Bradykinin Activation of Phospholipase D (∗)
  1564. Molecular species of Ceramide and mono-, di-, tri-, and tetraglycosylCeramide in bran and endosperm of rice grains
  1565. Fabry’s disease as an α-galactosidosis: evidence for an α-configuration in trihexosyl Ceramide
  1566. Isolation, characterization, and expression of cDNA clones that encode rat UDP‐galactose: Ceramide galactosyltransferase
  1567. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl Ceramide alters in vivo tissue targetting and results in a …
  1568. Alteration of the sphingomyelin/Ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-α-mediated …
  1569. Interleukin-1β-induced Ceramide and Diacylglycerol Generation 5 Lead to Activation of the c-Jun NH2-terminal Kinase and the Transcription Factor ATF2 in …
  1570. Ceramide metabolism in brain
  1571. Sphingomyelinase and cell-permeable Ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts.
  1572. The Dimeric and Catalytic Subunit Forms of Protein Phosphatase 2A from Rat Brain Are Stimulated by C2-Ceramide (∗)
  1573. The UDP‐galactose: Ceramide galactosyltransferase: Expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for …
  1574. Activation of CD95 (APO‐1/Fas) signaling by Ceramide mediates cancer therapy‐induced apoptosis
  1575. Occurrence of Ceramide-glycanase in the earthworm, Lumbricusterrestris
  1576. Mice genetically hyporesponsive to lipopolysaccharide (LPS) exhibit a defect in endocytic uptake of LPS and Ceramide
  1577. A Ceramide tetrasaccharide of human erythrocyte membrane reacting with anti-type XIV pneumococcal polysaccharide antiserum
  1578. Sequential operation of Ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling
  1579. Rapid method to detect Shiga toxin and Shiga-like toxin I based on binding to globotriosyl Ceramide (Gb3), their natural receptor
  1580. Influence of phospholipid chain length on verotoxin/globotriaosyl Ceramide binding in model membranes: comparison of a supported bilayer film and liposomes
  1581. Structural study on tetraglycosyl Ceramide and gangliosides isolated from human red blood cells
  1582. N-Acetylsphingosine (C2–Ceramide) Inhibited Neutrophil Superoxide Formation and Calcium Influx (∗)
  1583. On the structure of cytolipin R, a Ceramide tetrahexoside hapten from rat lymphosarcoma
  1584. Ceramide quantitation: evaluation of a mixed micellar assay using E. coli diacylglycerol kinase.
  1585. Effect of L-carnitine treatment in vivo on apoptosis and Ceramide generation in peripheral blood lymphocytes from AIDS patients.
  1586. Ceramide mediates tumor necrosis factor effects on P450-aromatase activity in cultured granulosa cells
  1587. Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal Ceramide turnover in cultured living patient cells
  1588. Generation of diacylglycerol and Ceramide during homologous complement activation.
  1589. Elevation of Ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neurons
  1590. Metabolic effects of short‐chain Ceramide and glucosylCeramide on sphingolipids and protein kinase C
  1591. Orientation of the saccharide chains of glycolipids at the membrane surface: conformational analysis of the glucose-Ceramide and the glucose-glyceride linkages …
  1592. Chemical composition of Ceramide and cerebroside in azuki bean seeds
  1593. Factors affecting expression of glycolipid tumor antigens: influence of Ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylCeramide in …
  1594. Dissociation of endogenous cellular Ceramide from NF-kappa B activation.
  1595. The role of endogenous phosphatidylcholine and Ceramide in the biosynthesis of sphingomyelin in mouse fibroblasts
  1596. Evidence against an early signalling role for Ceramide in Fas-mediated apoptosis
  1597. Induction of Ceramide glucosyltransferase activity in cultured human keratinocytes: correlation with culture differentiation
  1598. Isolation and characterization of a novel monosialosylpentahexosyl Ceramide from Tay-Sachs brain.
  1599. CD19 has a potential CD77 (globotriaosyl Ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell …
  1600. Increased levels of Ceramide in the retina of a patient with Farber’s disease
  1601. Cloning, characterization, and expression of human Ceramide galactosyltransferase cDNA
  1602. Sphingomyelin and Ceramide-phosphoethanolamine synthesis by microsomes and plasma membranes from rat liver and brain.
  1603. BIOSYNTHESIS OF Ceramide BY RAT BRAIN HOMOGENATES1
  1604. Stereospecific Induction of Apoptosis in U937 Cells by N‐Octanoyl‐Sphingosine Stereoisomers and N‐Octyl‐Sphingosine: The Ceramide Amide Group is not …
  1605. Purification and Characterization of UDP-glucose: Ceramide Glucosyltransferase from Rat Liver Golgi Membranes (∗)
  1606. Ceramide and the regulation of apoptosis and the stress response
  1607. Serine protease inhibitors block neutral sphingomyelinase activation, Ceramide generation, and apoptosis triggered by daunorubicin
  1608. Glycolipid depletion using a Ceramide analogue (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells
  1609. Ceramide aminoethylphosphonate in the fungus Pythium prolatum
  1610. Synthesis of cerebroside, lactosyl Ceramide, and ganglioside GM3 analogs containing β-thioglycosidically linked Ceramide
  1611. Isolation and partial characterization of a major inositol-containing lipid in baker’s yeast, mannosyl-diinositol, diphosphoryl-Ceramide
  1612. Thermotropic characterization of phosphatidylcholine vesicles containing ganglioside GM1 with homogeneous Ceramide chain length
  1613. Acidic sphingomyelinase-generated Ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation.
  1614. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and Ceramide-induced apoptosis
  1615. … of I/i-active oligo-and polyglycosylCeramides from rabbit erythrocyte membranes. Determination of branching patterns of a Ceramide pentadecasaccharide by 1H …
  1616. Characterization of a novel glycosphingolipid, Ceramide nonasaccharide, isolated from spermatozoa of the fresh water bivalve, Hyriopsis schlegelii.
  1617. Role of lysosomal acid ceramidase in the metabolism of Ceramide in human skin fibroblasts
  1618. Ceramide is a competitive inhibitor of diacylglycerol kinase in vitro and in intact human leukemia (HL-60) cells.
  1619. Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa Ceramide-activated protein kinase.
  1620. Phospholipids of the sea anemone: Quantitative distribution; absence of carbon‐phosphorus linkages in glycerol phospholipids; structural elucidation of Ceramide …
  1621. Hydrolysis of Ceramide trihexoside by a specific α-galactosidase from human liver
  1622. Enantioselective Synthesis of D‐erythro‐Sphingosine and of Ceramide
  1623. Biologically active glycosides from asteroidea, XXVI. Stereochemistry of the four diastereomers of Ceramide and Ceramide lactoside
  1624. Determination of the presence of Ceramide aminoethylphosphonate and Ceramide N-methylaminoethylphosphonate in marine animals by fast atom bombardment …
  1625. Developmentally regulated expression of Ceramide in Trypanosoma cruzi
  1626. Enzymic hydrolysis of sphingolipids: Hydrolysis of Ceramide lactoside by an enzyme from rat brain
  1627. Enzymic hydrolysis of sphingolipids. Hydrolysis of Ceramide glucoside by an enzyme from ox brain
  1628. UDP-galactose-Ceramide galactosyltransferase in rat brain myelin subfractions during development
  1629. Glycosphingolipids in insects: Chemical structures of Ceramide monosaccharide, disaccharide, and trisaccharide from pupae of Calliphora vicina (Insecta: Diptera)
  1630. The effect of a synthetic Ceramide‐2 on transepidermal water loss after stripping or sodium lauryl sulfate treatment: an in vivo study
  1631. Biochemistry of Organ Glycolipid I. Ceramide-Oligohexosides of Human, Equine and Bovine Spleens
  1632. Mitogen-activated protein kinase activation during IgG-dependent phagocytosis in human neutrophils: inhibition by Ceramide.
  1633. Stimulation of the Ceramide pathway partially mimics lipopolysaccharide-induced responses in murine peritoneal macrophages
  1634. Cross-talk between Ceramide and PKC activity in the control of apoptosis in WEHI-231
  1635. Chronic exposure to κ‐opioids enhances the susceptibility of immortalized neurons (F‐11κ7) to apoptosis‐inducing drugs by a mechanism that may involve Ceramide
  1636. Turnover of endogenous Ceramide in cultured normal and Farber fibroblasts
  1637. … activation in vitro and in vivo induced by glycoinositolphospholipids from Trypanosoma cruzi. Assignment of the T cell-suppressive determinant to the Ceramide …
  1638. Characterization of the major ganglioside in human red cells and of a related tetrahexosyl Ceramide in white cells
  1639. Studies in vitro on the Biosynthesis of Ceramide and Sphingomyelin A Reevaluation of Proposed Pathways
  1640. Regulation of the stress response by Ceramide
  1641. Total synthesis of Ceramide trihexoside accumulating with fabry’s disease
  1642. Permissive effect of Ceramide on growth factor-induced cell proliferation
  1643. Monosialogangliosides of Rabbit Skeletal Muscle. Characterization of N-Acetylneuraminosyl Lacto-N-noroctaosyl Ceramide
  1644. Phase behavior of artificial stratum corneum lipids containing a synthetic pseudo-Ceramide: a study of the function of cholesterol
  1645. Ceramide Triggers Meiotic Cell Cycle Progression in Xenopus Oocytes.: A POTENTIAL MEDIATOR OF PROGESTERONE-INDUCED MATURATION∗
  1646. A Ceramide analogue (PDMP) inhibits glycolipid synthesis in fish embryos
  1647. Characterization of the iso-branched sphinganines from the Ceramide phospholipids of Bacteroides melaninogenicus
  1648. Up-regulation of ganglioside biosynthesis, functional synapse formation, and memory retention by a synthetic Ceramide analog (L-PDMP)
  1649. Golgi staining by two fluorescent Ceramide analogues in cultured fibroblasts requires metabolism.
  1650. Ceramide inhibits IgE-mediated activation of phospholipase D, but not of phospholipase C, in rat basophilic leukemia (RBL-2H3) cells.
  1651. Inhibition of Ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B.
  1652. Nature of Ceramide in bovine milk
  1653. Anomeric structure of Ceramide digalactoside isolated from the kidney of a patient with Fabry’s disease
  1654. Ceramide-induced translocation of protein kinase C ζ in primary cultures of astrocytes
  1655. [14C] Ceramide Synthesis by Sphingolipid CeramideN-Deacylase: New Assay for Ceramidase Activity Detection
  1656. Free Ceramide, sphingomyelin, and glucosylCeramide of isolated rat intestinal cells.
  1657. The synthesis of Ceramide phosphoinositol
  1658. Involvement of a Ceramide activated protein phosphatase in the differentiation of neuroblastoma Neuro2a cells
  1659. Influence of L-carnitine on CD95 cross-lining-induced apoptosis and Ceramide generation in human cell lines: correlation with its effects on purified acidic and neutral …
  1660. Changes in the activity and mRNA levels of phospholipase D during Ceramide‐induced apoptosis in rat C6 glial cells
  1661. The mode of Ceramide action: the alkyl chain protrusion model
  1662. Studies of the action of Ceramide-like substances (d- andl-PDMP) on sphingolipid glycosyltransferases and purified lactosylCeramide synthase
  1663. Increased concentrations of phosphatidate, diacylglycerol and Ceramide in ras-and tyrosine kinase (fps)-transformed fibroblasts
  1664. Cholesterol deprivation affects the fluorescence properties of a Ceramide analog at the Golgi apparatus of living cells.
  1665. Factors affecting surface expression of glycolipids: influence of lipid environment and Ceramide composition on antibody recognition of cerebroside sulfate in …
  1666. Ceramide does not mediate the effect of tumour necrosis factor α on superoxide generation in human neutrophils
  1667. Protein kinase C in the developing kidney: isoform expression and effects of Ceramide and PKC inhibitors
  1668. Requirement of AP-1 for Ceramide-induced apoptosis in human leukemia HL-60 cells
  1669. Rat intestinal glycolipids: II. Distribution and biosynthesis of glycolipids and Ceramide in villus and crypt cells
  1670. … 1β in Inducing Transcriptional Down-regulation of Muscarinic M2 Receptor Gene Expression: INVOLVEMENT OF PROTEIN KINASE A AND Ceramide …
  1671. Glycosphingolipids in insects. Chemical structures of Ceramide tetra-, penta-, hexa-, and heptasaccharides from Calliphora vicina pupae (Insecta: Diptera).
  1672. Ceramide: role in growth inhibitory cascades
  1673. UDPglucose-Ceramide glucosyltransferase from porcine submaxillary glands is associated with the Golgi apparatus
  1674. Molecular cloning, chromosomal mapping, and characterization of the mouse UDP-galactose: Ceramide galactosyltransferase gene
  1675. Metabolism of short-chain Ceramide and dihydroCeramide analogues in Chinese hamster ovary (CHO) cells
  1676. Composition of long chain bases in Ceramide of the guinea pig Harderian gland
  1677. Age‐related changes in the Ceramide composition of the major gangliosides present in rat brain subcellular fractions enriched in plasma membranes of neuronal and …
  1678. Synthesis of neoglycoconjugates using oligosaccharide transferring activity of Ceramide glycanase
  1679. Isolation and characterization of Ceramide trihexosidases (form A) from human plasma
  1680. Studies on galactosyl Ceramide and lactosyl Ceramide β-galactosidase
  1681. Synthesis of a fluorescent derivative of glucosyl Ceramide for the sensitive determination of glucocerebrosidase activity
  1682. Isolation and characterization of a novel ganglioside, monosialosyl pentahexaosyl Ceramide from human brain
  1683. The phosphorylcholine acceptor in the phosphatidylcholine: Ceramide cholinephosphotransferase reaction is the enzyme a transferase or a hydrolase?
  1684. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl Ceramide
  1685. Influence of Bcl-2 overexpression on the Ceramide pathway in daunorubicin-induced apoptosis of leukemic cells
  1686. Molecular arrangements in sphingolipids: crystal structure of the Ceramide N-(2D, 3D-dihydroxyoctadecanoyl)-phytosphingosine
  1687. Preparative isolation of cerebrosides (galactosyl and glucosyl Ceramide)
  1688. Novel Ceramide 1-sulfates, potent DNA topoisomerase I inhibitors isolated from the bryozoa Watersipora cucullata
  1689. Ceramide Reverses Brefeldin A (BFA) Resistance in BFA-resistant Cell Lines (∗)
  1690. Inhibition of Tumor-Necrosis-Factor α-and Ceramide-Induced Internucleosomal DNA Fragmentation by Herbimycin a in U937 Cells
  1691. Ceramide is not a signal for tumor necrosis factor–induced gene expression but does cause programmed cell death in human vascular endothelial cells
  1692. Identification of free Ceramide in human erythrocyte membrane.
  1693. Identification and characterization of a novel monocyte/macrophage differentiation-dependent gene that is responsive to lipopolysaccharide, Ceramide, and …
  1694. Ceramide selectively decreases tau levels in differentiated PC12 cells through modulation of calpain I
  1695. 1, 2-Diacylglycerol and Ceramide levels in insulin-resistant tissues of the rat in vivo.
  1696. Interconversion of the A and B forms of Ceramide trihexosidase from human plasma
  1697. OBSERVATIONS ON THE BIOSYNTHESIS OF RAT BRAIN Ceramide AND CEREBROSIDE IN VIVO
  1698. Molecular cloning and characterization of the mouse CGT gene encoding UDP-galactose Ceramide-galactosyltransferase (cerebroside synthetase)
  1699. The isolation and partial characterization of gangliosides and Ceramide polyhexosides from the lens of the human eye
  1700. Monosialo-lactoisohexaosyl-Ceramide: a ganglioside from human spleen.
  1701. Ceramide glucosylation in bean hypocotyl microsomes: evidence that steryl glucoside serves as glucose donor
  1702. Plasmodium falciparum-infected erythrocytes utilize a synthetic truncated Ceramide precursor for synthesis and secretion of truncated sphingomyelin
  1703. Existence of Ceramide in alfalfa leaves
  1704. Regulation of phosphatidylinositol: Ceramide phosphoinositol transferase in Saccharomyces cerevisiae
  1705. … of nuclear factor kappa B activation induced by tumor necrosis factor requires membrane-associated components. Comparison with pathway activated by Ceramide.
  1706. Taurocholate induces pericanalicular localization of C6-NBD-Ceramide in isolated hepatocyte couplets
  1707. Isolation of Ceramide fractions from human stratum corneum lipid extracts by high-performance liquid chromatography
  1708. Biochemistry of Shellfish Lipid III. Purification and Elemental Analysis of Ceramide Aminoethylphosphonate from Corbicula Complex Lipid Mixtures
  1709. Ceramide and inositol content of the lipopeptidophosphoglycan from Trypanosoma cruzi
  1710. Characterization of Blood‐Group‐H‐Active Ceramide Tetrasaccharide from Hog‐Stomach Mucosa
  1711. Cell-associated Ceramide in HIV-1-infected subjects
  1712. Occurrence of free Ceramide in Acetobacter xylinum
  1713. Interconversion of sphingomyelin and Ceramide in adult Schistosoma mansoni
  1714. Ceramide galactoside of enriched neuronal and glial fractions from rat brain
  1715. A long chain spin label for glycosphingolipid studies: transbilayer fatty acid interdigitation of lactosyl Ceramide
  1716. Ceramide: A novel second messenger and lipid mediator
  1717. Structure determination of a Ceramide pentadecasaccharide by two-dimensional J-resolved and J-correlated NMR spectroscopy
  1718. Isolation of Ceramide-monomethylaminoethylphosphonate from the lipids of Tetrahymena pyriformis W.
  1719. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and Ceramide
  1720. Ceramide synthesis in rat brain: characterization of the synthesis requiring pyridine nucleotide
  1721. Biochemistry of Shellfish Lipids: IX. Enzymatic Hydrolysis of Ceramide 2-Aminoethylphosphonate and Sphingoethanolamine
  1722. The enzymic synthesis of ganglioside: IV. UDP-N-acetylgalactosamine:(N-acetylneuraminyl)-galactosylglucosyl Ceramide N-acetylgalactosaminyl-transferase in rat …
  1723. Chromatography of lipids. I. An improved chromatographic procedure for the quantitative isolation of the neutral Ceramide-containing glycolipids from mammalian …
  1724. Ceramide phosphorylglycerol phosphate a new sphingolipid found in bacteria
  1725. Cell-permeable Ceramide inhibits the growth of B lymphoma Raji cells lacking TNF-alpha-receptors by inducing G0/G1 arrest but not apoptosis: a new model for …
  1726. Synthesis of mannose-(inositol-P) 2-Ceramide, the major sphingolipid in Saccharomyces cerevisiae, requires the IPT1 (YDR072c) gene
  1727. Chemical characterization of Ceramide and cerebroside in soybean leaves
  1728. Influence of topically applied Ceramide/phospholipid mixture on the barrier function of intact skin, atopic skin and experimentally induced barrier damage
  1729. Isolation of Ceramide phosphorylethanolamine from the blowfly Calliphora erythrocephala.
  1730. Spectrophotometric determination of molar amounts of glycosphingolipids and Ceramide by hydrolysis and reaction with trinitrobenzenesulfonic acid
  1731. Ceramide Accumulation Uncovers a Cycling Pathway for the cis-Golgi Network Marker, Infectious Bronchitis Virus M Protein
  1732. … OF MICROSOMAL FRACTIONS FROM BRAIN: SYNTHESIS OF GLUCOSYL Ceramide AND GALACTOSYL Ceramide DURING DEVELOPMENT AND THE …
  1733. Metabolism of glucosyl [13H] Ceramide by human skin fibroblasts from normal and glucosylceramidotic subjects.
  1734. Ceramide-like synthetic amides that inhibit cerebroside galactosidase
  1735. Monoclonal antibody to galactosylCeramide: discrimination of structural difference in the Ceramide moiety
  1736. … binding of propionibacterium granulosum to glycosphingolipids adsorbed on surfaces. An apparent recognition of lactose which is dependent on the Ceramide …
  1737. … neolactoglycolipids: sialosyl-, disialosyl-,O-acetyldisialosyl- and fucosyl- derivatives of neolactotetraosyl Ceramide and neolactohexaosyl Ceramide in the developing …
  1738. Formation of Ceramide phosphorylethanolamine from phosphatidylethanolamine in the rumen protozoon Entodinium caudatum (Short Communication)
  1739. Analysis of glycosphingolipids by fluorophore-assisted carbohydrate electrophoresis using Ceramide glycanase from Mercenaria mercenaria
  1740. Enzymic synthesis of cerebroside from Ceramide and uridine diphosphate galactose.
  1741. Fabry’s disease with partially deficient hydrolysis of Ceramide trihexoside
  1742. Synthetic studies toward the preparation of phosphonate analogs of sphingomyelin and Ceramide 1-phosphate using pentacovalent organophospholene methodology
  1743. Measurement of the rate of myelination using a fluorescent analogue of Ceramide
  1744. Glycosphingolipids in cestodes: Chemical structures of Ceramide monosaccharide, disaccharide, trisaccharide and tetrasaccharide from metacestodes of the fox …
  1745. Induction of nerve growth factor synthesis by sphingomyelinase and Ceramide in primary astrocyte cultures
  1746. Synthesis of sphingomyelin and Ceramide 1-phosphate from Ceramide without protection of the allylic hydroxyl group
  1747. … -1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and Ceramide.
  1748. Total synthesis of stereospecific sphingosine and Ceramide
  1749. Stability of carbohydrate-modified vesicles in vivo: comparative effects of Ceramide and cholesterol glycoconjugates.
  1750. Metabolism of Ceramide-containing endocytotic vesicles in human diploid fibroblasts.
  1751. Effects of niacinamide on Ceramide biosynthesis and differentiation of cultured human keratinocytes.
  1752. Ceramide selectively inhibits early events in the response of human neutrophils to tumor necrosis factor
  1753. A new approach to assay endo-type carbohydrases: bifluorescent-labeled substrates for glycoamidases and Ceramide glycanases
  1754. Consecutive Analysis of Sphingoglycolipids on the Basis of Sugar and Ceramide Moieties by High Performance Liquid Cromatography
  1755. Separation of molecular species of sphingomyelin and Ceramide by argentation and reversed-phase HPLC.
  1756. Structural and thermotropic properties of synthetic C16: 0 (palmitoyl) Ceramide: effect of hydration.
  1757. Sphingomyelinase and cell-permeable Ceramide analogs increase the release of plasminogen activator inhibitor-1 from cultured endothelial cells
  1758. Existence of glucosaminyl lactosyl Ceramide (amino CTH-I) in human erythrocyte membranes as a possible precursor of blood group-active glycolipids
  1759. Fas-mediated apoptosis and sphingomyelinase signal transduction: the role of Ceramide as a second messenger for apoptosis.
  1760. Evaluation of a trans configuration for the apoptosis-inducing activity of Ceramide
  1761. IsoglobotriaosylCeramideand the forssman glycolipid of dog small intestine occupy separate tissue compartments and differ in Ceramide composition
  1762. Ceramide structure of sphingomyelin from human milk fat globule membrane
  1763. Synthesis of triantennary blood group I antigens: Neolacto-glycopentadecaosyl Ceramide
  1764. Studies on the desaturation of sphinganine. Ceramide and sphingomyelin metabolism in the rat and in BHK 21 cells in tissue culture
  1765. Formation of free sphingosine and Ceramide from exogenous ganglioside GM1 by cerebellar granule cells in culture
  1766. Effects of Ceramide analogs on myelinating organ cultures
  1767. Substrate specificity for Ceramide in the enzymatic formation of sphingomyelin
  1768. Role of Ceramide in suramin-induced cancer cell death
  1769. Ceramide glycanase from the earthworm, Lumbricus terrestris
  1770. Glycosphingolipids in insects: The amphoteric moiety, N‐acetylglucosamine‐linked phosphoethanolamine, distinguishes a group of Ceramide oligosaccharides from the pupae …
  1771. Total synthesis of a hexaosyl Ceramide glycolipid acting as a receptor for macrophage migration inhibition-factor
  1772. The reactions of antibodies to paragloboside (lacto-N-neotetraosyl Ceramide) with human erythrocytes and lymphocytes
  1773. Composition and molecular species of Ceramide and cerebroside in scarlet runner beans (Phaseolus coccineus L.) and kidney beans (Phaseolus vulgaris L.)
  1774. Quantitation of lipids by charring on thin-layer plates and scintillation quenching: application to Ceramide determination
  1775. 1-beta-D-Arabinofuranosylcytosine stimulates Ceramide and diglyceride formation in HL-60 cells.
  1776. Comparative responses of liposomes prepared with different Ceramide antigens to antibody and complement
  1777. Opposite effects of tumor necrosis factor alpha on the sphingomyelin-Ceramide pathway in two myeloid leukemia cell lines: role of transverse sphingomyelin …
  1778. The in situ degradation of Ceramide, a potential lipid mediator, is not completely impaired in Farber disease
  1779. Phenotypic changes in 3T3 cells associated with the change of sphingolipid synthesis by a Ceramide analog, 2-decanoylamino-3-morpholino-1-phenylpropanol …
  1780. Differential effects of sphingomyelinase and cell-permeable Ceramide analogs on proliferation of Swiss 3T3 fibroblasts
  1781. Effect of the addition of Ceramide to dioleoylphosphatidylcholine vesicles: an ESR and SEM study
  1782. Isolation and partial characterization of an endogenous inhibitor of Ceramide glycosyltransferases from rat brain.
  1783. The human retinoblastoma gene product suppresses Ceramide-induced apoptosis in human bladder tumor cells.
  1784. Neutral glycosphingolipids and Ceramide composition of ethylnitrosourea‐induced rat neural tumors: accumulation of Ceramide in tumors
  1785. Occurrence of Ceramide digalactoside as the main glycosphingolipid in the marine sponge Halichondria japonica
  1786. The structure and distribution of Ceramide aminoethylphosphonates in the oyster (Ostrea gigas).
  1787. Subcellular distribution of UDP‐galactose: Ceramide galactosyltransferase in rat brain oligodendroglia
  1788. UDPgalactose: Ceramide galactosyltransferase of rat brain: a new method of purification and production of specific antibodies
  1789. Phosphonolipids. XX. Total synthesis of a naturally occurring Ceramide aminoethylphosphonate and of its enantiomer
  1790. … of the forssman glycolipid hapten and a leb-like glycolipid of dog small intestine, as revealed by mass spectrometry: Difference in Ceramide structure related to tissue …
  1791. Studies on the Glycosphingolipids of the Starfish, Asterina pectinifera I. The Isolation and Characterization of Ceramide Mono- and Di-Hexosides
  1792. Glycosphingolipids in insects: Chemical structures of two variants of a glucuronic‐acid‐containing Ceramide hexasaccharide from a pupae of Calliphora vicina (Insecta: Diptera) …
  1793. Ceramide and inflammation
  1794. Comparison of Ceramide synthase inhibitors with other phytotoxins produced by Fusarium species
  1795. Ceramide excluded from cell-free vesicular lipid transfer from endoplasmic reticulum to Golgi apparatus. Evidence for lipid sorting
  1796. Formation of stable lamellar structures with pseudo-Ceramide
  1797. Diacylglycerol and Ceramide kinetics in primary cultures of activated T-lymphocytes
  1798. Gangliotetraosyl-Ceramide, the rat T lymphocyte-macrophage-associated antigen: chemical detection and cellular distribution.
  1799. Sidedness of Ceramide-phosphoethanolamine synthesis on rat liver and brain microsomal membranes.
  1800. Haptenic activity of galactosyl Ceramide and its topographical distribution on liposomal membranes I. effect of cholesterol incorporation
  1801. Vitamin D3 and Ceramide reduce the invasion of tumor cells through extracellular matrix components by elevating protein phosphatase-2A.
  1802. Stereoselective total synthesis of the blood group I-active biantennary neolacto-glycodecaosyl Ceramide
  1803. A synthetic Ceramide analog, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, selectively inhibits adherence during macrophage differentiation …
  1804. Enzymic glycosphingolipid synthesis on polymer supports. II. Synthesis of lactosyl Ceramide
  1805. Gel phase preference of ganglioside GM1 at low concentration in two-component, two-phase phosphatidylcholine bilayers depends upon the Ceramide moiety
  1806. Suppression of Bcl-2 Messenger RNA Production May Mediate Apoptosis after Ionizing Radiation, Tumor Necrosis Factor α, and Ceramide
  1807. C2‐Ceramide and C6‐Ceramide inhibited priming for enhanced release of superoxide in monocytes, but had no effect on the killing of leukaemic cells by monocytes
  1808. The sphingomyelin–Ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid A, but not α-fibrinogen
  1809. A Novel Ceramide Trihexoside from the Eggs of the Sea Urchin, Hemicentrotus pulcherrimus
  1810. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of Ceramide from sphingomyelin and is blocked by bcl-XL
  1811. Di-O-alkylglycerol, mono-O-alkylglycerol and Ceramide inositol phosphates of LeishmaniaMexicanaMexicana promastigotes
  1812. [39] Ceramide glycanase from Leech, Hirudo medicinalis, and earthworm, Lumbricus terrestris
  1813. Transforming growth factor β1 attenuates Ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells
  1814. Bombesin-stimulated Ceramide production and MAP kinase activation in rabbit rectosigmoid smooth muscle cells
  1815. Developmental changes of monohexosylCeramide and free Ceramide in the large intestine of the rat
  1816. The cohydrolases in human spleen that stimulate glucosyl Ceramide β-glucosidase
  1817. A micromethod for the determination of Ceramide
  1818. Studies on Glycosphingolipids of Fresh-Water Bivalves V. The Structure of a Novel Ceramide Octasaccharide Containing Mannose-6-Phosphate Found in the Bivalve …
  1819. Synthesis of ganglioside GM3 and GM4 analogs having mimics of Ceramide moieties and their binding activities with influenza virus A
  1820. Forssman glycolipid variants of dog gastric mucosa: structure of a branched Ceramide octasaccharide
  1821. Effect of exogenous lipids on membrane-bound Ceramide glycosyltransferases of rat brain
  1822. Enzymatic Hydrolysis of Sphingolipids. VI. Hydrolysis of Ceramide Glycosides by Calf Brain β-N-Acetylhexosaminidase*
  1823. A convenient synthesis of sphingosine and Ceramide from D-xylose or D-galactose
  1824. C2-Ceramide primes specifically for the superoxide anion production induced by N-formylmethionylleucyl phenylalanine (fMLP) in human neutrophils
  1825. Reactivity of two anti-galactosyl Ceramide antibodies towards myelin basic protein
  1826. Ceramide-mediated and isoquinolinesulfonamide-sensitive pathways of neuronal death: anything in common?
  1827. Isolation of cerebroside containing glucose (Glucosyl Ceramide) and its possible significance in ganglioside synthesis
  1828. Enzymatic Formation of Plant Cerebroside: Properties of UDP-glucose: Ceramide Glu-cosyltransferase in Radish Seedlings
  1829. Blood group A active Ceramide hexasaccharide lacking N-acetylglucosamine isolated from hog stomach mucosa
  1830. Increased stratum corneum Ceramide levels and improved barrier function following topical treatment with tetraacetylphytosphingosine.
  1831. Exposure of galactosylCeramide to galactose oxidase in liposomes: dependence on lipid environment and Ceramide composition
  1832. A novel glycosphingolipid hydrolyzing enzyme, glycosphingolipid Ceramide deacylase, which cleaves the linkage between the fatty acid and sphingosine base in …
  1833. Ceramide-1-phosphate sugars: new types of glycophospholipids
  1834. Ceramide‐GALACTOSYLTRANSFERASE AND CEREBROSIDE‐SULPHOTRANSFERASE LOCALISATION IN GOLGI MEMBRANES ISOLATED BY A …
  1835. A simplified assay method for galactosyl Ceramide β-galactosidase
  1836. Linomide prevents the lethal effect of anti-Fas antibody and reduces Fas-mediated Ceramide production in mouse hepatocytes.
  1837. Ceramide synthesis from free fatty acids in rat brain: Function of NADPH and substrate specificity
  1838. Activation of phospholipase D in human fibroblasts by Ceramide and sphingosine: evaluation of their modulatory role in bradykinin stimulation of phospholipase D
  1839. A two-dimensional thin-layer chromatography procedure for simultaneous separation of Ceramide and diacylglycerol species
  1840. Activation of the sphingomyelin cycle by brefeldin A: effects of brefeldin A on differentiation and implications for a role for Ceramide in regulation of protein trafficking
  1841. Structure elucidation of blood group B-like and I-active Ceramide eicosa-and pentacosa-saccharides from rabbit erythrocyte membranes by combined gas …
  1842. The inhibitor-sensitive sites of galactosyl Ceramide galactosidase
  1843. UDP galactose: Ceramide galactosyltransferase and glutamate/aspartate transporter: copurification, separation and characterization of the two glycoproteins
  1844. Water‐Soluble Glycosphingolipids of Dog Gastric Mucosa: Characterization of a Branched Ceramide Heptasaccharide
  1845. Purification and properties of UDP-galactose: Ceramide galactosyltransferase from rat brain microsomes
  1846. Immune reactivities of antibodies against glycolipids—II comparative properties, using liposomes, of purified antibodies against mono-, di-and thihexosyl Ceramide …
  1847. A total synthesis of Forssman glycolipid, globopentaosyl Ceramide
  1848. Glycolipids from sponges, I. Glycosyl Ceramide composition of the marine sponge Agelas clathrodes
  1849. MelibiosylCeramide as the Sole Ceramide Dihexoside from the Eggs of the Sea Urchin, Anthocidaris crassispina
  1850. A rapid and simple assay method for UDP-glucose: Ceramide glucosyltransferase
  1851. Distribution of glycosphingolipids and Ceramide of rat small intestinal mucosa
  1852. Sphingomyelin is synthesized at the plasma membrane of oligodendrocytes and by purified myelin membranes: a study with fluorescent‐and radio‐labelled Ceramide …
  1853. Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant Ceramide in difluoromethylornithine-resistant leukaemia cells
  1854. Isolation and Characterization of a Monosialosylgangliopentaosyl Ceramide from Xenopus laevis Oocyte
  1855. Interferon-γ decreases cell surface expression of galactosyl Ceramide, the receptor for HIV-1 gp120 on human colonic epithelial cells
  1856. Interleukin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role of Ceramide on progesterone and prostaglandin …
  1857. Metabolism of Ceramide phosphorylethanolamine, phosphatidylinositol, phosphatidylserine and phosphatidylglycerol by housefly larvae
  1858. UDP‐galactose: Ceramide galactosyl transferase of isolated oligodendroglia
  1859. Structure of the Ceramide octadekahexoside isolated from gastric mucosa
  1860. Ganglioside shedding and changes in Ceramide biosynthesis in human ovarian tumors.
  1861. Ceramide lactoside in amniotic fluid: high concentration in chorioamnionitis and in preterm labor
  1862. In situ assay of acid sphingomyelinase and ceramidase based on LDL-mediated lysosomal targeting of Ceramide-labeled sphingomyelin
  1863. 1, 2-Diacylglycerol and Ceramide levels in rat skeletal muscle and liver in vivo. Studies with insulin, exercise, muscle denervation, and vasopressin.
  1864. The presence of sialidase-sensitive sialosylgangliotetraosyl Ceramide (GM1b) in stimulated murine macrophages. Deficiency of GM1b in Escherichia coli-activated …
  1865. Monensin inhibits synthesis of plasma membrane sphingomyelin by blocking transport of Ceramide through the Golgi: evidence for two sites of sphingomyelin …
  1866. Identification of molecular species of Ceramide 2-N-methyl-aminoethylphosphonates containing normal fatty acids and dihydroxy long chain bases from Turbo …
  1867. UDP-galactose: Ceramide galactosyltransferase of rat central-nervous-system myelin.
  1868. Inhibition of acyl-CoA: cholesterol acyltransferase in Chinese hamster ovary (CHO) cells by short-chain Ceramide and dihydroCeramide
  1869. A facile stereoselective synthesis of sphingosine and Ceramide
  1870. … virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl Ceramide/3’sulfo-galactosyl Ceramide-positive cell line
  1871. The enzymic synthesis of ganglioside: I. Brain uridine diphopphate D‐galactose: N‐acetyl‐galactosaminyl‐galactosyl‐glucosyl‐Ceramide galactosyl transferase
  1872. Upregulation of Bcl-2 and elevation of Ceramide in Batten disease
  1873. Determination of the anomeric configurations of Corbicula Ceramide di-and trihexoside by chromium trioxide oxidation
  1874. Ceramide synthase and ceramidases in the regulation of sphingoid base metabolism
  1875. Regulation of UDP‐galactose: Ceramide galactosyltransferase and UDP‐glucose: Ceramide glucosyltransferase after crush and transection nerve injury
  1876. A bi-fluorescence-labeled substrate for Ceramide glycanase based on fluorescence energy transfer
  1877. Synthesis of D-erythro-sphingomyelin and of D-erythro-Ceramide-1-phosphoinositol
  1878. … of HeLa Cells During the Cell Cycle: Suppression of Sphingomyelin and Higher‐Glycosphingolipid Synthesis and Accumulation of Ceramide and GlucosylCeramide in …
  1879. Activated Ki-ras Enhances Sensitivity of Ceramide-induced Apoptosis without c-Jun NH2-Terminal Kinase/Stress-activated Protein Kinase or Extracellular Signal …
  1880. A study of the bidimensional miscibility of Ceramide and dioleoylphosphatidylcholine
  1881. Purification of uridine diphosphate-galactose: glucosyl Ceramide, beta 1-4 galactosyltransferase from human kidney.
  1882. A part of glucosylCeramide formed from exogenous lactosylCeramide is not degraded to Ceramide but re-cycled and glycosylated in the Golgi apparatus
  1883. Ceramide glycanase from rat mammary tissues: inhibition by PPMP (D-/L-) and its probable role in signal transduction.
  1884. Metabolism of Ceramide trihexoside in cultured skin fibroblasts from Fabry’s patients, carriers and normal controls
  1885. Stereoselective total synthesis of wheat flour Ceramide dihexoside
  1886. Kinetic and topographical studies of the phosphatidylcholine: Ceramide choline phosphotransferase in plasma membrane particles from mouse ascites cells
  1887. Haptemc Activity of Galactosyl Ceramide and Its Topographical Distribution on Liposomal Membranes. Effects of Temperature and Phospholipid Composition
  1888. Thermotropic behavior of stratum corneum lipids containing a pseudo-Ceramide
  1889. Lack of in vitro Ceramide formation in the PNS of Trembler mice
  1890. Galactose to Ceramide linkage is essential for the binding of a polyclonal antibody to galactosyl Ceramide
  1891. Deacylation of Ceramide, triacylglycerol and phospholipids in guinea pig epidermal cells
  1892. The enzymic synthesis of ganglioside. II. UDP-galactose: N-acetylgalactosaminyl-(N-acetyl-neuraminyl) galactosyl-glucosyl-Ceramide galactosyltransferase in rat …
  1893. Cytolipin R and its possible precursor Ceramide trisaccharide from metastatic rat mammary tumor
  1894. Cerebrosides of frog brain. Structure of the Ceramide part of the cerebrosides
  1895. Biochemistry of Shellfish Lipids VIII. Ocurrence of Ceramide Mono- and Dihexoside in Corbicula, corbicula sandai
  1896. Accumulation of lactosyl Ceramide in leukocytes of patients with adult Gaucher’s disease
  1897. Involvement of the acyl chain of Ceramide in carbohydrate recognition by an anti-glycolipid monoclonal antibody: the case of an anti-melanoma antibody, M2590, to G …
  1898. Ceramide, triglyceride, and sterol ester in normal human whole brain at different ages
  1899. Synthesis of bi-fluorescence-labeled lactoside: A substrate for continual assay of Ceramide glycanase
  1900. Topical Ceramide corrected epidermal cell hyperproliferation and stratum corneum dysmaturation in atopic eczema
  1901. Synthesis of sulfated cerebroside analogs having mimicks of Ceramide and their anti-human immunodeficiency virus type 1 activities
  1902. Cyclic AMP accumulation in HeLa cells induced by cholera toxin. Involvement of the Ceramide moiety of GM1 ganglioside
  1903. Solubilization of UDPglucose-Ceramide glucosyltransferase from the Golgi apparatus
  1904. Globotriaosyl Ceramide glycolipid in seminoma: its clinicopathological importance in differentiation from testicular malignant lymphoma
  1905. Phosphono-sphingomyelins. I: Synthesis of Ceramide (trimethyl) aminoethyl phosphonate
  1906. Glycosphingolipids: deuterium NMR study of the influence of Ceramide fatty acid characteristics on the carbohydrate headgroup in phospholipid bilayers
  1907. Synthesis of ganglioside GM1 containing a thioglycosidic bond to its labeled Ceramide (s). A facile synthesis starting from natural gangliosides
  1908. Ceramide Dihexosides from the Spermatozoa of the Starfish, Asterias amurensis, Consist of Gentiobiosyl-, Cellobiosyl-, and Lactosy leer amide
  1909. Complex Fucolipids of Hog Gastric Mucosa Structure of the Ceramide Eikosahexoside
  1910. Glycosphingolipids: deuterium NMR study of the influence of carbohydrate headgroup structure on Ceramide acyl chain behavior in glycolipid-phospholipid bilayers
  1911. Total synthesis of a sulfated glucuronic acid containing glycoheptaosyl Ceramide, a minor glycolipid isolated from human cauda equina tissue
  1912. Release of Ceramide after membrane sphingomyelin hydrolysis decreases the basolateral secretion of triacylglycerol and apolipoprotein B in cultured human …
  1913. Isolation of Free Ceramide from Zymomonas mobilis
  1914. Synthetic studies on sialoglycoconjugates 40: stereocontrolled synthesis of sialyl Lewis X epitope and its Ceramide derivative
  1915. A fluorometric assay of Ceramide glycanase with 4-methylumbelliferyl β-d-lactoside derivatives
  1916. Fumonisins: naturally occurring inhibitors of Ceramide synthesis
  1917. Complete 1H-NMR spectral assignments for globotriaosyl-Z-and isoglobotriaosyl-E-Ceramide
  1918. Ceramide galactosyltransferase and cerebroside sulphotransferase in chicken brain cellular fractions and glial and neuronal cells in culture
  1919. Human Kidney α-Galactosidase: Multiplicity and Enzyme Activities for Ceramide Trihexoside and Some Aryl α-Galactosides
  1920. Ceramide, a sphingolipid second messenger
  1921. Synthesis of myelin glycosphingolipids (galactosylCeramide and galactosyl (3-O-sulfate) Ceramide (sulfatide)) by cloned cell lines derived from mouse …
  1922. Characterization and developmental changes of UDP‐galactose‐Ceramide galactosyl transferase in a rat CNS axolemma‐enriched fraction. Differences and …
  1923. Ceramide hexosides in Niemann-Pick disease brain
  1924. Bcl‐2 antagonizes apoptotic cell death induced by two new Ceramide analogues
  1925. Hypoxic injury to oligodendrocytes: Reversible inhibition of ATP‐dependent transport of Ceramide from the endoplasmic reticulum to the golgi
  1926. Analysis of Ceramide and monohexaosyl glycolipid derivatives by high-performance liquid chromatography and its application to the determination of the molecular …
  1927. Interaction of Shigella toxin with globotriaosyl Ceramide receptor—Containing membranes: A fluorescence study
  1928. Clear differences in Ceramide metabolism between glycosphingolipids and sphingomyelin in a human promyelocytic leukemia cell line HL-60 stimulated by a …
  1929. Structure elucidation of the blood group B like and blood group I active octaantennary Ceramide tetracontasaccharide from rabbit erythrocyte membranes by two …
  1930. Occurrence of phosphonotetraglycosyl Ceramide in the sea hare Dolabella auricularia
  1931. Temporal phases in apoptosis defined by the actions of Src Homology 2 domains, Ceramide, Bcl-2, interleukin-1β converting enzyme family proteases, and a dense …
  1932. Total synthesis of glycononaosyl Ceramide with a sialyl dimeric Lex sequence
  1933. Brain UDPgalactose: Ceramide galactosyltransferase: Purification of a catalytically active protein obtained after proteolytic digestion
  1934. Ceramide in rice grain
  1935. Effect of thiols on epidermal Ceramide biosynthesis.
  1936. Glycolipid sialosyltransferase activity in synaptosomes exhibits a product specificity for (2–8) disialosy lactosyl Ceramide (ganglioside GD3)
  1937. Uptake and metabolism of fluorescent Ceramide analogs by rat oligodendrocytes in culture
  1938. Ceramide biosynthesis in mouse brain microsomes: Comparison between C57/BL controls and quaking mutants
  1939. Enzymatic deficiency in neurological mutants. Brain uridine diphosphate galactose: Ceramide galactosyl transferase in Jimpy mouse
  1940. UDP-glucose: Ceramide glucosyltransferase of rat brain: an association with smooth microsomes and requirement of an intact membrane for enzyme activity
  1941. Bradykinin increases Ceramide and sphingosine content in human fibroblasts: possible involvement of glycosphingolipids
  1942. Sheep erythrocyte Forssman hapten, an isohapten system: Composition of the Ceramide
  1943. A novel synthesis of Ceramide from lignoceric acid and sphingosine by rat brain preparation; the amide formation requires a pyridine nucleotide
  1944. Effects of Ceramide and protein kinase C on the regulation of type I 5′-deiodinase in FRTL-5 rat thyroid cells
  1945. Glycolipids from sponges, II. Glycosyl Ceramide composition of the marine sponge Agelas longissima
  1946. Occurrence of Ceramide Aminoethylphosphonate in Edible Shellfish, AGEMAKI, Sinonovacula constricta
  1947. Novel modification of Ceramide: rat glioma ganglioside GM3 having 3‐O‐acetylated sphingenine
  1948. Kinetic changes in free Ceramide and cerebroside during germination of black gram
  1949. Characterization of a novel Ceramide octasaccharide isolated from whole tissue of a fresh-water bivalve, Corbicula sandai
  1950. Expression of the Ceramide galactosyltransferase gene during myelination of the mouse nervous system. Comparison with the genes encoding myelin basic proteins …
  1951. Distribution of Ceramide 2-aminoethylphosphonate in nature and its quantitative correlation to sphingomyelin
  1952. UDPgalactose: Ceramide galactosyltransferase and 2′, 3′-cyclic-nucleotide 3′-phosphodiesterase activities in rat brain after long-term exposure to methylmercury …
  1953. Structures of fucose‐containing Ceramide pentasaccharides from the plasma of blood group O Le(a−b−) nonsecretors
  1954. Structural analysis by mass spectrometry of the major mammalian retinal ganglioside, a sialyl‐sialyl‐dihexosyl‐Ceramide
  1955. Fabry’s disease (Ceramide trihexosidase deficiency): diagnostic confirmation by analysis of dental pulp
  1956. Alteration of Ceramide monohexoside in human diploid fetal lung fibroblasts during cell aging
  1957. Formation of Lysosulfatide, 3′, 6′-Anhydropsychosine, Ceramide, and Sphingosine by Saponification of Cerebroside Sulfate: Effect of the Sulfate Group on the …
  1958. Solubilization and partial characterization of fatty acyl-CoA: sphingosine acyltransferase (Ceramide synthetase) from rat liver and brain
  1959. Properties of immobilized FIG α-galactosidase and effect of Ceramide-3 content of plasma from patients with fabry’s disease
  1960. Detection of the gangliosideN-glycolyl-neuraminyl-lactosyl-Ceramide by biotinylatedEscherichia coli K99 lectin
  1961. The presence of Ceramide hydrolase and synthetase in pig lens epithelium.
  1962. Less polar glycolipids in Alaskan pollack brain: isolation and characterization of acyl galactosyl diacylglycerol, acyl galactosyl Ceramide, and acyl glucosyl Ceramide.
  1963. Immunogenic properties of mannose-containing Ceramide tetrasaccharide from fresh-water bivalve, Hyriopsis schlegelii
  1964. Occurrence of Ceramide phosphorylethanolamine containing hydroxy fatty acid in a bivalve
  1965. … galactosphingolipid synthesis in an immortalized Schwann cell line: evidence for different intracellular locations of galactosylCeramide sulfotransferase and Ceramide …
  1966. Enantiospecific Syntheses of Sphingosine and Ceramide Stereoisomers with 3S Configuration from d-Glucose
  1967. High-energy collision-induced dissociation of Ceramide ions from permethylated glycosphingolipids
  1968. Sidedness of Ceramide-phosphoethanolamine synthesis on rat liver plasma membrane
  1969. Localization of mRNA for UDP-galactose: Ceramide galactosyltransferase in the brain during mouse development
  1970. Immunocytochemical localization of UDP-galactose: Ceramide galactosyltransferase in myelin and oligodendroglial cells of rat brain
  1971. Ceramide GLYCOSYLTRANSFERASES IN CULTURED RAT CEREBELLUM: CHANGES WITH AGE, WITH DEMYELINATION, AND WITH INHIBITION OF …
  1972. Immunogenic properties of mannose-containing Ceramide disaccharide and immunochemical detection of its hapten in the two kinds of crustacean, Euphausia …
  1973. FREE Ceramide IN BLOOD AND ITS RELEVANCE TO ATHEROSCLEROSIS. PART 1.
  1974. Formation of free fatty acid and Ceramide during brain handling: lability of sphingomyelin
  1975. On the Biosynthesis of Cerebrosides Containing 2-Hydroxy Acids: MASS SPECTROMETRIC EVIDENCE FOR BIOSYNTHESIS VIA THE Ceramide PATHWAY
  1976. UDP-galactose: Ceramide galactosyltransferase of rat central nervous system myelin during development
  1977. A total synthesis of a stage specific embryonic antigen-3 (SSEA-3), globopentaosyl Ceramide, IV3GalGb4Cer. Use of 2, 4, 6-trimethylbenzoyl group as a …
  1978. Induction of Oligodendrocyte Apoptosis by C2-Ceramide
  1979. Regional and developmental estimations of UDP galactose: Ceramide galactosyltransferase activity in the rat brain
  1980. Ceramide stimulates prostaglandin production by human amnion and decidual cells
  1981. N-Hexyl-0-glucosyl sphingosine, an inhibitor of glucosyl Ceramide, β-glucosidase
  1982. [14] Ceramide glycanase from the leech Macrobdella decora and oligosaccharide-transferring activity
  1983. Solubilization and characterization of microsomal‐associated phosphatidylinositol: Ceramide phosphoinositol transferase from Saccharomyces cerevisiae
  1984. Enzymatic synthesis of glucocerebroside by UDP-glucose: Ceramide glucosyltransferase during ontogenesis of chicken retina
  1985. Hydrolysis of sphingomyelin to Ceramide with hydrofluoric acid
  1986. Brain-specific Ceramide synthesis activity: Change during brain maturation and in jimpy mouse brain
  1987. C6-Ceramide maintains elevated cytosolic calcium levels in activated platelets
  1988. The metastability of glucosyl Ceramide in aqueous phase: effect of hydration and phosphatidylcholines of various chain length
  1989. Rapid internalization of exogenous ganglioside GM3 and its metabolism to Ceramide in human myelogenous leukemia HL‐60 cells compared with control ganglioside …
  1990. Inhibitory action of sphingosine or Ceramide on amylase secretion from isolated rat pancreatic acini
  1991. Sphingosine and phytosphingosine from D-threose synthesis of a 4-keto-Ceramide
  1992. On the biosynthesis of cerebrosides containing non-hydroxy acids: 2. Mass spectrometric evidence for the Ceramide pathway
  1993. 1, 2-Diacylglycerol and Ceramide levels in rat liver and skeletal muscle in vivo
  1994. 1H NMR Ganglioside Ceramide Resonance Region on the Differential Diagnosis of Low and High Malignancy of Brain Gliomas
  1995. Sulfatide and sphingomyelin loading of living cells as tools for the study of Ceramide turnover by lysosomal ceramidase-Implications for the diagnosis of farber-disease
  1996. Occurrence of nonenzymatic N‐acetylation of sphinganine with acetyl coenzyme a producing C2‐H2‐Ceramide and its inconvertibility to apoptotic C2‐Ceramide
  1997. Accumulation of isogloboside and ganglio-N-tetraosyl Ceramide having blood group B determinant in the hepatomas of female LEC rats
  1998. Constituents of Ceramide of a Native Mushroom
  1999. Synthesis of 2‐N‐oleoylamino‐octadecane‐1,3‐diol: a new Ceramide highly effective for the treatment of skin and hair
  2000. Resistance to anti‐IgM‐induced apoptosis in a WEHI‐231 subline is due to insufficient production of Ceramide
  2001. Synthetic studies on selectin ligands/inhibitors: a systematic synthesis of sulfatide and its higher congeners carrying 2-(tetradecyl) hexadecyl group as a Ceramide …
  2002. Cattle blood group J glycolipid—I Isolation and identification of the trihexoside Ceramide component of J hapten
  2003. The Rise and Fall of Ceramide and 1, 2-Diacylglycerol (DAG): Modulation by Transforming Growth Factor-β1 (TGFβ1) and by Epidermal Growth Factor (EGF)
  2004. A comparative study on Ceramide composition of cetacean brain gangliosides.
  2005. Factors affecting the hydrolysis of Ceramide-3 by alpha-galactosidase A from human liver.
  2006. In vivo metabolism of fluorescent Ceramide in central nervous system myelin of adult rats
  2007. Turnover In Vivo of Lactosyl‐Ceramide and Other Glycosphingolipids in the Adult Rat Brain
  2008. Tumor necrosis factor α increases tyrosine phosphorylation of a 23-Kda nuclear protein in U937 cells through Ceramide signaling pathway
  2009. Reactivity of sphingosine base in enzymatic synthesis of Ceramide
  2010. … synthesis of gangliosides: Uridine diphosphate galactose: N-acetylgalactosaminyl-(N-acetylneuraminyl)-galactosyl-glucosyl-Ceramide galactosyltranferase in rat …
  2011. A comparison of the properties and bile salt specificities of galactosylCeramide and lactosyl Ceramide β-galactosidase activities in human leucocytes and fibroblasts
  2012. Preparation of superoxide dismutase entrapped in Ceramide-containing liposomes for oral administration
  2013. … spongiform encephalopathy: I. Changes in the activities of 2′, 3′-cyclic nucleotide 3′-phosphohydrolase, oligodendroglial Ceramide galactosyl transferase, and …
  2014. First‐trimester enzyme exclusion of farber disease using a micromethod with [3H]Ceramide
  2015. Assignment of a UDP-glucose: Ceramide glucosyltransferase gene (UGCG) to human chromosome band 9q31 by in situ hybridization
  2016. Stimulation of human immunodeficiency virus type 1 expression by Ceramide
  2017. Efficient synthesis of sphingosine‐1‐phosphate, Ceramide‐1‐phosphate, lysosphingomyelin, and sphingomyelin
  2018. UPD-galactose: Ceramide galactosyltransferase activity in dissociated cell cultures from brain hemispheres of newborn rats
  2019. Evidence for the biosynthesis of Ceramide-phosphoethanolamine in brain synaptic plasma membrane vesicles and in sciatic nerve microsomes from normal and …
  2020. … molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of Ceramide in biologic action …
  2021. Dependence of rat liver CMP-N-acetylneuraminate: GM1 sialyltransferase (SAT IV) activity on the Ceramide composition of GM1 ganglioside
  2022. Phosphonolipids. XIX. Synthesis of a naturally occurring Ceramide aminoethylphosphonate and its enantiomer
  2023. Synthetic Studies on Sialoglycoconjugates 82: First Total Synthesis of Sialyl Globopentaosyl Ceramide (V3Neu5AcGb5Cer) and its Positional Isomer …
  2024. Studies on sphingolipids of Barnea (Umitakea) dilatata japonica. I. Cerebroside and Ceramide aminoethylphosphonate
  2025. Synthesis of sialo-oligosaccharides and their Ceramide derivatives as tools for elucidation of biologic functions of gangliosides
  2026. A convenient synthesis of galactocerebroside using D-glucosamine as a chiral source of the Ceramide moiety
  2027. Ceramide hexosides in rabbit meat
  2028. Sphingomyelin and Ceramide: phosphoethanolamine synthesis in ram spermatozoa plasma membrane.
  2029. Inhibition of thrombin-stimulated cell proliferation by Ceramide is not through inhibition of extracellular signal-regulated protein kinase
  2030. Thermotropic behavior of phosphatidylcholine-glucosyl Ceramide mixtures: Effects of phospholipid acyl chain composition and interaction with water
  2031. Phosphatidylethanolamine-Ceramide-ethanolaminephosphotransferase activity in synaptic plasma membrane vesicles: comparison with sialidase and ouabain …
  2032. Benzopurpurin and related compounds inhibit the binding of gp120 to galactosyl Ceramide/sulfatide and infection of human immunodeficiency virus
  2033. Ceramide from the marine sponge Phyllospongia sp
  2034. Specific cleavage of the glycosidic bond between the carbohydrate and Ceramide portions in glycosphingolipids using trifluoroacetolysis
  2035. … Studies on Sialoglycoconjugates 89: Synthesis of Ganglioside GM3 and KDN-GM3 Containing Different Carbon-Chain Length Fatty Acyl Groups at the Ceramide …
  2036. 2-Hydroxy fatty acid-and phytosphingosine-containing Ceramide 2-N-methylaminoethyl-phosphonate from turbo cornutus
  2037. Purification of GM 1-ganglioside and Ceramide lactoside β-galactosidase from rabbit brain
  2038. Immunohistochemical study of globotriaosyl Ceramide (Gb3) in testicular tumors
  2039. … type 2 chain in A-active hexaglycosylCeramide of rat small intestine at weaning time. Demonstration by affinity chromatography and Ceramide glycanase hydrolysis of …
  2040. UPD-Galactose: Ceramide Galactosyltransferase. Kinetic Properties and Effect of Detergents and Phospholipids on the Partially Purified Enzyme of Rat Brain
  2041. Involvement of a CrmA-insensitive ICE/Ced-3-like protease in Ceramide-induced apoptosis.
  2042. Studies on the Interaction of Clostridium perfringens Sialidase with Sialic Acid Linked to the Internal Galactose in Monosialogangliotetraosyl Ceramide
  2043. Biologically active glycosides from asteroidea, XVII. Glycosphingolipids from the starfish Acanthaster planci, 3. Isolation and structure of two new Ceramide lactosides
  2044. Recognition by a natural cytotoxic antibody of lactoneotetraglycosyl Ceramide as an antigenic molecule in a syngeneic rat fibrosarcoma
  2045. Chemical effects of ionizing radiations on Ceramide digalactoside and component molecules
  2046. Characterization of the lacto series of gangliosides, especially of disialo-lacto-N-norhexaosyl Ceramide isolated from adult bovine nasal cartilage
  2047. Spectroscopical characteristics of galactosylCeramide-pyrene and Ceramide-pyrene incorporated in model and in clathrin coated vesicles
  2048. Biologically Active Glycosides from Asteroidea, XXX. – Synthesis of an Optically Active Ceramide of GM1‐Type Ganglioside from (+)‐diethyl L‐Tartrate
  2049. Synthetic studies on sialoglycoconjugates 70: synthesis of sialyl and sulfo lewis× analogs containing a Ceramide or 2-(Tetradecyl) hexadecyl residue
  2050. Influence of phospholipid environment on the phosphatidylethanolamine: Ceramide-phosphorylethanolamine transferase activity in rat liver plasma membranes.
  2051. Effect of structural variability of the Ceramide part on the saccharide-Ceramide linkage in model glycolipids studied by Molecular Mechanics and Molecular Dynamics …
  2052. UDP galactose: Ceramide galactosyltransferase, CDP choline: 1, 2‐diacyl‐sn‐glycerol phosphocholine transferase, and microsomal reductases in major regions of …
  2053. Occurrence of 2-O-Acyl Galactosyl Ceramide in Whale Brain
  2054. Sphingolipids of Hemifusus ternatanus Ceramide monohexosides and Ceramide aminoethylphosphonate of the viscera
  2055. A role for Ceramide in meiosis
  2056. Effect of phospholipids on UDP-glucose: Ceramide glucosyltransferase from Golgi membranes.
  2057. Synthetic Studies on Sialoglycoconjugates 12: Total Synthesis of Sialyl Neolactotetraosyl Ceramide
  2058. Sexual differences in galactose metabolism: galactosyl Ceramide galactosidase and other galactosidases in mouse kidney
  2059. … and biological activity of the isomers and analogs of (4E, 8E, 2S, 3R, 2’R)-N-2′-hydroxyhexadecanoyl-9-methyl-4, 8-sphingadienine, the Ceramide portion of the …
  2060. The Role of Ceramide in the Cellular Stress Response
  2061. Biochemical Studies on GM1-Gangliosidosis and Ceramide Trihexosidosis
  2062. Udpgalactose: Ceramide galactosyltransferase in cultured oligodendrocytes: An enzymological and immunological study
  2063. The partial synthesis of some naturally occurring glycosphingolipids with special reference to 0-β-D-galactosyl-(1→ 4)-0-β-D-galactosyl-(1→ 1)-Ceramide
  2064. Hydrolases of the Simple Sphingolipids: Ceramide, Glucocerebroside, and Galactocerebroside
  2065. Application of monoclonal antibody KH2 against lactosyl and neolactotetraosyl Ceramide to immunohistochemical study of human cancers
  2066. Effect of Ceramide on cell growth and cell cycle related proteins in U-937 cells
  2067. Ceramide: a lipid mediator of apoptotic signal transduction
  2068. Ceramide inhibits nitric oxide production in alveolar macrophages of endotoxin and ethanol plus endotoxin-treated rats
  2069. Invivo conversion of 3-ketoCeramide to Ceramide in rat liver
  2070. The distribution and excretion of tritium labeled cerebroside (galactosyl Ceramide) radioactivity by the monkey
  2071. Calculation of the conformation of glycosphingolipids 1. β-d-glucosyl-N-(2-d-hydroxyoctadecanoyl)-d-dihydrosphingosine (glucosyl-Ceramide) and α-dN …
  2072. Structural Determination of Long Chain Bases of Ceramide Aminoethylphosphonate, Hemifusus ternatanus. I. Structure of Octadeca Sphinga-4, 11-dienine
  2073. [65e] Phosphorylcholine-Ceramide transferase: Cytidine diphosphate choline+ N-acyl-threo-trans-sphingosine→ Sphingomyelin+ CMP
  2074. … on the Thioglycosides of N-Acetylneuraminic Acid 10: Synthesis of S-(α-Sialosyl)-(2→6)-O-2-acetamido-2-deoxy-β-D-Hexopyranosyl Ceramide and Its Related …
  2075. Studies on the induction of apoptosis in WEHI 231 cells by pharmacological agents and lipid mediators. Sphingosine and Ceramide induce apoptosis in WEHI 231.
  2076. Ceramide Aminoethylphosphonate in the Egg of the JANBOTANISHI
  2077. Effects of C2-Ceramide on cell cycle alteration and c-fos gene expression in U-937 cells
  2078. The Phase Behavior of Artificial Intercellular Stratum Corneum Lipids Containing a Synthetic Pseudo-Ceramide and the Formation Mechanism of Lamellar …
  2079. Effect of a fatty acid moiety of phospholipid and Ceramide on purified GalT-3 (UDP-Gal: GM2 beta 1-3 galactosyltransferase) activity from embryonic chicken brain.
  2080. Synthesis of (2s, 3r, 4e, 8e)-n-(2′ r)-2′-hydroxyhexadecanoyl-9-methyl-4, 8-sphingadienine, the Ceramide portion of the fruiting-inducing cerebroside in a …
  2081. Chromatographic and Spectroscopic Analysis of Globotriaosyl Ceramide from Bovine Spermatozoa
  2082. Studies on the Lipids of Japanese Littleneck, Tapes japonica Deshayes. III On the Ceramide 2-Aminoethylphosphonate
  2083. Occurrence of 2-O-acyl galactosyl Ceramide in human and bovine brains
  2084. Total synthesis of a stage specific embryonic antigen-1 (SSEA-1) a glycoheptaosyl Ceramide V3FucnLc6Cer
  2085. Tumor necrosis factor-α induces interleukin-6 mRNA and protein in human granulosa luteinizing cells via protein tyrosine kinase without involving Ceramide
  2086. Stereoselective total synthesis of tri-and tetrahexoside wheat flour Ceramide
  2087. [18] Replacement of glycosphingolipid Ceramide residues by glycerolipid for microtiter plate assays
  2088. Ceramide composition of whole brain synaptosomal gangliosides from mice genetically bred for divergent ethanol sensitivities
  2089. Apoptotic damage of DNA in human leukaemic HL-60 cells treated with C2-Ceramide was detected after G1 blockade of the cell cycle
  2090. Activation of NF kappa B and potentiation of TNF-induced NF kappa B activation by Ceramide analogues in leukemic cell lines despite the absence of an observed …
  2091. THE LIPIDS OF EGG YOLK. 5. Presence of Ceramide
  2092. Molecular cloning and expression of Ceramide galactosyltransferases. Comparison with other glycosyltransferases
  2093. Glycosyl Imidates, 43 Synthesis of Lactoneotetraosyl Ceramide
  2094. Synthetic Studies Toward the Preparation of Phosphonate Analogs of Sphingomyelins and Ceramide 1-Phosphate Using Pentacovalent Organophosphorus …
  2095. Sialylation of lacto‐N‐neotetraosyl Ceramide by a solubilized sialyltransferase(s) from chicken skeletal muscle: Effect of phosphatidylcholine and sphingomyelin
  2096. Epidermal permeability barrier function regulates mRNA levels for the key enzymes of cholesterol, fatty acid and Ceramide synthesis.
  2097. Ceramide: a central regulator of the cellular response to injury and stress
  2098. Effect of Ceramide on c-myc Gene Expression during Differentiation of U-937 Cells
  2099. Characterization Of Ceramide Mixtures by Fast Atom Bombardmentand Tandem Mass Spectrometry
  2100. Sphingolipids of Euhadra hickonis. I. Ceramide monohexosides and sphingophosphonolipids of viscera
  2101. Comparative effects of sulfhydryl reagents on membrane-bound and solubilized UDP-glucose: Ceramide glucosyltransferase from Golgi membranes. Evidence for …
  2102. Induction of Ceramide glucosyltransferase activity in cultured human keratinocytes: correlation with culture differentiation.
  2103. Diacylglycerol and Ceramide inara-C stimulated HL-60 cell differentiation and apoptosis
  2104. Sphingolipid changes in rat cerebral cortex during focal ischemia–how does Ceramide accumulate in an ischemic condition?
  2105. Inhibition of gp120 binding to galactosyl Ceramide and sulfatide by potential anti-HIV compounds
  2106. The role of Ceramide in cell death
  2107. Phosphatidylethanolamine: Ceramide-ethanolaminephosphotransferase activity in synaptic plasma membrane vesicles. Influence of some cations and phospholipid …
  2108. Synthesis of a glioma-related ganglioside, O-Ac GM3 having 3-O-Ac Ceramide and its substrate property toward hydrolases
  2109. … N-Acetyl-Neuraminic Acid 8: Synthesis of S-(α-Sialyl)-(2→ 6)-β-Hexopyranosyl and -(2→ 6′)-β-Lactosyl Ceramides Containing β-Thioglycosidically Linked Ceramide
  2110. Isolation and Characterization of Ceramide 2-Aminoethyiphosphonate from Ova of the Fresh-Water Bivalve, Hyriopsis schlegelii
  2111. Purification and characterization of UDP-gal: Ceramide galactosyltransferase and reconstitution of its activity by incorporation into liposomes
  2112. Determination of Ceramide in Mouse Epiderm by Thin-layer Chromatography and G el Image-Forming System
  2113. Isolation and Purification of Ceramide-aminoethylphosphonate in the
  2114. Ceramide to grow into a full regimen
  2115. The retarded rate of acid-catalyzed solvolysis of glycoside bonds between reducing-end glucose residue and Ceramide in glycosphingolipids compared with that of …
  2116. The Presence of a Novel Compound, Ceramide-1-Phosphate, in HL-60 Cells
  2117. Biochemistry of Organ Glycolipid: I. Ceramide-Oligohexosides of Human, Equine and Bovine Spleens
  2118. Acid lipase expression in cultured human keratinocytes: potential role in epidermal Ceramide metabolism
  2119. The Evidence for the Functioning of Ceramide as a Second Messenger
  2120. Ceramide-mediated c-jun Gene Expression in U-937 Cells
  2121. Original Articles; Effects of Sphingomyelin Hydrolysis and Ceramide on the Inhibition of Cell Growth
  2122. … of Sialyl-α (2→ 6)-D-glucopyranosyl, 2-Acetamido-2-deoxyhexopyranosyl, and Sialyl-α (2→ 3)-2-acetamido-2-deoxy-D-glucopyranosyl Ceramide or the Analogs at …
  2123. Occurrence of Ceramide Aminoethylphosphonate in Edible
  2124. Radiochemical Decomposition of lactosyl‐6‐[3H]‐Ceramide
  2125. Surface expression of glycolipids: effect of membrane environment and glycolipid Ceramide structure.
  2126. The androgen-sensitive LNCaP prostate cancer cells undergo apoptosis in response to C2-Ceramide treatment: a role of Ceramide in induction of apoptosis
  2127. Synthesis of a Ganglioside GM3 Position Isomer, N-Acetylneuraminosyl-α (2→ 6)-lactosyl-β (1→ 1)-Ceramide
  2128. Programmed Cell Death lnduced by Ceramide
  2129. Immunochemical Studies on Phosphonolipids (Ceramide 2-Aminoethylphosphonate)
  2130. Role for Ceramide in apoptosis of leukemia cells
  2131. Ceramide, Aging and Cellular Senescence
  2132. Apoptosis and Ceramide Generation by Peripheral Blood Lymphocytes from AIDS
  2133. Rapid internalization of exogenous ganglioside GM3 and its metabolism to Ceramide in human myelogenous leukemia HL-60 cells compared with control …
  2134. Branched Long-chain Bases in Ceramide 2-Aminoethylphosphonate from Ova of the Fresh-water Bivalve, Hyriopsis schlegelii
  2135. Synthesis of Ganglioside GM3 and GM4 Analogs Having Mimics of Ceramide Moieties and Their Binding Activities with Influenza Virus A.
  2136. Phase behavior of artificial intercellular stratum corneum lipids containing a synthetic pseudo-Ceramide and mechanism for the formation of lamellar membranes
  2137. Ceramide changes during FAS (CD95/APO-1) mediated programmed cell death are blocked with the ICE protease inhibitor zVAD. FMK: Evidence against an …
  2138. Cell Cycle Alteration and Apoptosis Induced by Ceramide in IM-9 Cells
  2139. Biological relations between parasite polyhexosamine of the Ceramide complex and blood group antigen.
  2140. … synthesis of (2S, 3S, 4R)-2-[(2′ R)-2-benzoyloxydocosanoylamino]-16-methylheptadecane-1, 3, 4,-triol 3, 4-dibenzoate, a partially protected Ceramide part of sponge …
  2141. Steady-state fluorescence anisotropy and neutral lipid, phospholipid, and Ceramide composition of normal and hereditary lysosomal β-glucosidase deficient …
  2142. … Studies on Sialoglycoconjugates 88: Synthesis of Ganglioside GM3 and GM4 Analogs Containing 2- OR 3-Branched Fatty-Alkyl Residues in Place of Ceramide
  2143. … of the protein kinase C enzyme system. Chapter Two. Syntheses of fumonisin analogues as non-metabolizable protein kinase C inhibitors and as proposed Ceramide …
  2144. Biochemistry of Organ Glycolipids: III. The Structures of Human Kidney Cerebroside Sulfuric Ester, Ceramide Dihexoside and Ceramide Trihexoside
  2145. Abnormal expression of sphingomyelin acylase results in the Ceramide deficiency and the vulnerable basis to inflammation in atopic dermatitis.
  2146. Induction of p21 and apoptosis by Ceramide in Human Hepatoma Cells
  2147. Induction of decidual cell prostaglandin E 2 by Ceramide.
  2148. Effects of Ceramide on c-fos and c-jun Gene Expression during Differentiation of U-937 Cells.
  2149. Effects of Sini decoction on atherosclerosis and Ceramide content of aorta in rabbits
  2150. Characterization of beta (1-3) galactosyltransferase and Ceramide glycanase involved in biosynthesis and degradation of gangliosides
  2151. Ceramide mechanism of anti-myocardial ischemia/reperfusion injury of effective position in Sini Decoction
  2152. Ceramide-MEDIATED SIGNAL TRANSDUCTION AND c-jun GENE EXPRESSION DURING DIFFERENTIATION OP U-931 CELLS
  2153. Chemistry of Lipid of the Posthemolytic Residue or Stroma of Erythrocytes: XVI. Occurrence of Ceramide Pentasaccharide in the Membrane of Erythrocytes and …
  2154. Ceramide, a Mediator of Cytosine Arabinoside Induced Apoptosis
  2155. Induction of p53-independent p21 during Ceramide-mediated G1 arrest in Human Hepatoma cells
  2156. Linking AZT to Ceramide Increases Drug Uptake, Retention and Antiviral Action While Decreasing Bone Marrow Toxicity
  2157. Biochemistry of Shellfish Lipid:III. Purification and Elemental Analysis of Ceramide Aminoethylphosphonate from Corbicula Complex Lipid Mixtures
  2158. Crystallographic and molecular structure of trihexosyl-Ceramide deposits characteristic of Fabry’s disease (particularly the rheumatic form). Digital imaging processing
  2159. Characterization of monoclonal antibodies directed to glucosyl Ceramide, galactosyl Ceramide and lactosyl Ceramide
  2160. … and biological activity of the isomers and analogs of (4E, 8E, 2S, 3R, 2’R)-N-2′-hydroxyhexadecanoyl-9-methyl-4, 8-sphingadienine, the Ceramide portion of the …
  2161. Effect of thyroxine on synthesis of Ceramide, sphingomyelin and phosphatidylcholine in rat hepatocytes
  2162. Regulation of sodium-potassium ion-ATPase by sulfogalactosyl Ceramide in the gill basolateral membrane of rainbow trout (Oncorhynchus mykiss)
  2163. Ceramide and Cell Suicide Pathways: 449
  2164. bile acids, Ceramide, chylomicrons, gangliosides, and lecithin-all of which are considered in the text.
  2165. Expression of UDP-galactose: Ceramide galactosyltransferase gene in jimpy mutant mice.
  2166. … . V. The structure of a novel Ceramide octasaccharide containing mannose-6-phosphate found in the bivalve, Corbicula sandai.: V. The Structure of a Novel Ceramide …
  2167. Detection of S-100 antigen and anti Ceramide antibody in sera of leprosy patients with and without reaction.
  2168. … by monocytes as well as on the proliferative activity of this lymphokine on thymocytes depends on the structures of both oligosaccharide and Ceramide moieties of the …
  2169. Acetyl-Ceramide induced apoptosis in cultured human keratinocytes.
  2170. P-50: Sphingomyelinase and Ceramide mimic TNF-α inhibitory effect on insulin-induced tyrosine phosphorylation of IRS-1
  2171. A Reverse transcriptase Inhibitor-Ceramide Prodrug Providing greater Cell & Organ Uptake, Retention, Antiviral Action and Reduced Marrow Progenitor Cell Toxicity …
  2172. {omicron}-{beta}-D-Galp-(1 {yields} 1)-D-glycerol and {omicron}-{beta}-D-Galp-(1 {yields} 1)-Ceramide of Ramalina celastri;{omicron}-{beta}-D-Galp-(1 {yields} 1)-D …
  2173. Regulation of Ceramide production and apoptosis
  2174. Signal transduction of stress via Ceramide
  2175. Ceramide and apoptosis
  2176. Ceramide in the eukaryotic stress response
  2177. Inhibition of Akt kinase by cell-permeable Ceramide and its implications for Ceramide-induced apoptosis
  2178. Ceramide interaction with the respiratory chain of heart mitochondria
  2179. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis
  2180. Ceramide in apoptosis—does it really matter?
  2181. Ceramide and sphingomyelinases in the regulation of stress responses
  2182. p53-dependent Ceramide response to genotoxic stress.
  2183. The lipids C2-and C16-Ceramide form large stable channels: implications for apoptosis
  2184. Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473
  2185. Mass spectrometric identification of increased C16 Ceramide levels during apoptosis
  2186. The role of Ceramide composition in the lipid organisation of the skin barrier
  2187. Role of Ceramide 1 in the molecular organization of the stratum corneum lipids
  2188. Inhibition of PKB/Akt1 by C2-Ceramide involves activation of Ceramide-activated protein phosphatase in PC12 cells
  2189. Cathepsin D targeted by acid sphingomyelinase‐derived Ceramide
  2190. Ceramide as a second messenger: sticky solutions to sticky problems
  2191. Stress signals for apoptosis: Ceramide and c-Jun kinase
  2192. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A
  2193. Modification of Ceramide metabolism increases cancer cell sensitivity to cytotoxics.
  2194. Role of Ceramide in lipopolysaccharide (LPS)-induced signaling: LPS increases Ceramide rather than acting as a structural homolog
  2195. Ceramide directly activates protein kinase C ζ to regulate a stress-activated protein kinase signaling complex
  2196. BAD enables Ceramide to signal apoptosis via Ras and Raf-1
  2197. Anti-tumoral action of cannabinoids: involvement of sustained Ceramide accumulation and extracellular signal-regulated kinase activation
  2198. Heat-induced elevation of Ceramide in Saccharomyces cerevisiae via de novo synthesis
  2199. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by Ceramide
  2200. Increase of Ceramide and Induction of Mixed Apoptosis/Necrosis by N -(4-Hydroxyphenyl)- retinamide in Neuroblastoma Cell Lines
  2201. Mitochondria and cells produce reactive oxygen species in virtual anaerobiosis: relevance to Ceramide-induced apoptosis
  2202. Induction of Ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine
  2203. Phase behavior and molecular interactions in mixtures of Ceramide with dipalmitoylphosphatidylcholine
  2204. Diversity and complexity of Ceramide signalling in apoptosis
  2205. Vectorial budding of vesicles by asymmetrical enzymatic formation of Ceramide in giant liposomes
  2206. Biophysics of Ceramide signaling: interaction with proteins and phase transition of membranes
  2207. Ceramide induces cytochrome c release from isolated mitochondria: importance of mitochondrial redox state
  2208. Quantitative measurement of different Ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS)
  2209. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate
  2210. Cytokine-mediated induction of Ceramide production is redox-sensitive: implications to proinflammatory cytokine-mediated apoptosis in demyelinating …
  2211. De novo‐synthesized Ceramide signals apoptosis in astrocytes via extracellular signal‐regulated kinase
  2212. … endothelial cells are a rich and regulatable source of secretory sphingomyelinase: implications for early atherogenesis and Ceramide-mediated cell signaling
  2213. High-expression of sphingomyelin deacylase is an important determinant of Ceramide deficiency leading to barrier disruption in atopic Dermatitis1
  2214. Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-α and Ceramide
  2215. N-acylated serinol is a novel Ceramide mimic inducing apoptosis in neuroblastoma cells
  2216. Expression of glucosylCeramide synthase, converting Ceramide to glucosylCeramide, confers adriamycin resistance in human breast cancer cells
  2217. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced Ceramide and cytokine production, and neuronal apoptosis
  2218. The formation of Ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion
  2219. L‐carnitine prevents doxorubicin‐induced apoptosis of cardiac myocytes: role of inhibition of Ceramide generation
  2220. Effect of the lactic acid BacteriumStreptococcus thermophilus on Ceramide levels in human KeratinocytesIn vitro and stratum corneum in vivo
  2221. Ceramide path in human lung cell death
  2222. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by Ceramide
  2223. Fourier transform infrared spectroscopy and differential scanning calorimetry studies of fatty acid homogeneous Ceramide 2
  2224. Selective Ceramide binding to protein kinase C-α and-δ isoenzymes in renal mesangial cells
  2225. Ceramidase activity in bacterial skin flora as a possible cause of Ceramide deficiency in atopic dermatitis
  2226. Ceramide mediates radiation-induced death of endothelium
  2227. Quantitative analysis of Ceramide molecular species by high performance liquid chromatography
  2228. UDP-galactose: Ceramide galactosyltransferase is a class I integral membrane protein of the endoplasmic reticulum
  2229. The use of diglyceride kinase for quantifying Ceramide
  2230. The yins and yangs of Ceramide
  2231. Atypical PKC ζ is activated by Ceramide, resulting in coactivation of NF‐κb/JNK kinase and cell survival
  2232. Ordering of Ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells
  2233. FK506 prevents stroke-induced generation of Ceramide and apoptosis signaling
  2234. Specific and sensitive assay for alkaline and neutral ceramidases involving C12-NBD-Ceramide
  2235. Epidermal growth factor inhibits Ceramide‐induced apoptosis and lowersn> Ceramide levels in primary placental trophoblasts
  2236. H2O2 acts on cellular membranes to generate Ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells
  2237. Cloning of an alkaline ceramidase from Saccharomyces cerevisiae: an enzyme with reverse (CoA-independent) Ceramide synthase activity
  2238. Calcium-independent activation of endothelial nitric oxide synthase by Ceramide
  2239. Suppression of Ceramide-mediated apoptosis by HSP70
  2240. Integrins αvβ3 and αvβ5 Are Expressed by Endothelium of High-Risk Neuroblastoma and Their Inhibition Is Associated with Increased Endogenous Ceramide
  2241. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of Ceramide
  2242. Permeability barrier disorder in Niemann–Pick disease: sphingomyelin–Ceramide processing required for normal barrier homeostasis
  2243. Sphingomyelin hydrolysis to Ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology
  2244. Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome
  2245. Sphingomyelinase and Ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes
  2246. p21 promotes Ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells
  2247. Difference in Ceramide composition between” dry” and” normal” skin in patients with atopic dermatitis
  2248. Stress‐induced apoptosis is not mediated by endolysosomal Ceramide
  2249. Ceramide activates NFκB by inducing the processing of p105
  2250. Natural Ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue
  2251. Nitric oxide inhibits tumor necrosis factor-α-induced apoptosis by reducing the generation of Ceramide
  2252. Sphingomyelin synthase, a potential regulator of intracellular levels of Ceramide and diacylglycerol during SV40 transformation: does sphingomyelin synthase …
  2253. Activation of sphingolipid turnover and chronic generation of Ceramide and sphingosine in liver during aging
  2254. Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons
  2255. Non‐enzymatic triggering of the Ceramide signalling cascade by solar UVA radiation
  2256. Two Ceramide subfractions detectable in Cer (AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema
  2257. Nitric oxide donors induce stress signaling via Ceramide formation in rat renal mesangial cells
  2258. Implication of radical oxygen species in Ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin
  2259. Role of the Outward Delayed Rectifier K+ Current in Ceramide‐Induced Caspase Activation and Apoptosis in Cultured Cortical Neurons
  2260. Altered sphingomyelinase and Ceramide expression in the setting of ischemic and nephrotoxic acute renal failure
  2261. Doxorubicin induces slow Ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes
  2262. Apoptosis and dysregulated Ceramide metabolism in a murine model of alcohol‐enhanced lipopolysaccharide hepatotoxicity
  2263. Positive feedback control of neutral sphingomyelinase activity by Ceramide
  2264. Modulation of the Ceramide level, a novel therapeutic concept
  2265. Cell-cycle-dependent changes in Ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M
  2266. Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via Ceramide synthase
  2267. Ordering of Ceramide formation, caspase activation, and mitochondrial changes during CD95-and DNA damage–induced apoptosis
  2268. Ceramide regulates the transcription of cyclooxygenase-2: evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 …
  2269. Inhibition of neutral sphingomyelinase activation and Ceramide formation by glutathione in hypoxic PC12 cell death
  2270. Purification and characterization of Ceramide-activated protein phosphatases
  2271. Binding and antigen presentation of Ceramide-containing glycolipids by soluble mouse and human CD1d molecules
  2272. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death: inhibitory effects of Bcl-2 on Ceramide formation and caspase-3 activation
  2273. Advances in the signal transduction of Ceramide and related sphingolipids
  2274. Effect of Ceramide on KCa Channel Activity and Vascular Tone in Coronary Arteries
  2275. Ceramide analysis utilizing gas chromatography–mass spectrometry
  2276. Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of Ceramide for sphingomyelin synthesis in Chinese hamster ovary cells
  2277. The identification of three biologically relevant globotriaosyl Ceramide receptor binding sites on the Verotoxin 1 B subunit
  2278. Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than Ceramide
  2279. Lipopolysaccharide and Ceramide use divergent signaling pathways to induce cell death in murine macrophages
  2280. Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries
  2281. … by Ceramide synthase: formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of Ceramide …
  2282. Keloid fibroblasts resist Ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor
  2283. Reversal of radiation resistance in LNCaP cells by targeting apoptosis through Ceramide synthase
  2284. Requirement of seminolipid in spermatogenesis revealed by UDP-galactose: Ceramide galactosyltransferase-deficient mice
  2285. A role for neutral sphingomyelinase-mediated Ceramide production in T cell receptor–induced apoptosis and mitogen-activated protein kinase–mediated signal …
  2286. Molecular cloning and characterization of the mouse Ceramide glucosyltransferase gene
  2287. Multidrug resistance modulators and doxorubicin synergize to elevate Ceramide levels and elicit apoptosis in drug‐resistant cancer cells
  2288. … plays a drug-efflux–independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-Ceramide …
  2289. Ceramide initiates NFκB-mediated caspase activation in neuronal apoptosis
  2290. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl Ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains
  2291. Effects of Ceramide on apoptosis, proteoglycan degradation, and matrix metalloproteinase expression in rabbit articular cartilage
  2292. Restoration of TNF‐α‐induced Ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P‐glycoprotein blocker PSC833
  2293. C2‐Ceramide induces apoptosis in a human squamous cell carcinoma cell line
  2294. Induction of endocytic vesicles by exogenous C6-Ceramide
  2295. Lack of Ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation
  2296. Exchange of C16-Ceramide between Phospholipid Vesicles
  2297. Uncoupling Ceramide glycosylation by transfection of glucosylCeramide synthase antisense reverses adriamycin resistance
  2298. The Role of De Novo Ceramide Synthesis in Chemotherapy‐Induced Apoptosis
  2299. Combined cytotoxic action of paclitaxel and Ceramide against the human Tu138 head and neck squamous carcinoma cell line
  2300. Apoptotic signal of Fas is not mediated by Ceramide
  2301. Partial purification and characterization of sphingosine N-acyltransferase (Ceramide synthase) from bovine liver mitochondrion-rich fraction
  2302. … -induced apoptosis in PC12 cells is associated with diminished membrane phosphatidylcholine and sphingomyelin, accumulation of Ceramide and diacylglycerol, and …
  2303. Ceramide accumulation during oxidant renal tubular injury: mechanisms and potential consequences.
  2304. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.
  2305. Ceramide generation in nitric oxide-induced apoptosis: activation of magnesium-dependent neutral sphingomyelinase via caspase-3
  2306. Glycosylation of Ceramide potentiates cellular resistance to tumor necrosis factor-α-induced apoptosis
  2307. Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje …
  2308. Possible involvement of Ceramide in the regulation of rat Leydig cell function
  2309. Sphingomyelinase and Ceramide analogs induce contraction and rises in [Ca2+]i in canine cerebral vascular muscle
  2310. Does Ceramide play a role in neural cell apoptosis?
  2311. Membrane-Destabilizing Properties of C2-Ceramide May Be Responsible for Its Ability To Inhibit Platelet Aggregation
  2312. Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the Ceramide signalling pathway
  2313. The role of Ceramide in the cellular response to cytotoxic agents
  2314. A possible role of nuclear Ceramide and sphingosine in hepatocyte apoptosis in rat liver
  2315. Tumor Necrosis Factor, Ceramide, Transforming Growth Factor-β1, and Aging Reduce Na+/I− Symporter Messenger Ribonucleic Acid Levels in FRTL-5 Cells
  2316. Regulation of intracellular Ceramide content in B16 melanoma cells: biological implications of Ceramide glycosylation
  2317. Ceramide second messengers and Ceramide assays
  2318. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new Ceramide‐activated enzyme
  2319. HPTLC analysis of sphingomylein, Ceramide and sphingosine in ischemic/reperfused rat heart
  2320. Role of enhanced Ceramide generation in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells
  2321. Association of Ceramide accumulation with photodynamic treatment‐induced cell death
  2322. Differential responses of oligodendrocytes to tumor necrosis factor and other pro‐apoptotic agents: role of Ceramide in apoptosis
  2323. Verotoxin/globotriaosyl Ceramide recognition: angiopathy, angiogenesis and antineoplasia
  2324. Bipotential roles of Ceramide in the growth of hippocampal neurons: Promotion of cell survival and dendritic outgrowth in dose‐and developmental stage–dependent …
  2325. Role of an acidic compartment in tumor‐necrosis‐factor‐α− induced production of Ceramide, activation of caspase‐3 and apoptosis
  2326. Tumor necrosis factor induces Ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells
  2327. Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and Ceramide generation in the gerbil hippocampus
  2328. TNF-α-induced endothelium-independent vasodilation: a role for phospholipase A2-dependent Ceramide signaling
  2329. Ceramide induces expression of the senescence histochemical marker, β-galactosidase, in human fibroblasts
  2330. Ceramide can induce cell death in sensory neurons, whereas Ceramide analogues and sphingosine promote survival
  2331. Role of Ceramide in neuronal cell death and differentiation
  2332. Synthetic assembly of trisaccharide moieties of globotriaosyl Ceramide using carbosilane dendrimers as cores. A new type of functional glyco-material
  2333. … of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl Ceramide fatty acid isoform …
  2334. TNF-α pretreatment prevents subsequent activation of cultured brain cells with TNF-α and hypoxia via Ceramide
  2335. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells
  2336. Oxalate-induced Ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells
  2337. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and Ceramide depletion.
  2338. Digestion of Ceramide by human milk bile salt-stimulated lipase
  2339. Early transitory rise in intracellular pH leads to Bax conformation change during Ceramide-induced apoptosis
  2340. Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35
  2341. Reconstitution of ATP-and cytosol-dependent transport of de novo synthesized Ceramide to the site of sphingomyelin synthesis in semi-intact cells
  2342. Signal transduction and the regulation of apoptosis: roles of Ceramide
  2343. Dexamethasone suppresses tumor necrosis factor-α-induced apoptosis in osteoblasts: possible role for Ceramide
  2344. Synergistic Cytotoxicity in Solid Tumor Cell Lines Between N-(4-Hydroxyphenyl)retinamide and Modulators of Ceramide Metabolism
  2345. Lamellar granule biogenesis: a role for Ceramide glucosyltransferase, lysosomal enzyme transport, and the Golgi
  2346. Sphingomyelin, glycosphingolipids and Ceramide signalling in cells exposed to P‐fimbriated Escherichia coli
  2347. The structure of D-erythro-C18 Ceramide at the air-water interface
  2348. … and characterization of a neutral ceramidase from mouse liver: a single protein catalyzes the reversible reaction in which Ceramide is both hydrolyzed and …
  2349. Role of c-jun expression increased by heat shock-and Ceramide-activated caspase-3 in HL-60 cell apoptosis: possible involvement of Ceramide in heat shock …
  2350. Regulation of rheumatoid synovial cell growth by Ceramide
  2351. Dual role of Ceramide in the control of apoptosis following IL-2 withdrawal
  2352. Radiation-induced apoptosis: The Ceramide-SAPK signaling pathway and clinical aspects
  2353. New Ceramide from Marine Sponge Haliclona koremella and Related Compounds as Antifouling Substances against Macroalgae
  2354. Differential effects of glycolipid biosynthesis inhibitors on Ceramide‐induced cell death in neuroblastoma cells
  2355. Effect of Ceramide on intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells
  2356. Analysis of sphingomyelin, glucosylCeramide, Ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry.
  2357. A potential role for Ceramide in the regulation of mouse epidermal keratinocyte proliferation and differentiation
  2358. CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-Ceramide pathway
  2359. Effect of L-carnitine treatment in vivo on apoptosis and Ceramide generation in peripheral blood lymphocytes from AIDS patients.
  2360. Resistance to CD95/Fas-induced and Ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release
  2361. Nitric oxide stimulates chronic Ceramide formation in glomerular endothelial cells
  2362. Metabolism and apoptotic properties of elevated Ceramide in HT29rev cells
  2363. Renal cortical Ceramide patterns during ischemic and toxic injury: assessments by HPLC-mass spectrometry
  2364. Ceramide‐independent CD28 and TCR signaling but reduced IL‐2 secretion in T cells of acid sphingomyelinase‐deficient mice
  2365. Reduction of sphingomyelin level without accumulation of Ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and …
  2366. Potential role for Ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density …
  2367. Ceramide-induced apoptosis occurs independently of caspases and is decreased by leupeptin
  2368. Possible involvement of cytochrome c release and sequential activation of caspases in Ceramide-induced apoptosis in SK-N-MC cells
  2369. Initiation of ionizing radiation-induced apoptosis: DNA damage-mediated or does Ceramide have a role?
  2370. Globotriaosyl Ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor–mediated apoptosis by regulating Lyn kinase …
  2371. Synthesis of Ceramide Analogues Having the C (4)− C (5) Bond of the Long-Chain Base as Part of an Aromatic or Heteroaromatic System
  2372. Proapoptotic activity of a Trypanosoma cruzi Ceramide-containing glycolipid turned on in host macrophages by IFN-γ
  2373. Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by Ceramide
  2374. Extended Ceramide exposure activates the trkA receptor by increasing receptor homodimer formation
  2375. BCR–ABL accelerates C2-Ceramide-induced apoptosis
  2376. Synthesis and apoptogenic activity of fluorinated Ceramide and dihydroCeramide analogues
  2377. Involvement of p27kip1 in Ceramide-mediated apoptosis in HL-60 cells
  2378. Inhibitory effects of TNFα on mouse tumor Leydig cells: possible role of Ceramide in the mechanism of action
  2379. Ceramide induces cytochrome c release from isolated mitochondria
  2380. Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism
  2381. A new 6-hydroxy-4-sphingenine-containing Ceramide in human skin
  2382. Ceramide induction of COX-2 and PGE2 in pulmonary A549 cells does not involve activation of NF-κB
  2383. Ceramide inhibits L-type calcium channel currents in rat pinealocytes
  2384. Apoptosis induction in synovial fibroblasts by Ceramide: in vitro and in vivo effects
  2385. Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of Ceramide in response to pro‐apoptotic stimuli
  2386. Relationships of apoptotic signaling mediated by Ceramide and TNF-α in U937 cells
  2387. Aryl hydrocarbon receptor regulation of Ceramide-induced apoptosis in murine hepatoma 1c1c7 cells: a function independent of aryl hydrocarbon receptor …
  2388. Apoptosis induced by Ceramide in hepatocellular carcinoma Bel7402 cells.
  2389. … 1-phosphate inhibits activation of caspases that cleave poly (ADP-ribose) polymerase and lamins during Fas-and Ceramide-mediated apoptosis in Jurkat T …
  2390. Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and Ceramide content
  2391. Changes in Ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells
  2392. Partial lithium-associated protection against apoptosis induced by C2-Ceramide in cerebellar granule neurons
  2393. Caspase-dependent Ceramide production in Fas-and HLA class I-mediated peripheral T cell apoptosis
  2394. Stereoselective preparation of Ceramide and its skeleton backbone modified analogues via cyclic thionocarbonate intermediates derived by catalytic asymmetric …
  2395. The growth arrest and downregulation of c-myc transcription induced by Ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F …
  2396. Down-regulation of Ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis
  2397. Ceramide-induced TCR up-regulation
  2398. Is Ceramide signaling a target for vascular therapeutic intervention?
  2399. Activation of the sphingomyelinase/Ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death.
  2400. Characterization of UDP-glucose: Ceramide glucosyltransferases from different organisms
  2401. Inhibition of human erythroid colony formation by Ceramide
  2402. Streptolysin O-permeabilized granulocytes shed L-selectin concomitantly with Ceramide generation via neutral sphingomyelinase
  2403. Application of exogenous Ceramide to cultured rat spinal motoneurons promotes survival or death by regulation of apoptosis depending on its concentrations
  2404. Activation of a Plasma Membrane–Associated Neutral Sphingomyelinase and Concomitant Ceramide Accumulation During IgG-Dependent Phagocytosis in Human …
  2405. Comparative analysis of Ceramide structural modification found in fungal cerebrosides by electrospray tandem mass spectrometry with low energy collision‐induced …
  2406. Tumor necrosis factor-α and Ceramide induce cell death through different mechanisms in rat mesangial cells
  2407. On the complexities of Ceramide changes in cells undergoing apoptosis: lack of evidence for a second messenger function in apoptotic induction
  2408. The role of the endothelium in Ceramide-induced vasodilation
  2409. Daunorubicin-and mitoxantrone-triggered phosphatidylcholine hydrolysis: implication in drug-induced Ceramide generation and apoptosis
  2410. Ceramide-β-d-Glucuronide: Synthesis, Digestion, and Suppression of Early Markers of Colon Carcinogenesis
  2411. [24] Ceramide kinase
  2412. Two distinct phospholipases C of Listeria monocytogenes induce Ceramide generation, nuclear factor-κB activation, and E-selectin expression in human endothelial …
  2413. Incorporation of Ceramide 3B in dermatocosmetic emulsions: effect on the transepidermal water loss of sodium lauryl sulphate‐damaged skin
  2414. Apoptosis Induced by Doxorubicin in Neurotumor Cells Is Divorced from Drug Effects on Ceramide Accumulation and May Involve Cell Cycle‐Dependent Caspase …
  2415. Ceramide induces caspase‐independent apoptosis in rat hepatocytes sensitized by inhibition of RNA synthesis
  2416. Ceramide-induced apoptosis of human thyroid cancer cells resistant to apoptosis by irradiation
  2417. Ceramide-induced sustained depression of synaptic currents mediated by ionotropic glutamate receptors in the hippocampus: an essential role of postsynaptic protein …
  2418. GlucosylCeramide synthase does not attenuate the Ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens
  2419. Different effects of cell‐permeable Ceramide analogs on platelet activation
  2420. Helicobacter pylori–dependent Ceramide production may mediate increased interleukin 8 expression in human gastric cancer cell lines
  2421. The roles of Ceramide in the regulation of neuronal growth and development
  2422. Tumor necrosis factor-α induces apoptosis in immortalized hypothalamic neurons: involvement of Ceramide-generating pathways
  2423. Apoptosis and activation of the sphingomyelin-Ceramide pathway induced by oxidized low density lipoproteins are not causally related in ECV-304 …
  2424. Limited role of Ceramide in lipopolysaccharide-mediated mitogen-activated protein kinase activation, transcription factor induction, and cytokine release
  2425. A novel pathway for tumor necrosis factor-α and Ceramide signaling involving sequential activation of tyrosine kinase, p21ras, and phosphatidylinositol 3 …
  2426. TNF-α increases Ceramide without inducing apoptosis in alveolar type II epithelial cells
  2427. The p75NTR-induced apoptotic program develops through a Ceramide-caspase pathway negatively regulated by nitric oxide
  2428. Fas-induced apoptosis in rat thecal/interstitial cells signals through sphingomyelin-Ceramide pathway
  2429. Influence of Bax or Bcl-2 overexpression on the Ceramide-dependent apoptotic pathway in glioma cells
  2430. Fas or Ceramide induce apoptosis by Ras-regulated phosphoinositide-3-kinase activation
  2431. Ceramide, a mediator of interleukin 1, tumour necrosis factor α, as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells
  2432. Dimyristoylphosphatidylcholine/C16: 0-Ceramide binary liposomes studied by differential scanning calorimetry and wide-and small-angle x-ray scattering
  2433. Protective effects of the TNF-Ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons
  2434. … of a novel trans double bond Ceramide analogue via catalytic asymmetric dihydroxylation of an enyne. The role of the trans double bond of Ceramide in the fusion of …
  2435. Ceramide-mediated stimulation of inducible nitric oxide synthase (iNOS) and tumor necrosis factor (TNF) accumulation in murine macrophages requires tyrosine …
  2436. Adamantyl globotriaosyl Ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor
  2437. Induction of Apoptosis by All-trans-Retinoic Acid and C2-Ceramide Treatment in Rat Stromal–Vascular Cultures
  2438. Sphingomyelinase and Ceramide inhibit formation of F-actin ring in and bone resorption by rabbit mature osteoclasts
  2439. Induction of apoptosis by synthetic Ceramide analogues in the human keratinocyte cell line HaCaT
  2440. CML and apoptosis: the Ceramide pathway.
  2441. Ceramide induces apoptosis to immature cerebellar granule cells in culture
  2442. Ceramide transport from endoplasmic reticulum to Golgi apparatus is not vesicle-mediated
  2443. Substrate specificity and some other enzymatic properties of dihydroCeramide desaturase (Ceramide synthase) in fetal rat skin
  2444. Ceramide inhibits inwardly rectifying K+ currents via a Ras-and Raf-1-dependent pathway in cultured oligodendrocytes
  2445. Suramin induced Ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons
  2446. Biochemical and morphological identification of Ceramide-induced cell cycle arrest and apoptosis in cultured granulosa cells
  2447. Synthesis of β-d-Galactosyl Ceramide Methylene Isostere
  2448. Enzymatic synthesis of ω-amino-Ceramide: preparation of a sensitive fluorescent substrate for ceramidase
  2449. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by Ceramide is mediated by extracellular signal-regulated and stress …
  2450. Atomic force microscopic study on the surface properties of phospholipid monolayers containing Ceramide 3
  2451. Acid sphingomyelinase-derived Ceramide is not required for inflammatory cytokine signalling in murine macrophages
  2452. Molecular cloning and expression of mouse Ceramide glucosyltransferase
  2453. Protein tyrosine kinase p56 lck is required for Ceramide-induced but not tumor necrosis factor-induced activation of NF-κB, AP-1, JNK, and apoptosis
  2454. An accessory role for Ceramide in interleukin-1β induced prostaglandin synthesis
  2455. Potentiation by vitamin D analogs of TNFα and Ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2
  2456. Induction of p21 during Ceramide-mediated apoptosis in human hepatocarcinoma cells
  2457. Globotriaosyl Ceramide (Gb_3) expression in human tumour cells: Intracellular trafficking defines a new retrograde transport pathway from the cell surface to the …
  2458. Biomodulatory role of Ceramide in basic fibroblast growth factor‐induced proliferation of cerebellar astrocytes in primary culture
  2459. Enhancement of hydrolytic activity of sphingolipid Ceramide N-deacylase in the aqueous–organic biphasic system
  2460. Inhibition of caspase activity prevents anti-IgM induced apoptosis but not Ceramide generation in WEHI 231 B cells
  2461. Involvement of de novo Ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death
  2462. Ceramide prevents motoneuronal cell death through inhibition of oxidative signal
  2463. Neurotrophic factors prevent Ceramide‐induced apoptosis downstream of c‐Jun N‐terminal kinase activation in PC12 cells
  2464. A New Ceramide with a Novel Branched-Chain Fatty Acid Isolated from the Epiphytic Dinoflagellate Coolia monotis
  2465. Caspases mediate C2-Ceramide-induced apoptosis of the human oligodendroglial cell line, MO3. 13
  2466. Induction of the manganese superoxide dismutase gene by sphingomyelinase and Ceramide
  2467. Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells
  2468. Ceramide 2 (N‐acetyl sphingosine) is associated with reduction in Bcl‐2 protein levels by Western blotting and with apoptosis in cultured human keratinocytes
  2469. Ceramide promotes calpain-mediated proteolysis of protein kinase C β in murine polymorphonuclear leukocytes
  2470. Ceramide triggers intracellular calcium release via the IP3 receptor inXenopus laevisoocytes
  2471. Ceramide increases steroid hormone production in MA-10 Leydig cells
  2472. Ceramide derivatives for therapeutic agents
  2473. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates Ceramide synthesis and increases vinblastine sensitivity in drug-sensitive …
  2474. … is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and Ceramide
  2475. Synthesis and immobilization of Ceramide analogs on silica particles
  2476. Regulation of UDP‐glucose: Ceramide glucosyltransferase‐1 by Ceramide
  2477. Synthesis and biological evaluation of Ceramide analogues with substituted aromatic rings or an allylic fluoride in the sphingoid moiety
  2478. Ceramide induces cell death in the human prostatic carcinoma cell lines PC3 and DU145 but does not seem to be involved in Fas-mediated apoptosis
  2479. Functional significance of globotriaosyl Ceramide in interferon‐α2/type 1 interferon receptor‐mediated antiviral activity
  2480. Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by Ceramide
  2481. Evidence that Ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates
  2482. Involvement of caspase 3-and 8-like proteases in Ceramide-induced apoptosis of cardiomyocytes
  2483. Elevated Ceramide is downstream of altered calcium homeostasis in low serum-induced apoptosis
  2484. Phosphatidic acid is a potent and selective inhibitor of protein phosphatase 1 and an inhibitor of Ceramide-mediated responses
  2485. … of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs, and C2-Ceramide
  2486. Sphingosine-and Ceramide-analog toxins—an update
  2487. Hypothesis: Ceramide conditionally activates atypical protein kinases C, Raf-1 and KSR through binding to their cysteine-rich domains.
  2488. Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein‐deficient mouse but not in fibroblasts …
  2489. Programmed cell death in cortical chick embryo astrocytes is associated with activation of protein kinase PK60 and Ceramide formation
  2490. Ceramide and cyclic adenosine monophosphate (cAMP) induce cAMP response element binding protein phosphorylation via distinct signaling pathways while having …
  2491. Identification of Ceramide targets in interleukin-1 and tumor necrosis factor-α signaling in mesangial cells
  2492. Isolation and chemical composition of the Ceramide of the Candida lipolytica yeast
  2493. The mitogen-activated protein kinase pathway inhibits Ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937
  2494. L-selectin stimulates the neutral sphingomyelinase and induces release of Ceramide
  2495. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and Ceramide generation are not signaling mechanisms for the actions of tumor …
  2496. Distinct effects of Ceramide‐generating pathways in prostate adenocarcinoma cells
  2497. Inhibition of phosphatidylcholine synthesis precedes apoptosis induced by C2-Ceramide: protection by exogenous phosphatidylcholine
  2498. Regulation of cyclin-dependent kinase 2 activity by Ceramide
  2499. Decreased phospholipase D (PLD) activity in Ceramide-induced apoptosis of human keratinocyte cell line HaCaT
  2500. Akt mediates insulin rescue from apoptosis in brown adipocytes: effect of Ceramide
  2501. Involvement of protein kinase C-β and Ceramide in tumor necrosis factor-α-induced but not Fas-induced apoptosis of human myeloid leukemia cells
  2502. Ceramide-induced vasorelaxation An inhibitory action on protein kinase C
  2503. CD95 (Fas/APO-1) signals Ceramide generation independent of the effector stage of apoptosis
  2504. [14] Inositolphosphoryl Ceramide synthase from yeast
  2505. 12-O-Tetradecanoylphorbol-13-acetate-induced Apoptosis in LNCaP Cells Is Mediated through Ceramide Synthase
  2506. Up-regulation of neutral glycosphingolipid synthesis upon long term inhibition of Ceramide synthesis by fumonisin B1
  2507. Alteration of the daunorubicin‐triggered sphingomyelin‐Ceramide pathway and apoptosis in MDR cells: Influence of drug transport abnormalities
  2508. Synthesis of two unique compounds, a Ceramide and a cerebroside, occurring in human stratum corneum
  2509. A Synthetic Ceramide Analog (l‐PDMP) Up‐regulates Neuronal Function
  2510. Stimulation by Ceramide of Phospholipase A2 Activation through a Mechanism Related to the Phospholipase C-Initiated Signaling Pathway in Rabbit Platelets
  2511. Effect of aromatic short-chain analogues of Ceramide on axonal growth in hippocampal neurons
  2512. Apparent cooperativity in multivalent verotoxin-globotriaosyl Ceramide binding: kinetic and saturation binding studies with [125I] verotoxin
  2513. Ceramide-induced apoptosis in fas-resistant Hodgkin’s disease cell lines is caspase independent
  2514. Lack of costimulation by both sphingomyelinase and C2 Ceramide in resting human T cells
  2515. Interleukin‐10 and interleukin‐13 inhibit proinflammatory cytokine‐induced Ceramide production through the activation of phosphatidylinositol 3‐kinase
  2516. Involvement of protein kinase C-regulated Ceramide generation in inostamycin-induced apoptosis
  2517. Ceramide-mediated apoptosis of hepatocytes in vivo: a matter of the nucleus?
  2518. Galactocerebroside and not glucocerebroside or Ceramide stimulate epidermal β-glucocerebrosidase activity
  2519. Induction of tissue factor production but not the upregulation of adhesion molecule expression by Ceramide in human vascular endothelial cells
  2520. Distinct sites of action of Bcl-2 and Bcl-xL in the Ceramide pathway of apoptosis
  2521. Modulation of Ceramide-activated protein phosphatase 2A activity by low molecular weight aromatic compounds
  2522. A novel sulfonic-acid analogue of Ceramide is the major extractable lipid of the gram-negative marine bacterium Cyclobacterium marinus WH
  2523. Ceramide mimics tumour necrosis factor‐α in the induction of cell cycle arrest in endothelial cells: Induction of the tumour suppressor p53 with decrease in …
  2524. Regulation of phospholipase D activity and Ceramide production in daunorubicin-induced apoptosis in A-431 cells
  2525. Tumor Necrosis Factor-α, Sphingomyelinase, and Ceramide Inhibit Store-operated Calcium Entry in Thyroid FRTL-5 Cells
  2526. Globotriaosyl Ceramide modulates interferon-α-induced growth inhibition and CD19 expression in Burkitt’s lymphoma cells
  2527. Serine palmitoyltransferase inhibition reverses anti-proliferative effects of Ceramide synthase inhibition in cultured renal cells and suppresses free sphingoid base …
  2528. The formation of Ceramide from sphingomyelin is associated with cellular apoptosis.
  2529. Acceleration by Ceramide of calcium-dependent translocation of phospholipase A2 from cytosol to membranes in platelets
  2530. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular Ceramide formation
  2531. Rectangular solid domains in Ceramide–cholesterol monolayers–2D crystals
  2532. Ceramide-induced apoptosis is mediated by caspase activation independently from retinoblastoma protein post-translational modification
  2533. Activation of caspase-9 and -3 during H2O2-induced apoptosis of PC12 cells independent of Ceramide formation
  2534. C2‐Ceramide attenuates phenylephrine‐induced vasoconstriction and elevation in [Ca2+]i in rat aortic smooth muscle
  2535. Synthesis and intermembrane transfer of pyrene-labelled liponucleotides: Ceramide phosphothymidines
  2536. Exogenous C2-Ceramide activates c-fos serum response element via Rac-dependent signalling pathway
  2537. Redistribution of cytochrome c is not an essential requirement in C2-Ceramide induced apoptosis in HL-60 cells
  2538. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during Ceramide-induced apoptosis
  2539. Absolute Configuration of a Ceramide with a Novel Branched-chain Fatty Acid Isolated from the Epiphytic Dinoflagellate, Coolia monotis
  2540. Divergence in regulation of nitric-oxide synthase and its cofactor tetrahydrobiopterin by tumor necrosis factor-α: Ceramide potentiates nitric oxide synthesis …
  2541. Non-steroidal anti-inflammatory drugs (NSAIDs) block the late, prostanoid-dependent/Ceramide-independent component of ovarian IL-1 action: implications for the …
  2542. Effect of Ceramide on interleukin-6 synthesis in osteoblast-like cells
  2543. Enzymatic Synthesis of 14C-Glycosphingolipids by Reverse Hydrolysis Reaction of Sphingolipid Ceramide N-Deacylase: Detection of Endoglycoceramidase Activity …
  2544. Regulation of Raf-1 kinase by TNF via its second messenger Ceramide and cross-talk with mitogenic signalling
  2545. Killing of T lymphocytes by synthetic Ceramide is by a nonapoptotic mechanism and is abrogated following mitogenic activation
  2546. Effects of Ceramide, the Fas signal intermediate, on apoptosis and phospholipase D activity in mouse ovarian granulosa cells in vitro
  2547. Stage-associated expression of Ceramide structures in glycosphingolipids from the human trematode parasite Schistosoma mansoni
  2548. Suppression of heat shock protein-70 by Ceramide in heat shock-induced HL-60 cell apoptosis
  2549. Identification of Ceramide-phosphorylethanolamine in Oomycete plant pathogens: Pythium ultimum, phytophthora infestans, and Phytophthora capsici
  2550. CD95 (Fas/APO-1) induces Ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase
  2551. Selective Stimulation by Ceramide of the Expression of the α Isoform of Retinoic Acid and Retinoid X Receptors in Osteoblastic Cells: A ROLE OF …
  2552. … increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects: correlation with its suppressive effect on lymphocyte apoptosis and Ceramide …
  2553. [5] Assays for the biosynthesis of sphingomyelin and Ceramide phosphoethanolamine
  2554. Postcolumn fluorescence as an alternative to evaporative light scattering detection for Ceramide analysis with gradient elution in non-aqueous reversed-phase liquid …
  2555. Src kinase and PI 3-kinase as a transduction pathway in Ceramide-induced contraction of colonic smooth muscle
  2556. Increased tyrosine kinase activity but not calcium mobilization is required for Ceramide-induced apoptosis
  2557. Ceramide enhances susceptibility of membrane phospholipids to phospholipase A2 through modification of lipid organization in platelet membranes
  2558. Ceramide potentiates, but sphingomyelin inhibits, vitamin D-induced keratinocyte differentiation: comparison between keratinocytes and HL-60 cells
  2559. Mitochondrial free calcium levels (Rhod‐2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during Ceramide‐dependent cell death
  2560. Hepatocyte growth factor protects gastric epithelial cells against Ceramide-induced apoptosis through induction of cyclooxygenase-2
  2561. A deficiency in Syk enhances Ceramide-induced apoptosis in DT40 lymphoma B cells
  2562. Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells
  2563. … regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not Ceramide synthesis in cultured human …
  2564. [27] Analysis of Ceramide 1-phosphate and sphingosine-1-phosphate phosphatase activities
  2565. Ceramide-induced cell death in cultured rat retinal pigment epithelial cells
  2566. … of human breast adenocarcinoma MCF7 resistance to tumor necrosis factor-induced cell death: lack of correlation between JNK activation and Ceramide …
  2567. Effect of C2 Ceramide on the inositol phospholipid metabolism (uptake of 32P, 3H-serine and 3H-palmitic acid) and apoptosis-related morphological changes in …
  2568. Ceramide glycanase activities in human cancer cells
  2569. Progesterone release of lipid second messengers at the amphibian oocyte plasma membrane: role of Ceramide in initiating the G2/M transition
  2570. Preparation of fluorescence-labeled GM1 and sphingomyelin by the reverse hydrolysis reaction of sphingolipid Ceramide N-deacylase as substrates for assay of …
  2571. C2-Ceramide increases cytoplasmic calcium concentrations in human parathyroid cells
  2572. Apoptosis parallels Ceramide content in the developing rat kidney
  2573. Local delivery of Ceramide for restenosis: is there a future for lipid therapy?
  2574. A facile regioselective synthesis of sphingosine 1-phosphate and Ceramide 1-phosphate
  2575. Involvement of caspase-3 and GD3 ganglioside in Ceramide-induced apoptosis in Farber disease
  2576. Variable Expression of Apoptotic Phenotype in Keratinocytes Treated with Ultraviolet Radiation; Ceramide; Or Suspended in Semisolid Methylcellulose.
  2577. [50] Preparation of radioactive gangliosides, 3H or 14C isotopically labeled at oligosaccharide or Ceramide moieties
  2578. Effect of Ceramide on apoptosis and phospholipase D activity in FRTL-5 thyroid cells
  2579. Synthesis of D‐erythro‐Ceramide‐1‐phosphoinositol and Its Aminoglucosylated Derivative − Intermediates in GPI‐Anchor Biosynthesis
  2580. Interferon-γ-Induced Differentiation and Apoptosis of HT29 Cells: Dissociation of (Glucosyl) Ceramide Signaling
  2581. Mass spectrometric analysis of Ceramide composition in mono‐, di‐, tri‐, and tetraglycosylCeramides from mouse kidney: an experimental model for uropathogenic …
  2582. Ligation of the WC1 receptor induces γδ T cell growth arrest through fumonisin B1-sensitive increases in cellular Ceramide
  2583. A convenient oxidation of natural glycosphingolipids to their “Ceramide acids” for neoglycoconjugation: bovine serum albumin-glycosylCeramide acid …
  2584. Ceramide selectively inhibits apoptosis-associated events in NGF-deprived sympathetic neurons
  2585. Redox-sensitive events in Fas-induced apoptosis in human NK cells include Ceramide generation and protein tyrosine dephosphorylation.
  2586. Suppressed UDP‐galactose: Ceramide galactosyltransferase and myelin protein mRNA in twitcher mouse brain
  2587. Activation of integrin and Ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines
  2588. Selective involvement of caspase-3 in Ceramide induced apoptosis in AK-5 tumor cells
  2589. Endothelium dependent and independent relaxations induced by Ceramide in vascular smooth muscles.
  2590. The role of Ceramide in the modulation of intracellular Ca2+ levels by interleukin 1β in rat cortical synaptosomes
  2591. Fingerprinting of large oligosaccharides linked to Ceramide by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: highly heterogeneous …
  2592. Bradykinin inhibits Ceramide production and activates phospholipase D in rabbit cortical collecting duct cells
  2593. Ceramide induces apoptosis in neuroblastoma cell cultures resistant to CD95 (Fas/APO-1)-mediated apoptosis
  2594. Lipid microsphere preparation of a lipophilic Ceramide derivative suppresses colony formation in a murine experimental pulmonary metastasis model
  2595. … necrosis factor-α-induced release of plasminogen activator inhibitor-1 from human umbilical vein endothelial cells: involvement of intracellular Ceramide …
  2596. Domain Formation and Phase Separation in Mixed Phospatidylcholine/Ceramide 3 Monolayers and Bilayers
  2597. SDZ PSC 833 the drug resistance modulator activates cellular Ceramide formation by a pathway independent of P-glycoprotein
  2598. Proximal promoter region is sufficient to regulate tissue‐specific expression of UDP‐galactose: Ceramide galactosyltransferase gene
  2599. Hydrophobic nature of mammalian Ceramide glycanases: purified from rabbit and rat mammary tissues.
  2600. Content and structure of Ceramide and sphingomyelin and sphingomyelinase activity in mouse hepatoma-22.
  2601. Oxidation of glycosphingolipids under basic conditions: synthesis of glycosyl “serine acids” as opposed to “Ceramide acids”. Precursors for neoglycoconjugates with …
  2602. The lipid moiety of the GPI-anchor of the major plasma membrane proteins in Paramecium primaurelia is a Ceramide: variation of the amide-linked fatty acid …
  2603. C2-Ceramide attenuates prostaglandin F2α-induced vasoconstriction and elevation of [Ca2+] i in canine cerebral vascular smooth muscle
  2604. Apoptosis induced by N-hexanoylsphingosine in CHP-100 cells associates with accumulation of endogenous Ceramide and is potentiated by inhibition of …
  2605. [52] Enzymatic synthesis of [14C] Ceramide,[14C] glycosphingolipids, and ω-aminoCeramide
  2606. Selective phosphotyrosine phosphatase inhibition and increased Ceramide formation is associated with B-cell death by apoptosis
  2607. Ceramide enhances growth hormone (GH)-releasing hormone-stimulated cyclic adenosine 3′, 5′-monophosphate accumulation but inhibits GH release in rat …
  2608. Globotriaosyl Ceramide and globoside as major glycolipid components of fibroblasts in scirrhous gastric carcinoma tissues
  2609. Regulation by Ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
  2610. Ceramide accumulation precedes caspase-dependent apoptosis in CHP-100 neuroepithelioma cells exposed to the protein phosphatase inhibitor okadaic acid
  2611. Ceramide‐enhanced urokinase‐type plasminogen activator (uPA) release is mediated by protein kinase C in cultured microglia
  2612. Acyl Chain Length-Specific Ceramide-Induced Changes in Intracellular Ca2+ Concentration and Progesterone Production Are Not Regulated by Tumor Necrosis …
  2613. Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the Ceramide-mediated inhibition of human keratinocyte growth
  2614. Ceramide selectively inhibits calcium-mediated potentiation of β-adrenergic-stimulated cyclic nucleotide accumulation in rat pinealocytes
  2615. A comparison of the effects of lipopolysaccharide and Ceramide on arachidonic acid metabolism in THP-1 monocytic cells
  2616. The Effects of a Ceramide analogue, N-acetylsphingosine, on basal and tumor necrosis factor-α-stimulated production of prostaglandins and cytokines in gestational …
  2617. Glucocorticoid receptor-mediated post-Ceramide inhibition of the interleukin-1β-dependent induction of ovarian prostaglandin endoperoxide synthase-2 in rats
  2618. Ceramide stimulates the uptake of neutral red in human neutrophils, monocytes, and lymphocytes
  2619. Specific processing of poly (ADP‐ribose) polymerase, accompanied by activation of caspase‐3 and elevation/reduction of Ceramide/hydrogen peroxide levels, during …
  2620. Ceramide and apoptosis
  2621. Interfacial hydration of Ceramide in stratum corneum model membrane measured by 2H NMR of D2O
  2622. Total Synthesis of Glycohexa- and Nonaosyl Ceramide with a Sialyl Lea and Sialyl Dimeric Lea Sequence
  2623. Induction of programmed cell death in human retinoblastoma Y79 cells by C2-Ceramide
  2624. Phthalocyanine 4-photodynamic therapy induces Ceramide generation and apoptosis in acid sphingomyelinase-deficient mouse embryonic fibroblasts.
  2625. Increases in Ceramide levels in normal human mesangial cells subjected to different cellular stresses result from changes in distinct enzyme activities and can …
  2626. Involvement of the Ceramide signaling pathway in modulating the differentiated state of porcine thyroid cells
  2627. Protective effect of cell-permeable Ceramide analogs against modeccin, ricin, Pseudomonas toxin, and diphtheria toxin
  2628. Sphingomyelin and Ceramide mass assay
  2629. Tumor necrosis factor-α, sphingosine, Ceramide: Which is the appropriate marker of inflammation?
  2630. Bilayer properties of totally synthetic C16: 0-lactosyl-Ceramide
  2631. Apoptosis of cultured neuroblastoma cells is induced by Ceramide and not by ligation of the Fas/Apo-1/CD95 receptor
  2632. GlucosylCeramide synthesized in vitro from endogenous Ceramide is uncoupled from synthesis of lactosylCeramide in Golgi membranes from chicken embryo neural …
  2633. Activation of SAPK and increase in Bak levels during Ceramide and indomethacin-induced apoptosis in HT29 cells
  2634. Cytokines and septic myocardial depression: Nitric oxide versus sphingosine/Ceramide?
  2635. The effect of a Ceramide analog, N-acetylsphingosine on the induction of proliferation and IL-2 synthesis in T cells from young and old F344 rats
  2636. Release of plasminogen activator inhibitor‐1 from human astrocytes is regulated by intracellular Ceramide
  2637. Synthesis and biological evaluation of Ceramide analogues with substituted aromatic rings or an allylic fluoride in the sphingoid moiety
  2638. Structural elucidation of the Ceramide moiety of starfish gangliosides by collision-induced dissociation of the sodium ion complex
  2639. Ceramide synergizes with phorbol ester or okadaic acid to induce IκB degradation
  2640. [31] Properties of animal Ceramide glycanases
  2641. Assignment of a UDP-glucose: Ceramide glucosyltransferase gene (Ugcg) to mouse chromosome band 4B3 by in situ hybridization
  2642. Differential activation of phosphoinositide 3-kinase by endothelin and Ceramide in colonic smooth muscle cells
  2643. Ceramide does not inhibit protein kinase C β-dependent phospholipase D activity stimulated by anti-Fas monoclonal antibody in A20 cells
  2644. Density dependent interaction of polymeric analogs of beta-galactosyl Ceramide with GP120 of human immunodeficiency virus 1.
  2645. Measurement of sphingomyelin and Ceramide cellular levels after sphingomyelinase-mediated sphingomyelin hydrolysis
  2646. A direct method for the simultaneous measurement of Ceramide and phospholipase D activity
  2647. Oxidation of aglycone of glycosphingolipids: serine and Ceramide acid precursors for soluble glycoconjugates.
  2648. The role of Ceramide in apoptosis
  2649. Measurement of 1, 2-diacylglycerol and Ceramide in hearts subjected to ischemic preconditioning
  2650. DECREASED PHOSPHOLIPASE D ACTIVITIES IN Ceramide-INDUCED APOPTOSIS OE RBL-2H3 MAST CELLS
  2651. Synthesis of aryl 3′-sulfo-β-lactosides as fluorogenic and chromogenic substrates for Ceramide glycanases
  2652. Ceramide: a stress response mediator involved in growth suppression
  2653. Sex‐and age‐related differences in Ceramide dihexosides of primary human brain tumors
  2654. Effect of Ceramide-analogues on the actin cytockeleton of Tetrahymena pyriformis GL. A confocal microscopic analysis
  2655. Comparison of Ceramide Monohexoside and Sulfatide in Brain and Liver of Japanese Pilchard (Sardines)
  2656. Spatial and temporal expression of UDP-galactose: Ceramide galactosyl transferase mRNA during rat brain development
  2657. Preparation, Characteristics and Toxicity of Ricin-containing Galactosyl Ceramide Liposomes.
  2658. A novel Ceramide from starfish Asterias rollestoni Bell—rollCeramide A
  2659. … Studies on Selectin Ligands/Inhibitors: Synthesis and Inhibitory Activity of 2-O-Fucosyl Sulfatides Containing 2-Branched Fatty Alkyl Residues in Place of Ceramide
  2660. Inhibition of the synthesis of glycosphingolipid by a Ceramide analogue (PPMP) in the gastrulation of Bufo arenarum
  2661. Mitochondrial Role in the Signal Transduction Pathway of Ceramide-Induced Apoptosis
  2662. Ceramide-mediated cell death was accompanied with changes of c-Myc and Rb protein
  2663. Antigenicity of the carbohydrate moiety of ganglioside GM3 having 3-O-acetyl Ceramide
  2664. The effects of Ceramide and its analogues on the secretion of the mucocyst content of Tetrahymena.
  2665. The yins and yangs of Ceramide
  2666. Effects of emodin on activity of sphingomylinase and content of Ceramide in rabbit aorta of experimental atherosclerosis
  2667. Ceramide Transmits the Lipolytic Action of TNF-[Alpha] Signal in 3T3-L1 Adipocytes
  2668. Molecular Mechanisms in the Activation of Apoptotic and Antiapoptotic Pathways by Ceramide
  2669. Characterization of the Contribution of Ceramide to Chemotherapy Sensitization in Breast Cancer Cells
  2670. Stimulation by Ceramide of Phospholipase A2 Activation through a Mechanism Related to the Phospholipase C-Initiated Signaling Pathway in Rabbit Platelets.
  2671. Apoptosis and Ceramide Generation by Peripheral Blood Lymphocytes from AIDS
  2672. Bax is required for Ceramide-regulation of cell death
  2673. The Integrin-Mediated Suppression of Apoptosis Correlates with Suppression of Ceramide Generation† 780
  2674. Differences in the Induction of Apoptosis After Treatment with γ-Irradiation and C2-Ceramide
  2675. Ceramide is not involved in nuclear translocation of NF-{kappa} B in L5178Y sublines
  2676. Ceramide generation in nitric oxide-induced apoptosis
  2677. Ceramide Accumulation in the Heart of a Hypoxic Rat Model Mimicking Cyanotic Congenital Heart Disease
  2678. Comparative Molecular Field Analysis (CoMFA) of Ceramide Derivatives
  2679. Cathepsin D targeted by acid sphingomyelinase‐derived Ceramide
  2680. Determination of Ceramide-Induced Apoptotic Cell Death in Mouse Granulosa Cell Cultured In Vitro
  2681. Stress signaling of apoptosis via Ceramide and c-jun kinase
  2682. Role of Ceramide in induction of Fos, Jun, and collagenase in chondrocytes
  2683. Purification and characterization of inositolphosphoryl Ceramide synthase from the yeast Saccharomyces cerevisiae
  2684. Analysis of the role of Ceramide in tumor necrosis factor signal transduction in human endothelial cells
  2685. 44 Involvement of Ceramide and JNK in CD40-Mediated Growth Inhibition
  2686. Effect of a Ceramide/cholesterol/FFA–containing body lotion on the barrier function of aged skin
  2687. Effect of L-carnitine treatment in vivo on apoptosis and Ceramide generation in peripheral blood lymphocytes from AIDS patients: correlation with in vitro results
  2688. p27kip1 promotes Ceramide-induced apoptosis in HL-60 cells
  2689. Effects of TNF-[Alpha] and Ceramide Treatment on Insulin Signal Transduction in Rat Adipocytes
  2690. Utilization of the second messenger, Ceramide, by the chemotherapeutic agent daunorubicin and the reaper protein during induction of apoptosis
  2691. Induction of inducible nitric oxide synthase by Ceramide in human colon carcinoma HT-29 cell
  2692. Benzene-derived quinol-thioethers induce apoptosis in hematopoietic tissue via a unique Ceramide signaling pathway
  2693. De novo Synthesis Pathway of Ceramide Causes Hypoxia-induced Apoptosis of SH-SY5Y Human Neurublastoma Cells
  2694. Skin Ceramide composition of atopic dermatitis patients.
  2695. HIV-1gp120 binding conformation of galactosyl Ceramide: Studies of the biomimetic synthesis of porphobilinogen
  2696. Ceramide 2 (N-acetyl sphingosine) induces G1 arrest and Rb dephosphorilation in cultured human keratinocytes
  2697. Potential involvement of Ceramide in IFN-γ-induced ICAM-1 and HLA-DR expression on cultured normal human epidermal keratinocytes.
  2698. The mechanism of Ceramide-induced circular smooth muscle cells contraction in feline esophagus
  2699. Ceramide signals through the extracellular-signal-regulated protein kinase (ERK) pathway via Ras and Raf-1
  2700. Ceramide-induced apoptosis is prevented through p53
  2701. Chemical Hypoxia Activates De novo Synthesis Pathway of Ceramide in SH-SY5Y Human Neuroblastoma Cells
  2702. Ceramide and apoptosis induced by radiation
  2703. Yeast Ceramide synthetase gene family
  2704. The Inhibition of γ-Radiation Induced Apoptosis in Astrocytoma-Derived Cell Lines Is Associated with a Failure of Ceramide Synthesis and Fas-Mediated Apoptosis
  2705. Rax, the cellular pkr activator, potentiates Ceramide-induced apoptosis in hematopoietic cells
  2706. Effect of C2 Ceramide on the inositol phospholipid metabolism (uptake of 32P, 3H-serine and 3H-palmitic acid) and…
  2707. Ceramide-induced thyroid cell apoptosis
  2708. The Regulation of Prostaglandin E2 Synthesis by Interleukin-1β and Ceramide in Human Fibroblasts: Effects on Cyclooxygenase-1, Cyclooxygenase-2, and …
  2709. Induction of Ganglioside Biosynthesis, Neurite Outgrowth and Functional Synapse Formation by a Symthetic Ceramide Analog
  2710. Inhibitory Effect of Ceramide on PI 3-kinase-PKC [Zeta] Activation
  2711. A rapid method for the identification of Ceramide activated protein phosphatase
  2712. Effect of Ceramide on apoptosis of rat granulosa cells in vitro
  2713. Promotion of Ceramide-induced apoptosis by p21 in human hepatocarcinoma cells
  2714. The Ceramide pathway increases cholesterol mobilization and steroidogenic acute regulatory protein mRNA
  2715. Purified human Ceramide-activated protein kinase
  2716. Ceramide-Induced Apoptotic Cell Death in Mouse Granulosa Cells
  2717. Characterization of Ceramide activated protein phosphatase: effect of cations
  2718. Apoptosis Triggered by the Absence of an Integrin Signal: Role of the Sphingolipid Ceramide
  2719. Expression Patterns of Ceramide Glucosyltransferase during Mice Postimplantation Embryogenesis
  2720. GD3 ganglioside mediates programmed cell death triggered by CD95 (Fas/APO-1) and Ceramide
  2721. Role of Ceramide in the activation and activation-induced cell death of gammadelta~(+) T cells
  2722. Inhibition of Insulin-and PDGF-Stimulated Phosphatidylinositol Trisphosphate Production by Ceramide
  2723. Glycosphingolipid engineering using a sphingolipid Ceramide N-deacylase (SCDase); SCDase wo mochiita sufuingo toshishitsu kogaku
  2724. Protective effects of C2-Ceramide against glutamate-induced neurotoxicity in cultured cortical neurons
  2725. Introduction of p53-independent p21 during Ceramide-mediated G1 arrest in SK-Hep 1 cell
  2726. An experimental study on the cytotoxicity and characteristics of ricin-containing galactosyl Ceramide liposomes to human hepatoma cells
  2727. The role of Ceramide in the signal transduction during the NIH 3T3 cell apoptosis induced by UVB irradiation: II. Variations of intracellular Ca~(2+) and pH during the …
  2728. Cathepsin D targeted by acid sphingomyelinase-derived Ceramide M. Heinrich, M. Wickel, W. Schneider-Brachert, C. Sandberg, J. Gahr, R. Schwandner, T. Weber
  2729. C2-Ceramide triggers a BCL-2 mediated apoptosis in normal human keratinocytes.
  2730. Effect of C {sub 2} Ceramide on the inositol phospholipid metabolism (uptake of {sup 32} P,{sup 3} H-serine and {sup 3} H-palmitic acid) and apoptosis-related …
  2731. G1 Arrest and Rb Dephosphorilation is Induced by Ceramide 2 (N-Acetyl Sphingosine) in Cultured Human Keratinocytes.
  2732. Inhibitory action of sphingosine or Ceramide on amylase secretion from isolated rat pancreatic acini
  2733. Ceramide in apoptosis: an overview and current perspectives
  2734. Radiation and Ceramide-induced apoptosis
  2735. Ceramide-enriched membrane domains
  2736. Raft Ceramide in molecular medicine
  2737. Ceramide synthesis and metabolism as a target for cancer therapy
  2738. Ceramide enables fas to cap and kill
  2739. Regulation of insulin action by Ceramide: dual mechanisms linking Ceramide accumulation to the inhibition of Akt/protein kinase B
  2740. Targeting Ceramide metabolism—a strategy for overcoming drug resistance
  2741. Molecular machinery for non-vesicular trafficking of Ceramide
  2742. Mitochondrial Ceramide and the induction of apoptosis
  2743. … Ceramide in Response to Exogenous Short Chain Ceramide in the A549 Human Lung Adenocarcinoma Cell Line: ROLE FOR ENDOGENOUS Ceramide …
  2744. Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1
  2745. Ceramide in apoptosis signaling: relationship with oxidative stress
  2746. Ceramide: second messenger or modulator of membrane structure and dynamics?
  2747. Molecular mechanisms and regulation of Ceramide transport
  2748. Intracellular signal transduction pathways activated by Ceramide and its metabolites
  2749. The therapeutic potential of modulating the Ceramide/sphingomyelin pathway
  2750. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans
  2751. Ceramide, a target for antiretroviral therapy
  2752. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind
  2753. Involvement of Ceramide in hyperosmotic shock-induced death of erythrocytes
  2754. Palmitate-induced apoptosis can occur through a Ceramide-independent pathway
  2755. Ceramide kinase, a novel lipid kinase: molecular cloning and functional characterization
  2756. Astroglial expression of Ceramide in Alzheimer’s disease brains: a role during neuronal apoptosis
  2757. Ceramide, membrane rafts and infections
  2758. Ceramide and cell death receptor clustering
  2759. Molecular mechanisms of Ceramide-mediated CD95 clustering
  2760. Ceramide regulates cellular homeostasis via diverse stress signaling pathways
  2761. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice
  2762. Rhinoviruses infect human epithelial cells via Ceramide-enriched membrane platforms
  2763. Regulation of death receptor signaling and apoptosis by Ceramide
  2764. Ceramide glycosylation potentiates cellular multidrug resistance
  2765. Novel Ceramide analogs as potential chemotherapeutic agents in breast cancer
  2766. Lip1p: a novel subunit of acyl‐CoA Ceramide synthase
  2767. CD95 signaling via Ceramide-rich membrane rafts
  2768. Mitochondria and Ceramide: intertwined roles in regulation of apoptosis
  2769. Ceramide-induced inhibition of Akt is mediated through protein kinase Cζ: implications for growth arrest
  2770. Ceramide-mediated clustering is required for CD95-DISC formation
  2771. Involvement of oxidative stress-induced abnormalities in Ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease
  2772. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2
  2773. C26-CoA-dependent Ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p
  2774. De novo-synthesized Ceramide is involved in cannabinoid-induced apoptosis
  2775. The structural requirements for Ceramide activation of serine-threonine protein phosphatases
  2776. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with Ceramide
  2777. Perturbation of sphingolipid metabolism and Ceramide production in HIV‐dementia
  2778. Ceramide: a new second messenger of cannabinoid action
  2779. Ceramide mediates caspase‐independent programmed cell death
  2780. Ceramide-1-phosphate: a novel regulator of cell activation
  2781. Lag1p and Lac1p Are Essential for the Acyl-CoA–dependent Ceramide Synthase Reaction in Saccharomyces cerevisae
  2782. Substrate specificity of human Ceramide kinase
  2783. The Ca2+ concentration of the endoplasmic reticulum is a key determinant of Ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 …
  2784. Ceramide 1-phosphate, a mediator of phagocytosis
  2785. Host defense against Pseudomonas aeruginosa requires Ceramide-rich membrane rafts
  2786. Induction of apoptotic cell death and prevention of tumor growth by Ceramide analogues in metastatic human colon cancer
  2787. Taxol-induced Ceramide generation and apoptosis in human breast cancer cells
  2788. Sphingomyelin and Ceramide as regulators of development and lifespan
  2789. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and Ceramide
  2790. Possible role of Ceramide as an indicator of chemoresistance: decrease of the Ceramide content via activation of glucosylCeramide synthase and sphingomyelin …
  2791. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via Ceramide synthesis
  2792. Ceramide levels are inversely associated with malignant progression of human glial tumors
  2793. Ceramide: does it matter for T cells?
  2794. Role of sphingomyelinase and Ceramide in modulating rafts: do biophysical properties determine biologic outcome?
  2795. Ceramide-rich membrane rafts mediate CD40 clustering
  2796. Ceramide as an activator lipid of cathepsin D
  2797. Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins
  2798. Ceramidases in the regulation of Ceramide levels and function
  2799. A role for Ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids
  2800. Stimulation of erythrocyte Ceramide formation by platelet-activating factor
  2801. Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation
  2802. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-α is mediated by Ceramide
  2803. Pivotal role of the cell death factor BNIP3 in Ceramide-induced autophagic cell death in malignant glioma cells
  2804. Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages
  2805. Activation of the Drosophila MLK by Ceramide reveals TNF-α and Ceramide as agonists of mammalian MLK3
  2806. Plasma Ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
  2807. Membrane restructuring via Ceramide results in enhanced solute efflux
  2808. Ceramide in the antiapoptotic effect of ischemic preconditioning
  2809. Vesicular and nonvesicular transport of Ceramide from ER to the Golgi apparatus in yeast
  2810. Interfacial interactions of Ceramide with dimyristoylphosphatidylcholine: impact of the N-acyl chain
  2811. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function
  2812. Roles for C16-Ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-α
  2813. Sphingoid bases and de novo Ceramide synthesis: enzymes involved, pharmacology and mechanisms of action
  2814. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCζ-dependent mechanism
  2815. Direct binding to Ceramide activates protein kinase Cζ before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells
  2816. Ceramide mediates insulin resistance by tumor necrosis factor-α in brown adipocytes by maintaining Akt in an inactive dephosphorylated state
  2817. Characterization of a Ceramide kinase-like protein
  2818. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells
  2819. Killing tumours by Ceramide-induced apoptosis: a critique of available drugs
  2820. Substantial sulfatide deficiency and Ceramide elevation in very early Alzheimer’s disease: potential role in disease pathogenesis
  2821. Ceramide induces aSMase expression: implications for oxLDI‐induced apoptosis
  2822. Delayed ERK activation by Ceramide reduces melanin synthesis in human melanocytes
  2823. Mouse anti-Ceramide antiserum: a specific tool for the detection of endogenous Ceramide
  2824. The synthesis and biological characterization of a Ceramide library
  2825. Production and metabolism of Ceramide in normal and ischemic-reperfused myocardium of rats
  2826. Golgi fragmentation is associated with Ceramide-induced cellular effects
  2827. Subcellular compartmentalization of Ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?
  2828. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity
  2829. Roles for inositol-phosphoryl Ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans
  2830. Ceramide kinase mediates cytokine-and calcium ionophore-induced arachidonic acid release
  2831. Ultraviolet A-induced signaling involves a Ceramide-mediated autocrine loop leading to Ceramide de novo synthesis
  2832. Ceramide/Long-Chain Base Phosphate Rheostat in Saccharomyces cerevisiae: Regulation of Ceramide Synthesis by Elo3p and Cka2p
  2833. Role of the Ceramide-signaling pathways in ionizing radiation-induced apoptosis
  2834. Ceramide generation by two distinct pathways in tumor necrosis factor α-induced cell death
  2835. Differential Regulation of Ceramide Synthase Components LAC1 and LAG1 in Saccharomyces cerevisiae
  2836. Liposomal delivery enhances short-chain Ceramide-induced apoptosis of breast cancer cells
  2837. The roles of Ceramide and complex sphingolipids in neuronal cell function
  2838. Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway
  2839. An inverse relationship between Ceramide synthesis and clinical severity in patients with psoriasis
  2840. Ceramide in apoptosis: a revisited role
  2841. Characterizing the effects of saturated fatty acids on insulin signaling and Ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes
  2842. Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin
  2843. Role of membrane sphingomyelin and Ceramide in platform formation for Fas-mediated apoptosis
  2844. Dual effect of Ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase
  2845. A novel inhibitor of Ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis
  2846. Sphingoid bases and Ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells
  2847. Lipopolysaccharide and Ceramide docking to CD14 provokes ligand‐specific receptor clustering in rafts
  2848. Exercise and training effects on Ceramide metabolism in human skeletal muscle
  2849. A functional role for the B56 α-subunit of protein phosphatase 2A in Ceramide-mediated regulation of Bcl2 phosphorylation status and function
  2850. Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway
  2851. A central role for Ceramide in the age‐related acceleration of apoptosis in the female germline
  2852. De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells: DEPENDENCE ON PROTEIN …
  2853. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo Ceramide signaling
  2854. Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries
  2855. FAS activation induces dephosphorylation of SR proteins: dependence on the de novo generation of Ceramide and activation of protein phosphatase 1
  2856. Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis
  2857. Killing cancer cells by poly‐drug elevation of Ceramide levels: a hypothesis whose time has come?
  2858. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells
  2859. Updates on functions of Ceramide in chemotherapy-induced cell death and in multidrug resistance
  2860. Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione
  2861. Ceramide, stress, and a” LAG” in aging
  2862. Fumonisins and fumonisin analogs as inhibitors of Ceramide synthase and inducers of apoptosis
  2863. Role of Ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells
  2864. Cannabinoids and Ceramide: two lipids acting hand-by-hand
  2865. Ceramide pathways modulate ethanol‐induced cell death in astrocytes
  2866. Ceramide down‐regulates System A amino acid transport and protein synthesis in rat skeletal muscle cells
  2867. Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–Ceramide pathway
  2868. Bioorganic chemistry of Ceramide
  2869. Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells
  2870. Role of Ceramide in ischemic preconditioning
  2871. Enlargement and contracture of C2-Ceramide channels
  2872. Mutation of CERKL, a novel human Ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26)
  2873. Ceramide and reactive oxygen species generated by H2O2 induce caspase-3-independent degradation of Akt/protein kinase B
  2874. Synthesis of α-galactosyl Ceramide, a potent immunostimulatory agent
  2875. The AMP-activated protein kinase prevents Ceramide synthesis de novo and apoptosis in astrocytes
  2876. Sphingosine-phosphate lyase enhances stress-induced Ceramide generation and apoptosis
  2877. Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3β, and induction of the mitochondrial-dependent intrinsic …
  2878. Ceramide and other sphingolipids in cellular responses
  2879. Natural Ceramide reverses Fas resistance of acid sphingomyelinase−/− hepatocytes
  2880. Immunotherapeutic potential for Ceramide-based activators of iNKT cells
  2881. Systemic delivery of liposomal short-chain Ceramide limits solid tumor growth in murine models of breast adenocarcinoma
  2882. Ceramide induces the dephosphorylation and inhibition of constitutively activated Akt in PTEN negative U87mg cells
  2883. Ceramide inhibits the potassium channel Kv1. 3 by the formation of membrane platforms
  2884. Cell surface Ceramide generation precedes and controls FcγRII clustering and phosphorylation in rafts
  2885. Protein kinase Cδ amplifies Ceramide formation via mitochondrial signaling in prostate cancer cells
  2886. AcylCeramide head group architecture affects lipid organization in synthetic Ceramide mixtures
  2887. LAG1 puts the focus on Ceramide signaling
  2888. Thalidomide-induced antiangiogenic action is mediated by Ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate
  2889. Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein
  2890. Resistance to TRAIL is associated with defects in Ceramide signaling that can be overcome by exogenous C6-Ceramide without requiring down-regulation of cellular …
  2891. Characterization and direct quantitation of Ceramide molecular species from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry
  2892. Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires Ceramide
  2893. Bax-dependent apoptosis induced by Ceramide in HL-60 cells
  2894. Increase of Ceramide in adriamycin-induced HL-60 cell apoptosis: detection by a novel anti-Ceramide antibody
  2895. Preparation of liposomes containing Ceramide 3 and their membrane characteristics
  2896. Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin-1
  2897. Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis
  2898. Ceramide mediates tumor-induced dendritic cell apoptosis
  2899. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release
  2900. Intracellular Ceramide synthesis and protein kinase Cζ activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells
  2901. Upregulation of Ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia
  2902. Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of Ceramide in brain and in plasma
  2903. The role of sphingosine and Ceramide kinases in inflammatory responses
  2904. Sphingosine 1-phosphate and Ceramide 1-phosphate: expanding roles in cell signaling
  2905. Cannabinoids protect astrocytes from Ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway
  2906. Human homologues of LAG1 reconstitute Acyl-CoA-dependent Ceramide synthesis in yeast
  2907. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-Ceramide and involves mitochondria
  2908. Ceramide‐induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation
  2909. Synthesis and characterization of novel Ceramide analogs for induction of apoptosis in human cancer cells
  2910. The Ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts
  2911. Ceramide accumulation precedes caspase-3 activation during apoptosis of A549 human lung adenocarcinoma cells
  2912. Increasing intracellular Ceramide: an approach that enhances the cytotoxic response in prostate cancer cells
  2913. p53-independent Ceramide formation in human glioma cells during γ-radiation-induced apoptosis
  2914. Sphingosine kinase activity counteracts Ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression
  2915. Serine palmitoyltransferase: role in apoptotic de novo Ceramide synthesis and other stress responses
  2916. Ceramide constituents from five mushrooms
  2917. Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-Ceramide loaded mature dendritic cells in cancer patients
  2918. Ceramide signaling in fenretinide-induced endothelial cell apoptosis
  2919. Death-associated protein (DAP) kinase plays a central role in Ceramide-induced apoptosis in cultured hippocampal neurons
  2920. Structural determinants of sphingolipid recognition by commercially available anti-Ceramide antibodies
  2921. Acid and neutral sphingomyelinase, Ceramide synthase, and acid ceramidase activities in cutaneous aging
  2922. Ceramide is involved in r (+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells
  2923. Ceramide metabolite, not intact Ceramide molecule, may be responsible for cellular toxicity
  2924. Intracellular delivery of Ceramide lipids via liposomes enhances apoptosis in vitro
  2925. Inhibition of Ceramide production reverses TNF-induced insulin resistance
  2926. … ‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and Ceramide …
  2927. Ceramide-1-phosphate: the “missing” link in eicosanoid biosynthesis and inflammation
  2928. Sphingomyelinase activity of LDL: a link between atherosclerosis, Ceramide, and apoptosis?
  2929. Positively charged Ceramide is a potent inducer of mitochondrial permeabilization
  2930. Elevated sphingomyelinase activity and Ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for …
  2931. Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins
  2932. Ceramide‐induced cell death in primary neuronal cultures: upregulation of Ceramide levels during neuronal apoptosis
  2933. Ceramide-induced apoptosis by translocation, phosphorylation, and activation of protein kinase Cδ in the Golgi complex
  2934. Acid sphingomyelinase-derived Ceramide signaling in apoptosis
  2935. High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a Ceramide-dependent manner
  2936. A new Ceramide from the basidiomycete Russula cyanoxantha
  2937. Sphingosine forms channels in membranes that differ greatly from those formed by Ceramide
  2938. Effect of globotriaosyl Ceramide fatty acid α-hydroxylation on the binding by verotoxin 1 and verotoxin 2
  2939. Ceramide, a putative second messenger for nerve growth factor, modulates the TTX‐resistant Na+ current and delayed rectifier K+ current in rat sensory neurons
  2940. Molecular mechanisms of Ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line
  2941. … has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent on Ceramide pathway, and Bcl …
  2942. Synthesis of cyclopropene analogues of Ceramide and their effect on dihydroCeramide desaturase
  2943. p53 regulates Ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells
  2944. C16 Ceramide accumulates following androgen ablation in LNCaP prostate cancer cells
  2945. The effect of Ceramide on phosphatidylcholine membranes: a deuterium NMR study
  2946. Regulation of apoptosis during neuronal differentiation by Ceramide and b-series complex gangliosides
  2947. Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed Ceramide increase
  2948. Effects of Ceramide inhibition on experimental radiation-induced oral mucositis
  2949. High Ceramide content liposomes with in vivo antitumor activity.
  2950. Mechanisms involved in exogenous C2-and C6-Ceramide-induced cancer cell toxicity
  2951. Lipid metabolism: Ceramide transfer protein adds a new dimension
  2952. Saturated free fatty acids, palmitic acid and stearic acid, induce apoptosis by stimulation of Ceramide generation in rat testicular Leydig cell
  2953. Ceramide: a potential mediator of apoptosis in human retinal pigment epithelial cells
  2954. Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-κB activity
  2955. BcR-induced apoptosis involves differential regulation of C16 and C24-Ceramide formation and sphingolipid-dependent activation of the proteasome
  2956. Inhibitory actions of Ceramide upon PKC-ε/ERK interactions
  2957. Synthesis of a resveratrol analogue with high Ceramide-mediated proapoptotic activity on human breast cancer cells
  2958. Rapid shortening of telomere length in response to Ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate …
  2959. Ceramide-induced apoptosis: role of catalase and hepatocyte growth factor
  2960. Thalidomide suppresses NF-κB activation induced by TNF and H2O2, but not that activated by Ceramide, lipopolysaccharides, or phorbol ester
  2961. Ceramide Promotes Apoptosis in Lung Cancer-Derived A549 Cells by a Mechanism Involving c-Jun NH2-Terminal Kinase
  2962. Selective apoptosis of pluripotent mouse and human stem cells by novel Ceramide analogues prevents teratoma formation and enriches for neural precursors in ES …
  2963. Resveratrol structure and Ceramide-associated growth inhibition in prostate cancer cells.
  2964. Lithium blocks the PKB and GSK3 dephosphorylation induced by Ceramide through protein phosphatase-2A
  2965. Ceramide biosynthesis is required for the formation of the oligomeric H+-ATPase Pma1p in the yeast endoplasmic reticulum
  2966. Ceramide regulation of apoptosis versus differentiation: a walk on a fine line. Lessons from neurobiology
  2967. Efficient synthesis of α-galactosyl Ceramide analogues using glycosyl iodide donors
  2968. Effect of a lipid‐rich emollient containing Ceramide 3 in experimentally induced skin barrier dysfunction
  2969. Interfacial regulation of acid ceramidase activity: stimulation of Ceramide degradation by lysosomal lipids and sphingolipid activator proteins
  2970. c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and Ceramide
  2971. Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD (P) H oxidase, oxidant stress, and Ceramide
  2972. Anti-Plasmodium activity of Ceramide analogs
  2973. Ceramide triggers Weibel–Palade body exocytosis
  2974. Epidermal barrier lipids in human vernix caseosa: corresponding Ceramide pattern in vernix and fetal skin
  2975. New advances on structural and biological functions of Ceramide in apoptotic/necrotic cell death and cancer
  2976. Ceramide-induced intracellular oxidant formation, iron signaling, and apoptosis in endothelial cells: protective role of endogenous nitric oxide
  2977. DAP kinase activity is critical for C2‐Ceramide‐induced apoptosis in PC12 cells
  2978. Ceramide-induced alterations in dopamine transporter function
  2979. Newbouldiaquinone and newbouldiamide: A new naphthoquinone–anthraquinone coupled pigment and a new Ceramide from Newbouldia laevis
  2980. P53 mediates Ceramide-induced apoptosis in SKN-SH cells
  2981. Nerve growth factor-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through Ceramide generated by neutral …
  2982. Polymorphism of Ceramide 3. Part 1: an investigation focused on the head group of N-octadecanoylphytosphingosine
  2983. Selective inhibition of juxtanuclear translocation of protein kinase C βII by a negative feedback mechanism involving Ceramide formed from the salvage …
  2984. The characterization of molecular organization of multilamellar emulsions containing pseudoCeramide and type III synthetic Ceramide
  2985. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum Ceramide levels and signs and symptoms of atopic dermatitis patients
  2986. Lcb4p is a key regulator of Ceramide synthesis from exogenous long chain sphingoid base in Saccharomyces cerevisiae
  2987. Ceramide mediates growth inhibition of the Plasmodium falciparum parasite
  2988. Role of Ceramide during cisplatin-induced apoptosis in C6 glioma cells
  2989. Ceramide increases mitochondrial free calcium levels via caspase 8 and Bid: role in initiation of cell death
  2990. Cyclooxygenase inhibitors block cell growth, increase Ceramide and inhibit cell cycle
  2991. Synthesis of α-galactosyl Ceramide and the related glycolipids for evaluation of their activities on mouse splenocytes
  2992. Do longevity assurance genes containing Hox domains regulate cell development via Ceramide synthesis?
  2993. Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries
  2994. Acute activation of de novo sphingolipid biosynthesis upon heat shock causes an accumulation of Ceramide and subsequent dephosphorylation of SR …
  2995. Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/Ceramide production and oxidative stress …
  2996. Increase of nuclear Ceramide through caspase-3-dependent regulation of the “sphingomyelin cycle” in Fas-induced apoptosis
  2997. Overcoming resistance to γ-rays in squamous carcinoma cells by poly-drug elevation of Ceramide levels
  2998. Neutral sphingomyelinase inhibitor scyphostatin prevents and Ceramide mimics mechanotransduction in vascular endothelium
  2999. Modulation of Ceramide-induced NF-κB binding activity and apoptotic response by caffeic acid in U937 cells: comparison with other antioxidants
  3000. Ceramide mediates age-associated increase in macrophage cyclooxygenase-2 expression
  3001. Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following Ceramide glycanase digestion and anthranilic acid labeling
  3002. Mitochondrial Ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin
  3003. Ceramide triggers an NF-κB-dependent survival pathway through calpain
  3004. Subtype-specific translocation of the δ subtype of protein kinase C and its activation by tyrosine phosphorylation induced by Ceramide in HeLa cells
  3005. Structure of cholesterol/Ceramide monolayer mixtures: implications to the molecular organization of lipid rafts
  3006. Current status and perspectives in Ceramide-targeting molecular medicine
  3007. Homocysteine activates NADH/NADPH oxidase through Ceramide-stimulated Rac GTPase activity in rat mesangial cells
  3008. Synthesis of a cyclopropene analogue of Ceramide, a potent inhibitor of dihydroCeramide desaturase
  3009. Ceramide inhibits cell proliferation through Akt/PKB inactivation and decreases melanin synthesis in Mel‐Ab cells
  3010. Formation of phosphatidic acid, Ceramide, and diglyceride on radiolysis of lipids: identification by MALDI-TOF mass spectrometry
  3011. De novo Ceramide synthesis participates in the ultraviolet B irradiation-induced apoptosis in undifferentiated cultured human keratinocytes
  3012. Ceramide 1-phosphate acts as a positive allosteric activator of group IVA cytosolic phospholipase A2α and enhances the interaction of the enzyme with …
  3013. De novo Ceramide accumulation due to inhibition of its conversion to complex sphingolipids in apoptotic photosensitized cells
  3014. Role of Ceramide synthase in oxidant injury to renal tubular epithelial cells
  3015. Ceramide activates microglia to enhance the production/secretion of brain‐derived neurotrophic factor (BDNF) without induction of deleterious factors in vitro
  3016. Structure, Cellular Distribution, Antigenicity, and Biological Functions of Fonsecaea pedrosoi Ceramide Monohexosides
  3017. Ceramide alters endothelial cell permeability by a nonapoptotic mechanism
  3018. Inhibition of rat sympathetic neuron apoptosis by Ceramide. Role of p75NTR in Ceramide generation
  3019. Acyl-CoA-binding protein, Acb1p, is required for normal vacuole function and Ceramide synthesis in Saccharomyces cerevisiae
  3020. A specific Ceramide kinase assay to measure cellular levels of Ceramide
  3021. Ceramide Induces Release of Pro-Apoptotic Proteins from Mitochondria by Either a Ca2+-Dependent or a Ca2+-Independent Mechanism
  3022. Hippocampal programmed cell death after status epilepticus: evidence for NMDA‐receptor and Ceramide‐mediated mechanisms
  3023. Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids
  3024. Ceramide regulates protein synthesis by a novel mechanism involving the cellular PKR activator RAX
  3025. Molecular mechanisms of TNF-α-induced Ceramide formation in human glioma cells: p53-mediated oxidant stress-dependent and-independent pathways
  3026. Decreased levels of covalently bound Ceramide are associated with ultraviolet B-induced perturbation of the skin barrier
  3027. Elevation of Ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine–palmitoyl transferase
  3028. Nanoscale properties of mixed fengycin/Ceramide monolayers explored using atomic force microscopy
  3029. Tumor necrosis factor-α induces stress fiber formation through Ceramide production: role of sphingosine kinase
  3030. Opposite regulation of the mitochondrial apoptotic pathway by C2‐Ceramide and PACAP through a MAP‐kinase‐dependent mechanism in cerebellar granule cells
  3031. Modelling the stratum corneum lipid organisation with synthetic lipid mixtures: the importance of synthetic Ceramide composition
  3032. Phytosphingosine and sphingosine Ceramide headgroup hydrogen bonding: structural insights through thermotropic hydrogen/deuterium exchange
  3033. Localization of Ceramide and glucosylCeramide in human epidermis by immunogold electron microscopy
  3034. GlucosylCeramide synthesis and synthase expression protect against Ceramide-induced stress
  3035. Angiostatin effects on endothelial cells mediated by Ceramide and RhoA
  3036. Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation
  3037. Transient mechanoactivation of neutral sphingomyelinase in caveolae to generate Ceramide
  3038. Pituitary adenylate cyclase‐activating polypeptide prevents C2‐Ceramide‐induced apoptosis of cerebellar granule cells
  3039. Design, synthesis, and characterization of the antitumor activity of novel Ceramide analogues
  3040. Ceramide Signaling
  3041. Cross-talk between nitric oxide and superoxide determines Ceramide formation and apoptosis in glomerular cells
  3042. Modulators of Ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy
  3043. Synergistic interaction between sphingomyelin and gemcitabine potentiates Ceramide-mediated apoptosis in pancreatic cancer
  3044. Shape transitions and lattice structuring of Ceramide-enriched domains generated by sphingomyelinase in lipid monolayers
  3045. Generation of Ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival
  3046. FTIR spectroscopic studies of lipid dynamics in phytosphingosine Ceramide models of the stratum corneum lipid matrix
  3047. Ceramide enhances cholesterol efflux to apolipoprotein AI by increasing the cell surface presence of ATP-binding cassette transporter A1
  3048. Role of Ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells
  3049. Ceramide induces non-apoptotic cell death in human glioma cells
  3050. Synthetic Ceramide analogues as skin permeation enhancers: structure–activity relationships
  3051. Role of Ceramide in TNF-α-induced impairment of endothelium-dependent vasorelaxation in coronary arteries
  3052. Interaction among molecules in mixtures of Ceramide/stearic acid, Ceramide/cholesterol and Ceramide/stearic acid/cholesterol
  3053. Ceramide reduction and transcriptional up-regulation of glucosylCeramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells
  3054. Structural requirements of Ceramide and sphingosine based inhibitors of mitochondrial ceramidase
  3055. Downregulation of the HERG (KCNH2) K+ channel by Ceramide: evidence for ubiquitin-mediated lysosomal degradation
  3056. P-glycoprotein modulates Ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs
  3057. Association of the Golgi UDP-galactose transporter with UDP-galactose: Ceramide galactosyltransferase allows UDP-galactose import in the endoplasmic reticulum
  3058. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and Ceramide-1-phosphate
  3059. Suppressor analysis points to the subtle role of the LAG1 Ceramide synthase gene in determining yeast longevity
  3060. Involvement of neutral ceramidase in Ceramide metabolism at the plasma membrane and in extracellular milieu
  3061. Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and Ceramide generation in cultured normal human keratinocytes
  3062. The effect on the skin barrier function of Ceramide
  3063. Synthesis of novel internal standards for the quantitative determination of plasma Ceramide trihexoside in Fabry disease by tandem mass spectrometry
  3064. Efficient synthesis of α-C-galactosyl Ceramide immunostimulants: use of ethylene-promoted olefin cross-metathesis
  3065. Effects of C2-Ceramide on the Malme-3M melanoma cell line
  3066. Serum deprivation increases Ceramide levels and induces apoptosis in undifferentiated HN9. 10e cells
  3067. Endothelial apoptosis induced by inhibition of integrins αvβ3 and αvβ5 involves Ceramide metabolic pathways
  3068. Ceramide-dependent caspase 3 activation is prevented by coenzyme Q from plasma membrane in serum-deprived cells
  3069. Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl Ceramide binding by recombinant prokaryotic and eukaryotic …
  3070. Aberrant sphingomyelin/Ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related …
  3071. Cycloserine and threo-dihydrosphingosine inhibit TNF-α-induced cytotoxicity: evidence for the importance of de novo Ceramide synthesis in TNF-α signaling
  3072. … biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc: Ceramide glucosyltransferase strongly affects spore …
  3073. C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in Ceramide-induced neuronal apoptosis
  3074. LASS5 is the predominant Ceramide synthase isoform involved in de novo sphingolipid synthesis in lung epithelia
  3075. Ceramide induces caspase‐dependent and‐independent apoptosis in A‐431 cells
  3076. Calorimetric and spectroscopic investigations of phytosphingosine Ceramide membrane organisation
  3077. NO induced apoptosis of vascular smooth muscle cells accompanied by Ceramide increase
  3078. Akt protein kinase inhibits non-apoptotic programmed cell death induced by Ceramide
  3079. Ceramide 1-phosphate formation in neutrophils
  3080. Low glucose-enhanced TRAIL cytotoxicity is mediated through the Ceramide–Akt–FLIP pathway
  3081. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of Ceramide synthase
  3082. The role of neutral sphingomyelinase produced Ceramide in lipopolysaccharide‐mediated expression of inducible nitric oxide synthase
  3083. Kit signaling inhibits the sphingomyelin-Ceramide pathway through PLCγ1: implication in stem cell factor radioprotective effect
  3084. Ceramide induces cell cycle arrest and upregulates p27kip in nasopharyngeal carcinoma cells
  3085. Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking Ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL …
  3086. Ceramide increases oxidative damage due to inhibition of catalase by caspase-3-dependent proteolysis in HL-60 cell apoptosis
  3087. N -(4-Hydroxyphenyl)retinamide Elevates Ceramide in Neuroblastoma Cell Lines by Coordinate Activation of Serine Palmitoyltransferase and Ceramide …
  3088. Amyloid‐β peptide enhances tumor necrosis factor‐α‐induced iNOS through neutral sphingomyelinase/Ceramide pathway in oligodendrocytes
  3089. Shiga toxin binding to globotriaosyl Ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells
  3090. Effect of cholesterol on miscibility and phase behavior in binary mixtures with synthetic Ceramide 2 and octadecanoic acid. Infrared studies
  3091. Ceramide inhibits IL-2 production by preventing protein kinase C-dependent NF-κB activation: possible role in protein kinase Cθ regulation
  3092. Prolactin acts as a potent survival factor against C2‐Ceramide‐induced apoptosis in human granulosa cells
  3093. The protective effect of Ceramide in immature rat brain hypoxia—ischemia involves up-regulation of BCL-2 and reduction of TUNEL-positive cells
  3094. Role of Ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells
  3095. Phyllanthus urinaria induces the Fas receptor/ligand expression and Ceramide-mediated apoptosis in HL-60 cells
  3096. Ceramide in nitric oxide inhibition of glioma cell growth: evidence for the involvement of Ceramide traffic
  3097. P-glycoprotein is implicated in the inhibition of Ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylCeramide …
  3098. Reactive oxygen species production by mitochondria in endothelial cells exposed to reoxygenation after hypoxia and glucose depletion is mediated by Ceramide
  3099. Ceramide regulates lipopolysaccharide-induced phosphatidylinositol 3-kinase and Akt activity in human alveolar macrophages
  3100. Distinct stress and cell destruction pathways are engaged by TNF and Ceramide during apoptosis of MCF-7 cells
  3101. Differential binding of Ceramide to MEKK1 in glomerular endothelial and mesangial cells
  3102. Ceramide kinase targeting and activity determined by its N-terminal pleckstrin homology domain
  3103. … Reactions of N-Acylimino Esters for Direct Formation of N-Acylated Amino Acid Derivatives. Efficient Synthesis of a Novel Inhibitor of Ceramide Trafficking, HPA-12
  3104. Calmodulin is involved in the Ca2+-dependent activation of Ceramide kinase as a calcium sensor
  3105. Simultaneous quantitative analysis of Ceramide and sphingosine in mouse blood by naphthalene-2, 3-dicarboxyaldehyde derivatization after hydrolysis with …
  3106. Cell Permeable Exogenous Ceramide Reduces Infarct Size in Spontaneously Hypertensive Rats Supporting In Vitro Studies That Have Implicated Ceramide in …
  3107. Cell line dependent involvement of Ceramide in ultraviolet light-induced apoptosis
  3108. Neutral ceramidase gene: role in regulating Ceramide-induced apoptosis
  3109. Nerve growth factor signaling of p75 induces differentiation and Ceramide‐mediated apoptosis in Schwann cells cultured from degenerating nerves
  3110. Mass spectrometric analysis of Ceramide perturbations in brain and fibroblasts of mice and human patients with peroxisomal disorders
  3111. Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by Ceramide
  3112. Oxidation of pyridine nucleotides during Fas-and Ceramide-induced apoptosis in Jurkat cells: correlation with changes in mitochondria, glutathione depletion …
  3113. Ceramide in rafts (detergent‐insoluble fraction) mediates cell death in neurotumor cell lines
  3114. TGF-β1 suppresses apoptosis via differential regulation of MAP kinases and Ceramide production
  3115. Dopamine release in PC12 cells is mediated by Ca2+‐dependent production of Ceramide via sphingomyelin pathway
  3116. UVA radiation stimulates Ceramide production: relationship to oxidative stress and potential role in ERK, JNK, and p38 activation
  3117. … activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing Ceramide in mouse
  3118. Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis
  3119. Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid Ceramide
  3120. Acyl chain length affects Ceramide action on sterol/sphingomyelin-rich domains
  3121. Enhanced phagocytosis through inhibition of de novo Ceramide synthesis
  3122. Psychosine is as potent an inducer of cell death as C6-Ceramide in cultured fibroblasts and in MOCH-1 cells
  3123. Sphingomyelinase and Ceramide analogs induce vasoconstriction and leukocyte–endothelial interactions in cerebral venules in the intact rat brain: Insight into …
  3124. Biochemical characterization of the reverse activity of rat brain ceramidase: a CoA-independent and fumonisin B1-insensitive Ceramide synthase
  3125. Life and death decisions: Ceramide generation and EGF receptor trafficking are modulated by oxidative stress
  3126. Gangliosides Link the Acidic Sphingomyelinase–Mediated Induction of Ceramide to 12-Lipoxygenase–Dependent Apoptosis of Neuroblastoma in Response to …
  3127. Interactions of vitamin D analogue CB1093, TNFα and Ceramide on breast cancer cell apoptosis
  3128. Polymorphism of Ceramide 6: a vibrational spectroscopic and X-ray powder diffraction investigation of the diastereomers of N-(α-hydroxyoctadecanoyl) …
  3129. Rebamipide inhibits Ceramide-induced interleukin-8 production in Kato III human gastric cancer cells
  3130. New Ceramide fromAlocasia macrorrhiza
  3131. Detection and activation of human Vα24+ natural killer T cells using α-galactosyl Ceramide-pulsed dendritic cells
  3132. Acute exposure of Ceramide enhances cardiac contractile function in isolated ventricular myocytes
  3133. Ceramide inhibits lipopolysaccharide-mediated nitric oxide synthase and cyclooxygenase-2 induction in macrophages: effects on protein kinases and transcription …
  3134. Does protein kinase R mediate TNF-α-and Ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a …
  3135. Ceramide-induced impairment of endothelial function is prevented by CuZn superoxide dismutase overexpression
  3136. On the importance of the phosphocholine methyl groups for sphingomyelin/cholesterol interactions in membranes: a study with Ceramide …
  3137. Prevalence of necrosis in C2-Ceramide–induced cytotoxicity in NB16 neuroblastoma cells
  3138. Temporal relationships between Ceramide production, caspase activation and mitochondrial dysfunction in cell lines with varying sensitivity to anti-Fas-induced …
  3139. Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells
  3140. Inhibition of CTP: phosphocholine cytidylyltransferase by C2-Ceramide and its relationship to apoptosis
  3141. Cell death induction by betulinic acid, Ceramide and TRAIL in primary glioblastoma multiforme cells
  3142. Ceramide-1-P induces Ca2+ mobilization in Jurkat T-cells by elevation of Ins (1, 4, 5)-P3 and activation of a store-operated calcium channel
  3143. Crocin prevents the death of PC-12 cells through sphingomyelinase-Ceramide signaling by increasing glutathione synthesis
  3144. Apoptotic activities of C2-Ceramide and C2-dihydroCeramide homologues against HL-60 cells
  3145. Ceramide lances the lungs
  3146. Uptake and metabolism of low density lipoproteins with elevated Ceramide content by human microvascular endothelial cells: implications for the regulation of …
  3147. Increasing endogenous Ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation‐induced mitochondrial injury and apoptotic cell killing
  3148. … c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes: role of acidic sphingomyelinase-mediated Ceramide generation in FAS …
  3149. Differential carbohydrate epitope recognition of globotriaosyl Ceramide by verotoxins and a monoclonal antibody: Role in human renal glomerular binding
  3150. Favorable and unfavorable lateral interactions of Ceramide, neutral glycosphingolipids and gangliosides in mixed monolayers
  3151. Intratesticular delivery of tumor necrosis factor-α and Ceramide directly abrogates steroidogenic acute regulatory protein expression and Leydig cell steroidogenesis in …
  3152. The role of Ceramide in receptor-and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells
  3153. Stereoselective Synthesis and Structure−Activity Relationship of Novel Ceramide Trafficking Inhibitors. (1R,3R)-N-(3-Hydroxy-1-hydroxymethyl-3-phenylpropyl) …
  3154. The Natural LewisX‐Bearing Lipids Promote Membrane Adhesion: Influence of Ceramide on Carbohydrate–Carbohydrate Recognition
  3155. Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying Ceramide-mediated metabolic dysfunction of the β …
  3156. Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines
  3157. Study of pH variation on the skin using cosmetic formulation s with and without vitamins A, E or Ceramide: by a non-invasive method
  3158. L-Serine and glycine based Ceramide analogues as transdermal permeation enhancers: polar head size and hydrogen bonding
  3159. Stearoyl-CoA desaturase-1 deficiency reduces Ceramide synthesis by downregulating serine palmitoyltransferase and increasing β-oxidation in skeletal muscle
  3160. Ceramide inhibition of NF‐κB activation involves reverse translocation of classical protein kinase C (PKC) isoenzymes: requirement for kinase activity and carboxyl …
  3161. Ceramide generation occurring during 7β-hydroxycholesterol-and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger …
  3162. Ceramide induces activation of the mitochondrial/caspases pathway in Jurkat and SCC61 cells sensitive to γ-radiation but activation of this sequence is defective in …
  3163. Sphingolipid Synthesis via Olefin Cross Metathesis:  Preparation of a Differentially Protected Building Block and Application to the Synthesis of d-erythro-Ceramide
  3164. Quantitative measurement of different Ceramide species from crude cellular extracts by normal‐phase high‐performance liquid chromatography coupled to …
  3165. Fas, Ceramide and serum withdrawal induce apoptosis via a common pathway in a type II Jurkat cell line
  3166. Reversal of non‐hydroxy: α‐hydroxy galactosylCeramide ratio and unstable myelin in transgenic mice overexpressing UDP‐galactose: Ceramide galactosyltransferase
  3167. Observation of different Ceramide species from crude cellular extracts by normal‐phase high‐performance liquid chromatography coupled to atmospheric pressure …
  3168. Ceramide modulates the lipid membrane organization at molecular and supramolecular levels
  3169. Designing anticancer drugs via the achilles heel: Ceramide, allylic ketones, and mitochondria
  3170. GlucosylCeramide synthase activity and Ceramide levels are modulated during cerebral ischemia after ischemic preconditioning
  3171. Interleukin-4 suppresses the enhancement of Ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-α and …
  3172. Bovine milk gangliosides: changes in Ceramide moiety with stage of lactation
  3173. New glyceroglycolipid and Ceramide from Premna microphylla
  3174. Ceramide and sphingosine 1-phosphate in anti-cancer therapies
  3175. Slight impairment of Na+, K+-ATPase synergistically aggravates Ceramide-and β-amyloid-induced apoptosis in cortical neurons
  3176. Cytochrome c dissociation and release from mitochondria by truncated Bid and Ceramide
  3177. Synthesis of a novel Ceramide analogue via Tebbe methylenation and evaluation of its antiproliferative activity
  3178. Effect of acute exercise and training on metabolism of Ceramide in the heart muscle of the rat
  3179. Ceramide and sphingosine have an antagonistic effect on the plasma-membrane Ca2+-ATPase from human erythrocytes
  3180. Polymorphism of Ceramide 3. Part 2: a vibrational spectroscopic and X-ray powder diffraction investigation of N-octadecanoyl phytosphingosine and the analogous …
  3181. Ceramide analogue 14S24 ((S)-2-tetracosanoylamino-3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro
  3182. Influence of Ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells
  3183. Synthesis and stereochemistry of Ceramide B,(2S, 3R, 4E, 6R)-N-(30-hydroxytriacontanoyl)-6-hydroxy-4-sphingenine, a new Ceramide in human epidermis
  3184. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein–induced activation of the sphingomyelin/Ceramide pathway and smooth muscle cell …
  3185. High-performance liquid chromatography analysis of ganglioside carbohydrates at the picomole level after Ceramide glycanase digestion and fluorescent labeling with …
  3186. Synthetic α-mannosyl Ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant Vα19-Jα26 TCR α chain
  3187. Elevation of de novo Ceramide synthesis in tumor masses and the role of microsomal dihydroCeramide synthase
  3188. Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis
  3189. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate Ceramide and induce apoptotic cell death
  3190. Identification of Ceramide binding proteins in neuronal cells: a critical point of view
  3191. Ceramide inhibits axonal growth and nerve growth factor uptake without compromising the viability of sympathetic neurons
  3192. Role of NKT cells and α-galactosyl Ceramide
  3193. The EP3 receptor stimulates Ceramide and diacylglycerol release and inhibits growth of primary keratinocytes
  3194. Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages
  3195. Enhanced de Novo Ceramide Generation through Activation of Serine Palmitoyltransferase by the P-Glycoprotein Antagonist SDZ PSC 833 in Breast Cancer Cells
  3196. Analysis of sphingomyelin and Ceramide levels and the enzymes regulating their metabolism in response to cell stress
  3197. Fenretinide stimulates redox-sensitive Ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity
  3198. Isolation and Structure of a New Ceramide from the Basidiomycete Hygrophorus eburnesus
  3199. β-Sitosterol stimulates Ceramide metabolism in differentiated Caco2 cells
  3200. NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine Ceramide and sphingosine‐1‐phosphate levels accompanying G1 …
  3201. Differential regulation of Ceramide in lipid‐rich microdomains (rafts): Antagonistic role of palmitoyl: protein thioesterase and neutral sphingomyelinase 2
  3202. Suppression of mast cell degranulation by a novel Ceramide kinase inhibitor, the F-12509A olefin isomer K1
  3203. Involvement of endogenous Ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human …
  3204. Ceramide binding to African–American hair fibre correlates with resistance to hair breakage
  3205. Secretory phospholipase A2 induces apoptosis via a mechanism involving Ceramide generation
  3206. Ceramide inhibition of mammalian phospholipase D1 and D2 activities is antagonized by phosphatidylinositol 4, 5-bisphosphate
  3207. Catalytic enantioselective synthesis of a novel inhibitor of Ceramide trafficking,(1R, 3R)-N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl) dodecanamide (HPA-12)
  3208. Instability of N-acetylated fumonisin B1 (FA1) and the impact on inhibition of Ceramide synthase in rat liver slices
  3209. Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain Ceramide and is decreased by raloxifene
  3210. Effect of overexpression of a neutral sphingomyelinase on CD95-induced Ceramide production and apoptosis
  3211. Bile salt-stimulated carboxyl ester lipase influences lipoprotein assembly and secretion in intestine: a process mediated via Ceramide hydrolysis
  3212. Glutathione peroxidase-1 overexpression prevents Ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells
  3213. Ceramide inhibits the outward potassium current in rat pinealocytes
  3214. Characterization of Ceramide-induced apoptotic death in cerebellar granule cells in culture
  3215. Nerve growth factor-induced glutamate release is via p75 receptor, Ceramide, and Ca2+ from ryanodine receptor in developing cerebellar neurons
  3216. Occurrence of an α-galacturonosyl-Ceramide in the dioxin-degrading bacterium Sphingomonas wittichii
  3217. Nitric oxide regulates synthesis of gene products involved in keratinocyte differentiation and Ceramide metabolism
  3218. Ceramide, tumor necrosis factor and alcohol‐induced liver disease
  3219. Laser induces apoptosis and Ceramide production in human retinal pigment epithelial cells
  3220. Ceramide-and ERK-dependent pathway for the activation of CCAAT/enhancer binding protein by interleukin-1β in hepatocytes
  3221. C2-Ceramide Influences the Expression and Insulin-Mediated Regulation of Cyclic Nucleotide Phosphodiesterase 3B and Lipolysis in 3T3-L1 Adipocytes
  3222. Coupled assay of sphingomyelin and Ceramide molecular species by gas liquid chromatography
  3223. Defects in cell growth regulation by C18: 0-Ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas
  3224. Ceramide Inhibits the Inwardly Rectifying Potassium Current in GH3 Lactotrophs
  3225. … 1 (uog1), a mammalian homolog of the yeast Longevity Assurance Gene 1 (LAG1), regulatesN-Stearoyl-sphinganine (C18-(Dihydro) Ceramide) synthesis in a …
  3226. Impaired Ceramide signalling in spontaneously hypertensive rat vascular smooth muscle: a possible mechanism for augmented cell proliferation
  3227. Ceramide generation in situ alters leukocyte cytoskeletal organization and β2-integrin function and causes complete degranulation
  3228. Ceramide increases Fas-mediated apoptosis in glioblastoma cells through FLIP down-regulation
  3229. Modulation of Ceramide content and lack of apoptosis in the chronically hypoxic neonatal rat heart
  3230. Ceramide involvement in homocamptothecin-and camptothecin-induced cytotoxicity and apoptosis in colon HT29 cells
  3231. Oligodendrocyte‐specific Ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT‐deficient mice and demonstrates that CGT activity does not …
  3232. Ceramide triggers caspase activation during γ-radiation-induced apoptosis of human glioma cells lacking functional p53
  3233. Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in Ceramide hydrolysis on atopic skin by Pseudomonas ceramidase
  3234. Ceramide‐induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic features
  3235. IGF-I protects cortical neurons against Ceramide-induced apoptosis via activation of the PI-3K/Akt and ERK pathways; is this protection independent of CREB and Bcl …
  3236. Cross-talk between phosphatidic acid and Ceramide during ethanol-induced apoptosis in astrocytes
  3237. Activation of the JAK/STAT pathway by Ceramide in cultured human fibroblasts
  3238. Enterotoxigenic Escherichia coli strains bind bovine milk gangliosides in a Ceramide-dependent process
  3239. Inhibition of growth and telomerase activity by novel cationic Ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells
  3240. Regulation of nociceptin/orphanin FQ gene expression in astrocytes by Ceramide
  3241. Dynamic ergosterol-and Ceramide-rich domains in the peroxisomal membrane serve as an organizing platform for peroxisome fusion
  3242. A lipid analogue that inhibits sphingomyelin hydrolysis and synthesis, increases Ceramide, and leads to cell death
  3243. Mitochondrial effects with Ceramide-induced cardiac apoptosis are different from those of palmitate
  3244. Leishmania donovani Suppresses Activated Protein 1 and NF-κB Activation in Host Macrophages via Ceramide Generation: Involvement of Extracellular Signal …
  3245. Fumonisin-induced tumor necrosis factor-α expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by Ceramide synthase …
  3246. Mitochondrial cytochrome c release mediates Ceramide-induced activator protein 2 activation and gene expression in keratinocytes
  3247. Regulation of polymorphonuclear leukocyte degranulation and oxidant production by Ceramide through inhibition of phospholipase D
  3248. Identification of genes involved in Ceramide-dependent neuronal apoptosis using cDNA arrays
  3249. Ceramide increase cytoplasmic Ca2+ concentration in Jurkat T cells by liberation of calcium from intracellular stores and activation of a store-operated calcium …
  3250. Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger Ceramide
  3251. Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-α-mediated apoptosis in human colon HT-29 cells through …
  3252. Ceramide and cholesterol: possible connections between normal aging of the brain and Alzheimer’s disease. Just hypotheses or molecular pathways to be identified?
  3253. Effects of Ceramide on aggrecanase activity in rabbit articular cartilage
  3254. Apoptotic death by Ceramide: will the real killer please stand up?
  3255. Formation of Ceramide-enriched domains in lipid particles enhances the binding of apolipoprotein E
  3256. Ceramide in Regulation of Apoptosis: Implication in multitoxicant resistance
  3257. The total syntheses of D-erythro-sphingosine, N-palmitoylsphingosine (Ceramide), and glucosylCeramide (cerebroside) via an azidosphingosine analog
  3258. Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of Ceramide synthesis
  3259. Tumor necrosis factor-α-induced cyclooxygenase-2 expression via sequential activation of Ceramide-dependent mitogen-activated protein kinases, and IκB kinase 1/2 …
  3260. Poly-drug cancer therapy based on Ceramide.
  3261. The role of de novo Ceramide synthesis in the mechanism of action of the tricyclic xanthate D609
  3262. Characterization of zebrafish caspase-3 and induction of apoptosis through Ceramide generation in fish fathead minnow tailbud cells and zebrafish embryo
  3263. Ceramide accelerates dephosphorylation of extracellular signal-regulated kinase 1/2 to decrease prostaglandin D2 production in RBL-2H3 cells
  3264. Decreased activity and enhanced nuclear export of CCAAT-enhancer-binding protein β during inhibition of adipogenesis by Ceramide
  3265. Control of Ceramide-induced apoptosis by IGF-1: involvement of PI-3 kinase, caspase-3 and catalase
  3266. Radiation‐induced apoptosis of oligodendrocytes and its association with increased Ceramide and down‐regulated protein kinase B/Akt activity
  3267. Inositol phosphoCeramide synthase is a regulator of intracellular levels of diacylglycerol and Ceramide during the G1 to S transition in Saccharomyces cerevisiae
  3268. Ceramide and glucosamine antagonism of alternate signaling pathways regulating insulin-and osmotic shock-induced glucose transporter 4 translocation
  3269. Modulation of CYP3A4 expression by Ceramide in human colon carcinoma HT-29 cells
  3270. Significant role of Ceramide pathway in experimental gastric ulcer formation in rats
  3271. Reduced expression of Bax in Ceramide-resistant HL-60 subline
  3272. Superoxide potently induces Ceramide formation in glomerular endothelial cells
  3273. Isolation of Ceramide fractions from skin sample by subcritical chromatography with packed silica and evaporative light scattering detection
  3274. Ceramide and glutathione define two independently regulated pathways of cell death initiated by p53 in Molt-4 leukaemia cells
  3275. Metabolic formation of Ceramide-1-phosphate in cerebellar granule cells: evidence for the phosphorylation of Ceramide by different metabolic pathways
  3276. Ceramide in primary astrocytes from cerebellum: metabolism and role in cell proliferation
  3277. C2-Ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis
  3278. Enhancement of radiosensitivity by combined Ceramide and dimethylsphingosine treatment in lung cancer cells
  3279. Ceramide 1-phosphate enhances calcium entry through voltage-operated calcium channels by a protein kinase C-dependent mechanism in GH4C1 rat pituitary cells
  3280. Renal apoptosis parallels Ceramide content after prolonged ureteral obstruction in the neonatal rat
  3281. Characterization of the reversible nature of the reaction catalyzed by sphingolipid Ceramide N‐deacylase: A novel form of reverse hydrolysis reaction
  3282. … and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of Ceramide and reactive oxygen …
  3283. Divergent role of Ceramide generated by exogenous sphingomyelinases on NF-κB activation and apoptosis in human colon HT-29 cells
  3284. Saturated free fatty acid release and intracellular Ceramide generation during apoptosis induction are closely related processes
  3285. The sphingomyelin/Ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue‐type plasminogen …
  3286. PAF, Ceramide and pulmonary edema: alveolar flooding and a flood of questions
  3287. Increased Akt protein expression is associated with decreased Ceramide content in skeletal muscle of troglitazone-treated mice
  3288. Fumonisin-induced blockade of Ceramide synthase in sphingolipid biosynthetic pathway alters aortic input impedance spectrum of pigs
  3289. Ceramide 1-phosphate increases intracellular free calcium concentrations in thyroid FRTL-5 cells: evidence for an effect mediated by inositol 1, 4, 5-trisphosphate and …
  3290. Increase in Ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells
  3291. Amphimelibiosides A−F, Six New Ceramide Dihexosides Isolated from a Japanese Marine Sponge Amphimedon sp.
  3292. Glycoinositol phospholipids from Trypanosoma cruzi transmit signals to the cells of the host immune system through both Ceramide and glycan chains
  3293. Loss of cyclin A and G1-cell cycle arrest are a prerequisite of Ceramide-induced toxicity in human arterial endothelial cells
  3294. Ceramide accumulation is independent of camptothecin-induced apoptosis in prostate cancer LNCaP cells
  3295. Mannosyl-Diinositolphospho-Ceramide, the Major Yeast Plasma Membrane Sphingolipid, Governs Toxicity of Kluyveromyces lactis Zymocin
  3296. CrmA protects against apoptosis and Ceramide formation in PC12 cells
  3297. Brefeldin A and filipin distinguish two globotriaosyl Ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity
  3298. Induction of apoptosis in chicken oviduct cells by C2-Ceramide.
  3299. Ceramide‐induced apoptosis of D283 medulloblastoma cells requires mitochondrial respiratory chain activity but occurs independently of caspases and is not …
  3300. Regulation of Ceramide signaling by plasma membrane coenzyme Q reductases
  3301. Ceramide analogues in apoptosis: a new strategy for anticancer drug development
  3302. Inflammatory mediator and β-amyloid (25–35)-induced Ceramide generation and iNOS expression are inhibited by vitamin E
  3303. Generation of receptor-active, globotriaosyl Ceramide/cholesterol lipid ‘rafts’ in vitro: A new assay to define factors affecting glycosphingolipid receptor activity
  3304. Ceramide inhibits L-type calcium channel currents in GH3 cells
  3305. Short-chain Ceramide regulates hepatic methionine adenosyltransferase expression
  3306. Synthesis of a novel fluorescent Ceramide analogue and its use in the characterization of recombinant ceramidase from Pseudomonas aeruginosa PA01
  3307. … cell death in mitotic neural progenitor cells by asymmetric distribution of prostate apoptosis response 4 (PAR-4) and simultaneous elevation of endogenous Ceramide
  3308. CTP:phosphocholine cytidylyltransferase inhibition by Ceramide via PKC-α, p38 MAPK, cPLA2, and 5-lipoxygenase
  3309. Positive inotropic effect of Ceramide in adult ventricular myocytes: mechanisms dissociated from its reduction in Ca2+ influx
  3310. Synthesis of homoCeramides, novel Ceramide analogues, and their lack of effect on the growth of hippocampal neurons
  3311. Method for quantitative determination of cerebroside in “plant Ceramide” foodstuffs by high performance liquid chromatography with evaporative light scattering …
  3312. Mobile phase compositions for Ceramide III by normal phase high performance liquid chromatography
  3313. Inhibition of Ceramide synthesis in plants by phytotoxins
  3314. Quantitative Studies of Binding between Synthetic Galactosyl Ceramide Analogues and HIV‐1 Gp120 at Planar Membrane Surfaces
  3315. Ceramide induces translocation of protein kinase C-α to the Golgi compartment of human embryonic kidney cells by interacting with the C2 domain
  3316. Pravastatin Attenuates Ceramide‐Induced Cytotoxicity in Mouse Cerebral Endothelial Cells with HIF‐1 Activation and VEGF Upregulation
  3317. … human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into Ceramide …
  3318. N-(4-hydroxyphenyl) retinamide increases Ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes
  3319. Structure of the Ceramide moiety of GM1 ganglioside determines its occurrence in different detergent-resistant membrane domains in HL-60 cells
  3320. The molecular relationship between deficient UDP-galactose uridyl transferase (GALT) and Ceramide galactosyltransferase (CGT) enzyme function: a possible cause …
  3321. Anoxia and reoxygenation of human endothelial cells decreases Ceramide glucosyltransferase expression and activates caspases
  3322. The 4, 5-double bond of Ceramide regulates its dipole potential, elastic properties, and packing behavior
  3323. Vesnarinone causes oxidative damage by inhibiting catalase function through Ceramide action in myeloid cell apoptosis
  3324. Suppression of Ceramide-induced cell death by hepatitis C virus core protein
  3325. HIV-1 gp41 envelope residues 650–685 exposed on native virus act as a lectin to bind epithelial cell galactosyl Ceramide
  3326. Stimulation by de novo-synthesized Ceramide of phospholipase A2-dependent cholesterol esterification promoted by the uptake of oxidized low-density lipoprotein in …
  3327. Inhibition of steroidogenesis and induction of apoptosis in rat luteal cells by cell-permeable Ceramide in vitro.
  3328. Mitochondrial cytochrome c release precedes transmembrane depolarisation and caspase-3 activation during Ceramide-induced apoptosis of Jurkat T cells
  3329. Up‐regulation of prosaposin by the retinoid HPR and the effect on Ceramide production and integrin receptors
  3330. Synthesis of Ceramide mimics with a pseudo cyclic framework
  3331. Inhibitory effect of Ceramide on insulin-induced protein kinase Cζ translocation in rat adipocytes
  3332. Synthesis of the glycosphingolipid β-galactosyl Ceramide and analogues via olefin cross metathesis
  3333. Fenretinide cytotoxicity for Ewing’s sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by Ceramide …
  3334. Heat shock and Ceramide have different apoptotic pathways in radiation induced fibrosarcoma (RIF) cells
  3335. Nitric oxide, Ceramide and sphingomyelinase-coupled receptors: a tale of enzymes and messengers coordinating cell death, survival and differentiation
  3336. T‐Cell Receptor Downregulation by Ceramide‐Induced Caspase Activation and Cleavage of the ζ Chain
  3337. Inhibitory activity of a Ceramide library on interleukin-4 production from activated T cells
  3338. Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of Ceramide through acid sphingomyelinase …
  3339. Nano capsulization of Ceramide and the efficacy of atopy skin
  3340. Oleandrin suppresses activation of nuclear transcription factor-κB and activator protein-1 and potentiates apoptosis induced by Ceramide
  3341. Ceramide and sphingosine rapidly induce apoptosis of murine mast cells supported by interleukin-3 and stem cell factor
  3342. Role of Ceramide in Ca2+-sensing receptor-induced apoptosis
  3343. Involvement of Ceramide in the mechanism of Cr (VI)-induced apoptosis of CHO cells
  3344. Effects of cations on Ceramide-activated protein phosphatase 2A
  3345. The thermotropic phase behaviour of phyto-Ceramide 1 as investigated by ATR-FTIR and DSC
  3346. Aggregation behaviour of Ceramide class 3 lipids
  3347. Ceramide-induced enhancement of secretory phospholipase A2 expression via generation of reactive oxygen species in tumor necrosis factor-α-stimulated mesangial …
  3348. Inhibition of sodium-calcium exchange by Ceramide and sphingosine
  3349. … B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of α-N-acetylneuraminyllactosyl-Ceramide in light and small …
  3350. A study of the safety & effect of products containing Ceramide, glucan for atopic dermatitis
  3351. Characterization of the human UDP-galactose: Ceramide galactosyltransferase gene promoter
  3352. Ceramide influences neurite outgrowth and neuroblastoma cell apoptosis regulated by novel protein kinase C isoforms
  3353. Synthesis of non-natural C2-homo-Ceramide and its apoptotic activity against HL-60 cells
  3354. C2-Ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma
  3355. Improved irras apparatus for studies of aqueous monolayer films: Determination of the orientation of each chain in a fatty-acid homogeneous Ceramide 2
  3356. Insulin or bFGF and C2 Ceramide increase newborn rat retinal ganglion cell survival rate
  3357. Keratinocytes Rapidly Readjust Ceramide–Sphingomyelin Homeostasis and Contain a Phosphatidylcholine–Sphingomyelin Transacylase
  3358. Ordering Ceramide-induced cell detachment and apoptosis in human neuroepithelioma
  3359. Synthesis of novel and non-natural Ceramide analogues derived from l-glutamic acid
  3360. Brain microvessel endothelin type A receptors are coupled to Ceramide production
  3361. Ceramide enhances acrosomal exocytosis triggered by calcium and the calcium ionophore A23187 in boar spermatozoa
  3362. Differential Expression of Proteins in Response to Ceramide-Mediated Stress Signal in Colon Cancer Cells by 2-D Gel Electrophoresis and MALDI-TOF− MS
  3363. Cloning of a mouse β1, 3N-acetylglucosaminyltransferase GlcNAc (β1, 3) Gal (β1, 4) Glc-Ceramide synthase gene encoding the key regulator of lacto-series …
  3364. Gold sodium thiomalate (GSTM) inhibits lipopolysaccharide stimulated tumor necrosis factor-α through Ceramide pathway
  3365. Study on Ceramide expression and DNA content in patients with healthy mucosa, leukoplakia, and carcinoma of the larynx
  3366. Ceramide negatively regulates glutathione S-transferase gene transactivation via repression of hepatic nuclear factor-1 that is degraded by the ubiquitin proteasome …
  3367. Nitric oxide production stimulated by the basic fibroblast growth factor requires the synthesis of Ceramide
  3368. Human diploid fibroblasts that undergo a senescent-like differentiation have elevated Ceramide and diacylglycerol
  3369. Interactions of Adriamycin, Cytochrome c, and Serum Albumin withLipid Monolayers Containing Poly (ethylene glycol)-Ceramide
  3370. Treatment of atopic blepharitis by controlling eyelid skin water retention ability with Ceramide gel application
  3371. Ceramide induces a loss in cytosolic peroxide levels in mononuclear cells
  3372. Requirement of Ceramide for adhesion of Helicobacter pylori to glycosphingolipids
  3373. TNFα reduces the expression of peroxisome proliferator-activated receptor γ (PPARγ) via the production of Ceramide and activation of atypical PKC
  3374. Avascular necrosis of the femoral head in a patient with Fabry’s disease: Identification of Ceramide trihexoside in the bone by delayed‐extraction matrix‐assisted laser …
  3375. In vivo influence of Ceramide accumulation induced by treatment with a glucosylCeramide synthase inhibitor on ischemic neuronal cell death
  3376. Ceramide inhibition of phospholipase D and its relationship to RhoA and ARF1 translocation in GTPγS-stimulated polymorphonuclear leukocytes
  3377. Ceramide-induced apoptosis in rabbit corneal fibroblasts
  3378. Isolation and Structural Determination of Four New Ceramide Lactosides from the Starfish Luidia maculata
  3379. Modulation by C2 Ceramide of the nicotinic transmission within the coeliac ganglion in the rabbit
  3380. Synthesis of D-erythro-sphingosine and D-erythro-Ceramide
  3381. Enhanced Ceramide generation and induction of apoptosis in human leukemia cells exposed to DT388–granulocyte-macrophage colony-stimulating factor (GM-CSF) …
  3382. A synthetic Ceramide analog ameliorates spatial cognition deficit and stimulates biosynthesis of brain gangliosides in rats with cerebral ischemia
  3383. Synergistic effect of interleukin (IL)-1α and Ceramide analogue on the production of IL-6, IL-8, and macrophage colony-stimulating factor by endometrial …
  3384. Simultaneous quantitative determination method for Ceramide species from crude cellular extracts by high-performance liquid chromatography–thermospray mass …
  3385. Tanacetamide C: One new Ceramide from Tanacetum artemisioides
  3386. INTERLEUKIN 1β (IL-1β) ACTION IN PORCINE THYROID CELLS INVOLVES THE Ceramide SIGNALLING PATHWAY
  3387. Distinct apoptotic phenotypes induced by radiation and Ceramide in both p53-wild-type and p53-mutated lymphoblastoid cells
  3388. Enhancement of C2-Ceramide antitumor activity by small interfering RNA on X chromosome—linked inhibitor of apoptosis protein in resistant human glioma cells
  3389. C 2-Ceramide inhibits LPS-induced nitric oxide production in RAW 264.7 macrophage cells through down-regulating the activation of Akt
  3390. IL-1 stimulates Ceramide accumulation without inducing apoptosis in intestinal epithelial cells
  3391. Secreted frizzled-related protein 1 (SFRP1) protects fibroblasts from Ceramide-induced apoptosis
  3392. Uptake and Rapid Transfer of Fluorescent Ceramide Analogues to Acidosomes (Late Endosomes) in Paramecium
  3393. Lipoarabinomannan-induced cell signaling involves Ceramide and mitogen-activated protein kinase
  3394. Dominant-negative suppression of HNF-1α results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to Ceramide-, but not to high …
  3395. C2-Ceramide-induced circular smooth muscle cell contraction involves PKC-ε and p44/p42 MAPK activation in cat oesophagus
  3396. Glycosphingolipids from Magnaporthe grisea cells: expression of a Ceramide dihexoside presenting phytosphingosine as the long-chain base
  3397. Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in Ceramide synthesis in response to N-(4-hydroxyphenyl)retinamide
  3398. Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-Ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer …
  3399. Tumor necrosis factor α and Ceramide depolarise the resting membrane potential of thyroid FRTL-5 cells via a protein kinase Cζ-dependent regulation of K+ channels
  3400. Synthesis of a Ceramide sphingolipid as a potential sex pheromone of the hair crab Erimacrus isenbeckii using butane-2, 3-diacetal desymmetrised glycolic acid …
  3401. Identification of two RNA cis-elements that function to regulate the 5′ splice site selection of Bcl-x pre-mRNA in response to Ceramide
  3402. Measurement of Ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy
  3403. Ceramide does not act as a general second messenger for ultraviolet-induced apoptosis
  3404. Bcl-2 rescues Ceramide-and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation
  3405. Characterization of C2-Ceramide-resistant HL-60 subline (HL-CR): involvement of PKC δ in C2-Ceramide resistance
  3406. C2-Ceramide as a cell death inducer in HC11 mouse mammary epithelial cells
  3407. Synergistic Effect of Interleukin‐1α and Ceramide Analogue on Production of Prostaglandin E2 and F2α by Endometrial Stromal Cells
  3408. Differential sensitivity to short-chain Ceramide analogues of human intestinal carcinoma cells grown in tumor spheroids versus monolayer culture
  3409. Transcriptional regulation of the human UDP-galactose: Ceramide galactosyltransferase (hCGT) gene expression: functional role of GC-box and CRE
  3410. Ceramide: a messenger of cell death
  3411. Transmembrane domain of Bcl-2 is required for inhibition of Ceramide synthesis, but not cytochrome c release in the pathway of inostamycin-induced apoptosis
  3412. Phase diagram and emulsion properties of n-octyl β-d-glucoside/water/octanoic acid containing pseudo-Ceramide mixtures
  3413. The leucine 10 residue in the pleckstrin homology domain of Ceramide kinase is crucial for its catalytic activity
  3414. A chicken-or-egg conundrum in apoptosis: which comes first? Ceramide or PKCδ?
  3415. The gel phase structure of hydrated Ceramide 3b as investigated by synchrotron X-ray and atomic force microscopy
  3416. Ceramide attenuates high glucose-induced cardiac contractile abnormalities in cultured adult rat ventricular myocytes.
  3417. Potentiation of Ceramide-induced apoptosis by p27kip1 Overexpression
  3418. Changes in Ceramide levels upon catechins-induced apoptosis in lovo cells
  3419. Ceramide, an apoptotic rheostat, inhibits CCAAT/enhancer binding protein-β and NF-E2-related factor-2 activation: The role in glutathione S-transferase A2 gene …
  3420. Cell cycle arrest of hematopoietic cell lines after treatment with Ceramide is commonly associated with retinoblastoma activation
  3421. Dissociated ROS production and Ceramide generation in sulfasalazine-induced cell death in Raw 264.7 cells
  3422. Diacylglycerol and Ceramide formation induced by dopamine D2S receptors via Gβγ-subunits in Balb/c-3T3 cells
  3423. Reduced levels of the adenomatous polyposis coli (APC) protein are associated with Ceramide-induced apoptosis of colon cancer cells
  3424. Stimulation of astrocyte-enriched culture with C2 Ceramide increases proenkephalin mRNA: involvement of cAMP-response element binding protein and mitogen …
  3425. Sphingomyelinase but not Ceramide induces nitric oxide synthase expression in rat brain microglia
  3426. [14C] serine from phosphatidylserine labels Ceramide and sphingomyelin in L929 cells: evidence for a new metabolic relationship between glycerophospholipids and …
  3427. Activation of serine/threonine protein phosphatase-1 is required for Ceramide-induced survival of sympathetic neurons
  3428. Sphingosine-induced c-jun expression: differences between sphingosine-and C2-Ceramide-mediated signaling pathways
  3429. A Tandem Mass Spectrometric Approach for Determining the Structure of Molecular Species of Ceramide in the Marine Sponge, Haliclona Cribricutis
  3430. Tissue-specific Ceramide response in the chronically hypoxic rat model mimicking cyanotic heart disease
  3431. High levels of exogenous C2‐Ceramide promote morphological and biochemical evidences of necrotic features in thyroid follicular cells
  3432. … membrane-bound CD54 (mCD54) and soluble form of CD54 (sCD54) in endothelial cells by glucosyl transferase inhibitor: possible role of Ceramide for the shedding …
  3433. … enhances the DNA single-strand breakage induced by the short-chain lipid hydroperoxide analogue tert-butylhydroperoxide via Ceramide-dependent inhibition of …
  3434. Ceramide 1-(2-cyanoethyl) phosphate enhances store-operated Ca2+ entry in thyroid FRTL-5 cells
  3435. Selective and transient activation of protein kinase C α by fumonisin B1, a Ceramide synthase inhibitor mycotoxin, in cultured porcine renal cells
  3436. Growth Hormone-induced Diacylglycerol and Ceramide Formation via Gαi3 and Gβγ in GH4 Pituitary Cells: POTENTIATION BY DOPAMINE-D2 RECEPTOR …
  3437. The role of Ceramide of human macrophage gangliosides in activation of human macrophages
  3438. Synthesis of 7‐Oxasphingosine and‐Ceramide Analogues and Their Evaluation in a Model for Apoptosis
  3439. Ceramide blocks PDGF-induced DNA synthesis in mesangial cells via inhibition of Akt kinase in the absence of apoptosis
  3440. C2-Ceramide induces vasodilation in phenylephrine-induced pre-contracted rat thoracic aorta: role of RhoA/Rho-kinase and intracellular Ca2+ concentration
  3441. The Clinical Efficacy of Multi-Lameller Emulsion (MLE) contained Pseudo-Ceramide (PC-9S) on Atopic Dermatitis
  3442. Identification of the LIM kinase-1 as a Ceramide-regulated gene in renal mesangial cells
  3443. Involvement of the ubiquitin-mediated proteolytic system in the signaling pathway induced by Ceramide in primary astrocyte cultures
  3444. Lactic acidosis stimulates ganglioside and Ceramide generation without sphingomyelin hydrolysis in rat cortical astrocytes
  3445. Bradykinin stimulates Ceramide production by activating specific BK-B1 receptor in rat small artery
  3446. Ceramide glycosylation and fatty acid hydroxylation influence serological reactivity in Trypanosoma cruzi glycosphingolipids
  3447. Involvement of phosphatidylinositol 3-kinase in nuclear translocation of protein kinase C ζ induced by C2-Ceramide in rat hepatocytes
  3448. Modelling of Ceramide interactions with porous graphite carbon in non-aqueous liquid chromatography
  3449. Nerve conduction velocity measurements reveal the functional deficit in Ceramide galactosyl transferase-deficient (cgt−/−) mice
  3450. Insights into Ceramide 3A molecular arrangement
  3451. Quantitative Analysis of Ceramide III of Saccharomyces cerevisiae by Normal Phase HPLC
  3452. … phosphoenol ether derived from a dienone. Approaches to the syntheses of phosphonate analogs of sphingomyelin, sphingosine 1-phosphate and Ceramide 1 …
  3453. Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-Ceramide, a stable analog of the ganglioside GM3-lactone
  3454. Effect of Ceramide analogs on interleukin-1a-induced production of rostaglandin E2 by amnion-derived (WISH) cells
  3455. Sphingomyelin and Ceramide in brain aging, neuronal plasticity and neurodegenerative disorders
  3456. Epigallocatechin-3-gallate suppresses galactose-α1, 4-galactose-β1, 4-glucose Ceramide expression in TNF-α stimulated human intestinal epithelial cells …
  3457. Protection of LLC-PK1 cells against hydrogen peroxide-induced cell death by modulation of Ceramide level
  3458. A turn in the road: How studies on the pharmacology of glucosylCeramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with Ceramide …
  3459. Interleukin-1β (IL-1β) induces a crosstalk between cAMP and Ceramide signaling pathways in thyroid epithelial cells
  3460. A novel GlcNAcα1-HPO3-6Gal(1-1)Ceramide antigen and alkylated inositol-phosphoglycerolipids expressed by the liver fluke Fasciola hepatica
  3461. Aromatase inhibition by 15-deoxy-prostaglandin J2 (15-dPGJ2) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced Ceramide production
  3462. A Novel Ceramide from the Indian Marine Sponge Fasciospongia Cavernosa
  3463. Emulsion properties of pseudo-Ceramide PC104/water/polyoxyethylene cholesteryl ether and polyoxyethylene cetyl ether mixtures
  3464. Phenoxodiol, a synthetic analog of genistein, generates Ceramide and is equipotent in wild-type and multidrug-resistant human tumor cells
  3465. Neutralizing Ceramide: A major breakthrough or yet another marginal target for the treatment of acute lung injury?
  3466. Conformationally restrained Ceramide analogues: effects of lipophilic modifications on the antiproliferative activity
  3467. Ceramide-epoxides
  3468. Ceramide modulates nicotinic receptor‐dependent Ca2+ signaling in rat chromaffin cells
  3469. Interleukin‐1β inhibits ATP‐induced protein kinase B activation in renal mesangial cells by two different mechanisms: the involvement of nitric oxide and Ceramide
  3470. Π-A isotherms, phase behaviors, and lamellar structures of synthetic vitamin E Ceramide mixed with cholesterol and linoleic acid
  3471. Sphingolipids as Emerging Drug Targets: Therapeutic Applications of Ceramide Analogs
  3472. First total synthesis of α-(2→ 3)/α-(2→ 6)-disialyl lactotetraosyl Ceramide and disialyl Lewis A ganglioside as cancer-associated carbohydrate antigens
  3473. Ceramide signaling under oxidative stress
  3474. Molecular cloning of Chinese hamster Ceramide glucosyltransferase and its enhanced expression in peroxisome-defective mutant Z65 cells
  3475. Nano capsulization of Ceramide and the efficacy of atopy skin
  3476. Potentiation of okadaic acid-induced Ceramide elevation but not apoptosis by inhibition of glucosylCeramide synthase in human neuroepithelioma cells
  3477. C2‐Ceramide and reactive oxygen species inhibit pituitary adenylate cyclase activating polypeptide (PACAP)‐induced cyclic‐AMP‐dependent signalling pathway
  3478. Ceramide is Involved in  Cytotoxicity in Human Neuroblastoma Cells
  3479. Structural analysis of Ceramide-amino-ethyl-phosphonate in edible mediterranean cephalopods
  3480. Procedure for separation of GM2 ganglioside species with different Ceramide structures by a flash reversed-phase silica gel liquid chromatography
  3481. Differential involvement of Ceramide in TNFalpha-mediated activation of NF-kappaB in primary human keratinocytes and HaCaT keratinocytes.
  3482. Developmental patterns of Ceramide glucosyltransferase (GlcT-1) expression in the mouse: in situ hybridization using DIG-labeled RNA probes.
  3483. Sphingomyelinase amplifies BMP-4-induced osteocalcin synthesis in osteoblasts: role of Ceramide
  3484. GalCer Synthase (Ceramide Galactosyltransferase, CGT)
  3485. Combating cancer-drug resistance: The Ceramide connection
  3486. Ceramide generation and apoptosis in autoimmunity
  3487. GlcCer synthase (UDP-glucose: Ceramide glucosyltransferase, UGCG)
  3488. Synthesis of (2S,2′R,3S,4R)-2-(2′-Hydroxy-21′-methyldocosanoylamino)- 1,3,4-pentadecanetriol, the Ceramide Sex Pheromone of the Female Hair Crab,…
  3489. Effect of cellular zinc on the regulation of C2-Ceramide induced apoptosis in mammary epithelial and macrophage cell lines
  3490. Rapid induction of senescence-like changes in human umbilic vein endothelial cells (HUVECs) by C6 Ceramide
  3491. Ceramide trafficking: learning from the rebels
  3492. … 1 upregulates ovarian prostaglandin endoperoxide synthase-2 expression: evidence for prostaglandin-dependent/Ceramide-independent transcriptional stimulation …
  3493. Gas-phase structure and conformation of the glycosidase and Ceramide glucosyltransferase inhibitor N-benzyl deoxynojirimycin
  3494. Sphingosine 1-phosphate acts as a signal molecule in Ceramide signal transduction of TNF-α-induced activator protein-1 in osteoblastic cell line MC3T3-E1 cells
  3495. Ceramide-driven stress signals in cancer and aging
  3496. Ceramide: Cell Regulation from a Lipid Perspective
  3497. Ceramide is a key mediator in the apoptosis of retina photoreceptors
  3498. Ceramide-Induced Apoptosis in Cultured Keratocyte
  3499. Chromatographic analysis of Ceramide III ofSaccharomyces cerevisiae
  3500. … death in embryonic chick cardiomyocyte is more dependent on caspase-2 than caspase-3 inhibition and is independent of sphingomyelinase activation and Ceramide …
  3501. The Application of Nanoliposome Composed of Ceramide as an Anti-irritant in Cosmetics
  3502. Synthesis and cytotoxicity of new 3-alkyl-1-(1-methyl-2-phenylethyl) ureas related to Ceramide
  3503. Ceramide, Ceramidase, and FasL Gene Therapy in Prostate Cancer
  3504. Effects of antioxidation and Ceramide of improved prescription of didang-tang (IPDT) on exprimental atherosclerosis rabbits
  3505. Light at the end of the “Tunel”? Role of Ceramide in seizure-induced programmed cell death
  3506. A new Ceramide from two edible mushrooms, Grifola frondosa and Lyophyllum connatum
  3507. Top down analysis Ceramide-induced mitochondrial dysfunctions: role of mitochondrial swelling
  3508. The metalloprotease-directed shedding of BP 180 (collagen XVII) from human keratinocytes in culture is unaffected by Ceramide and cell-matrix interaction
  3509. Prevention of PC-12 cell death by crocin via sphingomyelinase-Ceramide signaling by increase of glutathione biosynthesis
  3510. Repeated administration of alpha-galactosyl Ceramide attenuates of Natural Killer T cells
  3511. Safingol, an inhibitor of sphingosine kinase, stimulates autophagy in a Ceramide-independent and phosphatidylinositol (PI)-3 kinase-mediated manner
  3512. Utilization of the lipids of the deep-sea grenadier: the high content of Ceramide derivatives in the internal organ lipids of genus Corypaenoides
  3513. Benzene increases the ratio of arachidonic acids to docosahexaenoic acids and inhibits the de novo synthesis of Ceramide in the rat liver
  3514. Molecular targeting therapy for leukemia by sphingolipid Ceramide
  3515. Inhibition of Ceramide synthase in corn seedlings infected with Fusarium verticillioides or exposed directly to fumonisin B1 in soil
  3516. Ceramide–induced Upregulation of Redoxin Proteins in RPE and Effect of Hepatocyte Growth Factor
  3517. Elevated Ceramide levels contribute to the age-associated decline in vascular endothelial nitric oxide. Pharmacologic administration of lipoic acid partially …
  3518. Cyclosporin A enhances Ceramide signalling in human breast cancer cells in response to N-(4-hydroxyphenyl) retinamide
  3519. Ceramide Inhibits IL-2 Production by
  3520. Gold sodium thiomalate (GSTM) inhibits lipopolysaccharide stimulated tumor necrosis factor-α through Ceramide pathway
  3521. … of methyl-3, 5-diiodo-4-(4′-methoxyphenoxy) benzoate: Drug-induced protein dephosphorylations and inhibition of the permissive action of Ceramide on growth factor …
  3522. Commentary:“Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer’s disease. Just hypotheses or molecular …
  3523. Therapeutic applications of Ceramide lipids for apoptosis induction
  3524. Synthesis of biologically relevant sphingoid-and Ceramide-analogues.
  3525. Regulation of C2-Ceramide-induced neuronal death
  3526. ROLE OF Ceramide IN TNF-α-INDUCED IMPAIRMENT OF ENDOTHELIUM-DEPENDENT VASORELAXATION IN SMALL BOVINE CORONARY ARTERIES
  3527. Compartmentalization and properties of Ceramide metabolizing enzymes.
  3528. Down-regulation of Ceramide synthase-6 during epithelial-to-mesenchymal
  3529. The Application of Nanoliposome Composed of Ceramide as an Anti-irritant in Cosmetics
  3530. The role of Ceramide in growth arrest and terminal differentiation of human leukaemia cells
  3531. Light at the End of the “TUNEL”? Role of Ceramide in Seizure-induced Programmed Cell Death.
  3532. Practical Synthesis of -Galactosyl Ceramide, KRN 7000.
  3533. Role of Ceramide in Hypoxia-induced Neuronal Cell Death
  3534. Alternative splicing mechanisms mediated by Ceramide for the regulation of apoptosis
  3535. Ceramide and reactive oxygen species (ROS) as signal transduction molecules in inflammation
  3536. The Development and Evaluation of Systemic Drug Delivery Systems for C6-Ceramide as a Breast Cancer Chemotherapeutic Agent
  3537. Ceramide-1-Phosphate a Novel Mediator for Phagocytosis.
  3538. In vivo antineoplastic efficacy of Ceramide via novel drug delivery systems
  3539. Regulation of Ceramide metabolism in glioma cells: evidence on the role of phosphatidylinosotol-4-kinases
  3540. Characterization of the apoptotic molecular events induced by a lysosomotropic Ceramide analog in prostate cancer cells
  3541. Ceramide pathway and Apoptosis in Autoimmunity and Atherosclerosis
  3542. Astroglial expression of Ceramide in Alzheimer’s disease brains
  3543. Molecular mechanisms of responses to radiation through Ceramide
  3544. Pharmacological preconditioning with Ceramide: implication of antideath signaling through the upregulation of the antiapoptotic gene Bcl-2
  3545. Modulation of Human Cytochrome P450 3A4 Expression by Ceramide, a Lipid Second Messenger
  3546. Epigallocatechin-3-gallate Suppresses Galactose-1, 4-galactose-1, 4-glucose Ceramide Expression in TNF-Stimulated Human IntestinalEpithelial Cells Through …
  3547. The role of Ceramide in the antagonism of insulin signal transduction by free fatty acids in skeletal muscle
  3548. p38 MAP kinase is involved in Ceramide-induced apoptosis in HL-60 cells
  3549. Induction effects of C2-Ceramide on early apoptosis in rat glioma cell C6
  3550. Antitumor properties of Ceramide
  3551. Role of catalase in Ceramide–induced apoptosis and its protection by hepatocyte growth factor.
  3552. Effects of β-sitosterol and tamoxifen on growth and Ceramide metabolism in breast cancer cells
  3553. TNF-a and Ceramide as Mediators of Neuronal Tolerance to Brain Ischemia
  3554. Interventional effect of emodin on the changes of sphingomylinase activity and Ceramide content in experimental rabbit with atherosclerosis
  3555. Nitric oxide modulates Ceramide traffic in human glioma cells: a fluorescence microscopy study
  3556. Inhibition of C2-Ceramide induced contraction in cat esophageal smooth muscle cell by newly synthesized Ceramide analogues
  3557. Investigation of the interaction of Ceramide and acyl-coenzyme A with the mitochondrial associated protein, endozepine, using heteronuclear NMR
  3558. Ceramide Initiates NF Kappa B‐Mediated Caspase Activation In Neuronal Apoptosis
  3559. Hypoxia-induced Neuronal Cell Death is Caused by Increase in the de novo Synthesis of Ceramide Linked to Caspase Activation
  3560. Investigation of the binding of Ceramide and palmitoyl-CoA to murine t-ACBP using heteronuclear NMR spectroscopy: NRF/Royal Society programme
  3561. Asymmetric syntheses of new analogues of Ceramide
  3562. Ceramide is Linked to Glutamate-induced Cell Death in Cultured Cortical Neurons
  3563. TNF-and Ceramide are involved in the mediation of neuronal tolerance to brain ischemia
  3564. Role of the de novo Ceramide and Arachidonic Acid in Paclitaxel-Induced Apoptosis
  3565. Ceramide permeabilization of mitochondrial outer membrane: Pharmacological characterization and relation to MAC and Bax
  3566. Channel formation by the pro-apoptotic sphingolipid Ceramide
  3567. TNF-α and Ceramide are involved in the mediation of neuronal tolerance to brain ischemia
  3568. Autophagic Cell Death in Leukemia Cells Regulated by Ceramide and Sphingosine-1-Phosphate through Mammalian Target of Rapamycin.
  3569. Roles for C16-Ceramide and Sphingosine 1-Phosphate in Regulating Hepatocyte Apoptosis in Response to Tumor Necrosis Factor-* DS
  3570. Studies on the human UDP-galactose: Ceramide galactosyltransferase gene promoter
  3571. Distribution of neutral/alkaline ceramidase in marine invertebrates revealed by fluorescence-labeled Ceramide
  3572. Multidrug resistance in neuroblastoma cell lines is not associated with altered mRNA expression for Ceramide pathway enzymes
  3573. Delayed ERK Activation by Ceramide Reduces Melanin Synthesis in Human Melanocytes
  3574. Caloric restriction prevents the age-associated activation of amyloidβ-peptide generation induced by the p75NTR-Ceramide signaling pathway
  3575. Cell Surface Ceramide Generation Precedes and Controls Fc RII Clustering and Phosphorylation in Rafts
  3576. Characterization of a POROSTM-fumonisin B1 Affinity Column for Isolating Ceramide Synthase from Rat Liver
  3577. The involvement of Ceramide/sphingomyelinase in high and low LET radiation induced apoptosis in human tumor cells
  3578. The Apoptosis Induced by Ceramide in the Endothelial Cell
  3579. Ceramide-mediated signaling in vascular endothelial cells: A novel mechanism responsible for endothelial dysfunction in coronary circulation
  3580. The roles of Ceramide on the cellular signal transduction in RAW 264.7 murine macrophages activated with lipopolysaccharide and interferon-gamma.
  3581. Ceramide triggers caspase activation during y-radiation-induced apoptosis of human glioma cells lacking functional p53
  3582. Preventive Effect of Fibroblast Growth Factor and Hepatocyte Growth Factor on Ceramide‐Induced Dysfunction Human Small Intestinal Cells
  3583. Possible involvement of Pseudomonas sphingolipid Ceramide N-deacylase in red spot disease of eels
  3584. Anti-tumor Agent, Paclitaxel, Induces de novo Synthesis of Ceramide, Which May Lead to Apoptosis in Human Breast Cancer MCF-7 Cells
  3585. Does C6-Ceramide induce activation of a rectifying chloride channel (ORCC) in vivo in patients with CysSc Fibrosis
  3586. Phase behaviors, lamellar structures, and physical properties of synthetic vitamin E Ceramide (Tocomide) mixed with cholesterol and linoleic acid
  3587. The mechanism of C2-Ceramide-induced contraction of smooth muscle cells in cat esophagus
  3588. The Study on the Mechanism of Cyclosporine A-induced Nephroptoxicity: The Effects of Ceramide and Phospholipase A2 on Cyclosporine A-induced Apoptosis of …
  3589. p38 mitogen-activated protein kinase (MAPK) regulates Ceramide-induced apoptosis in HL-60 cells.
  3590. Identification of Proteineous Biomarkers for Cadmium-and Ceramide-Induced Toxicity in Human Brain Cells through Display Proteomic Analysis
  3591. Mechanism of intracellular trafficking of Ceramide
  3592. Dietary supplementation of silk protein increases Ceramide synthesis and moisturization of skin in the animal model of atopic dermatitis, NC/Nga mice
  3593. Sterol Glucosides and Ceramide Glucosides: Cloning of Enzymes Contributing to Their Biosynthesis
  3594. Study of Ceramide monohexoside in ovarian cell line COC1/DDP resistant to cisplantin
  3595. Roles of sphingomyelin and Ceramide in membrane structure, apolipoprotein binding, and cell uptake of lipid particles
  3596. The functional effects of Ceramide on the monocyte CD36 scavenger receptor and NADPH oxidase
  3597. Synergistic Cytotoxicity of Human Breast Cancer Cells by a Novel Nano-Particle Based Delivery of Ceramide With Paclitaxel and/or Doxorubicin
  3598. p38 MAP kinase and Akt regulate Bax translocation from mitochondria during Ceramide-mediated apoptosis
  3599. Regulation of human UDP‐galactose: Ceramide β‐galactosyltransferase (CGT) gene expression
  3600. Fas and Ceramide inhibition of the phosphatidylinositol-3-kinase (PI3K) cell survival pathway in human granulosa luteal cells (hGLC).
  3601. Impairment of Retinoic Acid Receptor-Ceramide Signaling in Retinoic Acid-Resistant Breast Cancer Cells. Implications for Retinoid Differentiation Therapy of Breast …
  3602. Arachidonic acid release by cPLA (2) and Ceramide synthesis may be causally related to nitric oxide induced apoptosis in vascular smooth muscle cells
  3603. Functional impacts of transgenic overexpression of UDP-galactose: Ceramide galactosyltransferase and polysialyltransferase on the development of …
  3604. The correlation between Ceramide and p53 in endothelial cells apoptosis induced by AngⅡ
  3605. Intracellular Ceramide induces apoptosis in breast carcinoma cells.
  3606. A role of sphingomyelin lipid circle components in inflammation process caused by CCl/sub 4/at rats liposomes loaded by sphingomyelin or Ceramide administered
  3607. Ceramide mediated apoptotic pathway is involved in galectin-1 induced apoptosis in Jurkat T lymphocytes
  3608. Significant Role of Ceramide Pathway in Experimental Gastric Ulcer Formation in Rats.
  3609. Cell apoptosis induced by Ceramide in human colon cancer cells
  3610. 405: Lysosomotropic Ceramide Analogue LCL-204, Acid Ceramidase (AC) Inhibitor, a Potential Novel Chemotherapy for Prostate Cancer (PCA)
  3611. The mechanism of ET-1 or C2-Ceramide-induced the contraction of circular smooth muscle cells in cat esophagus
  3612. Combating cancer-drug resistance: the Ceramide connection
  3613. Workshop 2: Approaches for Studying the Biological Roles of Sphingolipids. Probing apoptosis during neuronal development with novel Ceramide analogs
  3614. Significance of Ceramide from precancerous lesion to carcinoma of larynx
  3615. Mechanisms of the anti-proliferative effects of exogenous Ceramide in chemoresistant and chemosensitive human breast carcinoma cells.
  3616. Attenuated Ceramide-induced Neuronal Apoptosis by Acanthopanax senticous
  3617. SF508 Protects Ceramide-induced Neuronal Cell Death
  3618. Activation of CD95 Receptor Modulates CYP3A4 Expression Through Ceramide and Nitric Oxide Production in Human Colon Carcinoma HT-29 Cells
  3619. Commentary:“Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer’s disease. Just hypotheses or molecular …
  3620. Influence of ionizing radiation and Taxotere pathway Ceramide pathway on apoptosis activation in Guerin’s carcinoma
  3621. Protective Effect of Magnolol Against Ceramide-induced Apoptosis in SK-N-SH cells
  3622. … OF ENDOTHELIAL DIFFERENTIATION GENE (EDG) RECEPTORS AND EFFECT OF SHINGOSINE-1-PHOSPHATE AND Ceramide ON PROLIFERATION IN …
  3623. The Protective Role of Estrogen by Down-regulation of Bax in Ceramide Induced Neuronal Cell Death
  3624. … by Augé et al,“Role for Matrix Metalloproteinase-2 in Oxidized Low-Density Lipoprotein-Induced Activation of the Sphingomyelin/Ceramide Pathway and Smooth …
  3625. Shifting of Cholesterol Maximum Solubility in Lipid Bilayers by Ceramide
  3626. BCL-2 Down Regulating Ceramide De Novo Pathway
  3627. Ceramide Induces the Generation of Reactive Oxygen Species in Activated RAW 264.7 Murine Macrophage Cells
  3628. 9: 46 AM: Telomerase Modulation by Gemcitabine and Ceramide Analogs in Human Head and Neck Cancer
  3629. 676. A Role for Ceramide in AdGFPFasLTET Gene Therapy
  3630. Ceramide-induced apoptosis in lung cancer derived A549 cells is independent of PP2A but may involve JNK
  3631. ROLE OF Ceramide SIGNALLING DURING FENRETINIDE AND RETINOIC ACID ACTION ON OVARIAN CANCER CELLS
  3632. Downregulation of inducible nitric oxide synthase expression by a Ceramide analogue in RAW 264.7 murine macrophages
  3633. Sphingolipids in inflammation: The synergistic role of sphingosine-1-phosphate in COX-2 induction and Ceramide-1-phosphate in cPLA (2) binding …
  3634. Apoptosis of# gamma## delta# T cells and# alpha## beta# T cells induced by Ceramide
  3635. … )) are elevated. We have shown previously that IL-1 activates phospholipid signaling pathways in intestinal epithe-lial cells (IEC), leading to increased Ceramide …
  3636. A new natural Ceramide N-octadecanoyl-phytosphingosine from soft coral Sinularia sp
  3637. Potentiation of COX-2 Induction by C2-Ceramide, a Potential Cell Death Marker
  3638. A new Ceramide from the soft coral lobophytum sp.
  3639. MeHg-induced Ceramide generation by the activation of acid form of sphingomyelinase in MDCK cells
  3640. Study on the hydrolyzation of the sphingomyelin from pig erythrocyte membrane to Ceramide
  3641. Suppression of Heat Shock Protein-70 by Ceramide in Heat Shock-induced HL-60 Cell Apoptosis
  3642. An Anti-cancer Drug, Paclitaxel. Induces Apoptosis in MCF-7 Human Breast Cancer Cells by Generating Ceramide and Arachidonic Acid
  3643. A novel GlcNAca1-HPO3-6Gal (1-1) Ceramide antigen and alkylated inositol-phosphoglycerolipids expressed by the liver fluke Fasciola hepatica
  3644. The sphingomyelin-Ceramide pathway in cytokine-induced apoptotic signalling
  3645. Phase behaviour of aqueous dispersions of mixtures of Ceramide, cholesterol and protonated fatty acid
  3646. Ceramide, a mediator of apoptosis, synergizes with paclitaxel to induce regression of the L3. 6 human pancreatic carcinoma implanted in SCID mice
  3647. PROLACTIN PROTECTS AGAINST Ceramide (C2)-INDUCED APOPTOSIS IN HUMAN OVARIAN GRANULOSA CELLS (GC)
  3648. The cross talk between nitric oxide and Ceramide: Coordinate interactions among signaling pathways regulating cell death, survival, and differentiation
  3649. Potentiation of Lipopolysaccharide-Inducible COX-2 Expression by C2-Ceramide: The Role of JNK- and AP-1-Mediated C/EBP Activation
  3650. A Novel Sphingomyelin Synthase Gene, SMS1-Regulated Sphingomyelin/Ceramide-Rich Microdomain Plays a Crucial Role in Fas-Mediated Apoptosis.
  3651. Morphological and functional status of liver at rats having toxic hepatites during injections of the liposomes loaded by sphingomyelin or Ceramide
  3652. Cell specific reversal of PSC 833-induced growth inhibition in human breast cancer cells by inhibitors of de novo Ceramide synthesis
  3653. New green synthesis process of Ceramide analogousover solid catalysts. 26th World Congress of the ISF, 25-28 september 2005, Prague, République Tchèque.
  3654. … that increased local produc-tion ofcytokines and inflammatory mediators could account for an increased osteoclastic activity and, via the Ceramide-NF-KB signalling …
  3655. Ceramide method of apoptosis activation in the Geren tumor at combined action of ionizing irradiation and taxoter
  3656. Ceramide-induced apoptosis by translocation, phosphorylation and activation of protein kinase Cδ at Golgi complex
  3657. YW1-06 Protein kinase Cδ amplifies Ceramide formation via mitochondrial signaling in prostate cancer cells (Young Urologist Research Workshop)
  3658. Homologs of the yeast longevity-assurance gene (LAG1) in Trypanosoma cruzi: unraveling the mechanisms of Ceramide biosynthesis
  3659. UVB Radiation Induces Neutral and Acidic Sphingomyelinases in Normal Human Keratinocytes: Trigger for Ceramide Pathway.
  3660. Ceramide generated in the outer leaflet of the plasma membrane controls signalling of FcRIIA immunoreceptor
  3661. Physiological and pathophysiological aspects of Ceramide
  3662. Ceramide: physiological and pathophysiological aspects
  3663. When do Lasses (longevity assurance genes) become CerS (Ceramide synthases)?: Insights into the regulation of Ceramide synthesis
  3664. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy* s⃞
  3665. Ceramide synthases and Ceramide levels are increased in breast cancer tissue
  3666. Biological aspects of Ceramide-enriched membrane domains
  3667. Ceramide-enriched membrane domains—structure and function
  3668. Ceramide: a common pathway for atherosclerosis?
  3669. DihydroCeramide hinders Ceramide channel formation: Implications on apoptosis
  3670. Ceramide and Cerebrosides from the Octocoral Sarcophyton ehrenbergi
  3671. Ceramide biosynthesis in keratinocyte and its role in skin function
  3672. Ceramide starves cells to death by downregulating nutrient transporter proteins
  3673. Characterization of overall Ceramide species in human stratum corneums⃞
  3674. The sphingolipid salvage pathway in Ceramide metabolism and signaling
  3675. CERT-mediated trafficking of Ceramide
  3676. Ceramide-induced cell death in malignant cells
  3677. Development and characterization of a novel anti-Ceramide antibody
  3678. Regulation of Ceramide biosynthesis by TOR complex 2
  3679. Targeting Ceramide metabolism with a potent and specific Ceramide kinase inhibitor
  3680. Central role of Ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome
  3681. A role for Ceramide in driving cancer cell resistance to doxorubicin
  3682. Increased skeletal muscle Ceramide level in men at risk of developing type 2 diabetes
  3683. Necessary role for the Lag1p motif in (dihydro) Ceramide synthase activity
  3684. CERT and intracellular trafficking of Ceramide
  3685. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis
  3686. Ceramide signaling in cancer and stem cells
  3687. Characterization of Ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate
  3688. Changes in mitochondrial dynamics during Ceramide-induced cardiomyocyte early apoptosis
  3689. Effects of Ceramide and other simple sphingolipids on membrane lateral structure
  3690. Ceramide kinase uses Ceramide provided by Ceramide transport protein: localization to organelles of eicosanoid synthesiss⃞
  3691. Comprehensive quantification of Ceramide species in human stratum corneum [S]
  3692. Ceramide 1-phosphate/Ceramide, a switch between life and death
  3693. Recent advances in the immunobiology of Ceramide
  3694. Sphingosine and Ceramide signalling in apoptosis
  3695. The role of Ceramide in major depressive disorder
  3696. Ceramide-induced autophagy: to junk or to protect cells?
  3697. HPLC for simultaneous quantification of total Ceramide, glucosylCeramide, and Ceramide trihexoside concentrations in plasma
  3698. Ceramide in apoptotic signaling and anticancer therapy
  3699. Ceramide-containing membranes: the interface between biophysics and biology
  3700. Ceramide and mitochondria in ischemia/reperfusion
  3701. Effects of Ceramide on liquid-ordered domains investigated by simultaneous AFM and FCS
  3702. Ceramide 1-phosphate (C1P) promotes cell migration: Involvement of a specific C1P receptor
  3703. Mechanisms of Ceramide-mediated neurodegeneration
  3704. Inhibition of Ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
  3705. Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins
  3706. Ceramide is a mediator of apoptosis in retina photoreceptors
  3707. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of Ceramide in liver cells
  3708. Ceramide recruits and activates protein kinase C ζ (PKCζ) within structured membrane microdomains
  3709. Clinical relevance of Ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): Attenuation of C18-Ceramide in HNSCC …
  3710. Ceramide-platform formation and-induced biophysical changes in a fluid phospholipid membrane
  3711. Detergent-resistant, Ceramide-enriched domains in sphingomyelin/Ceramide bilayers
  3712. Human skeletal muscle Ceramide content is not a major factor in muscle insulin sensitivity
  3713. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations
  3714. JNK3 signaling pathway activates Ceramide synthase leading to mitochondrial dysfunction
  3715. Protection from high fat diet-induced increase in Ceramide in mice lacking plasminogen activator inhibitor 1
  3716. The permeability enhancing mechanism of DMSO in Ceramide bilayers simulated by molecular dynamics
  3717. Modulation of intracellular Ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer
  3718. Ceramidases: regulators of cellular responses mediated by Ceramide, sphingosine, and sphingosine-1-phosphate
  3719. Regulators of mitotic arrest and Ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs
  3720. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and Ceramide
  3721. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of Ceramide
  3722. Adipose tissue inflammation and increased Ceramide content characterize subjects with high liver fat content independent of obesity
  3723. A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death
  3724. Sphingomyelin synthase-related protein SMSr controls Ceramide homeostasis in the ER
  3725. Ceramide synthase 1 is regulated by proteasomal mediated turnover
  3726. Ceramide triggers budding of exosome vesicles into multivesicular endosomes
  3727. Schlank, a member of the Ceramide synthase family controls growth and body fat in Drosophila
  3728. Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death
  3729. Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells
  3730. Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells
  3731. Fenretinide corrects newly found Ceramide deficiency in cystic fibrosis
  3732. Implication of Ceramide, Ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis
  3733. Remodeling of cellular cytoskeleton by the acid sphingomyelinase/Ceramide pathway
  3734. Ceramide transfer protein function is essential for normal oxidative stress response and lifespan
  3735. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway
  3736. Ceramide Biogenesis Is Required for Radiation-Induced Apoptosis in the Germ Line of C. elegans
  3737. A modified α-galactosyl Ceramide for staining and stimulating natural killer T cells
  3738. Adult Ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas
  3739. Rapid distribution of liposomal short-chain Ceramide in vitro and in vivo
  3740. TRAIL activates acid sphingomyelinase via a redox mechanism and releases Ceramide to trigger apoptosis
  3741. Role of Ceramide in membrane protein organization investigated by combined AFM and FCS
  3742. Regulation of primary cilia formation by Ceramide [S]
  3743. Kinetic characterization of mammalian Ceramide synthases: Determination of Km values towards sphinganine
  3744. Absence of fluid-ordered/fluid-disordered phase coexistence in Ceramide/POPC mixtures containing cholesterol
  3745. Disruption of Ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response
  3746. Ceramide: a novel player in reactive oxygen species-induced signaling?
  3747. Transmembrane topology of Ceramide synthase in yeast
  3748. De novo C16- and C24-Ceramide generation contributes to spontaneous neutrophil apoptosis
  3749. Molecular-dynamics simulation of a Ceramide bilayer
  3750. Regulation of secretory transport by protein kinase D–mediated phosphorylation of the Ceramide transfer protein
  3751. Emerging pathways in genetic Parkinson’s disease: potential role of Ceramide metabolism in Lewy body disease
  3752. Regulation and traffic of Ceramide 1-phosphate produced by Ceramide kinase: comparative analysis to glucosylCeramide and sphingomyelin
  3753. Involvement of astroglial Ceramide in palmitic acid‐induced Alzheimer‐like changes in primary neurons
  3754. Superoxide dismutase protects against apoptosis and alveolar enlargement induced by Ceramide
  3755. Ceramide in bacterial infections and cystic fibrosis
  3756. Ceramide-domain formation and collapse in lipid rafts: membrane reorganization by an apoptotic lipid
  3757. Ceramide is the key mediator of oxidative stress‐induced apoptosis in retinal photoreceptor cells
  3758. Ceramide kinase and the Ceramide-1-phosphate/cPLA2α interaction as a therapeutic target
  3759. Gene expression of Ceramide kinase, galactosyl Ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer
  3760. Regulation of Ceramide-induced neuronal death: cell metabolism meets neurodegeneration
  3761. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1 …
  3762. Inhibition of Ceramide–redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats
  3763. Efficient trafficking of Ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT
  3764. Cholesterol-rich fluid membranes solubilize Ceramide domains: implications for the structure and dynamics of mammalian intracellular and plasma …
  3765. Mutations in the neutral sphingomyelinase gene SMPD3 implicate the Ceramide pathway in human leukemias
  3766. Searching for the molecular arrangement of transmembrane Ceramide channels
  3767. Ceramide involvement in apoptosis and apoptotic diseases
  3768. Organelle-targeted nanocarriers: specific delivery of liposomal Ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo
  3769. Interorganelle trafficking of Ceramide is regulated by phosphorylation-dependent cooperativity between the PH and START domains of CERT
  3770. Aureobasidin A arrests growth of yeast cells through both Ceramide intoxication and deprivation of essential inositolphosphorylCeramides
  3771. Alterations of Ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic …
  3772. Ceramide induces endothelial cell senescence
  3773. Ceramide mediates the rapid phase of febrile response to IL-1β
  3774. A PAMPA study of the permeability‐enhancing effect of new Ceramide analogues
  3775. De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of Ceramide accumulation following p53 up-regulation
  3776. Combining nanoliposomal Ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development
  3777. Increased transepidermal water loss and decreased Ceramide content in lesional and non‐lesional skin of dogs with atopic dermatitis
  3778. FTY720 inhibits Ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells
  3779. Caged Ceramide 1-phosphate analogues: synthesis and properties
  3780. Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α–Mediated Ceramide De novo Synthesis in Colon Cancer Cells
  3781. Synthesis of a novel Ceramide analogue and its use in a high‐throughput fluorogenic assay for ceramidases
  3782. Distinct Ceramide Synthases Regulate Polarized Growth in the Filamentous Fungus Aspergillus nidulans
  3783. Physicochemical and biological characterization of Ceramide-containing liposomes: paving the way to Ceramide therapeutic application
  3784. Ceramide-and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells
  3785. Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to Ceramide increase
  3786. Curcumin mediates Ceramide generation via the de novo pathway in colon cancer cells
  3787. Ceramide Kinase and Ceramide‐1‐Phosphate
  3788. Cystic fibrosis fatty acid imbalance is linked to Ceramide deficiency and corrected by fenretinide
  3789. Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and Ceramide in nanoemulsion formulations
  3790. Ceramide 1-phosphate inhibits serine palmitoyltransferase and blocks apoptosis in alveolar macrophages
  3791. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space
  3792. Fluorescent annexin A1 reveals dynamics of Ceramide platforms in living cells
  3793. The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with Ceramide metabolism
  3794. Differential recognition of CD1d-α-galactosyl Ceramide by the Vβ8. 2 and Vβ7 semi-invariant NKT T cell receptors
  3795. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4
  3796. Effect of Ceramide N-acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts)
  3797. The effect of Ceramide-containing skin care products on eczema resolution duration
  3798. Ceramide-1-phosphate activates cytosolic phospholipase A2α directly and by PKC pathway
  3799. Raft domain reorganization driven by short-and long-chain Ceramide: a combined AFM and FCS study
  3800. Hepatic Ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis
  3801. Increase of Skin-Ceramide Levels in Aged Subjects following a Short-Term Topical Application of Bacterial Sphingomyelinase from Streptococcus Thermophilus
  3802. ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of Ceramide linoleic esters
  3803. Protection of C. elegans from Anoxia by HYL-2 Ceramide Synthase
  3804. Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways
  3805. Ceramide effects in the bicelle structure
  3806. AMPK inhibitor Compound C stimulates Ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells
  3807. Wild-type levels of Ceramide and Ceramide-1-phosphate in the retina of Ceramide kinase-like-deficient mice
  3808. Ceramide and glucosylCeramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells
  3809. β‐Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting Ceramide metabolism
  3810. Involvement of de novo Ceramide synthesis in radiocontrast-induced renal tubular cell injury
  3811. Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain
  3812. Formation of Ceramide/sphingomyelin gel domains in the presence of an unsaturated phospholipid: a quantitative multiprobe approach
  3813. Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-Ceramide pathway
  3814. Oxysterol-binding protein and vesicle-associated membrane protein–associated protein are required for sterol-dependent activation of the Ceramide transport protein
  3815. The role of Ceramide trihexoside (globotriaosylCeramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature
  3816. Biodistribution and pharmacokinetic analysis of Paclitaxel and Ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer …
  3817. Targeting of PKCζ and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by Ceramide
  3818. Tithoniamarin and tithoniamide: a structurally unique isocoumarin dimer and a new Ceramide from Tithonia diversifolia
  3819. A Ceramide and Cerebroside from the Starfish Asterias amurensis Lütken and Their Plant-Growth Promotion Activities
  3820. Involvement of nitric oxide in the promotion of cell survival by Ceramide 1-phosphate
  3821. Ceramide regulation of nuclear protein imports⃞
  3822. Targeting the conversion of Ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy
  3823. Detergent-resistant globotriaosyl Ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology
  3824. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular Ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles
  3825. Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells
  3826. Lipid alterations in experimental murine colitis: role of Ceramide and imipramine for matrix metalloproteinase-1 expression
  3827. Paclitaxel and Ceramide co‐administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer
  3828. Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi trafficking of Ceramide
  3829. Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation
  3830. Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in Ceramide transfer protein mutant mice
  3831. Ceramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis
  3832. Ceramide inhibits LPS‐induced production of IL‐5, IL‐10, and IL‐13 from mast cells
  3833. Distribution in skin of Ceramide after oral administration to rats
  3834. Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an Acyl-CoA chain length …
  3835. Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines
  3836. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via Ceramide-dependent CD95 and PERK activation
  3837. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry
  3838. Effect of exercise duration on Ceramide metabolism in the rat heart
  3839. (Dihydro) Ceramide synthase 1–regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by …
  3840. Ceramide promotes restructuring of model raft membranes
  3841. On the presence of C2-Ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by Ceramide kinase
  3842. Differential expression of (dihydro) Ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/Lass2
  3843. Ceramide and sphingomyelin species of fibroblasts and neurons in culture
  3844. Sphingomyelinase generation of Ceramide promotes clustering of nanoscale domains in supported bilayer membranes
  3845. Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic Ceramide
  3846. Surface tension induced by sphingomyelin to Ceramide conversion in lipid membranes
  3847. Cholesterol displacement by Ceramide in sphingomyelin-containing liquid-ordered domains, and generation of gel regions in giant lipidic vesicles
  3848. The CB2 cannabinoid receptor signals apoptosis via Ceramide-dependent activation of the mitochondrial intrinsic pathway
  3849. Ceramide analogue 14S24 selectively recovers perturbed human skin barrier
  3850. Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through Ceramide accumulation and Akt activation
  3851. Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by Ceramide synthase to form cytotoxic N‐acyl‐metabolites
  3852. Lipid raft composition modulates sphingomyelinase activity and Ceramide-induced membrane physical alterations
  3853. Effect of exercise duration on the key pathways of Ceramide metabolism in rat skeletal muscles
  3854. Sphingosine, a product of Ceramide hydrolysis, influences the formation of Ceramide channels
  3855. Doxorubicin enhances TRAIL-induced cell death via Ceramide-enriched membrane platforms
  3856. Modulation of Ceramide metabolism enhances viral protein apoptin’s cytotoxicity in prostate cancer
  3857. Casein kinase Iγ2 down-regulates trafficking of Ceramide in the synthesis of sphingomyelin
  3858. JNK and Ceramide kinase govern the biogenesis of lipid droplets through activation of group IVA phospholipase A2
  3859. Inhibition of de novo Ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation
  3860. Ceramide-induced formation of ROS and ATP depletion trigger necrosis in lymphoid cells
  3861. 2-Hydroxy-Ceramide synthesis by Ceramide synthase family: enzymatic basis for the preference of FA chain length
  3862. Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis: a link to Ceramide synthase-3
  3863. Combined therapeutic use of AdGFPFasL and small molecule inhibitors of Ceramide metabolism in prostate and head and neck cancers: a status report
  3864. Ceramide-enriched membrane domains in infectious biology and development
  3865. Role of MAPK in Ceramide-induced cell death in primary cultured astrocytes from mouse embryonic brain
  3866. Benjaminamide: A new Ceramide and other compounds from the twigs of Ficus benjamina (Moraceae)
  3867. Mechanisms of Ceramide‐mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1
  3868. Protein kinase C-induced activation of a Ceramide/protein phosphatase 1 pathway leading to dephosphorylation of p38 MAPK
  3869. Laportoside A and laportomide A: a new cerebroside and a new Ceramide from leaves of Laportea ovalifolia
  3870. Neutropenia with impaired immune response to Streptococcus pneumoniae in Ceramide kinase-deficient mice
  3871. Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK
  3872. Cholesterol precursors stabilize ordinary and Ceramide-rich ordered lipid domains (lipid rafts) to different degrees: implications for the Bloch hypothesis and …
  3873. A possible mechanism underlying the Ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin …
  3874. SAP155 Binds to Ceramide‐responsive RNA cis‐element 1 and regulates the alternative 5′ splice site selection of Bcl‐x pre‐mRNA
  3875. A new take on Ceramide: starving cells by cutting off the nutrient supply
  3876. Importance of C16 Ceramide accumulation during apoptosis in prostate cancer cells
  3877. A Concise Synthesis of Tetrahydroxy-LCB, α-Galactosyl Ceramide, and 1,4-Dideoxy-1,4-imino-l-ribitol via d-Allosamines as Key Building Blocks
  3878. LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro) Ceramide synthase with relatively broad substrate specificity
  3879. Ceramide-Enriched Membrane Domains in Red Blood Cells and the Mechanism of Sphingomyelinase-Induced Hot− Cold Hemolysis
  3880. Regulation of neural progenitor cell motility by Ceramide and potential implications for mouse brain development
  3881. Long‐chain Ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes
  3882. The carboxyl-terminal domain of atypical protein kinase Cζ binds to Ceramide and regulates junction formation in epithelial cells
  3883. A new intranasal influenza vaccine based on a novel polycationic lipid—Ceramide carbamoyl-spermine (CCS): I. Immunogenicity and efficacy studies in mice
  3884. … phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and Ceramide‐activated phosphatase 2A
  3885. Protein phosphatase 2Cϵ is an endoplasmic reticulum integral membrane protein that dephosphorylates the Ceramide transport protein CERT to enhance its …
  3886. Membrane organization and ionization behavior of the minor but crucial lipid Ceramide-1-phosphate
  3887. De novo Ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma
  3888. Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria …
  3889. IL‐1β induces a MyD88‐dependent and Ceramide‐mediated activation of Src in anterior hypothalamic neurons
  3890. A novel soluble mimic of the glycolipid, globotriaosyl Ceramide inhibits HIV infection
  3891. Lysosomal Ceramide mediates gemcitabine-induced death of glioma cells
  3892. Design, synthesis, and biological activity of a family of novel Ceramide analogues in chemoresistant breast cancer cells
  3893. Sphingomyelin synthase SMS2 displays dual activity as Ceramide phosphoethanolamine synthase [S]
  3894. Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of Ceramide metabolism
  3895. Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma In vitro and In vivo
  3896. Evidence of free fatty acid interdigitation in stratum corneum model membranes based on Ceramide [AP] by deuterium labelling
  3897. Ceramide 1 and Ceramide 3 act synergistically on skin hydration and the transepidermal water loss of sodium lauryl sulfate‐irritated skin
  3898. Long-chain Ceramide is a potent inhibitor of the mitochondrial permeability transition pore
  3899. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator Ceramide as a key regulator of cellular fate
  3900. Enzymatic production of Ceramide from sphingomyelin
  3901. Modulation of total Ceramide and constituent Ceramide species in the acutely and chronically hypoxic mouse heart at different ages
  3902. Preparation and characterization of Ceramide-based liposomes with high fusion activity and high membrane fluidity
  3903. Fatty acid‐induced defects in insulin signalling, in myotubes derived from children, are related to Ceramide production from palmitate rather than the accumulation of …
  3904. The proapoptotic C16-Ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells
  3905. A CERTain role for Ceramide in taxane-induced cell death
  3906. Ceramide-dependent PP2A regulation of TNFα-induced IL-8 production in respiratory epithelial cells
  3907. Evaluation of a new pressure ulcer preventive dressing containing Ceramide 2 with low frictional outer layer
  3908. Decreased Ceramide transport protein (CERT) function alters sphingomyelin production following UVB irradiation
  3909. Fumonisin Disruption of Ceramide Biosynthesis in Maize Roots and the Effects on Plant Development and Fusarium verticillioides-Induced Seedling Disease
  3910. Effect of dietary cholesterol and high fat on Ceramide concentration in rat tissues
  3911. Ceramide: a contributor to insulin resistance or an innocent bystander?
  3912. Anti-apoptotic Bcl-2 family proteins disassemble Ceramide channels
  3913. Liquid chromatography-mass spectrometry for comprehensive profiling of Ceramide molecules in human hair
  3914. PPARalpha agonist induces the accumulation of Ceramide in the heart of rats fed high-fat diet
  3915. Spinal Ceramide modulates the development of morphine antinociceptive tolerance via peroxynitrite-mediated nitroxidative stress and neuroimmune activation
  3916. Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor δ in human keratinocytes
  3917. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and Ceramide 1-phosphate
  3918. Role of JNK1-dependent Bcl-2 phosphorylation in Ceramide-induced macroautophagy
  3919. Ceramide kinase regulates phospholipase C and phosphatidylinositol 4, 5, bisphosphate in phototransduction
  3920. … Drives Cholesterol Out of the Ordered Lipid Bilayer Phase into the Crystal Phase in 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine/Cholesterol/Ceramide Ternary …
  3921. Neutral sphingomyelinase-induced Ceramide accumulation by oxidative stress during carbon tetrachloride intoxication
  3922. Arrangement of Ceramide [EOS] in a stratum corneum lipid model matrix: new aspects revealed by neutron diffraction studies
  3923. The murine TRAIL receptor signals caspase-independent cell death through Ceramide
  3924. Potent antitumor activity of a novel cationic pyridinium-Ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in …
  3925. Calcium-independent phospholipase A2 (iPLA2β)-mediated Ceramide generation plays a key role in the cross-talk between the endoplasmic reticulum (ER) …
  3926. Fatty acid-dependent globotriaosyl Ceramide receptor function in detergent resistant model membranes
  3927. Increase of Ceramide in the liver and plasma after carbon tetrachloride intoxication in the rat
  3928. Skeletal muscle lipogenic protein expression is not different between lean and obese individuals: a potential factor in Ceramide accumulation
  3929. Design, synthesis, and preliminary biological evaluation of a novel triazole analogue of Ceramide
  3930. Functionally different pools of Shiga toxin receptor, globotriaosyl Ceramide, in HeLa cells
  3931. Galactosyl Ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells
  3932. Effect of Ceramide on nonraft proteins
  3933. Cadmium-induced Ceramide formation triggers calpain-dependent apoptosis in cultured kidney proximal tubule cells
  3934. Apoptosis Occurs via the Ceramide Recycling Pathway in Human HaCaT Keratinocytes
  3935. Subcellular localization of Ceramide kinase and Ceramide kinase-like protein requires interplay of their Pleckstrin Homology domain-containing N-terminal regions …
  3936. The generation and behavioral analysis of Ceramide kinase-null mice, indicating a function in cerebellar Purkinje cells
  3937. Ceramide production associated with retinal apoptosis after retinal detachment
  3938. Shift in sphingolipid metabolism leads to an accumulation of Ceramide in senescence
  3939. Ceramide metabolism determines glioma cell resistance to chemotherapy
  3940. A new functional motif in Hox domain-containing Ceramide synthases: identification of a novel region flanking the Hox and TLC domains essential for activity
  3941. Mechanism of inhibition of sequestration of protein kinase C α/βII by Ceramide: Roles of Ceramide-activated protein phosphatases and phosphorylation …
  3942. Effects of a short-chain Ceramide on bilayer domain formation, thickness, and chain mobililty: DMPC and asymmetric Ceramide mixtures
  3943. Further characterization of mammalian Ceramide kinase: substrate delivery and (stereo) specificity, tissue distribution, and subcellular localization studies
  3944. Conformation of Ceramide 6 molecules and chain-flip transitions in the lipid matrix of the outermost layer of mammalian skin, the stratum corneum
  3945. Ceramide attenuates hypoxic cell death via reactive oxygen species signaling
  3946. … Leukemia Cell Death through a Process Involving XIAP Down-Regulation, Oxidative Injury, and the Acid Sphingomyelinase-Dependent Generation of Ceramide
  3947. GSK-3β acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in Ceramide-induced mitochondrial apoptosis
  3948. Ceramide mediates inhibition of the renal epithelial sodium channel by tumor necrosis factor-α through protein kinase C
  3949. Lithium inhibits Ceramide-and etoposide-induced protein phosphatase 2A methylation, Bcl-2 dephosphorylation, caspase-2 activation, and apoptosis
  3950. Role of lipid rafts in Ceramide and nitric oxide signaling in the ischemic and preconditioned hearts
  3951. Apoptosis and the activity of Ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia
  3952. Bax distribution into mitochondrial detergent‐resistant microdomains is related to Ceramide and cholesterol content in postischemic hearts
  3953. Cationic long-chain Ceramide LCL-30 induces cell death by mitochondrial targeting in SW403 cells
  3954. Propofol pretreatment reduces Ceramide production and attenuates intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion in rats
  3955. A new covalently bound Ceramide from human stratum corneum –ω‐hydroxyacylphytosphingosine
  3956. Ceramide regulates atypical PKCζ/λ-mediated cell polarity in primitive ectoderm cells: a novel function of sphingolipids in morphogenesis
  3957. Mitochondrially targeted Ceramide LCL-30 inhibits colorectal cancer in mice
  3958. Quantification of the nanomechanical stability of Ceramide-enriched domains
  3959. Improvement of atopic dermatitis and reduction of skin allergic responses by oral intake of konjac Ceramide
  3960. Potential roles of membrane fluidity and Ceramide in hyperthermia and alcohol stimulation of TRAIL apoptosis
  3961. Lipid domain morphologies in phosphatidylcholine− Ceramide monolayers
  3962. A Ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation
  3963. Effects of Ceramide, ceramidase inhibition and expression of Ceramide kinase on cytosolic phospholipase A2α; additional role of Ceramide-1-phosphate in …
  3964. … of cytotoxic levels of Ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo Ceramide synthesis and inhibition …
  3965. Tithoniaquinone A and tithoniamide B: A new anthraquinone and a new Ceramide from leaves of Tithonia diversifolia
  3966. Structures of the human Ceramide activator protein saposin D
  3967. Expression of Ceramide glucosyltransferases, which are essential for glycosphingolipid synthesis, is only required in a small subset of C. elegans cells
  3968. Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating Ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in …
  3969. Acid sphingomyelinase mediated release of Ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1
  3970. Ceramide traffic in C6 glioma cells: evidence for CERT-dependent and independent transport from ER to the Golgi apparatus
  3971. Transbilayer movement of Ceramide in the plasma membrane of live cells
  3972. Ceramide Synthase Inhibition by Fumonisin B1 Treatment Activates Sphingolipid-Metabolizing Systems in Mouse Liver
  3973. Regulation of the sphingosine-recycling pathway for Ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function
  3974. Ceramide regulates SR protein phosphorylation during adenoviral infection
  3975. Lack of Ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells
  3976. Plasma glucosylCeramide and Ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention
  3977. Ceramide-induced preconditioning involves reactive oxygen species
  3978. Morphological effects of Ceramide on DMPC/DHPC bicelles
  3979. Central leptin regulates total Ceramide content and sterol regulatory element binding protein-1C proteolytic maturation in rat white adipose tissue
  3980. A new Ceramide from Ramaria botrytis (Pers.) Ricken
  3981. Stress-Induced Cell Death Is Mediated by Ceramide Synthesis in Neurospora crassa
  3982. E‐LDL and Ox‐LDL differentially regulate Ceramide and cholesterol raft microdomains in human Macrophages
  3983. Simulations of skin barrier function: free energies of hydrophobic and hydrophilic transmembrane pores in Ceramide bilayers
  3984. Alzheimer’s disease, Ceramide, visfatin and NAD
  3985. Potassium loss is involved in tobacco cell death induced by palmitoleic acid and Ceramide
  3986. Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, Ceramide and Ceramide phosphate
  3987. Synthesis of constrained Ceramide analogs and their potent antileukemic activities
  3988. Characteristic expression of globotriaosyl Ceramide in human ovarian carcinoma‐derived cells with anticancer drug resistance
  3989. Mechanistic insights into the hydrolysis and synthesis of Ceramide by neutral ceramidase
  3990. Dietary Soy Protein Reduces Cardiac Lipid Accumulation and the Ceramide Concentration in High-Fat Diet-Fed Rats and ob/ob Mice
  3991. Mechanisms involved in Ceramide-induced cell cycle arrest in human hepatocarcinoma cells
  3992. Ceramide mediates TNF-α-induced insulin resistance on GLUT4 gene expression in brown adipocytes
  3993. Caspase-dependent and-independent cell death of Jurkat human leukemia cells induced by novel synthetic Ceramide analogs
  3994. Starvation in the midst of plenty: making sense of Ceramide-induced autophagy by analysing nutrient transporter expression
  3995. Effect of sphingomyelinase-mediated generation of Ceramide on aggregation of low-density lipoprotein
  3996. Enhanced Ceramide-induced apoptosis in Ceramide kinase overexpressing cells
  3997. Functional modulation of mitochondria by eicosapentaenoic acid provides protection against Ceramide toxicity to C6 glioma cells
  3998. Modulation of Ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin
  3999. A fluorescent plate reader assay for Ceramide kinase
  4000. A New Ceramide from Suillus luteus and Its Cytotoxic Activity against Human Melanoma Cells
  4001. Death or survival: membrane Ceramide controls the fate and activation of antigen-specific T-cells depending on signal strength and duration
  4002. PKB/Akt inhibits Ceramide‐induced apoptosis in neuroblastoma cells by blocking apoptosis‐inducing factor (AIF) translocation
  4003. Ceramide-induced starvation triggers homeostatic autophagy
  4004. Clathrin-dependent pathways and the cytoskeleton network are involved in Ceramide endocytosis by a parasitic protozoan, Giardia lamblia
  4005. Changes in sphingomyelinases, Ceramide, Bax, Bcl2, and caspase-3 during and after experimental status epilepticus
  4006. Ceramide accelerates ultraviolet-induced MMP-1 expression through JAK1/STAT-1 pathway in cultured human dermal fibroblasts
  4007. Synthesis of α-galactosyl Ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment
  4008. Conjugated linoleic acid increases skeletal muscle Ceramide content and decreases insulin sensitivity in overweight, non-diabetic humans
  4009. Characterization of glycoinositolphosphoryl Ceramide structure mutant strains of Cryptococcus neoformans
  4010. Chemical mapping of Ceramide distribution in sphingomyelin-rich domains in monolayers
  4011. Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle …
  4012. Differential effects of Ceramide species on exocytosis in rat PC12 cells
  4013. … homology domain of Ceramide kinase and phosphatidylinositol 4, 5-bisphosphate regulates the plasma membrane targeting and Ceramide 1-phosphate levels
  4014. Direct interaction between the inhibitor 2 and Ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and …
  4015. Apoptosis induced by capsaicin in prostate PC-3 cells involves Ceramide accumulation, neutral sphingomyelinase, and JNK activation
  4016. Trans-Golgi Network and Endosome Dynamics Connect Ceramide Homeostasis with Regulation of the Unfolded Protein Response and TOR Signaling in Yeast
  4017. High tolerance to apoptotic stimuli induced by serum depletion and Ceramide in side-population cells: high expression of CD55 as a novel character for side …
  4018. Role of Ceramide structure and its microenvironment on the conformational order of model stratum corneum lipids mixtures: an approach by FTIR spectroscopy
  4019. De novo Ceramide biosynthesis is associated with resveratrol-induced inhibition of ornithine decarboxylase activity
  4020. Anandamide-induced apoptosis in Chang liver cells involves Ceramide and JNK/AP-1 pathway
  4021. Structure of Ceramide-1-phosphate at the air-water solution interface in the absence and presence of Ca2+
  4022. Enzymatic generation of Ceramide induces membrane restructuring: correlated AFM and fluorescence imaging of supported bilayers
  4023. Leishmania donovani-Induced Ceramide as the Key Mediator of Akt Dephosphorylation in Murine Macrophages: Role of Protein Kinase Cζ and Phosphatase
  4024. Mitomycin C, Ceramide, and 5-fluorouracil inhibit corneal haze and apoptosis after PRK
  4025. Structural organisation and phase behaviour of a stratum corneum lipid analogue: Ceramide 3A
  4026. Ceramide decreases surfactant protein B gene expression via downregulation of TTF-1 DNA binding activity
  4027. Paclitaxel and Ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells
  4028. Elastin peptides antagonize Ceramide-induced apoptosis
  4029. The influence of domain crowding on the lateral diffusion of Ceramide-enriched domains in a sphingomyelin monolayer
  4030. Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells.
  4031. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not Ceramide concentrations are increased in the nonalcoholic human fatty liver
  4032. Apoptosis induced by intracellular Ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species
  4033. ATP-induced apoptosis of thymocytes is mediated by activation of P2X7 receptor and involves de novo Ceramide synthesis and mitochondria
  4034. Production of Ceramide with Saccharomyces cerevisiae
  4035. Modulation of Vα19 NKT cell immune responses by α‐mannosyl Ceramide derivatives consisting of a series of modified sphingosines
  4036. MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a Ceramide/CD95/PERK–dependent mechanism
  4037. Stimulatory effect of dietary red ginseng on epidermal hydration and Ceramide levels in ultraviolet-irradiated hairless mice
  4038. Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of Ceramide and glucosylCeramide in lean and overweight subjects
  4039. SRp30a (ASF/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for Ceramide-responsiveness
  4040. Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent
  4041. Differential effects of Ceramide on cell viability and extracellular matrix remodeling in keratinocytes and fibroblasts
  4042. Ceramide causes pulmonary cell apoptosis and emphysema: a role for sphingolipid homeostasis in the maintenance of alveolar cells
  4043. Rapid phase change of lipid microdomains in giant vesicles induced by conversion of sphingomyelin to Ceramide
  4044. Propagation of undifferentiated human embryonic stem cells with nano-liposomal Ceramide
  4045. The role of sphingomyelin in regulating phase coexistence in complex lipid model membranes: competition between Ceramide and cholesterol
  4046. Ceramide kinase deficiency impairs microendothelial cell angiogenesis in vitro
  4047. A Ceramide‐1‐phosphate analogue, PCERA‐1, simultaneously suppresses tumour necrosis factor‐α and induces interleukin‐10 production in activated macrophages
  4048. … cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of Ceramide …
  4049. Regulation of autophagy by Ceramide-CD95-PERK signaling
  4050. Diversity and complexity of Ceramide generation after exposure of jurkat leukemia cells to irradiation
  4051. Synthesis and biological activity of α-galactosyl Ceramide KRN7000 and galactosyl (α1→ 2) galactosyl Ceramide
  4052. … dihydroCeramide production after Photofrin-PDT alone and improved tumour response after the combination with the Ceramide analogue LCL29. Evidence …
  4053. Regulation of thioredoxin by Ceramide in retinal pigment epithelial cells
  4054. PACAP and C2‐Ceramide generate different AP‐1 complexes through a MAP‐kinase‐dependent pathway: involvement of c‐Fos in PACAP‐induced Bcl‐2 expression
  4055. Ceramide: from embryos to tumors
  4056. Ceramide and raft signaling are linked with each other in UVA radiation-induced gene expression
  4057. Effects of pioglitazone and high-fat diet on Ceramide metabolism in rat skeletal muscles
  4058. Inhibition of Ceramide biosynthesis ameliorates pathological consequences of spinal cord injury
  4059. Ceramide elevates 12-hydroxyeicosatetraenoic acid levels and upregulates 12-lipoxygenase in rat primary hippocampal cell cultures containing predominantly …
  4060. Effects of Ceramide-1-phosphate on cultured cells: dependence on dodecane in the vehicles⃞
  4061. Ceramide catabolism critically controls survival of human dendritic cells
  4062. Sphingolipid Metabolite Ceramide Causes Metabolic Perturbation Contributing to HERG K+ Channel Dysfunction
  4063. Ceramide-dependent regulation of human epidermal keratinocyte CD1d expression during terminal differentiation
  4064. Pioglitazone induces de novo Ceramide synthesis in the rat heart
  4065. Leptin-induced suppression of cardiomyocyte contraction is amplified by Ceramide
  4066. The nuclear Ceramide/diacylglycerol balance depends on the physiological state of thyroid cells and changes during UV-C radiation-induced apoptosis
  4067. Induction of apoptotic cell death by a Ceramide analog in PC-3 prostate cancer cells
  4068. Spinal Ceramide and neuronal apoptosis in morphine antinociceptive tolerance
  4069. Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression
  4070. Ceramide-induced cell death in lens epithelial cells
  4071. Goodpasture antigen-binding protein and its spliced variant, Ceramide transfer protein, have different functions in the modulation of apoptosis during zebrafish …
  4072. De novo Ceramide synthesis is required for N-linked glycosylation in plasma cells
  4073. C-Glycoside analogues of β-galactosylCeramide with a simple Ceramide substitute: Synthesis and binding to HIV-1 gp120
  4074. Anticancer activity of a Ceramide analog containing a disulfide linkage
  4075. Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with Ceramide using biodegradable polymeric …
  4076. Hydrophobic bile salts trigger Ceramide formation through endosomal acidification
  4077. Sphingomyelinase-induced Ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia
  4078. Effect of serial microdermabrasion on the Ceramide level in the stratum corneum
  4079. Neutral sphingomyelinase 2 is activated by cigarette smoke to augment Ceramide-induced apoptosis in lung cell death
  4080. … quantification of glucosylCeramide and galactosylCeramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid Ceramide N …
  4081. Parkin modulates gene expression in control and Ceramide-treated PC12 cells
  4082. Enhancing effects of Ceramide derivatives on 1, 25-dihydroxyvitamin D3-induced differentiation of human HL-60 leukemia cells
  4083. Potential mechanisms involved in Ceramide-induced apoptosis in human colon cancer HT29 cells
  4084. Loss of Regulators of Vacuolar ATPase Function and Ceramide Synthesis Results in Multidrug Sensitivity in Schizosaccharomyces pombe
  4085. Fabrication and characterization of pseudo-Ceramide-based liposomal membranes
  4086. Cytolytic T cells induce Ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease
  4087. Divergent syntheses of all stereoisomers of phytosphingosine and their use in the construction of a Ceramide library
  4088. Formation and function of Ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes
  4089. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylCeramide and α-hydroxy Ceramide accumulation, and altered prosaposin …
  4090. Undulating tubular liposomes through incorporation of a synthetic skin Ceramide into phospholipid bilayers
  4091. … expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer’s disease: a shift toward Ceramide accumulation at the …
  4092. Novel synthetic Ceramide derivatives increase intracellular calcium levels and promote epidermal keratinocyte differentiation
  4093. Involvement of acid β-glucosidase 1 in the salvage pathway of Ceramide formation
  4094. Ceramide-induced transbilayer (flip-flop) lipid movement in membranes
  4095. Role of human longevity assurance gene 1 and C18-Ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas
  4096. Phosphatidylinositol 4-kinase IIIβ regulates the transport of Ceramide between the endoplasmic reticulum and Golgi
  4097. Ceramide and adenosine 5′-monophosphate-activated protein kinase are two novel regulators of 11β-hydroxysteroid dehydrogenase type 1 expression and activity …
  4098. Identification of a nuclear localization signal in the retinitis pigmentosa-mutated RP26 protein, Ceramide kinase-like protein
  4099. A study to determine the effect of tacrolimus on Ceramide levels in the stratum corneum of patients with atopic dermatitis
  4100. Ceramide induces apoptosis via a peroxisome proliferator-activated receptor γ-dependent pathway
  4101. PKCζ protects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent Ceramide production
  4102. Phase Behavior of Aqueous Dispersions of Mixtures of N-Palmitoyl Ceramide and Cholesterol: A Lipid System with Ceramide−Cholesterol Crystalline Lamellar …
  4103. A critical β6–β7 loop in the pleckstrin homology domain of Ceramide kinase
  4104. Confluence induced threonine41/serine45 phospho-β-catenin dephosphorylation via Ceramide-mediated activation of PP1cγ
  4105. Inhibition of atopic dermatitis‐like skin lesions by topical application of a novel Ceramide derivative, K6PC‐9p, in NC/Nga mice
  4106. Modification of the Ceramide moiety of isoglobotrihexosylCeramide on its agonist activity in stimulation of invariant natural killer T cells
  4107. Altering the sphingosine-1-phosphate/Ceramide balance: a promising approach for tumor therapy
  4108. Neuroprotective effects of furopyrazole derivative of benzylindazole analogs on C2 Ceramide-induced apoptosis in cultured cortical neurons
  4109. … growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐Ceramide in CAD cells
  4110. Role of sphingomyelin and Ceramide in the regulation of the activity and fatty acid specificity of group V secretory phospholipase A2
  4111. Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of Ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury
  4112. Nanoliposomal short-chain Ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells
  4113. A soluble sulfogalactosyl Ceramide mimic promotes ΔF508 CFTR escape from endoplasmic reticulum associated degradation
  4114. Fumonisin concentration and Ceramide synthase inhibitory activity of corn, masa, and tortilla chips
  4115. Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation
  4116. Role of Ceramide kinase in peroxisome proliferator‐activated receptor beta‐induced cell survival of mouse keratinocytes
  4117. Ceramide structural features required to stimulate ABCA1-mediated cholesterol efflux to apolipoprotein AI
  4118. C2‐Ceramide mediates cerebellar granule cells apoptosis by activation of caspases‐2, ‐9, and ‐3
  4119. Ceramide-1-phosphate, in contrast to Ceramide, is not segregated into lateral lipid domains in phosphatidylcholine bilayers
  4120. Ceramide is a potent activator of plasma membrane Ca2+-ATPase from kidney proximal tubule cells with protein kinase A as an intermediate
  4121. Ceramide-dependent release of Ceramide kinase from cultured cells
  4122. Sphingosine-1-phosphate protects proliferating endothelial cells from Ceramide-induced apoptosis but not from DNA damage–induced mitotic death
  4123. Neuronal conduction of excitation without action potentials based on Ceramide production
  4124. Peroxisome proliferator-activated receptor α down-regulation is associated with enhanced Ceramide levels in age-associated cardiac hypertrophy
  4125. FcγRII activation induces cell surface Ceramide production which participates in the assembly of the receptor signaling complex
  4126. Ceramide kinase: a potential anti-inflammatory target?
  4127. Effect of externally applied electrostatic fields on the surface topography of Ceramide-enriched domains in mixed monolayers with sphingomyelin
  4128. The role of sphingosine-1-phosphate and Ceramide-1-phosphate in calcium homeostasis.
  4129. Identification of small molecule Ceramide kinase inhibitors using a homogeneous chemiluminescence high throughput assay
  4130. Rapid transmembrane diffusion of Ceramide and dihydroCeramide spin-labelled analogues in the liquid ordered phase
  4131. In Vitro and in Vivo Anti-angiogenic Activities and Inhibition of Hormone-Dependent and -Independent Breast Cancer Cells by Ceramide …
  4132. Effect of biotin supplementation on hoof health and Ceramide composition in dairy cattle
  4133. Ectopic and eutopic stromal endometriotic cells have a damaged Ceramide signaling pathway to apoptosis
  4134. Kinetics of the Ceramide kinase inhibitor K1, a suppressor of mast-cell activation
  4135. Cannabinoid receptor-mediated apoptosis induced by R (+)-methanandamide and Win55, 212-2 is associated with Ceramide accumulation and p38 activation in …
  4136. Doxorubicin induces Ceramide and diacylglycerol accumulation in rat hepatocytes through independent routes
  4137. Inhibition of caspases but not of calpains temporarily protect against C2-Ceramide-induced death of CAD cells
  4138. Divergent pathways for TNF and C2-Ceramide toxicity in HTC hepatoma cells
  4139. Effects of Ceramide inhibition on radiation-induced apoptosis in human leukemia MOLT-4 cells
  4140. Neutral sphingomyelinase-induced Ceramide triggers germinal vesicle breakdown and oxidant-dependent apoptosis in Xenopus laevis oocytes
  4141. Suppression of sphingomyelin synthase 1 by small interference RNA is associated with enhanced Ceramide production and apoptosis after photodamage
  4142. Involvement of de novo Ceramide biosynthesis in macrophage death induced by activation of ATP-sensitive P2X7 receptor
  4143. Antibody labeling of cholesterol/Ceramide ordered domains in cell membranes
  4144. Sphingomyelin synthase 1 suppresses Ceramide production and apoptosis post-photodamage
  4145. Immobilization of phospholipase C for the production of Ceramide from sphingomyelin hydrolysis
  4146. A new germacranolide and a new Ceramide from Salvia nubicola (Lamiaceae)
  4147. Smart drugs for smarter stem cells: making SENSe (sphingolipid-enhanced neural stem cells) of Ceramide
  4148. Top–down glycolipidomics: fragmentation analysis of ganglioside oligosaccharide core and Ceramide moiety by chip‐nanoelectrospray collision‐induced dissociation MS2–MS …
  4149. Synergistic IL-10 induction by LPS and the Ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways
  4150. A conserved cysteine motif essential for Ceramide kinase function
  4151. Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of Ceramide and PKCζ activation
  4152. … VIA Calcium-Independent Phospholipase A2 Participates in ER Stress-Induced INS-1 Insulinoma Cell Apoptosis by Promoting Ceramide Generation via Hydrolysis …
  4153. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 Ceramide or tamoxifen
  4154. The two Cs: Ceramide and cardiomyopathy1
  4155. Impedance spectroscopic investigation of the bilayer lipid membranes formed from the phosphatidylserine–Ceramide mixture
  4156. Stimulation of Ceramide formation and suicidal erythrocyte death by vitamin K3 (menadione)
  4157. Synthesis and cytotoxicity of new aromatic Ceramide analogs with alkylsulfonamido chains
  4158. Membrane domain formation, interdigitation, and morphological alterations induced by the very long chain asymmetric C24: 1 Ceramide
  4159. Effect of l-menthol on the thermotropic behavior of Ceramide 2/cholesterol mixtures as a model for the intercellular lipids in stratum corneum
  4160. Increase of Ceramide monohexoside and dipalmitoyl glycerophospholipids in the brain of Zellweger syndrome
  4161. The initial surface composition and topography modulate sphingomyelinase-driven sphingomyelin to Ceramide conversion in lipid monolayers
  4162. Identification of Mg2+-dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced Ceramide generation and apoptosis
  4163. Ceramide inhibits development and cytokinesis and induces apoptosis in preimplantation bovine embryos
  4164. C18 Ceramide analysis in mammalian cells employing reversed-phase high-performance liquid chromatography tandem mass spectrometry
  4165. Conversion of apical plasma membrane sphingomyelin to Ceramide attenuates the intoxication of host cells by cholera toxin
  4166. A novel biotinylated diazirinyl Ceramide analogue for photoaffinity labeling
  4167. Modulation of TNFα, IL-10 and IL-12p40 levels by a Ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages
  4168. Acid β-glucosidase 1 counteracts p38δ-dependent induction of interleukin-6: possible role for Ceramide as an anti-inflammatory lipid
  4169. Dysregulation of human bestrophin‐1 by Ceramide‐induced dephosphorylation
  4170. Ethanolaminephosphate side chain added to glycosylphosphatidylinositol (GPI) anchor by mcd4p is required for Ceramide remodeling and forward transport …
  4171. Sphingolipids and cellular cholesterol homeostasis. Effect of Ceramide on cholesterol trafficking and HMG CoA reductase activity
  4172. Resveratrol impairs the formation of MDA-MB-231 multicellular tumor spheroids concomitant with Ceramide accumulation
  4173. Simultaneous HPLC analysis of Ceramide and dihydroCeramide in human hairs
  4174. Cholesterol surrogates: a comparison of cholesterol and 16: 0 Ceramide in POPC bilayers
  4175. Structural Recognition of Cholesterol–Ceramide Monolayers by a Specific Monoclonal Antibody
  4176. Significance of Ceramide and DNA ploidy in laryngeal carcinogenesis
  4177. The expression of the Goodpasture antigen-binding protein (Ceramide transporter) in adult rat brain
  4178. Oral supplementation of Lithospermum erythrorhizon prevents the development of atopic dermatitis with reducing Ceramide degradation in the epidermis of NC/Nga …
  4179. … lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1: Cyclosporin A can lower serum and liver globotriaosyl Ceramide levels in the Fabry …
  4180. Ceramide induces apoptosis in human lung adenocarcinoma A549 cells through mitogen‐activated protein kinases
  4181. More chores for TOR: de novo Ceramide synthesis
  4182. Effects of sphingosine‐1‐phosphate and Ceramide‐1‐phosphate on rat intestinal smooth muscle cells: implications for postoperative ileus
  4183. HOS3, an ELO-like gene, inhibits effects of ABA and implicates a S-1-P/Ceramide control system for abiotic stress responses in Arabidopsis thaliana
  4184. Ceramide is responsible for the failure of compensatory nerve sprouting in apolipoprotein E knock-out mice
  4185. 4-HPR-mediated leukemia cell cytotoxicity is triggered by Ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2
  4186. Ceramide kinase expression is altered during macrophage-like cell differentiation of the leukemia cell line HL-60
  4187. Topical application of a novel Ceramide derivative, K6PC-9, inhibits dust mite extract-induced atopic dermatitis-like skin lesions in NC/Nga mice
  4188. Ceramide induces myogenic differentiation and apoptosis in Drosophila Schneider cells
  4189. Nitric oxide-enhanced caspase-3 and acidic sphingomyelinase interaction: a novel mechanism by which airway epithelial cells escape Ceramide-induced apoptosis
  4190. Dietary effect of silk protein on Ceramide synthesis and the expression of Ceramide metabolic enzymes in the epidermis of NC/Nga mice
  4191. Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 Ceramide
  4192. Natural products supporting the extracellular matrix: rice Ceramide and other plant extracts for skin health
  4193. Synthesis of threitol Ceramide and [14C] threitol Ceramide, non-glycosidic analogues of the potent CD1d antigen α-galactosyl Ceramide
  4194. Labeling the Golgi apparatus with BODIPY-FL-Ceramide (C5-DMB-Ceramide) for imaging
  4195. Ceramide kinase promotes Ca2+ signaling near IgG-opsonized targets and enhances phagolysosomal fusion in COS-1 cellss⃞
  4196. Confirmation of the Anomeric Structure of Galacturonic Acid in the Galacturonosyl‐Ceramide of Sphingomonas yanoikuyae
  4197. Programmed cell death in the lithium pilocarpine model: evidence for NMDA receptor and Ceramide-mediated mechanisms
  4198. Phosphatidylinositol 3-kinase/AKT pathway regulates the endoplasmic reticulum to golgi traffic of Ceramide in glioma cells: a link between lipid signaling …
  4199. Physicochemical analysis of phosphatidylcholine-Ceramide system in bilayer lipid membranes
  4200. Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of Ceramide
  4201. Syriacin, a novel unusual sulfated Ceramide glycoside from the freshwater sponge Ephydatia syriaca (Porifera, Demospongiae, Spongillidae)
  4202. C6‐Ceramide inhibited Na+ currents by intracellular Ca2+ release in rat myoblasts
  4203. Ceramide induces early and late apoptosis in human papilloma virus+ cervical cancer cells by inhibiting reactive oxygen species decay, diminishing the intracellular …
  4204. Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl Ceramide levels
  4205. C6-Ceramide-coated catheters promote re-endothelialization of stretch-injured arteries
  4206. Inhibition of skin inflammation and atopic dermatitis by topical application of a novel Ceramide derivative, K112PC-5, in mice
  4207. Involvement of lysophosphatidic acid, sphingosine 1-phosphate and Ceramide 1-phosphate in the metabolization of phosphatidic acid by lipid phosphate …
  4208. Influence of Ceramide 2 on in vitro skin permeation and retention of 5-ALA and its ester derivatives, for Photodynamic Therapy
  4209. Ceramide induces release of mitochondrial proapoptotic proteins in caspase-dependent and-independent manner in HT-29 cells
  4210. Self-recognition of N-linked glycans with multivalent GlcNAc, determined as Ceramide mimetic conjugate
  4211. UDP-GlcNAc2-epimerase regulates cell surface sialylation and Ceramide-induced cell death in human malignant lymphoma
  4212. Long-chain Ceramide Produced in Response to N-Hexanoylsphingosine does not Induce Apoptosis in CHP-100 Cells
  4213. Peptidoglycan induces cyclooxygenase-2 expression in macrophages by activating the neutral sphingomyelinase-Ceramide pathway
  4214. Effect of Ceramide on the contractility of pregnant rat uterus
  4215. N-oleoyl-D-erythro-sphingosine-based analysis of Ceramide by high performance liquid chromatography and its application to determination in diverse biological …
  4216. Safety studies of pseudo-Ceramide SLE66: Acute and short-term toxicity
  4217. Induction of promotive rather than suppressive immune responses from a novel NKT cell repertoire Vα19 NKT cell with α-mannosyl Ceramide analogues consisting of …
  4218. Phospholipase C-catalyzed sphingomyelin hydrolysis in a membrane reactor for Ceramide production
  4219. Computational modeling of a metabolic pathway in Ceramide de novo synthesis
  4220. Stress-induced Ceramide-activated protein phosphatase can compensate for loss of amphiphysin-like activity in Saccharomyces cerevisiae and functions to …
  4221. StARD13(Dlc-2) RhoGap Mediates Ceramide Activation of Phosphatidylglycerolphosphate Synthase and Drug Response in Chinese Hamster Ovary Cells
  4222. Ganglioside GM3 Derivatives with Truncated Ceramide Moiety: Facial Synthesis and Inhibitory Activity against KB Cell Growth
  4223. Thrombospondin-1 C-terminal-derived peptide protects thyroid cells from Ceramide-induced apoptosis through the adenylyl cyclase pathway
  4224. Fumonisin inhibition of Ceramide synthase: A possible risk factor for human neural tube defects
  4225. PLC‐dependent intracellular Ca2+ release was associated with C6‐Ceramide‐induced inhibition of Na+ current in rat granule cells
  4226. N-tosyl-l-phenylalanyl-chloromethyl ketone reduces Ceramide during hypoxic–ischemic brain injury in newborn rat
  4227. Chemoenzymatic synthesis of GM 3 and GM 2 gangliosides containing a truncated Ceramide functionalized for glycoconjugate synthesis and solid phase applications
  4228. Interleukin-4 depresses levels of transcripts for acid-sphingomyelinase and glucocerebrosidase and the amount of Ceramide in acetone-wounded epidermis, as …
  4229. Ceramide activates JNK to inhibit a cAMP-gated K+ conductance and Cl–secretion in intestinal epithelia
  4230. Kinetic study of sphingomyelin hydrolysis for Ceramide production
  4231. The Effect of Ginkgo biloba Extract (EGb 761) Pretreatment on Intestinal Epithelial Apoptosis Induced by Intestinal Ischemia/Reperfusion in Rats: Role of Ceramide
  4232. Ceramide response post-photodamage is absent after treatment with HA14-1
  4233. Apoptosis of human colon carcinoma HT-29 cells induced by Ceramide
  4234. A Straightforward Protocol for the Solution‐Phase Parallel Synthesis of Ceramide Analogues
  4235. … ‐crystallin and αB‐crystallin, newly identified interaction proteins of protease‐activated receptor‐2, rescue astrocytes from C2‐Ceramide‐and staurosporine‐induced …
  4236. The Ceramide contents of Saccharomyces cerevisiae in batch culture
  4237. The binding of HIV-1 gp41 membrane proximal domain to its mucosal receptor, galactosyl Ceramide, is structure-dependent
  4238. Changes in Ceramide in Stratum Corneum and Anti-inflamatory Effects of Sopungdojeok-tang on Atopic Dermatitis.
  4239. siRNA-mediated depletion of endogenous protein phosphatase 2Acα markedly attenuates Ceramide-activated protein phosphatase activity in insulin-secreting INS …
  4240. … -induced tumor necrosis factor-α and nitric oxide production by Clostridium perfringens α-toxin and its relation to α-toxin-induced intracellular Ceramide generation
  4241. Ceramide-1-phosphate, a new bioactive sphingolipid in regulating cell signaling
  4242. Oxysterol-binding protein and VAMP-associated protein are required for sterol-dependent activation of the Ceramide transport protein
  4243. The synthetic Ceramide analog L-PDMP partially protects striatal dopamine levels but does not promote dopamine neuron survival in murine models of parkinsonism
  4244. An efficient, one-pot synthesis of various Ceramide 1-phosphates from sphingosine 1-phosphate
  4245. Activation of telomerase and cyclooxygenase‐2 in PDGF and FGF inhibition of C2‐Ceramide‐induced apoptosis
  4246. Synthetic triterpenoids have cytotoxicity in pediatric acute lymphoblastic leukemia cell lines but cytotoxicity is independent of induced Ceramide increase in MOLT-4 …
  4247. Ethanolaminephosphate side chain added to GPI anchor by Mcd4p is required for Ceramide remodeling and forward transport of GPI proteins from ER to Golgi
  4248. Relaxation effect of synthetic Ceramide analogues in cat esophageal smooth muscle cells
  4249. Dietary sphingolipids suppress a subset of preneoplastic rat liver lesions exhibiting high PTEN, low phospho-Akt and high levels of Ceramide species
  4250. Effect of Ceramide on apoptosis of human colon cancer HT-29 cells
  4251. Influence of the Ceramide (III) and cholesterol on the structure of a non-hydrous phospholipid-based lamellar liquid crystal: Structural and thermal transition behaviors
  4252. The regulation of Ceramide content and insulin resistance in skeletal muscle
  4253. Ceramide Modulation of Antigen‐ Triggered Ca2+ Signals and Cell Fate: Diversity in the Responses of Various Immunocytes
  4254. Ceramide formation on the γ-irradiation of galactocerebroside as a constituent of micelles
  4255. … of colonocyte differentiation in CaCo-2 cells by sodium butyrate causes an increase in glucosylCeramide synthesis in order to avoid apoptosis based on Ceramide
  4256. Ceramide 1-Phosphate
  4257. … in cadmium-induced apoptosis: a novel role for Ceramides as activators of calpains. Focus on “Cadmium-induced Ceramide formation triggers calpain …
  4258. STUDIES ON THE ROLE OF ACID SPHINGOMYELINASE AND Ceramide IN THE REGULATION OF TACE ACTIVITY AND TNFα SECRETION BY MACROPHAGES
  4259. … -2 but not clusterin/apolipoprotein J protected human diploid fibroblasts and immortalized keratinocytes from Ceramide-induced apoptosis: Role of p53 in the Ceramide …
  4260. Inhibition of Ceramide de novo biosynthesis in an animal model of retinitis pigmentosa: I. Morphological and biochemical effects
  4261. Safety studies of pseudo-Ceramide SLE66. Part 3: Effects on embryo/fetal development in rats
  4262. 15 Bioactive Sphingolipids: An Overview on Ceramide, Ceramide 1-Phosphate DihydroCeramide, Sphingosine, Sphingosine 1-Phosphate
  4263. Ceramide inhibits CCN2 expression in fibroblasts
Related Posts

STAT3

Gsk3 (Inhibitor | Inhibitors)

Lowering Cholesterol Thru Fasting, Diet & Medicinal Plants

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping